drug_normalized,diseaseId,diseaseName,mechanism_score,safety_penalty,trial_penalty,risk_multiplier,phenotype_boost,phenotype_multiplier,final_score,n_trials,trial_statuses,trial_source,example_condition,example_whyStopped,is_known_indication,original_indications,signature_genes,n_signature_targets,ci_lower,ci_upper,ci_width,confidence_tier,n_evidence_paths
alirocumab,EFO_0004911,familial hypercholesterolemia,2.77804792833365,0.6997,0.0,0.8107,0.2303,1.2303,2.7706,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.678536,0.726464,0.047928,HIGH,4
alirocumab,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.6342867486984978,0.6997,0.0,0.8107,0.1946,1.1946,2.5511,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.649624,0.676466,0.026842,HIGH,4
alirocumab,EFO_0001645,coronary artery disease,2.44613693759838,0.6997,0.0,0.8107,0.2303,1.2303,2.4396,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.590022,0.63074,0.040718,HIGH,4
alirocumab,HP_0003124,Hypercholesterolemia,2.5837086872155477,0.6997,0.0,0.8107,0.0,1.0,2.0945,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.637152,0.663478,0.026326,HIGH,4
alirocumab,EFO_0000319,cardiovascular disease,2.415491241289434,0.6997,0.0,0.8107,0.0,1.0,1.9581,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.58263,0.622838,0.040207,HIGH,4
alirocumab,EFO_0000589,metabolic disease,2.3055488757387117,0.6997,0.0,0.8107,0.0,1.0,1.869,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.568557,0.592049,0.023492,HIGH,4
alirocumab,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.6997,0.0,0.8107,0.0,1.0,1.7973,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.554263,0.554263,0.0,HIGH,4
alirocumab,EFO_0000612,myocardial infarction,2.1587039312067464,0.6997,0.0,0.8107,0.0,1.0,1.75,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.520261,0.559091,0.03883,HIGH,4
alirocumab,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.6997,0.0,0.8107,0.2079,1.2079,1.7466,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.445905,0.445905,0.0,HIGH,4
alirocumab,MONDO_0018328,homozygous familial hypercholesterolemia,2.148464723176249,0.6997,0.0,0.8107,0.0,1.0,1.7417,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.524761,0.561827,0.037066,HIGH,4
alirocumab,MONDO_0021187,hyperlipidemia,2.1040568357817544,0.6997,0.0,0.8107,0.0,1.0,1.7057,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.526014,0.526014,0.0,HIGH,4
alirocumab,EFO_0003914,atherosclerosis,2.0172272109385148,0.6997,0.0,0.8107,0.0,1.0,1.6353,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.492706,0.527508,0.034802,HIGH,4
alirocumab,EFO_0000195,metabolic syndrome,1.5989738546727714,0.6997,0.0,0.8107,0.2398,1.2398,1.607,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.389027,0.41046,0.021432,HIGH,4
alirocumab,EFO_1001375,Myocardial Ischemia,1.8354966537754889,0.6997,0.0,0.8107,0.0,1.0,1.488,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.442366,0.475382,0.033016,HIGH,4
alirocumab,MONDO_0009387,familial lipoprotein lipase deficiency,1.4386859310417202,0.6997,0.0,0.8107,0.2398,1.2398,1.4459,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.351398,0.376219,0.024821,HIGH,4
alirocumab,EFO_0003777,heart disease,1.773792300626292,0.6997,0.0,0.8107,0.0,1.0,1.4379,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.410746,0.491881,0.081136,HIGH,4
alirocumab,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.6997,0.0,0.8107,0.0,1.0,1.4295,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.440834,0.440834,0.0,HIGH,4
alirocumab,EFO_0003913,angina pectoris,1.733713012728092,0.6997,0.0,0.8107,0.0,1.0,1.4054,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.421809,0.445047,0.023238,HIGH,4
alirocumab,EFO_0000712,stroke,1.5163324930556523,0.6997,0.0,0.8107,0.1386,1.1386,1.3996,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.300694,0.523436,0.222742,MEDIUM,4
alirocumab,HP_0003077,Hyperlipidemia,1.7264272674266656,0.6997,0.0,0.8107,0.0,1.0,1.3995,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.425743,0.443334,0.017591,HIGH,4
alirocumab,MONDO_0001336,familial hyperlipidemia,1.7148713527001924,0.6997,0.0,0.8107,0.0,1.0,1.3902,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.428718,0.428718,0.0,HIGH,4
alirocumab,EFO_0000400,diabetes mellitus,1.4041737247377832,0.6997,0.0,0.8107,0.2197,1.2197,1.3884,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.341633,0.360454,0.018821,HIGH,4
alirocumab,MONDO_0013144,hereditary antithrombin deficiency,1.390206303767071,0.6997,0.0,0.8107,0.2303,1.2303,1.3865,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.676469,0.713737,0.037268,HIGH,2
alirocumab,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.6997,0.0,0.8107,0.0,1.0,1.2525,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.386247,0.386247,0.0,HIGH,4
alirocumab,HP_0003146,Hypocholesterolemia,1.519787603332834,0.6997,0.0,0.8107,0.0,1.0,1.232,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.379947,0.379947,0.0,HIGH,4
alirocumab,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.6997,0.0,0.8107,0.0,1.0,1.1929,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,True,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.367893,0.367893,0.0,HIGH,4
alirocumab,EFO_0000275,atrial fibrillation,1.1767919069442716,0.6997,0.0,0.8107,0.2398,1.2398,1.1827,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.072621,0.515775,0.443154,LOW,4
alirocumab,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.6997,0.0,0.8107,0.0,1.0,1.1583,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.357214,0.357214,0.0,HIGH,4
alirocumab,HP_0004936,Venous thrombosis,1.1306796423669063,0.6997,0.0,0.8107,0.2398,1.2398,1.1364,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.550185,0.580495,0.030311,HIGH,2
alirocumab,Orphanet_79211,Combined hyperlipidemia,1.1062756269960068,0.6997,0.0,0.8107,0.2303,1.2303,1.1033,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.270207,0.289293,0.019086,HIGH,4
alirocumab,EFO_0005672,acute coronary syndrome,1.3444152821346198,0.6997,0.0,0.8107,0.0,1.0,1.0899,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.280993,0.421709,0.140716,MEDIUM,4
alirocumab,HP_0001976,Reduced antithrombin III activity,1.2937212142508865,0.6997,0.0,0.8107,0.0,1.0,1.0488,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.62952,0.664201,0.034681,HIGH,2
alirocumab,EFO_1000985,intermediate coronary syndrome,1.2710260283837655,0.6997,0.0,0.8107,0.0,1.0,1.0304,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.279558,0.359048,0.07949,HIGH,4
alirocumab,EFO_0004286,venous thromboembolism,1.2626208859932304,0.6997,0.0,0.8107,0.0,1.0,1.0236,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.046997,0.584314,0.537317,LOW,4
alirocumab,EFO_0008583,acute myocardial infarction,1.1953208910287108,0.6997,0.0,0.8107,0.0,1.0,0.969,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.288221,0.308302,0.020082,HIGH,4
alirocumab,EFO_0003144,heart failure,1.1943910450436237,0.6997,0.0,0.8107,0.0,1.0,0.9682,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.298598,0.298598,0.0,HIGH,4
alirocumab,HP_0011428,Short fetal femur length,1.187066470233723,0.6997,0.0,0.8107,0.0,1.0,0.9623,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.296767,0.296767,0.0,HIGH,4
alirocumab,EFO_0004264,vascular disease,1.1630272440108385,0.6997,0.0,0.8107,0.0,1.0,0.9428,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.290757,0.290757,0.0,HIGH,4
alirocumab,EFO_0004329,alcohol drinking,1.153512135309475,0.6997,0.0,0.8107,0.0,1.0,0.9351,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.280647,0.296109,0.015461,HIGH,4
alirocumab,MONDO_0100096,COVID-19,1.1404696119601427,0.6997,0.0,0.8107,0.0,1.0,0.9245,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.231762,0.338472,0.10671,MEDIUM,4
alirocumab,EFO_0003776,coronary artery bypass,1.1279602973638454,0.6997,0.0,0.8107,0.0,1.0,0.9144,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.28199,0.28199,0.0,HIGH,4
alirocumab,EFO_0003940,physical activity,1.1225894210654916,0.6997,0.0,0.8107,0.0,1.0,0.91,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.280647,0.280647,0.0,HIGH,4
alirocumab,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.6997,0.0,0.8107,0.0,1.0,0.91,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.280647,0.280647,0.0,HIGH,4
alirocumab,EFO_0003907,deep vein thrombosis,1.0937238054191556,0.6997,0.0,0.8107,0.0,1.0,0.8866,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.522221,0.571503,0.049281,HIGH,2
alirocumab,EFO_0003086,kidney disease,1.0396200487798937,0.6997,0.0,0.8107,0.0,1.0,0.8428,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.25303,0.263343,0.010313,HIGH,4
alirocumab,EFO_0003827,pulmonary embolism,1.0315689372997063,0.6997,0.0,0.8107,0.0,1.0,0.8362,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.480032,0.551537,0.071504,HIGH,2
alirocumab,EFO_0003884,chronic kidney disease,1.018479956512245,0.6997,0.0,0.8107,0.0,1.0,0.8256,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.214524,0.294716,0.080193,HIGH,4
alirocumab,HP_0001907,Thromboembolism,0.9830566798637128,0.6997,0.0,0.8107,0.0,1.0,0.7969,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.436461,0.546596,0.110135,MEDIUM,2
alirocumab,HP_0003040,Arthropathy,0.9594178191147148,0.6997,0.0,0.8107,0.0,1.0,0.7778,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.239854,0.239854,0.0,HIGH,4
alirocumab,EFO_0009578,placental retention,0.9588206730453008,0.6997,0.0,0.8107,0.0,1.0,0.7773,1,TERMINATED,STOPPED,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Funding withdrawn,False,Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Dyslipidemias,,,0.239705,0.239705,0.0,HIGH,4
angiotensin 1-7,MONDO_0013361,congenital prothrombin deficiency,1.299935146535446,0.0,0.0,1.0,0.2398,1.2398,1.6116,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.299935146535446,1.299935146535446,0.0,HIGH,1
angiotensin 1-7,Orphanet_325,Congenital factor II deficiency,1.266476485157081,0.0,0.0,1.0,0.2398,1.2398,1.5702,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.26647648515708,1.26647648515708,0.0,HIGH,1
angiotensin 1-7,EFO_0000537,hypertension,1.2855208629188144,0.0,0.0,1.0,0.1609,1.1609,1.4924,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,True,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.285520862918814,1.285520862918814,0.0,HIGH,1
angiotensin 1-7,MONDO_0009970,renal tubular dysgenesis of genetic origin,1.1507575486671622,0.0,0.0,1.0,0.2398,1.2398,1.4267,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.150757548667162,1.150757548667162,0.0,HIGH,1
angiotensin 1-7,MONDO_0008559,thrombophilia due to thrombin defect,1.1798238408285806,0.0,0.0,1.0,0.2079,1.2079,1.4252,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.17982384082858,1.17982384082858,0.0,HIGH,1
angiotensin 1-7,EFO_0000712,stroke,1.1953664077789092,0.0,0.0,1.0,0.1386,1.1386,1.3611,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.195366407778909,1.195366407778909,0.0,HIGH,1
angiotensin 1-7,EFO_0000400,diabetes mellitus,1.001683618212415,0.0,0.0,1.0,0.2197,1.2197,1.2218,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.001683618212415,1.001683618212415,0.0,HIGH,1
angiotensin 1-7,HP_0004936,Venous thrombosis,0.9854512486294406,0.0,0.0,1.0,0.2398,1.2398,1.2218,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9854512486294401,0.9854512486294401,0.0,HIGH,1
angiotensin 1-7,HP_0001873,Thrombocytopenia,1.000069803316702,0.0,0.0,1.0,0.2079,1.2079,1.208,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.000069803316702,1.000069803316702,0.0,HIGH,1
angiotensin 1-7,EFO_0000275,atrial fibrillation,0.9741978592537636,0.0,0.0,1.0,0.2398,1.2398,1.2078,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9741978592537631,0.9741978592537631,0.0,HIGH,1
angiotensin 1-7,MONDO_0017609,renal tubular dysgenesis,1.2017511378334431,0.0,0.0,1.0,0.0,1.0,1.2018,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.2017511378334431,1.2017511378334431,0.0,HIGH,1
angiotensin 1-7,MONDO_0007781,"essential hypertension, genetic",1.0249852458218305,0.0,0.0,1.0,0.1609,1.1609,1.19,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.02498524582183,1.02498524582183,0.0,HIGH,1
angiotensin 1-7,HP_0002014,Diarrhea,0.957762425825498,0.0,0.0,1.0,0.2398,1.2398,1.1874,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9577624258254971,0.9577624258254971,0.0,HIGH,1
angiotensin 1-7,EFO_0010702,opioid use disorder,1.1564263384674014,0.0,0.0,1.0,0.0,1.0,1.1564,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.156426338467401,1.156426338467401,0.0,HIGH,1
angiotensin 1-7,HP_0012531,Pain,1.1530053375354918,0.0,0.0,1.0,0.0,1.0,1.153,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.153005337535491,1.153005337535491,0.0,HIGH,1
angiotensin 1-7,EFO_0004286,venous thromboembolism,1.1370551086128282,0.0,0.0,1.0,0.0,1.0,1.1371,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.137055108612828,1.137055108612828,0.0,HIGH,1
angiotensin 1-7,MONDO_0005148,type 2 diabetes mellitus,0.9630843511372632,0.0,0.0,1.0,0.1792,1.1792,1.1356,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9630843511372631,0.9630843511372631,0.0,HIGH,1
angiotensin 1-7,MONDO_0004992,cancer,1.1049876390198252,0.0,0.0,1.0,0.0,1.0,1.105,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,True,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.104987639019825,1.104987639019825,0.0,HIGH,1
angiotensin 1-7,EFO_0005611,opioid dependence,1.094739056230181,0.0,0.0,1.0,0.0,1.0,1.0947,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.094739056230181,1.094739056230181,0.0,HIGH,1
angiotensin 1-7,EFO_1000954,habitual abortion,0.9272972624881122,0.0,0.0,1.0,0.1792,1.1792,1.0934,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9272972624881121,0.9272972624881121,0.0,HIGH,1
angiotensin 1-7,MONDO_0007079,alcohol dependence,0.977364438339319,0.0,0.0,1.0,0.1099,1.1099,1.0847,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9773644383393191,0.9773644383393191,0.0,HIGH,1
angiotensin 1-7,EFO_0003907,deep vein thrombosis,1.0833229679674583,0.0,0.0,1.0,0.0,1.0,1.0833,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.083322967967458,1.083322967967458,0.0,HIGH,1
angiotensin 1-7,HP_0002140,Ischemic stroke,1.075660534481664,0.0,0.0,1.0,0.0,1.0,1.0757,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,True,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.075660534481664,1.075660534481664,0.0,HIGH,1
angiotensin 1-7,EFO_0000612,myocardial infarction,1.0666726430429052,0.0,0.0,1.0,0.0,1.0,1.0667,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.066672643042905,1.066672643042905,0.0,HIGH,1
angiotensin 1-7,EFO_0004194,IGA glomerulonephritis,0.8569205827605783,0.0,0.0,1.0,0.2398,1.2398,1.0624,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.856920582760578,0.856920582760578,0.0,HIGH,1
angiotensin 1-7,MONDO_0024307,prothrombin deficiency,1.049402556648148,0.0,0.0,1.0,0.0,1.0,1.0494,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.049402556648148,1.049402556648148,0.0,HIGH,1
angiotensin 1-7,EFO_0003827,pulmonary embolism,1.0454759191694794,0.0,0.0,1.0,0.0,1.0,1.0455,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.045475919169479,1.045475919169479,0.0,HIGH,1
angiotensin 1-7,EFO_0003777,heart disease,1.0378530990669903,0.0,0.0,1.0,0.0,1.0,1.0379,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.03785309906699,1.03785309906699,0.0,HIGH,1
angiotensin 1-7,HP_0001907,Thromboembolism,1.0361105866943223,0.0,0.0,1.0,0.0,1.0,1.0361,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.036110586694322,1.036110586694322,0.0,HIGH,1
angiotensin 1-7,EFO_0003086,kidney disease,1.033572998362213,0.0,0.0,1.0,0.0,1.0,1.0336,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.033572998362213,1.033572998362213,0.0,HIGH,1
angiotensin 1-7,EFO_0003144,heart failure,1.0301239404233142,0.0,0.0,1.0,0.0,1.0,1.0301,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,True,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.030123940423314,1.030123940423314,0.0,HIGH,1
angiotensin 1-7,MONDO_0001134,essential hypertension,1.0165304035440093,0.0,0.0,1.0,0.0,1.0,1.0165,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,1.016530403544009,1.016530403544009,0.0,HIGH,1
angiotensin 1-7,EFO_0003884,chronic kidney disease,0.9968240082473134,0.0,0.0,1.0,0.0,1.0,0.9968,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9968240082473131,0.9968240082473131,0.0,HIGH,1
angiotensin 1-7,EFO_0000319,cardiovascular disease,0.9951582251789096,0.0,0.0,1.0,0.0,1.0,0.9952,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9951582251789091,0.9951582251789091,0.0,HIGH,1
angiotensin 1-7,EFO_0003890,drug dependence,0.9730996295634804,0.0,0.0,1.0,0.0,1.0,0.9731,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9730996295634801,0.9730996295634801,0.0,HIGH,1
angiotensin 1-7,HP_0012532,Chronic pain,0.9670198403404134,0.0,0.0,1.0,0.0,1.0,0.967,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9670198403404131,0.9670198403404131,0.0,HIGH,1
angiotensin 1-7,MONDO_0005277,migraine disorder,0.7996432665073555,0.0,0.0,1.0,0.2079,1.2079,0.9659,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.7996432665073551,0.7996432665073551,0.0,HIGH,1
angiotensin 1-7,HP_0002019,Constipation,0.9577162630870492,0.0,0.0,1.0,0.0,1.0,0.9577,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.957716263087049,0.957716263087049,0.0,HIGH,1
angiotensin 1-7,EFO_0005762,neuropathic pain,0.9558657413264998,0.0,0.0,1.0,0.0,1.0,0.9559,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.955865741326499,0.955865741326499,0.0,HIGH,1
angiotensin 1-7,EFO_0000373,congestive heart failure,0.952628643950579,0.0,0.0,1.0,0.0,1.0,0.9526,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9526286439505791,0.9526286439505791,0.0,HIGH,1
angiotensin 1-7,EFO_0000401,diabetic nephropathy,0.9401290468381912,0.0,0.0,1.0,0.0,1.0,0.9401,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.9401290468381911,0.9401290468381911,0.0,HIGH,1
angiotensin 1-7,MONDO_0000831,thrombotic disease,0.8995889438894917,0.0,0.0,1.0,0.0,1.0,0.8996,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.8995889438894911,0.8995889438894911,0.0,HIGH,1
angiotensin 1-7,HP_0004419,Recurrent thrombophlebitis,0.8990833904171056,0.0,0.0,1.0,0.0,1.0,0.8991,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.899083390417105,0.899083390417105,0.0,HIGH,1
angiotensin 1-7,EFO_0005672,acute coronary syndrome,0.8989041006135591,0.0,0.0,1.0,0.0,1.0,0.8989,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.8989041006135591,0.8989041006135591,0.0,HIGH,1
angiotensin 1-7,HP_0000093,Proteinuria,0.8933641730110159,0.0,0.0,1.0,0.0,1.0,0.8934,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.8933641730110151,0.8933641730110151,0.0,HIGH,1
angiotensin 1-7,EFO_0000555,irritable bowel syndrome,0.8854999633290198,0.0,0.0,1.0,0.0,1.0,0.8855,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.885499963329019,0.885499963329019,0.0,HIGH,1
angiotensin 1-7,EFO_0022041,response to tramadol,0.8702858609788808,0.0,0.0,1.0,0.0,1.0,0.8703,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.87028586097888,0.87028586097888,0.0,HIGH,1
angiotensin 1-7,MONDO_0005178,osteoarthritis,0.697829315820307,0.0,0.0,1.0,0.2303,1.2303,0.8585,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.697829315820307,0.697829315820307,0.0,HIGH,1
angiotensin 1-7,MONDO_0005090,schizophrenia,0.6910982345036026,0.0,0.0,1.0,0.2398,1.2398,0.8568,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.6910982345036021,0.6910982345036021,0.0,HIGH,1
angiotensin 1-7,EFO_1001395,Phlebitis,0.8466596340577744,0.0,0.0,1.0,0.0,1.0,0.8467,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Study funding ended prior to completion.,False,Aging; Brain Injuries; COVID-19; HIV Infections; Heart Failure,,,0.8466596340577741,0.8466596340577741,0.0,HIGH,1
aspirin,EFO_0000729,ulcerative colitis,6.057149256790778,1.0,0.0,0.7408,0.2398,1.2398,5.5632,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.66332,0.687562,0.024242,HIGH,9
aspirin,MONDO_0005178,osteoarthritis,5.985396936184747,1.0,0.0,0.7408,0.2303,1.2303,5.4551,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.657531,0.676756,0.019224,HIGH,9
aspirin,EFO_0000685,rheumatoid arthritis,5.892222396044779,1.0,0.0,0.7408,0.2398,1.2398,5.4118,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.647296,0.666221,0.018925,HIGH,9
aspirin,EFO_0001645,coronary artery disease,5.934693858188188,1.0,0.0,0.7408,0.2303,1.2303,5.4089,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.651961,0.671023,0.019061,HIGH,9
aspirin,MONDO_0005277,migraine disorder,6.04297923431694,1.0,0.0,0.7408,0.2079,1.2079,5.4077,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.66869,0.676947,0.008258,HIGH,9
aspirin,MONDO_0005129,cataract,5.686503462651316,1.0,0.0,0.7408,0.2398,1.2398,5.2228,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.631834,0.631834,0.0,HIGH,9
aspirin,HP_0002014,Diarrhea,5.336315049643433,1.0,0.0,0.7408,0.2398,1.2398,4.9012,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.58439,0.609991,0.025601,HIGH,9
aspirin,EFO_0000712,stroke,5.771945081038044,1.0,0.0,0.7408,0.1386,1.1386,4.8687,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.638698,0.646585,0.007887,HIGH,9
aspirin,EFO_0004274,gout,6.0186451964646155,1.0,0.0,0.7408,0.0,1.0,4.4587,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.663278,0.676929,0.013651,HIGH,9
aspirin,HP_0012531,Pain,5.939285859486934,1.0,0.0,0.7408,0.0,1.0,4.3999,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.645121,0.686864,0.041743,HIGH,9
aspirin,EFO_0004253,nephrolithiasis,4.9599613171140895,1.0,0.0,0.7408,0.1946,1.1946,4.3894,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.548848,0.555625,0.006778,HIGH,9
aspirin,HP_0002315,Headache,5.861649832735435,1.0,0.0,0.7408,0.0,1.0,4.3424,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.651294,0.651294,0.0,HIGH,9
aspirin,HP_0001945,Fever,5.850945009524446,1.0,0.0,0.7408,0.0,1.0,4.3345,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.644797,0.658068,0.013271,HIGH,9
aspirin,EFO_0002609,juvenile idiopathic arthritis,5.843632694095558,1.0,0.0,0.7408,0.0,1.0,4.3291,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.643991,0.657245,0.013254,HIGH,9
aspirin,HP_0100607,Dysmenorrhea,5.827912061520153,1.0,0.0,0.7408,0.0,1.0,4.3174,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.647546,0.647546,0.0,HIGH,9
aspirin,EFO_0003898,ankylosing spondylitis,5.810859933131266,1.0,0.0,0.7408,0.0,1.0,4.3048,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.645651,0.645651,0.0,HIGH,9
aspirin,HP_0001643,Patent ductus arteriosus,5.781133788032948,1.0,0.0,0.7408,0.0,1.0,4.2828,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.639715,0.647615,0.0079,HIGH,9
aspirin,MONDO_0002258,pharyngitis,5.7745018750198875,1.0,0.0,0.7408,0.0,1.0,4.2779,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.641611,0.641611,0.0,HIGH,9
aspirin,EFO_0007214,common cold,5.761587409964068,1.0,0.0,0.7408,0.0,1.0,4.2683,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.640176,0.640176,0.0,HIGH,9
aspirin,EFO_0005755,rheumatic disease,5.748578646692054,1.0,0.0,0.7408,0.0,1.0,4.2587,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.638731,0.638731,0.0,HIGH,9
aspirin,EFO_0010072,toothache,5.746916587575841,1.0,0.0,0.7408,0.0,1.0,4.2574,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.635929,0.643782,0.007853,HIGH,9
aspirin,HP_0003418,Back pain,5.736558999935033,1.0,0.0,0.7408,0.0,1.0,4.2497,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.634782,0.642621,0.007839,HIGH,9
aspirin,EFO_0005856,arthritis,5.668014019087259,1.0,0.0,0.7408,0.0,1.0,4.199,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.629779,0.629779,0.0,HIGH,9
aspirin,EFO_0000612,myocardial infarction,5.63498309978976,1.0,0.0,0.7408,0.0,1.0,4.1745,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.620997,0.633778,0.012781,HIGH,9
aspirin,HP_0003326,Myalgia,5.620954770693112,1.0,0.0,0.7408,0.0,1.0,4.1641,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.624551,0.624551,0.0,HIGH,9
aspirin,MONDO_0003937,spondylitis,5.603066046582771,1.0,0.0,0.7408,0.0,1.0,4.1509,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.622563,0.622563,0.0,HIGH,9
aspirin,HP_0002829,Arthralgia,5.602050169723993,1.0,0.0,0.7408,0.0,1.0,4.1501,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.62245,0.62245,0.0,HIGH,9
aspirin,EFO_0009846,muscle cramp,5.599539459049,1.0,0.0,0.7408,0.0,1.0,4.1482,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.622171,0.622171,0.0,HIGH,9
aspirin,EFO_0007328,influenza,5.555764290139795,1.0,0.0,0.7408,0.0,1.0,4.1158,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.610334,0.628178,0.017844,HIGH,9
aspirin,EFO_0009582,sprain,5.5237750575367635,1.0,0.0,0.7408,0.0,1.0,4.0921,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.613753,0.613753,0.0,HIGH,9
aspirin,EFO_0002496,actinic keratosis,5.513092179827513,1.0,0.0,0.7408,0.0,1.0,4.0842,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.612566,0.612566,0.0,HIGH,9
aspirin,EFO_0004142,colorectal neoplasm,4.563587906174372,1.0,0.0,0.7408,0.2079,1.2079,4.0838,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.507065,0.507065,0.0,HIGH,9
aspirin,EFO_0005752,eye inflammation,5.386587567932229,1.0,0.0,0.7408,0.0,1.0,3.9905,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.59851,0.59851,0.0,HIGH,9
aspirin,EFO_0000319,cardiovascular disease,5.342517003585305,1.0,0.0,0.7408,0.0,1.0,3.9578,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.586907,0.604067,0.017159,HIGH,9
aspirin,HP_0002018,Nausea,5.331750711664693,1.0,0.0,0.7408,0.0,1.0,3.9499,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.589988,0.597274,0.007286,HIGH,9
aspirin,MONDO_0002471,bursitis,5.322187361455284,1.0,0.0,0.7408,0.0,1.0,3.9428,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.591354,0.591354,0.0,HIGH,9
aspirin,EFO_0009454,gastric ulcer,5.260753351130155,1.0,0.0,0.7408,0.0,1.0,3.8973,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.584528,0.584528,0.0,HIGH,9
aspirin,HP_0200026,Ocular pain,5.259513463558505,1.0,0.0,0.7408,0.0,1.0,3.8963,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.58439,0.58439,0.0,HIGH,9
aspirin,Orphanet_733,Familial adenomatous polyposis,5.162614173592483,1.0,0.0,0.7408,0.0,1.0,3.8246,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.573624,0.573624,0.0,HIGH,9
aspirin,MONDO_0004857,tendinitis,5.153755182342614,1.0,0.0,0.7408,0.0,1.0,3.818,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.572639,0.572639,0.0,HIGH,9
aspirin,EFO_0005628,proctitis,5.146125837486617,1.0,0.0,0.7408,0.0,1.0,3.8123,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.571792,0.571792,0.0,HIGH,9
aspirin,MONDO_0005575,colorectal cancer,4.181318767578504,1.0,0.0,0.7408,0.2079,1.2079,3.7417,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.460797,0.470281,0.009484,HIGH,9
aspirin,MONDO_0000831,thrombotic disease,5.003788984034137,1.0,0.0,0.7408,0.0,1.0,3.7069,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.555977,0.555977,0.0,HIGH,9
aspirin,EFO_0000384,Crohn's disease,3.9418353156928503,1.0,0.0,0.7408,0.2398,1.2398,3.6204,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.431671,0.447447,0.015776,HIGH,9
aspirin,EFO_0000668,preeclampsia,3.9126503110758177,1.0,0.0,0.7408,0.2398,1.2398,3.5936,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.432957,0.438303,0.005347,HIGH,9
aspirin,MONDO_0004975,Alzheimer disease,3.9083532749744743,1.0,0.0,0.7408,0.2398,1.2398,3.5897,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.428005,0.443647,0.015642,HIGH,9
aspirin,HP_0004398,Peptic ulcer,4.8329224933071515,1.0,0.0,0.7408,0.0,1.0,3.5803,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.532607,0.543569,0.010962,HIGH,9
aspirin,EFO_0005757,vaginal inflammation,4.800077476520148,1.0,0.0,0.7408,0.0,1.0,3.556,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.533342,0.533342,0.0,HIGH,9
aspirin,EFO_0009364,non-allergic rhinitis,4.800077476520148,1.0,0.0,0.7408,0.0,1.0,3.556,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.533342,0.533342,0.0,HIGH,9
aspirin,EFO_0000275,atrial fibrillation,3.8150546696885166,1.0,0.0,0.7408,0.2398,1.2398,3.504,4,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.420434,0.429087,0.008653,HIGH,9
aspirin + ticagrelor,MONDO_0012354,platelet-type bleeding disorder 8,0.8597342147011692,0.0,0.0,1.0,0.2197,1.2197,1.0486,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.573156,0.573156,0.0,HIGH,3
aspirin + ticagrelor,Orphanet_36355,P2Y12 defect,0.8011717627408017,0.0,0.0,1.0,0.2197,1.2197,0.9772,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.534115,0.534115,0.0,HIGH,3
aspirin + ticagrelor,EFO_0001645,coronary artery disease,0.7535720243129644,0.0,0.0,1.0,0.2303,1.2303,0.9271,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.48709,0.532964,0.045874,HIGH,3
aspirin + ticagrelor,EFO_0000712,stroke,0.7080311832180894,0.0,0.0,1.0,0.1386,1.1386,0.8062,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.463509,0.489044,0.025536,HIGH,3
aspirin + ticagrelor,EFO_0000612,myocardial infarction,0.7573488325474169,0.0,0.0,1.0,0.0,1.0,0.7573,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.484781,0.545136,0.060355,HIGH,3
aspirin + ticagrelor,MONDO_0030030,Nizon-Isidor syndrome,0.5917340499221897,0.0,0.0,1.0,0.2398,1.2398,0.7336,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.394489,0.394489,0.0,HIGH,3
aspirin + ticagrelor,EFO_0005672,acute coronary syndrome,0.7298778073676812,0.0,0.0,1.0,0.0,1.0,0.7299,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.486585,0.486585,0.0,HIGH,3
aspirin + ticagrelor,EFO_0008583,acute myocardial infarction,0.7129891319882256,0.0,0.0,1.0,0.0,1.0,0.713,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.466755,0.492469,0.025714,HIGH,3
aspirin + ticagrelor,EFO_0004265,peripheral arterial disease,0.6715675489076496,0.0,0.0,1.0,0.0,1.0,0.6716,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.447712,0.447712,0.0,HIGH,3
aspirin + ticagrelor,HP_0004419,Recurrent thrombophlebitis,0.661032749724455,0.0,0.0,1.0,0.0,1.0,0.661,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.440688,0.440688,0.0,HIGH,3
aspirin + ticagrelor,MONDO_0005148,type 2 diabetes mellitus,0.5528758884416838,0.0,0.0,1.0,0.1792,1.1792,0.6519,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.353897,0.397957,0.04406,HIGH,3
aspirin + ticagrelor,MONDO_0000831,thrombotic disease,0.6475030229064457,0.0,0.0,1.0,0.0,1.0,0.6475,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.431669,0.431669,0.0,HIGH,3
aspirin + ticagrelor,EFO_0000275,atrial fibrillation,0.5061715429029404,0.0,0.0,1.0,0.2398,1.2398,0.6275,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.331363,0.349618,0.018255,HIGH,3
aspirin + ticagrelor,HP_0001249,Intellectual disability,0.5057754071366934,0.0,0.0,1.0,0.2398,1.2398,0.6271,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.331103,0.349344,0.018241,HIGH,3
aspirin + ticagrelor,HP_0001873,Thrombocytopenia,0.479744326032595,0.0,0.0,1.0,0.2079,1.2079,0.5795,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.31983,0.31983,0.0,HIGH,3
aspirin + ticagrelor,EFO_0000508,genetic disorder,0.5710102628984486,0.0,0.0,1.0,0.0,1.0,0.571,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.373809,0.394403,0.020594,HIGH,3
aspirin + ticagrelor,EFO_0000556,ischemia,0.5656557938536984,0.0,0.0,1.0,0.0,1.0,0.5657,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.377104,0.377104,0.0,HIGH,3
aspirin + ticagrelor,MONDO_0011382,sickle cell disease,0.4390487362809431,0.0,0.0,1.0,0.2398,1.2398,0.5443,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.281036,0.316025,0.034989,HIGH,3
aspirin + ticagrelor,EFO_0000266,aortic stenosis,0.4410417934086347,0.0,0.0,1.0,0.2303,1.2303,0.5426,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.294028,0.294028,0.0,HIGH,3
aspirin + ticagrelor,HP_0002140,Ischemic stroke,0.5026113086783149,0.0,0.0,1.0,0.0,1.0,0.5026,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.324875,0.355472,0.030597,HIGH,3
aspirin + ticagrelor,EFO_0003884,chronic kidney disease,0.4915385450450704,0.0,0.0,1.0,0.0,1.0,0.4915,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.321783,0.339511,0.017728,HIGH,3
aspirin + ticagrelor,MONDO_0100096,COVID-19,0.4785229195602742,0.0,0.0,1.0,0.0,1.0,0.4785,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.293252,0.370541,0.077289,HIGH,3
aspirin + ticagrelor,HP_0001892,Abnormal bleeding,0.4767886814327185,0.0,0.0,1.0,0.0,1.0,0.4768,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.317859,0.317859,0.0,HIGH,3
aspirin + ticagrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.4750385075319242,0.0,0.0,1.0,0.0,1.0,0.475,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.316692,0.316692,0.0,HIGH,3
aspirin + ticagrelor,EFO_0003875,peripheral vascular disease,0.4677017366554127,0.0,0.0,1.0,0.0,1.0,0.4677,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.311801,0.311801,0.0,HIGH,3
aspirin + ticagrelor,EFO_0000341,chronic obstructive pulmonary disease,0.4237528155402523,0.0,0.0,1.0,0.0693,1.0693,0.4531,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.271245,0.305015,0.03377,HIGH,3
aspirin + ticagrelor,EFO_1000985,intermediate coronary syndrome,0.4414710013265912,0.0,0.0,1.0,0.0,1.0,0.4415,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.294314,0.294314,0.0,HIGH,3
aspirin + ticagrelor,EFO_0007328,influenza,0.429921584347847,0.0,0.0,1.0,0.0,1.0,0.4299,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.281446,0.296951,0.015505,HIGH,3
aspirin + ticagrelor,EFO_0002618,pancreatic carcinoma,0.363935054968322,0.0,0.0,1.0,0.1792,1.1792,0.4291,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.207222,0.313427,0.106206,MEDIUM,3
aspirin + ticagrelor,EFO_0003106,pneumonia,0.4261421471138622,0.0,0.0,1.0,0.0,1.0,0.4261,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.284095,0.284095,0.0,HIGH,3
aspirin + ticagrelor,EFO_0003914,atherosclerosis,0.420919835852397,0.0,0.0,1.0,0.0,1.0,0.4209,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.272072,0.297696,0.025624,HIGH,3
aspirin + ticagrelor,EFO_0002615,internal carotid artery stenosis,0.4046081727158208,0.0,0.0,1.0,0.0,1.0,0.4046,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.269739,0.269739,0.0,HIGH,3
aspirin + ticagrelor,Orphanet_51636,WHIM syndrome,0.3240446555252246,0.0,0.0,1.0,0.2398,1.2398,0.4017,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.6480893110504491,0.6480893110504491,0.0,HIGH,1
aspirin + ticagrelor,MONDO_0024327,chronic renal failure syndrome,0.3911923595088404,0.0,0.0,1.0,0.0,1.0,0.3912,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.260795,0.260795,0.0,HIGH,3
aspirin + ticagrelor,EFO_0003870,brain aneurysm,0.390822205669856,0.0,0.0,1.0,0.0,1.0,0.3908,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.260548,0.260548,0.0,HIGH,3
aspirin + ticagrelor,EFO_0001365,age-related macular degeneration,0.3147046977739425,0.0,0.0,1.0,0.2398,1.2398,0.3902,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.20602,0.21737,0.01135,HIGH,3
aspirin + ticagrelor,HP_0002239,Gastrointestinal hemorrhage,0.3862871261607673,0.0,0.0,1.0,0.0,1.0,0.3863,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.257525,0.257525,0.0,HIGH,3
aspirin + ticagrelor,HP_0030680,Abnormal cardiovascular system morphology,0.3862871261607673,0.0,0.0,1.0,0.0,1.0,0.3863,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.257525,0.257525,0.0,HIGH,3
aspirin + ticagrelor,EFO_0003913,angina pectoris,0.3740584828306595,0.0,0.0,1.0,0.0,1.0,0.3741,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.249372,0.249372,0.0,HIGH,3
aspirin + ticagrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.3688735477751073,0.0,0.0,1.0,0.0,1.0,0.3689,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.245916,0.245916,0.0,HIGH,3
aspirin + ticagrelor,EFO_1000359,Malignant Pancreatic Neoplasm,0.3090297009286137,0.0,0.0,1.0,0.1386,1.1386,0.3519,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.20602,0.20602,0.0,HIGH,3
aspirin + ticagrelor,EFO_0003764,transient ischemic attack,0.3510732837751805,0.0,0.0,1.0,0.0,1.0,0.3511,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.234049,0.234049,0.0,HIGH,3
aspirin + ticagrelor,MONDO_0004992,cancer,0.3345885389778901,0.0,0.0,1.0,0.0,1.0,0.3346,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.052256,0.564665,0.512409,LOW,3
aspirin + ticagrelor,MONDO_8000006,WHIM syndrome 1,0.2633324089297616,0.0,0.0,1.0,0.2398,1.2398,0.3265,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.526664817859523,0.526664817859523,0.0,HIGH,1
aspirin + ticagrelor,EFO_0009959,diverticular disease,0.3255924595483411,0.0,0.0,1.0,0.0,1.0,0.3256,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.217062,0.217062,0.0,HIGH,3
aspirin + ticagrelor,EFO_1000044,pancreatic adenocarcinoma,0.318301322891359,0.0,0.0,1.0,0.0,1.0,0.3183,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.208374,0.219854,0.01148,HIGH,3
aspirin + ticagrelor,EFO_0003144,heart failure,0.318071708859123,0.0,0.0,1.0,0.0,1.0,0.3181,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.208224,0.219695,0.011471,HIGH,3
aspirin + ticagrelor,HP_0011869,Abnormal platelet function,0.3178591209551455,0.0,0.0,1.0,0.0,1.0,0.3179,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.211906,0.211906,0.0,HIGH,3
aspirin + ticagrelor,EFO_0009086,arteriosclerosis,0.3151542759136196,0.0,0.0,1.0,0.0,1.0,0.3152,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.206314,0.21768,0.011366,HIGH,3
aspirin + ticagrelor,EFO_0020925,angina unstable,0.3139321100135068,0.0,0.0,1.0,0.0,1.0,0.3139,1,TERMINATED,STOPPED,Peripheral Arterial Disease,AZ discontinued study,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.209288,0.209288,0.0,HIGH,3
atenolol,EFO_0000537,hypertension,2.7648523399896785,0.8705,0.0,0.7702,0.1609,1.1609,2.4721,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.185691,1.579161,0.39347,LOW,2
atenolol,EFO_0000319,cardiovascular disease,2.6895978577211235,0.8705,0.0,0.7702,0.0,1.0,2.0714,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.142742,1.546856,0.404114,LOW,2
atenolol,MONDO_0004979,asthma,2.2425656279647783,0.8705,0.0,0.7702,0.1792,1.1792,2.0366,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.948708,1.293858,0.34515,LOW,2
atenolol,EFO_0000712,stroke,2.3055197301580925,0.8705,0.0,0.7702,0.1386,1.1386,2.0218,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.916974,1.388546,0.471572,LOW,2
atenolol,MONDO_0005277,migraine disorder,2.112766553222864,0.8705,0.0,0.7702,0.2079,1.2079,1.9655,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.958447,1.154319,0.195872,MEDIUM,2
atenolol,EFO_0001645,coronary artery disease,2.0627772812727234,0.8705,0.0,0.7702,0.2303,1.2303,1.9545,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.619747,1.44303,0.823284,LOW,2
atenolol,EFO_0004190,open-angle glaucoma,2.0486093001152064,0.8705,0.0,0.7702,0.2079,1.2079,1.9058,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.964279,1.084331,0.120052,MEDIUM,2
atenolol,EFO_0000275,atrial fibrillation,1.916470860470868,0.8705,0.0,0.7702,0.2398,1.2398,1.8299,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.891684,1.024787,0.133103,MEDIUM,2
atenolol,EFO_0004278,sudden cardiac arrest,1.8793504251036557,0.8705,0.0,0.7702,0.2398,1.2398,1.7945,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.939675,0.939675,0.0,HIGH,2
atenolol,EFO_0003913,angina pectoris,2.2550898378129656,0.8705,0.0,0.7702,0.0,1.0,1.7368,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.962406,1.292683,0.330277,LOW,2
atenolol,EFO_0000612,myocardial infarction,2.1818594759074683,0.8705,0.0,0.7702,0.0,1.0,1.6804,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.989791,1.192068,0.202277,MEDIUM,2
atenolol,EFO_0003144,heart failure,2.138628884973927,0.8705,0.0,0.7702,0.0,1.0,1.6471,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.96392,1.174709,0.210789,MEDIUM,2
atenolol,MONDO_0005041,glaucoma,2.109681896155683,0.8705,0.0,0.7702,0.0,1.0,1.6248,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.964047,1.145635,0.181588,MEDIUM,2
atenolol,EFO_0000400,diabetes mellitus,1.7095068000119782,0.8705,0.0,0.7702,0.2197,1.2197,1.6059,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.748949,0.960557,0.211608,MEDIUM,2
atenolol,MONDO_0005148,type 2 diabetes mellitus,1.760505436755398,0.8705,0.0,0.7702,0.1792,1.1792,1.5988,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.765922,0.994583,0.228661,MEDIUM,2
atenolol,MONDO_0001134,essential hypertension,2.0569500209969207,0.8705,0.0,0.7702,0.0,1.0,1.5842,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.957045,1.099905,0.14286,MEDIUM,2
atenolol,HP_0012531,Pain,2.0400931450860074,0.8705,0.0,0.7702,0.0,1.0,1.5712,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.925479,1.114614,0.189134,MEDIUM,2
atenolol,EFO_0000373,congestive heart failure,2.0198549756275908,0.8705,0.0,0.7702,0.0,1.0,1.5556,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.950744,1.069111,0.118367,MEDIUM,2
atenolol,HP_0100806,Sepsis,2.0123632185196305,0.8705,0.0,0.7702,0.0,1.0,1.5498,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.927264,1.085099,0.157836,MEDIUM,2
atenolol,HP_0006536,Airway obstruction,1.9808972373903604,0.8705,0.0,0.7702,0.0,1.0,1.5256,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.861522,1.119375,0.257852,LOW,2
atenolol,HP_0004308,Ventricular arrhythmia,1.9439758503893232,0.8705,0.0,0.7702,0.0,1.0,1.4972,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.928275,1.0157,0.087425,HIGH,2
atenolol,EFO_0005252,orthostatic hypotension,1.5988579919833488,0.8705,0.0,0.7702,0.2079,1.2079,1.4874,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.799429,0.799429,0.0,HIGH,2
atenolol,EFO_1001069,ocular hypertension,1.9187195375117836,0.8705,0.0,0.7702,0.0,1.0,1.4777,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.95936,0.95936,0.0,HIGH,2
atenolol,EFO_0006834,septic shock,1.915071915036728,0.8705,0.0,0.7702,0.0,1.0,1.4749,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.901423,1.013649,0.112226,MEDIUM,2
atenolol,EFO_0007486,sinusitis,1.9013393553793392,0.8705,0.0,0.7702,0.0,1.0,1.4643,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.925185,0.976155,0.05097,HIGH,2
atenolol,MONDO_0019200,retinitis pigmentosa,1.556369626340392,0.8705,0.0,0.7702,0.2079,1.2079,1.4479,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.556369626340391,1.556369626340391,0.0,HIGH,1
atenolol,EFO_0001073,obesity,1.5703735467216058,0.8705,0.0,0.7702,0.1946,1.1946,1.4448,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.717603,0.852771,0.135168,MEDIUM,2
atenolol,MONDO_0005271,allergic disease,1.863581616006123,0.8705,0.0,0.7702,0.0,1.0,1.4353,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.889886,0.973696,0.083809,HIGH,2
atenolol,MONDO_0005180,Parkinson disease,1.4976292930336657,0.8705,0.0,0.7702,0.2398,1.2398,1.43,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.639144,0.858485,0.219341,MEDIUM,2
atenolol,EFO_0005251,hypotension,1.836737977312336,0.8705,0.0,0.7702,0.0,1.0,1.4146,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.918369,0.918369,0.0,HIGH,2
atenolol,EFO_0005531,urticaria,1.8041831446637624,0.8705,0.0,0.7702,0.0,1.0,1.3895,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.861522,0.942661,0.081138,HIGH,2
atenolol,EFO_0004269,cardiac arrhythmia,1.774063667224573,0.8705,0.0,0.7702,0.0,1.0,1.3663,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.863253,0.910811,0.047558,HIGH,2
atenolol,HP_0001742,Nasal congestion,1.7230449673998585,0.8705,0.0,0.7702,0.0,1.0,1.327,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.861522,0.861522,0.0,HIGH,2
atenolol,MONDO_0021661,coronary atherosclerosis,1.7021234839847263,0.8705,0.0,0.7702,0.0,1.0,1.3109,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.801188,0.900935,0.099747,HIGH,2
atenolol,EFO_0003956,seasonal allergic rhinitis,1.6961701191696688,0.8705,0.0,0.7702,0.0,1.0,1.3063,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.781567,0.914603,0.133036,MEDIUM,2
atenolol,EFO_0009492,cardiac arrest,1.6727991671939262,0.8705,0.0,0.7702,0.0,1.0,1.2883,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.758858,0.913941,0.155083,MEDIUM,2
atenolol,EFO_1000635,hemangioma,1.6538636043960024,0.8705,0.0,0.7702,0.0,1.0,1.2737,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.826932,0.826932,0.0,HIGH,2
atenolol,Orphanet_1872,Cone rod dystrophy,1.3336572725604836,0.8705,0.0,0.7702,0.2398,1.2398,1.2734,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.333657272560483,1.333657272560483,0.0,HIGH,1
atenolol,EFO_0000341,chronic obstructive pulmonary disease,1.530826494340825,0.8705,0.0,0.7702,0.0693,1.0693,1.2607,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.272469,1.258358,0.985889,LOW,2
atenolol,EFO_0004329,alcohol drinking,1.6314324799501214,0.8705,0.0,0.7702,0.0,1.0,1.2565,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.745505,0.885928,0.140423,MEDIUM,2
atenolol,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.8705,0.0,0.7702,0.2398,1.2398,1.2245,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.2823759951301381,1.2823759951301381,0.0,HIGH,1
atenolol,MONDO_0010679,Duchenne muscular dystrophy,1.2665345782543598,0.8705,0.0,0.7702,0.2398,1.2398,1.2093,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.54052,0.726015,0.185495,MEDIUM,2
atenolol,EFO_0000676,psoriasis,1.2386421513156345,0.8705,0.0,0.7702,0.2398,1.2398,1.1827,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.238642151315634,1.238642151315634,0.0,HIGH,1
atenolol,MONDO_0007947,Marfan syndrome,1.2311625158968411,0.8705,0.0,0.7702,0.2398,1.2398,1.1756,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.615581,0.615581,0.0,HIGH,2
atenolol,HP_0032263,Increased blood pressure,1.515202476348413,0.8705,0.0,0.7702,0.0,1.0,1.1669,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.72353,0.791672,0.068142,HIGH,2
atenolol,EFO_0000274,atopic eczema,1.2172900783318894,0.8705,0.0,0.7702,0.2398,1.2398,1.1623,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.0787,1.13859,1.05989,LOW,2
atenolol,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,0.8705,0.0,0.7702,0.2398,1.2398,1.1563,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,1.2110423777158301,1.2110423777158301,0.0,HIGH,1
atenolol,EFO_0003777,heart disease,1.4941913330961183,0.8705,0.0,0.7702,0.0,1.0,1.1508,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.63623,0.857961,0.221731,MEDIUM,2
atenolol,EFO_0000668,preeclampsia,1.1920881007918207,0.8705,0.0,0.7702,0.2398,1.2398,1.1383,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.540786,0.651302,0.110517,MEDIUM,2
atenolol,EFO_1002048,kidney failure,1.4715700044219706,0.8705,0.0,0.7702,0.0,1.0,1.1333,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Angina Pectoris; Atrial Fibrillation; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease,,,0.735785,0.735785,0.0,HIGH,2
atorvastatin + aspirin + losartan + amlodipine,MONDO_0014917,"developmental and epileptic encephalopathy, 42",2.1384499625253572,0.0,0.0,1.0,0.2398,1.2398,2.6512,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.41908,1.438741,0.019661,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,Orphanet_97,Familial paroxysmal ataxia,2.089114577184188,0.0,0.0,1.0,0.2398,1.2398,2.5901,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.392743,1.392743,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010979,Timothy syndrome,2.088111821927662,0.0,0.0,1.0,0.2398,1.2398,2.5888,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.392075,1.392075,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000275,atrial fibrillation,2.0436959262897982,0.0,0.0,1.0,0.2398,1.2398,2.5338,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.320032,1.444065,0.124033,MEDIUM,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000537,hypertension,2.165899518155409,0.0,0.0,1.0,0.1609,1.1609,2.5145,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.434215,1.453651,0.019436,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0100062,genetic developmental and epileptic encephalopathy,2.017106277306181,0.0,0.0,1.0,0.2398,1.2398,2.5008,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.341272,1.351669,0.010398,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000400,diabetes mellitus,2.0498000894145996,0.0,0.0,1.0,0.2197,1.2197,2.5002,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.309662,1.473508,0.163846,MEDIUM,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0007163,episodic ataxia type 2,1.975901108996574,0.0,0.0,1.0,0.2398,1.2398,2.4497,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.317267,1.317267,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0020756,"migraine, familial hemiplegic, 1",1.9648524090199415,0.0,0.0,1.0,0.2398,1.2398,2.436,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.309902,1.309902,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0042979,"hypokalemic periodic paralysis, type 1",1.8944693215975628,0.0,0.0,1.0,0.2398,1.2398,2.3487,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.251488,1.285962,0.034473,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010241,congenital stationary night blindness 2A,1.9234743786002833,0.0,0.0,1.0,0.2197,1.2197,2.3461,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.282316,1.282316,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0013960,sinoatrial node dysfunction and deafness,1.9356103280908183,0.0,0.0,1.0,0.2079,1.2079,2.3381,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.290407,1.290407,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0008457,spinocerebellar ataxia type 6,1.873982059619951,0.0,0.0,1.0,0.2398,1.2398,2.3233,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.249321,1.249321,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0009059,Spinocerebellar ataxia type 42,1.8563102251411112,0.0,0.0,1.0,0.2398,1.2398,2.3014,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.23754,1.23754,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0013464,episodic ataxia type 5,1.8560253227508623,0.0,0.0,1.0,0.2398,1.2398,2.3011,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.232824,1.246403,0.013579,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0859514,congenital myopathy 18,1.8191762319912237,0.0,0.0,1.0,0.2398,1.2398,2.2554,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.212784,1.212784,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000319,cardiovascular disease,2.242582307414629,0.0,0.0,1.0,0.0,1.0,2.2426,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.492363,1.498623,0.00626,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0014200,aldosterone-producing adenoma with seizures and neurological abnormalities,1.8074669584472045,0.0,0.0,1.0,0.2398,1.2398,2.2409,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.204978,1.204978,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0012742,Brugada syndrome 3,1.820370929938901,0.0,0.0,1.0,0.2079,1.2079,2.1989,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.213581,1.213581,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0001645,coronary artery disease,1.7845246558274583,0.0,0.0,1.0,0.2303,1.2303,2.1954,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.179651,1.199715,0.020065,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,Orphanet_1872,Cone rod dystrophy,1.7633617913077362,0.0,0.0,1.0,0.2398,1.2398,2.1862,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.175575,1.175575,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0859286,"neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures",1.760228356787351,0.0,0.0,1.0,0.2398,1.2398,2.1823,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.173486,1.173486,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0060551,"cerebellar atrophy, developmental delay, and seizures",1.770165807171474,0.0,0.0,1.0,0.2303,1.2303,2.1778,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.169373,1.201585,0.032211,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010371,Aland island eye disease,1.7696007000757776,0.0,0.0,1.0,0.2303,1.2303,2.1771,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.179734,1.179734,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0060758,"spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits",1.7473390287596384,0.0,0.0,1.0,0.2398,1.2398,2.1663,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.164893,1.164893,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0010276,neurodevelopmental disorder with seizures and non-epileptic hyperkinetic movements,1.7068446491489544,0.0,0.0,1.0,0.2398,1.2398,2.1161,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.137896,1.137896,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,HP_0001250,Seizure,2.0825922513017554,0.0,0.0,1.0,0.0,1.0,2.0826,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.383176,1.398833,0.015657,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0005138,acquired long QT syndrome,2.0333653579850033,0.0,0.0,1.0,0.0,1.0,2.0334,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.355577,1.355577,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0005090,schizophrenia,1.6060424822237902,0.0,0.0,1.0,0.2398,1.2398,1.9912,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.068473,1.075139,0.006666,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0015263,Brugada syndrome,1.6058245250044685,0.0,0.0,1.0,0.2398,1.2398,1.9909,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.996969,1.217711,0.220741,MEDIUM,6
atorvastatin + aspirin + losartan + amlodipine,Orphanet_178333,land Islands eye disease,1.615687910419268,0.0,0.0,1.0,0.2303,1.2303,1.9877,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.077125,1.077125,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010335,X-linked cone-rod dystrophy 3,1.5994815861462333,0.0,0.0,1.0,0.2398,1.2398,1.983,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.066321,1.066321,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000474,epilepsy,1.965602251231271,0.0,0.0,1.0,0.0,1.0,1.9656,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.306518,1.314285,0.007767,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0012507,retinal cone dystrophy 4,1.5372479074978334,0.0,0.0,1.0,0.2197,1.2197,1.875,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.024832,1.024832,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0032756,long QT syndrome 8,1.4944896504731866,0.0,0.0,1.0,0.2398,1.2398,1.8529,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.996326,0.996326,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0859313,neurodevelopmental disorder with speech impairment and with or without seizures,1.4933687174457682,0.0,0.0,1.0,0.2398,1.2398,1.8515,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.995579,0.995579,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0003144,heart failure,1.8474276446267353,0.0,0.0,1.0,0.0,1.0,1.8474,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.226403,1.242048,0.015645,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000712,stroke,1.6168904455785205,0.0,0.0,1.0,0.1386,1.1386,1.841,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.067543,1.088311,0.020767,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0033361,"developmental and epileptic encephalopathy, 52",1.4725482711584974,0.0,0.0,1.0,0.2398,1.2398,1.8256,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.981699,0.981699,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,HP_0000556,Retinal dystrophy,1.4517666342557924,0.0,0.0,1.0,0.2398,1.2398,1.7999,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.967844,0.967844,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0005148,type 2 diabetes mellitus,1.5204644393972904,0.0,0.0,1.0,0.1792,1.1792,1.7929,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.867677,1.300244,0.432566,LOW,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0004269,cardiac arrhythmia,1.7433419096078977,0.0,0.0,1.0,0.0,1.0,1.7433,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.090539,1.305606,0.215067,MEDIUM,6
atorvastatin + aspirin + losartan + amlodipine,HP_0001249,Intellectual disability,1.3985562108675211,0.0,0.0,1.0,0.2398,1.2398,1.7339,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.932371,0.932371,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000538,hypertrophic cardiomyopathy,1.3937059644788836,0.0,0.0,1.0,0.2398,1.2398,1.7279,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.928072,0.931267,0.003195,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0016293,congenital stationary night blindness,1.7136568447574838,0.0,0.0,1.0,0.0,1.0,1.7137,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.142438,1.142438,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0016525,familial hyperaldosteronism,1.4058966272704694,0.0,0.0,1.0,0.2079,1.2079,1.6982,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,0.937264,0.937264,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0005762,neuropathic pain,1.6916205191791005,0.0,0.0,1.0,0.0,1.0,1.6916,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.122289,1.138663,0.016374,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,EFO_0000612,myocardial infarction,1.685271056327457,0.0,0.0,1.0,0.0,1.0,1.6853,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.118076,1.134389,0.016313,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0001134,essential hypertension,1.683420262758753,0.0,0.0,1.0,0.0,1.0,1.6834,,,,,,True,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.12228,1.12228,0.0,HIGH,6
atorvastatin + aspirin + losartan + amlodipine,MONDO_0004985,bipolar disorder,1.6756395609775447,0.0,0.0,1.0,0.0,1.0,1.6756,,,,,,False,"Angina Pectoris; Angina Pectoris, Variant; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus",,,1.087096,1.177087,0.089991,HIGH,6
bms-823778,Orphanet_168588,Hyperandrogenism due to cortisone reductase deficiency,1.7938045935235976,0.0,0.0,1.0,0.2398,1.2398,2.2239,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.896902,0.896902,0.0,HIGH,2
bms-823778,EFO_0003948,gastroesophageal reflux disease,1.602376227037257,0.0,0.0,1.0,0.1792,1.1792,1.8895,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.801188,0.801188,0.0,HIGH,2
bms-823778,HP_0004398,Peptic ulcer,1.602376227037257,0.0,0.0,1.0,0.0,1.0,1.6024,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.801188,0.801188,0.0,HIGH,2
bms-823778,HP_0030839,Knee pain,0.9996016797305548,0.0,0.0,1.0,0.0,1.0,0.9996,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.499801,0.499801,0.0,HIGH,2
bms-823778,MONDO_0005148,type 2 diabetes mellitus,0.4182305568329269,0.0,0.0,1.0,0.1792,1.1792,0.4932,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,True,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.209115,0.209115,0.0,HIGH,2
bms-823778,MONDO_0017919,exstrophy-epispadias complex,0.3767219211320242,0.0,0.0,1.0,0.2398,1.2398,0.4671,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.188361,0.188361,0.0,HIGH,2
bms-823778,EFO_0000537,hypertension,0.3228297574145262,0.0,0.0,1.0,0.1609,1.1609,0.3748,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,True,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.161415,0.161415,0.0,HIGH,2
bms-823778,EFO_0000756,melanoma,0.2945677649562676,0.0,0.0,1.0,0.2197,1.2197,0.3593,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.147284,0.147284,0.0,HIGH,2
bms-823778,EFO_0000195,metabolic syndrome,0.2878281734626068,0.0,0.0,1.0,0.2398,1.2398,0.3568,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.143914,0.143914,0.0,HIGH,2
bms-823778,EFO_0000616,neoplasm,0.3132214591368887,0.0,0.0,1.0,0.0,1.0,0.3132,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.156611,0.156611,0.0,HIGH,2
bms-823778,MONDO_0004975,Alzheimer disease,0.2432327973535678,0.0,0.0,1.0,0.2398,1.2398,0.3016,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.121616,0.121616,0.0,HIGH,2
bms-823778,EFO_0000319,cardiovascular disease,0.2968985683354936,0.0,0.0,1.0,0.0,1.0,0.2969,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,True,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.148449,0.148449,0.0,HIGH,2
bms-823778,Orphanet_309005,Disorder of lipid metabolism,0.2960798848897005,0.0,0.0,1.0,0.0,1.0,0.2961,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,True,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.14804,0.14804,0.0,HIGH,2
bms-823778,MONDO_0011719,gastrointestinal stromal tumor,0.2383289376050514,0.0,0.0,1.0,0.2398,1.2398,0.2955,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.119164,0.119164,0.0,HIGH,2
bms-823778,HP_0001513,Obesity,0.2755987507637684,0.0,0.0,1.0,0.0,1.0,0.2756,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.137799,0.137799,0.0,HIGH,2
bms-823778,EFO_1001132,pseudotumor cerebri,0.2354512007075151,0.0,0.0,1.0,0.1609,1.1609,0.2733,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.117726,0.117726,0.0,HIGH,2
bms-823778,MONDO_0007763,nonpapillary renal cell carcinoma,0.2453270705149693,0.0,0.0,1.0,0.1099,1.1099,0.2723,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.122664,0.122664,0.0,HIGH,2
bms-823778,EFO_0003095,non-alcoholic fatty liver disease,0.2400948216103579,0.0,0.0,1.0,0.1099,1.1099,0.2665,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.120047,0.120047,0.0,HIGH,2
bms-823778,MONDO_0013616,"pigmented nodular adrenocortical disease, primary, 3",0.2266747572011426,0.0,0.0,1.0,0.1386,1.1386,0.2581,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.113337,0.113337,0.0,HIGH,2
bms-823778,EFO_0000729,ulcerative colitis,0.2031123327381256,0.0,0.0,1.0,0.2398,1.2398,0.2518,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.101556,0.101556,0.0,HIGH,2
bms-823778,EFO_1001069,ocular hypertension,0.2372170847128216,0.0,0.0,1.0,0.0,1.0,0.2372,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.118609,0.118609,0.0,HIGH,2
bms-823778,EFO_1001110,pituitary-dependent Cushing's disease,0.2354512007075151,0.0,0.0,1.0,0.0,1.0,0.2355,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.117726,0.117726,0.0,HIGH,2
bms-823778,MONDO_0013310,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,0.1979791421149142,0.0,0.0,1.0,0.1609,1.1609,0.2298,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.09899,0.09899,0.0,HIGH,2
bms-823778,MONDO_0958023,"lipodystrophy, congenital generalized, type 5",0.1619878099623182,0.0,0.0,1.0,0.2398,1.2398,0.2008,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.080994,0.080994,0.0,HIGH,2
bms-823778,MONDO_0008725,congenital lipoid adrenal hyperplasia due to STAR deficency,0.1692540956285971,0.0,0.0,1.0,0.1792,1.1792,0.1996,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.084627,0.084627,0.0,HIGH,2
bms-823778,MONDO_0007080,glucocorticoid-remediable aldosteronism,0.1506711096127565,0.0,0.0,1.0,0.2398,1.2398,0.1868,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.075336,0.075336,0.0,HIGH,2
bms-823778,EFO_0000384,Crohn's disease,0.1473085431673019,0.0,0.0,1.0,0.2398,1.2398,0.1826,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.073654,0.073654,0.0,HIGH,2
bms-823778,MONDO_0018479,congenital adrenal hyperplasia,0.1794079286591088,0.0,0.0,1.0,0.0,1.0,0.1794,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.089704,0.089704,0.0,HIGH,2
bms-823778,MONDO_0012923,congenital generalized lipodystrophy type 3,0.1426186785485597,0.0,0.0,1.0,0.2398,1.2398,0.1768,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.071309,0.071309,0.0,HIGH,2
bms-823778,Orphanet_228429,Generalized congenital lipodystrophy with myopathy,0.1426186785485597,0.0,0.0,1.0,0.2398,1.2398,0.1768,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.071309,0.071309,0.0,HIGH,2
bms-823778,HP_0000855,Insulin resistance,0.1728159360980293,0.0,0.0,1.0,0.0,1.0,0.1728,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.086408,0.086408,0.0,HIGH,2
bms-823778,Orphanet_411,Hyperlipoproteinemia type 1,0.1377389524138964,0.0,0.0,1.0,0.2398,1.2398,0.1708,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.068869,0.068869,0.0,HIGH,2
bms-823778,MONDO_0012381,hyperinsulinism due to INSR deficiency,0.1285328104662324,0.0,0.0,1.0,0.2303,1.2303,0.1581,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.064266,0.064266,0.0,HIGH,2
bms-823778,EFO_0000389,cutaneous melanoma,0.126783931269866,0.0,0.0,1.0,0.2398,1.2398,0.1572,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.063392,0.063392,0.0,HIGH,2
bms-823778,MONDO_0014098,CIDEC-related familial partial lipodystrophy,0.1220461298867404,0.0,0.0,1.0,0.2398,1.2398,0.1513,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.061023,0.061023,0.0,HIGH,2
bms-823778,EFO_1001354,Kleine-Levin Syndrome,0.1262253886992989,0.0,0.0,1.0,0.1792,1.1792,0.1488,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.063113,0.063113,0.0,HIGH,2
bms-823778,MONDO_0007762,hyperlipoproteinemia type V,0.1239179669323652,0.0,0.0,1.0,0.1946,1.1946,0.148,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.061959,0.061959,0.0,HIGH,2
bms-823778,Orphanet_70470,Hyperlipoproteinemia type 5,0.1239179669323652,0.0,0.0,1.0,0.1946,1.1946,0.148,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.061959,0.061959,0.0,HIGH,2
bms-823778,MONDO_0008733,familial glucocorticoid deficiency,0.1441432250731405,0.0,0.0,1.0,0.0,1.0,0.1441,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.072072,0.072072,0.0,HIGH,2
bms-823778,EFO_0001073,obesity,0.1188188746104159,0.0,0.0,1.0,0.1946,1.1946,0.1419,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.059409,0.059409,0.0,HIGH,2
bms-823778,MONDO_0012396,exercise-induced hyperinsulinism,0.1171840625921303,0.0,0.0,1.0,0.1946,1.1946,0.14,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.058592,0.058592,0.0,HIGH,2
bms-823778,MONDO_0009734,"hyperinsulinemic hypoglycemia, familial, 1",0.1146647347445597,0.0,0.0,1.0,0.2197,1.2197,0.1399,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.057332,0.057332,0.0,HIGH,2
bms-823778,EFO_1001979,Adrenocorticotropic hormone deficiency,0.1128046702589705,0.0,0.0,1.0,0.2303,1.2303,0.1388,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.056402,0.056402,0.0,HIGH,2
bms-823778,MONDO_0011236,hyperinsulinism due to glucokinase deficiency,0.1126398544184751,0.0,0.0,1.0,0.2197,1.2197,0.1374,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.05632,0.05632,0.0,HIGH,2
bms-823778,MONDO_0859149,hypertriglyceridemia 2,0.1160538968287343,0.0,0.0,1.0,0.1609,1.1609,0.1347,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.058027,0.058027,0.0,HIGH,2
bms-823778,Orphanet_364,Glycogen storage disease due to glucose-6-phosphatase deficiency,0.1070596609617069,0.0,0.0,1.0,0.2398,1.2398,0.1327,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.05353,0.05353,0.0,HIGH,2
bms-823778,Orphanet_79211,Combined hyperlipidemia,0.1074599280029097,0.0,0.0,1.0,0.2303,1.2303,0.1322,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.05373,0.05373,0.0,HIGH,2
bms-823778,MONDO_0011448,PPARG-related familial partial lipodystrophy,0.1057175891176743,0.0,0.0,1.0,0.2398,1.2398,0.1311,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.052859,0.052859,0.0,HIGH,2
bms-823778,EFO_0000478,esophageal adenocarcinoma,0.110756244812815,0.0,0.0,1.0,0.1792,1.1792,0.1306,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.055378,0.055378,0.0,HIGH,2
bms-823778,MONDO_0009294,glycogen storage disease VI,0.1045403331141367,0.0,0.0,1.0,0.2398,1.2398,0.1296,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,,False,"Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypertension; Lipid Metabolism Disorders",,,0.05227,0.05227,0.0,HIGH,2
bupivacaine liposome,EFO_0000275,atrial fibrillation,1.7995128897970418,0.0,0.0,1.0,0.2398,1.2398,2.231,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,True,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.812211,0.987301,0.17509,MEDIUM,2
bupivacaine liposome,MONDO_0011001,Brugada syndrome 1,1.8023214358886164,0.0,0.0,1.0,0.2303,1.2303,2.2173,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.848351,0.95397,0.105619,MEDIUM,2
bupivacaine liposome,MONDO_0011377,long QT syndrome 3,1.697753131485748,0.0,0.0,1.0,0.2398,1.2398,2.1049,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.848877,0.848877,0.0,HIGH,2
bupivacaine liposome,MONDO_0015263,Brugada syndrome,1.6972466443688696,0.0,0.0,1.0,0.2398,1.2398,2.1042,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.789685,0.907562,0.117878,MEDIUM,2
bupivacaine liposome,MONDO_0008195,paramyotonia congenita of Von Eulenburg,1.689541404919834,0.0,0.0,1.0,0.2398,1.2398,2.0947,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.844771,0.844771,0.0,HIGH,2
bupivacaine liposome,Orphanet_871,Familial progressive cardiac conduction defect,1.655498357539786,0.0,0.0,1.0,0.2398,1.2398,2.0525,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.790523,0.864975,0.074451,HIGH,2
bupivacaine liposome,MONDO_0007240,"progressive familial heart block, type 1A",1.654340201776926,0.0,0.0,1.0,0.2398,1.2398,2.051,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.804996,0.849344,0.044349,HIGH,2
bupivacaine liposome,MONDO_0008224,hyperkalemic periodic paralysis,1.672880494810728,0.0,0.0,1.0,0.2079,1.2079,2.0207,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.83644,0.83644,0.0,HIGH,2
bupivacaine liposome,MONDO_0018959,potassium-aggravated myotonia,1.61963259300252,0.0,0.0,1.0,0.2398,1.2398,2.008,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.809816,0.809816,0.0,HIGH,2
bupivacaine liposome,MONDO_0011003,dilated cardiomyopathy 1E,1.6165491805654075,0.0,0.0,1.0,0.2398,1.2398,2.0042,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.786607,0.829942,0.043336,HIGH,2
bupivacaine liposome,MONDO_0013530,"atrial fibrillation, familial, 10",1.603730627659406,0.0,0.0,1.0,0.2398,1.2398,1.9883,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.801865,0.801865,0.0,HIGH,2
bupivacaine liposome,MONDO_0024562,sick sinus syndrome 1,1.6000195407542703,0.0,0.0,1.0,0.2398,1.2398,1.9837,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.778564,0.821456,0.042892,HIGH,2
bupivacaine liposome,EFO_0004138,bundle branch block,1.558825027820817,0.0,0.0,1.0,0.2398,1.2398,1.9326,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.758518,0.800307,0.041788,HIGH,2
bupivacaine liposome,Orphanet_101016,Romano-Ward syndrome,1.5237792701247734,0.0,0.0,1.0,0.2398,1.2398,1.8892,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.717242,0.806538,0.089296,HIGH,2
bupivacaine liposome,Orphanet_590,Congenital myasthenic syndromes,1.5212353445653788,0.0,0.0,1.0,0.2398,1.2398,1.886,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.716044,0.805191,0.089147,HIGH,2
bupivacaine liposome,EFO_0005303,sudden infant death syndrome,1.5956883018796106,0.0,0.0,1.0,0.1792,1.1792,1.8816,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.776456,0.819232,0.042776,HIGH,2
bupivacaine liposome,MONDO_0957265,"congenital myopathy 22B, severe fetal",1.4763881113055324,0.0,0.0,1.0,0.2398,1.2398,1.8304,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.738194,0.738194,0.0,HIGH,2
bupivacaine liposome,EFO_0004269,cardiac arrhythmia,1.7999604534810545,0.0,0.0,1.0,0.0,1.0,1.8,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.840523,0.959438,0.118915,MEDIUM,2
bupivacaine liposome,MONDO_0011376,"ventricular fibrillation, paroxysmal familial, type 1",1.56378649793265,0.0,0.0,1.0,0.1386,1.1386,1.7806,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.74673,0.817057,0.070327,HIGH,2
bupivacaine liposome,EFO_0000407,dilated cardiomyopathy,1.4063712108217985,0.0,0.0,1.0,0.2398,1.2398,1.7436,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.661978,0.744393,0.082416,HIGH,2
bupivacaine liposome,MONDO_0005277,migraine disorder,1.4308315328628844,0.0,0.0,1.0,0.2079,1.2079,1.7284,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,True,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.663945,0.766887,0.102942,MEDIUM,2
bupivacaine liposome,MONDO_0042979,"hypokalemic periodic paralysis, type 1",1.389574834455016,0.0,0.0,1.0,0.2398,1.2398,1.7228,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.556473,0.833102,0.276629,LOW,2
bupivacaine liposome,MONDO_0013620,congenital myasthenic syndrome 16,1.38144927037614,0.0,0.0,1.0,0.2398,1.2398,1.7127,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.690725,0.690725,0.0,HIGH,2
bupivacaine liposome,HP_0001250,Seizure,1.6228735991273575,0.0,0.0,1.0,0.0,1.0,1.6229,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.73043,0.892444,0.162014,MEDIUM,2
bupivacaine liposome,MONDO_0004976,amyotrophic lateral sclerosis,1.2881801193834774,0.0,0.0,1.0,0.2398,1.2398,1.5971,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.62358,0.664601,0.041021,HIGH,2
bupivacaine liposome,MONDO_0005178,osteoarthritis,1.297894925123912,0.0,0.0,1.0,0.2303,1.2303,1.5967,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,True,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.602259,0.695636,0.093378,HIGH,2
bupivacaine liposome,MONDO_0957247,"congenital myopathy 22A, classic",1.2878274961170093,0.0,0.0,1.0,0.2398,1.2398,1.5966,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.643914,0.643914,0.0,HIGH,2
bupivacaine liposome,Orphanet_98913,Postsynaptic congenital myasthenic syndromes,1.2853389932936234,0.0,0.0,1.0,0.2398,1.2398,1.5935,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.642669,0.642669,0.0,HIGH,2
bupivacaine liposome,MONDO_0008223,hypokalemic periodic paralysis,1.5872469762431378,0.0,0.0,1.0,0.0,1.0,1.5872,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.772348,0.814899,0.04255,HIGH,2
bupivacaine liposome,MONDO_0016532,Lennox-Gastaut syndrome,1.2651172762351308,0.0,0.0,1.0,0.2398,1.2398,1.5685,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.594983,0.670135,0.075152,HIGH,2
bupivacaine liposome,HP_0012531,Pain,1.5397149192143809,0.0,0.0,1.0,0.0,1.0,1.5397,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.71447,0.825245,0.110775,MEDIUM,2
bupivacaine liposome,MONDO_0013234,"hypokalemic periodic paralysis, type 2",1.2440795049375328,0.0,0.0,1.0,0.2303,1.2303,1.5305,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.62204,0.62204,0.0,HIGH,2
bupivacaine liposome,Orphanet_228140,"Idiopathic ventricular fibrillation, not Brugada type",1.27919985744686,0.0,0.0,1.0,0.1946,1.1946,1.5281,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.610836,0.668364,0.057528,HIGH,2
bupivacaine liposome,EFO_0000319,cardiovascular disease,1.484529074353656,0.0,0.0,1.0,0.0,1.0,1.4845,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.536199,0.94833,0.412131,LOW,2
bupivacaine liposome,EFO_0000474,epilepsy,1.4814346564666525,0.0,0.0,1.0,0.0,1.0,1.4814,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.649763,0.831672,0.181909,MEDIUM,2
bupivacaine liposome,EFO_0000537,hypertension,1.2729484996565597,0.0,0.0,1.0,0.1609,1.1609,1.4778,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.349666,0.923283,0.573617,LOW,2
bupivacaine liposome,EFO_0000400,diabetes mellitus,1.193963171800323,0.0,0.0,1.0,0.2197,1.2197,1.4563,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.354849,0.839114,0.484264,LOW,2
bupivacaine liposome,HP_0001657,Prolonged QT interval,1.4500107336829962,0.0,0.0,1.0,0.0,1.0,1.45,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.674652,0.775359,0.100707,MEDIUM,2
bupivacaine liposome,MONDO_0004985,bipolar disorder,1.4419133207489212,0.0,0.0,1.0,0.0,1.0,1.4419,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.642476,0.799438,0.156962,MEDIUM,2
bupivacaine liposome,Orphanet_1344,Atrial stand still,1.1451688201532595,0.0,0.0,1.0,0.2398,1.2398,1.4198,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.546834,0.598335,0.051501,HIGH,2
bupivacaine liposome,MONDO_0019171,familial long QT syndrome,1.4099520013797475,0.0,0.0,1.0,0.0,1.0,1.41,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.656014,0.753938,0.097924,HIGH,2
bupivacaine liposome,EFO_1001219,trigeminal neuralgia,1.2516373885340482,0.0,0.0,1.0,0.1099,1.1099,1.3891,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.614437,0.6372,0.022763,HIGH,2
bupivacaine liposome,MONDO_0005090,schizophrenia,1.107585526761707,0.0,0.0,1.0,0.2398,1.2398,1.3732,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.425042,0.682543,0.257501,LOW,2
bupivacaine liposome,EFO_0004263,partial epilepsy,1.3648669703721972,0.0,0.0,1.0,0.0,1.0,1.3649,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.633336,0.731531,0.098196,HIGH,2
bupivacaine liposome,EFO_0003913,angina pectoris,1.3307974413117614,0.0,0.0,1.0,0.0,1.0,1.3308,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.613272,0.717525,0.104253,MEDIUM,2
bupivacaine liposome,HP_0007359,Focal-onset seizure,1.3190421919001754,0.0,0.0,1.0,0.0,1.0,1.319,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.638519,0.680523,0.042004,HIGH,2
bupivacaine liposome,EFO_0009552,hemorrhoid,1.3123389702540798,0.0,0.0,1.0,0.0,1.0,1.3123,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,True,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.622223,0.690116,0.067893,HIGH,2
bupivacaine liposome,HP_0000989,Pruritus,1.308971067116417,0.0,0.0,1.0,0.0,1.0,1.309,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.626523,0.682448,0.055925,HIGH,2
bupivacaine liposome,EFO_0005762,neuropathic pain,1.3085707223223548,0.0,0.0,1.0,0.0,1.0,1.3086,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,True,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.579823,0.728747,0.148924,MEDIUM,2
bupivacaine liposome,HP_0004308,Ventricular arrhythmia,1.2918155830077251,0.0,0.0,1.0,0.0,1.0,1.2918,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Lack of funds,False,Abdominal Pain; Acute Pain; Analgesia; Ankle Fractures; Aortic Coarctation,,,0.607539,0.684277,0.076738,HIGH,2
canakinumab (acz885),MONDO_0008633,Muckle-Wells syndrome,7.122296850763094,0.0,0.0,1.0,0.2398,1.2398,8.8301,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.791366,0.791366,0.0,HIGH,9
canakinumab (acz885),EFO_0004274,gout,8.045187443478783,0.0,0.0,1.0,0.0,1.0,8.0452,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.837822,0.978041,0.14022,MEDIUM,9
canakinumab (acz885),MONDO_0016168,cryopyrin-associated periodic syndrome,7.7603892416716675,0.0,0.0,1.0,0.0,1.0,7.7604,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.862265,0.862265,0.0,HIGH,9
canakinumab (acz885),Orphanet_47045,Familial cold urticaria,6.234012009732794,0.0,0.0,1.0,0.2398,1.2398,7.7289,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.692668,0.692668,0.0,HIGH,9
canakinumab (acz885),EFO_0000540,immune system disease,6.6706650185870995,0.0,0.0,1.0,0.1386,1.1386,7.5954,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.741185,0.741185,0.0,HIGH,9
canakinumab (acz885),EFO_0002609,juvenile idiopathic arthritis,7.528527341576587,0.0,0.0,1.0,0.0,1.0,7.5285,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.773071,0.931651,0.15858,MEDIUM,9
canakinumab (acz885),EFO_1001982,Antisynthetase syndrome,6.519680536841211,0.0,0.0,1.0,0.0,1.0,6.5197,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.724409,0.724409,0.0,HIGH,9
canakinumab (acz885),EFO_0007427,pericarditis,6.423383774962796,0.0,0.0,1.0,0.0,1.0,6.4234,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.713709,0.713709,0.0,HIGH,9
canakinumab (acz885),EFO_0003060,non-small cell lung carcinoma,5.283662442933737,0.0,0.0,1.0,0.1792,1.1792,6.2304,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.546659,0.639329,0.09267,HIGH,9
canakinumab (acz885),MONDO_0018088,familial Mediterranean fever,5.976685032155372,0.0,0.0,1.0,0.0,1.0,5.9767,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.664076,0.664076,0.0,HIGH,9
canakinumab (acz885),EFO_0005854,allergic rhinitis,5.830742491256941,0.0,0.0,1.0,0.0,1.0,5.8307,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.64786,0.64786,0.0,HIGH,9
canakinumab (acz885),EFO_1001999,systemic juvenile idiopathic arthritis,5.795296018857455,0.0,0.0,1.0,0.0,1.0,5.7953,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.640004,0.651757,0.011753,HIGH,9
canakinumab (acz885),MONDO_0017708,mevalonate kinase deficiency,5.573937399738753,0.0,0.0,1.0,0.0,1.0,5.5739,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.619326,0.619326,0.0,HIGH,9
canakinumab (acz885),MONDO_0004979,asthma,4.712558191779437,0.0,0.0,1.0,0.1792,1.1792,5.5569,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.512883,0.539719,0.026835,HIGH,9
canakinumab (acz885),HP_0000964,Eczematoid dermatitis,5.4635687443122665,0.0,0.0,1.0,0.0,1.0,5.4636,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.607063,0.607063,0.0,HIGH,9
canakinumab (acz885),EFO_1001231,uveitis,5.427591647309556,0.0,0.0,1.0,0.0,1.0,5.4276,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.603066,0.603066,0.0,HIGH,9
canakinumab (acz885),EFO_0003780,Behcet's syndrome,4.2636207724128825,0.0,0.0,1.0,0.2398,1.2398,5.286,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.473736,0.473736,0.0,HIGH,9
canakinumab (acz885),HP_0001945,Fever,5.205134689402737,0.0,0.0,1.0,0.0,1.0,5.2051,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.440779,0.784702,0.343923,LOW,9
canakinumab (acz885),HP_0000999,Pyoderma,5.1560869814937,0.0,0.0,1.0,0.0,1.0,5.1561,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.572899,0.572899,0.0,HIGH,9
canakinumab (acz885),EFO_0005772,neurodegenerative disease,5.044935217261816,0.0,0.0,1.0,0.0,1.0,5.0449,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.551082,0.575454,0.024372,HIGH,9
canakinumab (acz885),EFO_0000684,respiratory system disease,5.012388666010973,0.0,0.0,1.0,0.0,1.0,5.0124,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.553544,0.563709,0.010165,HIGH,9
canakinumab (acz885),MONDO_0100096,COVID-19,4.9031385052724845,0.0,0.0,1.0,0.0,1.0,4.9031,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.483583,0.629208,0.145625,MEDIUM,9
canakinumab (acz885),MONDO_0008903,lung cancer,4.115315964306312,0.0,0.0,1.0,0.1792,1.1792,4.8527,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.454475,0.462821,0.008346,HIGH,9
canakinumab (acz885),EFO_0002618,pancreatic carcinoma,4.115148389063007,0.0,0.0,1.0,0.1792,1.1792,4.8525,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.424709,0.512229,0.087521,HIGH,9
canakinumab (acz885),HP_0001943,Hypoglycemia,3.815793631494588,0.0,0.0,1.0,0.2398,1.2398,4.7308,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.423977,0.423977,0.0,HIGH,9
canakinumab (acz885),MONDO_0011776,CINCA syndrome,3.794228621675953,0.0,0.0,1.0,0.2398,1.2398,4.704,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.421581,0.421581,0.0,HIGH,9
canakinumab (acz885),EFO_0000729,ulcerative colitis,3.7408504862305367,0.0,0.0,1.0,0.2398,1.2398,4.6379,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.212592,0.716984,0.504392,LOW,9
canakinumab (acz885),MONDO_0005178,osteoarthritis,3.5996843364730293,0.0,0.0,1.0,0.2303,1.2303,4.4285,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.20117,0.696493,0.495322,LOW,9
canakinumab (acz885),EFO_0000685,rheumatoid arthritis,3.5716410414753565,0.0,0.0,1.0,0.2398,1.2398,4.4281,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.202038,0.687428,0.48539,LOW,9
canakinumab (acz885),EFO_0003914,atherosclerosis,4.371510645910084,0.0,0.0,1.0,0.0,1.0,4.3715,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.437401,0.550586,0.113185,MEDIUM,9
canakinumab (acz885),EFO_0007135,adult-onset Still's disease,4.3181921293998435,0.0,0.0,1.0,0.0,1.0,4.3182,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.479799,0.479799,0.0,HIGH,9
canakinumab (acz885),EFO_1000710,hidradenitis suppurativa,4.100272420012057,0.0,0.0,1.0,0.0,1.0,4.1003,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.455586,0.455586,0.0,HIGH,9
canakinumab (acz885),EFO_1001478,systemic inflammatory response syndrome,3.91651859781241,0.0,0.0,1.0,0.0,1.0,3.9165,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.432521,0.440464,0.007943,HIGH,9
canakinumab (acz885),EFO_0003106,pneumonia,3.895829057139267,0.0,0.0,1.0,0.0,1.0,3.8958,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.41788,0.455355,0.037475,HIGH,9
canakinumab (acz885),EFO_0001645,coronary artery disease,3.128141355827293,0.0,0.0,1.0,0.2303,1.2303,3.8484,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.136459,0.66259,0.52613,LOW,9
canakinumab (acz885),EFO_1000044,pancreatic adenocarcinoma,3.829744409749518,0.0,0.0,1.0,0.0,1.0,3.8297,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.425527,0.425527,0.0,HIGH,9
canakinumab (acz885),EFO_0000537,hypertension,3.1832285011186654,0.0,0.0,1.0,0.1609,1.1609,3.6955,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.285259,0.456342,0.171083,MEDIUM,9
canakinumab (acz885),EFO_0000275,atrial fibrillation,2.8599891210765014,0.0,0.0,1.0,0.2398,1.2398,3.5458,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.211125,0.477755,0.26663,LOW,9
canakinumab (acz885),MONDO_0005148,type 2 diabetes mellitus,3.001398063298683,0.0,0.0,1.0,0.1792,1.1792,3.5392,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.22656,0.489385,0.262825,LOW,9
canakinumab (acz885),MONDO_0004975,Alzheimer disease,2.7552604226966304,0.0,0.0,1.0,0.2398,1.2398,3.4159,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.185578,0.484144,0.298566,LOW,9
canakinumab (acz885),EFO_0007328,influenza,3.182608878332219,0.0,0.0,1.0,0.0,1.0,3.1826,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.162779,0.635879,0.473099,LOW,9
canakinumab (acz885),EFO_0001065,endometriosis,3.090369548788771,0.0,0.0,1.0,0.0,1.0,3.0904,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.331417,0.367288,0.035871,HIGH,9
canakinumab (acz885),MONDO_0005271,allergic disease,3.087130135893718,0.0,0.0,1.0,0.0,1.0,3.0871,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.343014,0.343014,0.0,HIGH,9
canakinumab (acz885),EFO_0000341,chronic obstructive pulmonary disease,2.8145317993130226,0.0,0.0,1.0,0.0693,1.0693,3.0096,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,True,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.196766,0.428686,0.23192,MEDIUM,9
canakinumab (acz885),EFO_0003767,inflammatory bowel disease,2.540025680218582,0.0,0.0,1.0,0.1792,1.1792,2.9951,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.179202,0.436759,0.257557,LOW,9
canakinumab (acz885),HP_0001977,Abnormal thrombosis,2.968007879733468,0.0,0.0,1.0,0.0,1.0,2.968,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.329779,0.329779,0.0,HIGH,9
canakinumab (acz885),EFO_0000319,cardiovascular disease,2.959013970223371,0.0,0.0,1.0,0.0,1.0,2.959,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.143272,0.605555,0.462282,LOW,9
canakinumab (acz885),MONDO_0004992,cancer,2.9504675762277324,0.0,0.0,1.0,0.0,1.0,2.9505,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.179968,0.576295,0.396327,LOW,9
canakinumab (acz885),EFO_0000400,diabetes mellitus,2.3736414269580064,0.0,0.0,1.0,0.2197,1.2197,2.8952,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.166947,0.405487,0.23854,MEDIUM,9
canakinumab (acz885),EFO_0000616,neoplasm,2.878141288375141,0.0,0.0,1.0,0.0,1.0,2.8781,1,TERMINATED,STOPPED,Peripheral Artery Disease,The study got terminated based on result from primary endpoint analysis,False,"Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Arthritis, Gouty; Arthritis, Juvenile; Arthritis, Rheumatoid",,,0.192182,0.50827,0.316088,LOW,9
cangrelor,MONDO_0012354,platelet-type bleeding disorder 8,1.7194684294023383,0.3481,0.0,0.9008,0.2197,1.2197,1.8893,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.573156,0.573156,0.0,HIGH,3
cangrelor,Orphanet_36355,P2Y12 defect,1.6023435254816034,0.3481,0.0,0.9008,0.2197,1.2197,1.7606,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.534115,0.534115,0.0,HIGH,3
cangrelor,EFO_0001645,coronary artery disease,1.5071440486259289,0.3481,0.0,0.9008,0.2303,1.2303,1.6703,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.48709,0.532964,0.045874,HIGH,3
cangrelor,EFO_0000712,stroke,1.4160623664361789,0.3481,0.0,0.9008,0.1386,1.1386,1.4525,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.463509,0.489044,0.025536,HIGH,3
cangrelor,EFO_0000612,myocardial infarction,1.5146976650948338,0.3481,0.0,0.9008,0.0,1.0,1.3645,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.484781,0.545136,0.060355,HIGH,3
cangrelor,MONDO_0030030,Nizon-Isidor syndrome,1.1834680998443794,0.3481,0.0,0.9008,0.2398,1.2398,1.3217,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.394489,0.394489,0.0,HIGH,3
cangrelor,EFO_0005672,acute coronary syndrome,1.4597556147353623,0.3481,0.0,0.9008,0.0,1.0,1.315,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.486585,0.486585,0.0,HIGH,3
cangrelor,EFO_0008583,acute myocardial infarction,1.425978263976451,0.3481,0.0,0.9008,0.0,1.0,1.2846,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.466755,0.492469,0.025714,HIGH,3
cangrelor,EFO_0004265,peripheral arterial disease,1.3431350978152992,0.3481,0.0,0.9008,0.0,1.0,1.2099,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.447712,0.447712,0.0,HIGH,3
cangrelor,HP_0004419,Recurrent thrombophlebitis,1.32206549944891,0.3481,0.0,0.9008,0.0,1.0,1.191,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.440688,0.440688,0.0,HIGH,3
cangrelor,MONDO_0005148,type 2 diabetes mellitus,1.1057517768833676,0.3481,0.0,0.9008,0.1792,1.1792,1.1746,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.353897,0.397957,0.04406,HIGH,3
cangrelor,MONDO_0000831,thrombotic disease,1.2950060458128914,0.3481,0.0,0.9008,0.0,1.0,1.1666,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.431669,0.431669,0.0,HIGH,3
cangrelor,EFO_0000275,atrial fibrillation,1.0123430858058808,0.3481,0.0,0.9008,0.2398,1.2398,1.1306,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.331363,0.349618,0.018255,HIGH,3
cangrelor,HP_0001249,Intellectual disability,1.011550814273387,0.3481,0.0,0.9008,0.2398,1.2398,1.1297,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.331103,0.349344,0.018241,HIGH,3
cangrelor,HP_0001873,Thrombocytopenia,0.95948865206519,0.3481,0.0,0.9008,0.2079,1.2079,1.0441,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.31983,0.31983,0.0,HIGH,3
cangrelor,EFO_0000508,genetic disorder,1.1420205257968972,0.3481,0.0,0.9008,0.0,1.0,1.0288,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.373809,0.394403,0.020594,HIGH,3
cangrelor,EFO_0000556,ischemia,1.1313115877073967,0.3481,0.0,0.9008,0.0,1.0,1.0191,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.377104,0.377104,0.0,HIGH,3
cangrelor,MONDO_0011382,sickle cell disease,0.8780974725618862,0.3481,0.0,0.9008,0.2398,1.2398,0.9807,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.281036,0.316025,0.034989,HIGH,3
cangrelor,EFO_0000266,aortic stenosis,0.8820835868172695,0.3481,0.0,0.9008,0.2303,1.2303,0.9776,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.294028,0.294028,0.0,HIGH,3
cangrelor,HP_0002140,Ischemic stroke,1.00522261735663,0.3481,0.0,0.9008,0.0,1.0,0.9055,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.324875,0.355472,0.030597,HIGH,3
cangrelor,EFO_0003884,chronic kidney disease,0.9830770900901408,0.3481,0.0,0.9008,0.0,1.0,0.8856,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.321783,0.339511,0.017728,HIGH,3
cangrelor,MONDO_0100096,COVID-19,0.9570458391205484,0.3481,0.0,0.9008,0.0,1.0,0.8621,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.293252,0.370541,0.077289,HIGH,3
cangrelor,HP_0001892,Abnormal bleeding,0.953577362865437,0.3481,0.0,0.9008,0.0,1.0,0.859,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.317859,0.317859,0.0,HIGH,3
cangrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.9500770150638485,0.3481,0.0,0.9008,0.0,1.0,0.8559,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,True,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.316692,0.316692,0.0,HIGH,3
cangrelor,EFO_0003875,peripheral vascular disease,0.9354034733108256,0.3481,0.0,0.9008,0.0,1.0,0.8426,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.311801,0.311801,0.0,HIGH,3
cangrelor,EFO_0000341,chronic obstructive pulmonary disease,0.8475056310805047,0.3481,0.0,0.9008,0.0693,1.0693,0.8164,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.271245,0.305015,0.03377,HIGH,3
cangrelor,EFO_1000985,intermediate coronary syndrome,0.8829420026531825,0.3481,0.0,0.9008,0.0,1.0,0.7954,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.294314,0.294314,0.0,HIGH,3
cangrelor,EFO_0007328,influenza,0.8598431686956941,0.3481,0.0,0.9008,0.0,1.0,0.7746,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.281446,0.296951,0.015505,HIGH,3
cangrelor,EFO_0002618,pancreatic carcinoma,0.727870109936644,0.3481,0.0,0.9008,0.1792,1.1792,0.7732,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.207222,0.313427,0.106206,MEDIUM,3
cangrelor,EFO_0003106,pneumonia,0.8522842942277244,0.3481,0.0,0.9008,0.0,1.0,0.7678,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.284095,0.284095,0.0,HIGH,3
cangrelor,EFO_0003914,atherosclerosis,0.841839671704794,0.3481,0.0,0.9008,0.0,1.0,0.7584,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.272072,0.297696,0.025624,HIGH,3
cangrelor,EFO_0002615,internal carotid artery stenosis,0.8092163454316417,0.3481,0.0,0.9008,0.0,1.0,0.729,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.269739,0.269739,0.0,HIGH,3
cangrelor,Orphanet_51636,WHIM syndrome,0.6480893110504493,0.3481,0.0,0.9008,0.2398,1.2398,0.7238,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.6480893110504491,0.6480893110504491,0.0,HIGH,1
cangrelor,MONDO_0024327,chronic renal failure syndrome,0.7823847190176809,0.3481,0.0,0.9008,0.0,1.0,0.7048,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.260795,0.260795,0.0,HIGH,3
cangrelor,EFO_0003870,brain aneurysm,0.7816444113397121,0.3481,0.0,0.9008,0.0,1.0,0.7041,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.260548,0.260548,0.0,HIGH,3
cangrelor,EFO_0001365,age-related macular degeneration,0.6294093955478851,0.3481,0.0,0.9008,0.2398,1.2398,0.7029,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.20602,0.21737,0.01135,HIGH,3
cangrelor,HP_0002239,Gastrointestinal hemorrhage,0.7725742523215346,0.3481,0.0,0.9008,0.0,1.0,0.696,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.257525,0.257525,0.0,HIGH,3
cangrelor,HP_0030680,Abnormal cardiovascular system morphology,0.7725742523215346,0.3481,0.0,0.9008,0.0,1.0,0.696,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.257525,0.257525,0.0,HIGH,3
cangrelor,EFO_0003913,angina pectoris,0.7481169656613191,0.3481,0.0,0.9008,0.0,1.0,0.6739,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.249372,0.249372,0.0,HIGH,3
cangrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.7377470955502146,0.3481,0.0,0.9008,0.0,1.0,0.6646,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.245916,0.245916,0.0,HIGH,3
cangrelor,EFO_1000359,Malignant Pancreatic Neoplasm,0.6180594018572275,0.3481,0.0,0.9008,0.1386,1.1386,0.6339,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.20602,0.20602,0.0,HIGH,3
cangrelor,EFO_0003764,transient ischemic attack,0.7021465675503611,0.3481,0.0,0.9008,0.0,1.0,0.6325,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.234049,0.234049,0.0,HIGH,3
cangrelor,MONDO_0004992,cancer,0.6691770779557803,0.3481,0.0,0.9008,0.0,1.0,0.6028,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.052256,0.564665,0.512409,LOW,3
cangrelor,MONDO_8000006,WHIM syndrome 1,0.5266648178595232,0.3481,0.0,0.9008,0.2398,1.2398,0.5882,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.526664817859523,0.526664817859523,0.0,HIGH,1
cangrelor,EFO_0009959,diverticular disease,0.6511849190966823,0.3481,0.0,0.9008,0.0,1.0,0.5866,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.217062,0.217062,0.0,HIGH,3
cangrelor,EFO_1000044,pancreatic adenocarcinoma,0.636602645782718,0.3481,0.0,0.9008,0.0,1.0,0.5735,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.208374,0.219854,0.01148,HIGH,3
cangrelor,EFO_0003144,heart failure,0.6361434177182461,0.3481,0.0,0.9008,0.0,1.0,0.5731,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.208224,0.219695,0.011471,HIGH,3
cangrelor,HP_0011869,Abnormal platelet function,0.6357182419102911,0.3481,0.0,0.9008,0.0,1.0,0.5727,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.211906,0.211906,0.0,HIGH,3
cangrelor,EFO_0009086,arteriosclerosis,0.6303085518272392,0.3481,0.0,0.9008,0.0,1.0,0.5678,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.206314,0.21768,0.011366,HIGH,3
cangrelor,EFO_0020925,angina unstable,0.6278642200270136,0.3481,0.0,0.9008,0.0,1.0,0.5656,1,TERMINATED,STOPPED,Atherosclerosis | Acute Coronary Syndrome (ACS),Insufficient evidence of the clinical effectiveness of cangrelor,False,Acute Coronary Syndrome; Coronary Disease; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention,,,0.209288,0.209288,0.0,HIGH,3
cellgram-cli,MONDO_0002009,major depressive disorder,8.123238578524923,0.0,0.0,1.0,0.1099,1.1099,9.0157,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.803471,0.825603,0.022132,HIGH,10
cellgram-cli,MONDO_0005148,type 2 diabetes mellitus,7.45543855649202,0.0,0.0,1.0,0.1792,1.1792,8.7913,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.707659,0.817512,0.109852,MEDIUM,10
cellgram-cli,EFO_0000729,ulcerative colitis,6.276678304197179,0.0,0.0,1.0,0.2398,1.2398,7.7818,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.624229,0.634546,0.010317,HIGH,10
cellgram-cli,MONDO_0003778,inborn error of immunity,5.900995717732101,0.0,0.0,1.0,0.2398,1.2398,7.316,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.5901,0.5901,0.0,HIGH,10
cellgram-cli,EFO_0000676,psoriasis,5.798813283212193,0.0,0.0,1.0,0.2398,1.2398,7.1893,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.579881,0.579881,0.0,HIGH,10
cellgram-cli,EFO_0000384,Crohn's disease,5.653447962971424,0.0,0.0,1.0,0.2398,1.2398,7.0091,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.565345,0.565345,0.0,HIGH,10
cellgram-cli,EFO_0004268,sclerosing cholangitis,5.609879879516417,0.0,0.0,1.0,0.2398,1.2398,6.9551,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.557914,0.567135,0.009221,HIGH,10
cellgram-cli,EFO_0000649,periodontitis,5.724090521511243,0.0,0.0,1.0,0.1792,1.1792,6.7497,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.569273,0.578682,0.009409,HIGH,10
cellgram-cli,HP_0100806,Sepsis,6.36131925422262,0.0,0.0,1.0,0.0,1.0,6.3613,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,True,Acute-On-Chronic Liver Failure; Sepsis,,,0.632647,0.643103,0.010456,HIGH,10
cellgram-cli,EFO_0005423,adolescent idiopathic scoliosis,5.661547497705439,0.0,0.0,1.0,0.0,1.0,5.6615,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.566155,0.566155,0.0,HIGH,10
cellgram-cli,EFO_0003898,ankylosing spondylitis,5.627408820350402,0.0,0.0,1.0,0.0,1.0,5.6274,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.562741,0.562741,0.0,HIGH,10
cellgram-cli,EFO_0001061,cervical carcinoma,4.826382335398982,0.0,0.0,1.0,0.1386,1.1386,5.4955,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.482638,0.482638,0.0,HIGH,10
cellgram-cli,EFO_0000400,diabetes mellitus,4.3141889498104895,0.0,0.0,1.0,0.2197,1.2197,5.2621,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.378327,0.535571,0.157244,MEDIUM,10
cellgram-cli,EFO_0000341,chronic obstructive pulmonary disease,4.787347186859817,0.0,0.0,1.0,0.0693,1.0693,5.1192,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.473517,0.486561,0.013043,HIGH,10
cellgram-cli,EFO_1000897,diabetic ketoacidosis,5.0743265517112,0.0,0.0,1.0,0.0,1.0,5.0743,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.507433,0.507433,0.0,HIGH,10
cellgram-cli,EFO_0004698,insomnia,4.500876374928694,0.0,0.0,1.0,0.1099,1.1099,4.9953,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.450088,0.450088,0.0,HIGH,10
cellgram-cli,EFO_0004616,"osteoarthritis, knee",4.862696327964578,0.0,0.0,1.0,0.0,1.0,4.8627,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.48627,0.48627,0.0,HIGH,10
cellgram-cli,EFO_0001073,obesity,3.97699289104423,0.0,0.0,1.0,0.1946,1.1946,4.7509,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.39552,0.402057,0.006537,HIGH,10
cellgram-cli,MONDO_0005178,osteoarthritis,3.73007498492625,0.0,0.0,1.0,0.2303,1.2303,4.589,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.370964,0.377095,0.006131,HIGH,10
cellgram-cli,MONDO_0100096,COVID-19,4.530805773245998,0.0,0.0,1.0,0.0,1.0,4.5308,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.448143,0.460487,0.012344,HIGH,10
cellgram-cli,EFO_0000195,metabolic syndrome,3.6060121233308298,0.0,0.0,1.0,0.2398,1.2398,4.4707,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.345342,0.389265,0.043924,HIGH,10
cellgram-cli,EFO_0000668,preeclampsia,3.569602416815892,0.0,0.0,1.0,0.2398,1.2398,4.4256,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.346187,0.378506,0.032318,HIGH,10
cellgram-cli,EFO_0004289,lymphoid leukemia,4.396335361378345,0.0,0.0,1.0,0.0,1.0,4.3963,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.439634,0.439634,0.0,HIGH,10
cellgram-cli,EFO_0007328,influenza,4.318284602788265,0.0,0.0,1.0,0.0,1.0,4.3183,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.431828,0.431828,0.0,HIGH,10
cellgram-cli,EFO_0005670,smoking initiation,4.273766085345647,0.0,0.0,1.0,0.0,1.0,4.2738,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.425035,0.43206,0.007025,HIGH,10
cellgram-cli,EFO_0003106,pneumonia,4.212650233523716,0.0,0.0,1.0,0.0,1.0,4.2127,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.421265,0.421265,0.0,HIGH,10
cellgram-cli,EFO_0020975,total knee arthroplasty,4.020588695558051,0.0,0.0,1.0,0.0,1.0,4.0206,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.402059,0.402059,0.0,HIGH,10
cellgram-cli,EFO_0004318,smoking behavior,3.953068824621539,0.0,0.0,1.0,0.0,1.0,3.9531,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.395307,0.395307,0.0,HIGH,10
cellgram-cli,EFO_0000783,myositis,3.357292922642978,0.0,0.0,1.0,0.1386,1.1386,3.8227,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.335729,0.335729,0.0,HIGH,10
cellgram-cli,EFO_0000555,irritable bowel syndrome,3.694428738586375,0.0,0.0,1.0,0.0,1.0,3.6944,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.369443,0.369443,0.0,HIGH,10
cellgram-cli,EFO_0000373,congestive heart failure,3.6544076389452727,0.0,0.0,1.0,0.0,1.0,3.6544,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.365441,0.365441,0.0,HIGH,10
cellgram-cli,EFO_0001645,coronary artery disease,2.9255081108656364,0.0,0.0,1.0,0.2303,1.2303,3.5991,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.179205,0.465765,0.28656,LOW,10
cellgram-cli,EFO_1001754,Abruptio Placentae,3.508827497077913,0.0,0.0,1.0,0.0,1.0,3.5088,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.350883,0.350883,0.0,HIGH,10
cellgram-cli,EFO_0000571,lung adenocarcinoma,2.9105541645071846,0.0,0.0,1.0,0.1792,1.1792,3.4321,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.289461,0.294245,0.004784,HIGH,10
cellgram-cli,EFO_0003834,cutaneous lupus erythematosus,3.39386600237726,0.0,0.0,1.0,0.0,1.0,3.3939,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.339387,0.339387,0.0,HIGH,10
cellgram-cli,MONDO_0004736,inborn disorder of amino acid metabolism,3.3533109428534056,0.0,0.0,1.0,0.0,1.0,3.3533,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.335331,0.335331,0.0,HIGH,10
cellgram-cli,EFO_0004247,mood disorder,3.3089841758127516,0.0,0.0,1.0,0.0,1.0,3.309,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.330898,0.330898,0.0,HIGH,10
cellgram-cli,HP_0003326,Myalgia,3.294393115420635,0.0,0.0,1.0,0.0,1.0,3.2944,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.329439,0.329439,0.0,HIGH,10
cellgram-cli,MONDO_0000812,vertebral column disorder,3.294393115420635,0.0,0.0,1.0,0.0,1.0,3.2944,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.329439,0.329439,0.0,HIGH,10
cellgram-cli,EFO_1000786,"osteoarthritis, hip",3.2716832588526445,0.0,0.0,1.0,0.0,1.0,3.2717,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.327168,0.327168,0.0,HIGH,10
cellgram-cli,EFO_0001421,liver disease,3.262151890858477,0.0,0.0,1.0,0.0,1.0,3.2622,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.324428,0.32979,0.005362,HIGH,10
cellgram-cli,EFO_0004257,neurotic disorder,3.25303098635838,0.0,0.0,1.0,0.0,1.0,3.253,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.325303,0.325303,0.0,HIGH,10
cellgram-cli,EFO_1001375,Myocardial Ischemia,3.1270031835214227,0.0,0.0,1.0,0.0,1.0,3.127,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.292838,0.350852,0.058014,HIGH,10
cellgram-cli,EFO_0009727,shortness of breath,3.1154264736594213,0.0,0.0,1.0,0.0,1.0,3.1154,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.311543,0.311543,0.0,HIGH,10
cellgram-cli,EFO_0000319,cardiovascular disease,3.107812763264993,0.0,0.0,1.0,0.0,1.0,3.1078,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.144858,0.557597,0.412739,LOW,10
cellgram-cli,EFO_0003832,gallbladder disease,3.0766561862008492,0.0,0.0,1.0,0.0,1.0,3.0767,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.307666,0.307666,0.0,HIGH,10
cellgram-cli,EFO_1001231,uveitis,3.0766561862008492,0.0,0.0,1.0,0.0,1.0,3.0767,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.307666,0.307666,0.0,HIGH,10
cellgram-cli,EFO_0001074,morbid obesity,2.9882141875122867,0.0,0.0,1.0,0.0,1.0,2.9882,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.297184,0.302096,0.004912,HIGH,10
cellgram-cli,EFO_0000275,atrial fibrillation,2.2785025788670357,0.0,0.0,1.0,0.2398,1.2398,2.8249,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.144041,0.394695,0.250654,LOW,10
cellgram-cli,HP_0000924,Abnormality of the skeletal system,2.812672849381592,0.0,0.0,1.0,0.0,1.0,2.8127,1,WITHDRAWN,STOPPED,Critical Limb Ischemia,Study was stopped by sponsers internal reason.,False,Acute-On-Chronic Liver Failure; Sepsis,,,0.281267,0.281267,0.0,HIGH,10
cholecalciferol,Orphanet_93160,Hypocalcemic vitamin D-resistant rickets,3.930347498216506,0.6318,0.0,0.8273,0.2398,1.2398,4.0314,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.310116,1.310116,0.0,HIGH,3
cholecalciferol,MONDO_0005148,type 2 diabetes mellitus,3.677773170254279,0.6318,0.0,0.8273,0.1792,1.1792,3.5879,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.646828,1.515473,0.868645,LOW,3
cholecalciferol,EFO_0000676,psoriasis,3.1057597788465263,0.6318,0.0,0.8273,0.2398,1.2398,3.1856,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.998578,1.053591,0.055013,HIGH,3
cholecalciferol,EFO_0000537,hypertension,3.3001576781882784,0.6318,0.0,0.8273,0.1609,1.1609,3.1698,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.66965,1.315254,0.645604,LOW,3
cholecalciferol,MONDO_0005301,multiple sclerosis,2.9514036041629255,0.6318,0.0,0.8273,0.2398,1.2398,3.0273,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.566983,1.19221,0.625227,LOW,3
cholecalciferol,EFO_0000400,diabetes mellitus,2.851000974669271,0.6318,0.0,0.8273,0.2197,1.2197,2.877,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.178293,1.336354,1.15806,LOW,3
cholecalciferol,EFO_0000729,ulcerative colitis,2.793185345964889,0.6318,0.0,0.8273,0.2398,1.2398,2.865,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.481734,1.155726,0.673992,LOW,3
cholecalciferol,MONDO_0011448,PPARG-related familial partial lipodystrophy,2.7333795678810473,0.6318,0.0,0.8273,0.2398,1.2398,2.8037,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.36669,1.36669,0.0,HIGH,2
cholecalciferol,EFO_0000384,Crohn's disease,2.7203282151120773,0.6318,0.0,0.8273,0.2398,1.2398,2.7903,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.595573,1.062377,0.466804,LOW,3
cholecalciferol,EFO_0000341,chronic obstructive pulmonary disease,3.1093554567045087,0.6318,0.0,0.8273,0.0693,1.0693,2.7508,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.587682,1.260837,0.673154,LOW,3
cholecalciferol,EFO_0001073,obesity,2.7399713301131094,0.6318,0.0,0.8273,0.1946,1.1946,2.708,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.580411,1.07978,0.49937,LOW,3
cholecalciferol,EFO_0003882,osteoporosis,2.9247508809746083,0.6318,0.0,0.8273,0.1099,1.1099,2.6856,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.974917,0.974917,0.0,HIGH,3
cholecalciferol,MONDO_0004979,asthma,2.7425952156345166,0.6318,0.0,0.8273,0.1792,1.1792,2.6756,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.618947,1.061824,0.442877,LOW,3
cholecalciferol,EFO_0003884,chronic kidney disease,3.1972979911642367,0.6318,0.0,0.8273,0.0,1.0,2.6452,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.984087,1.106605,0.122518,MEDIUM,3
cholecalciferol,MONDO_0014421,glucocorticoid resistance,2.5737579116229576,0.6318,0.0,0.8273,0.2398,1.2398,2.64,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.286879,1.286879,0.0,HIGH,2
cholecalciferol,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,2.4749316499235845,0.6318,0.0,0.8273,0.2398,1.2398,2.5386,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.237466,1.237466,0.0,HIGH,2
cholecalciferol,MONDO_0007915,systemic lupus erythematosus,2.4209372116993517,0.6318,0.0,0.8273,0.2398,1.2398,2.4832,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.468254,0.976342,0.508088,LOW,3
cholecalciferol,EFO_0004272,anemia (phenotype),2.4035643405558855,0.6318,0.0,0.8273,0.2398,1.2398,2.4654,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.801188,0.801188,0.0,HIGH,3
cholecalciferol,EFO_1001494,psoriasis vulgaris,2.9693655321989296,0.6318,0.0,0.8273,0.0,1.0,2.4567,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.951423,1.008971,0.057548,HIGH,3
cholecalciferol,EFO_0001645,coronary artery disease,2.3640154798978332,0.6318,0.0,0.8273,0.2303,1.2303,2.4062,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.454973,0.954521,0.499548,LOW,3
cholecalciferol,Orphanet_171871,Renal pseudohypoaldosteronism type 1,2.3307762736407676,0.6318,0.0,0.8273,0.2398,1.2398,2.3907,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.165388,1.165388,0.0,HIGH,2
cholecalciferol,EFO_1001173,secondary hyperparathyroidism,2.8685119688723555,0.6318,0.0,0.8273,0.0,1.0,2.3732,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.956171,0.956171,0.0,HIGH,3
cholecalciferol,HP_0002901,Hypocalcemia,2.836819561414222,0.6318,0.0,0.8273,0.0,1.0,2.347,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.945607,0.945607,0.0,HIGH,3
cholecalciferol,EFO_0000544,infection,2.7803906399030307,0.6318,0.0,0.8273,0.0,1.0,2.3003,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.57937,1.10051,0.521141,LOW,3
cholecalciferol,EFO_0009451,hypoparathyroidism,2.7720099307116146,0.6318,0.0,0.8273,0.0,1.0,2.2934,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.924003,0.924003,0.0,HIGH,3
cholecalciferol,EFO_0000274,atopic eczema,2.220247463040913,0.6318,0.0,0.8273,0.2398,1.2398,2.2774,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.171797,1.024225,0.852428,LOW,3
cholecalciferol,EFO_0000574,lymphoma,2.572036596340314,0.6318,0.0,0.8273,0.0693,1.0693,2.2754,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.526826,1.022605,0.495779,LOW,3
cholecalciferol,EFO_0000685,rheumatoid arthritis,2.1877901603657004,0.6318,0.0,0.8273,0.2398,1.2398,2.2441,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.093895,1.093895,0.0,HIGH,2
cholecalciferol,EFO_0000319,cardiovascular disease,2.689242513521384,0.6318,0.0,0.8273,0.0,1.0,2.2249,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.635862,1.02669,0.390828,LOW,3
cholecalciferol,EFO_0003144,heart failure,2.680741551909408,0.6318,0.0,0.8273,0.0,1.0,2.2179,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.554473,1.063134,0.508661,LOW,3
cholecalciferol,EFO_0000612,myocardial infarction,2.643105437241195,0.6318,0.0,0.8273,0.0,1.0,2.1867,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.546449,1.048328,0.501879,LOW,3
cholecalciferol,EFO_0000275,atrial fibrillation,2.1055043898388197,0.6318,0.0,0.8273,0.2398,1.2398,2.1597,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.052752,1.052752,0.0,HIGH,2
cholecalciferol,EFO_0004255,nephrotic syndrome,2.052277786883042,0.6318,0.0,0.8273,0.2398,1.2398,2.1051,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.026139,1.026139,0.0,HIGH,2
cholecalciferol,EFO_0000565,leukemia,2.540790253698812,0.6318,0.0,0.8273,0.0,1.0,2.1021,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.424379,1.058205,0.633826,LOW,3
cholecalciferol,MONDO_0011517,pseudohyperaldosteronism type 2,2.153578525452247,0.6318,0.0,0.8273,0.1792,1.1792,2.101,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,1.076789,1.076789,0.0,HIGH,2
cholecalciferol,EFO_1000049,pulmonary tuberculosis,2.488957141536419,0.6318,0.0,0.8273,0.0,1.0,2.0592,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.568975,0.959991,0.391016,LOW,3
cholecalciferol,EFO_0002609,juvenile idiopathic arthritis,2.4572560624052824,0.6318,0.0,0.8273,0.0,1.0,2.033,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.428338,1.014459,0.586121,LOW,3
cholecalciferol,MONDO_0004975,Alzheimer disease,1.951611513195969,0.6318,0.0,0.8273,0.2398,1.2398,2.0018,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.454348,0.748632,0.294284,LOW,3
cholecalciferol,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,1.947447499699361,0.6318,0.0,0.8273,0.2398,1.2398,1.9975,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.973724,0.973724,0.0,HIGH,2
cholecalciferol,MONDO_0005147,type 1 diabetes mellitus,1.9444693669502708,0.6318,0.0,0.8273,0.2398,1.2398,1.9945,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.625194,0.659637,0.034443,HIGH,3
cholecalciferol,MONDO_0005178,osteoarthritis,1.9570738942344823,0.6318,0.0,0.8273,0.2303,1.2303,1.992,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.978537,0.978537,0.0,HIGH,2
cholecalciferol,EFO_0005754,parathyroid disease,2.4035643405558855,0.6318,0.0,0.8273,0.0,1.0,1.9885,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.801188,0.801188,0.0,HIGH,3
cholecalciferol,MONDO_0004992,cancer,2.382024614992046,0.6318,0.0,0.8273,0.0,1.0,1.9707,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.201128,1.090448,0.88932,LOW,3
cholecalciferol,EFO_0000768,idiopathic pulmonary fibrosis,1.876449968441332,0.6318,0.0,0.8273,0.2398,1.2398,1.9247,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.938225,0.938225,0.0,HIGH,2
cholecalciferol,HP_0012531,Pain,2.3225384607480226,0.6318,0.0,0.8273,0.0,1.0,1.9215,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.41204,0.955249,0.54321,LOW,3
cholecalciferol,EFO_0004194,IGA glomerulonephritis,1.8731363011122255,0.6318,0.0,0.8273,0.2398,1.2398,1.9213,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.429567,0.721785,0.292218,LOW,3
cholecalciferol,EFO_0003095,non-alcoholic fatty liver disease,2.0777217701015824,0.6318,0.0,0.8273,0.1099,1.1099,1.9078,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.610376,0.733673,0.123297,MEDIUM,3
cholecalciferol,EFO_0000182,hepatocellular carcinoma,1.976785078832915,0.6318,0.0,0.8273,0.1609,1.1609,1.8987,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.59721,0.689787,0.092577,HIGH,3
cholecalciferol,EFO_0000660,polycystic ovary syndrome,1.897109062638286,0.6318,0.0,0.8273,0.2079,1.2079,1.8959,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,True,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.583906,0.656602,0.072696,HIGH,3
cholecalciferol,EFO_0007160,autoimmune thrombocytopenic purpura,1.9669064573153408,0.6318,0.0,0.8273,0.1609,1.1609,1.8892,2,"COMPLETED,TERMINATED","COMPLETED_NEGATIVE,STOPPED",Peripheral Arterial Disease,Insufficient recruitment,False,"Acquired Immunodeficiency Syndrome; Adenoma; Adrenoleukodystrophy; Anemia; Anemia, Iron-Deficiency",,,0.983453,0.983453,0.0,HIGH,2
cilostazol,MONDO_0019200,retinitis pigmentosa,1.556369626340392,0.5305,0.0,0.8529,0.2079,1.2079,1.6034,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.556369626340391,1.556369626340391,0.0,HIGH,1
cilostazol,EFO_0000537,hypertension,1.5791613657434134,0.5305,0.0,0.8529,0.1609,1.1609,1.5636,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.5791613657434131,1.5791613657434131,0.0,HIGH,1
cilostazol,EFO_0001645,coronary artery disease,1.4430304047823457,0.5305,0.0,0.8529,0.2303,1.2303,1.5141,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,True,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.443030404782345,1.443030404782345,0.0,HIGH,1
cilostazol,Orphanet_1872,Cone rod dystrophy,1.3336572725604836,0.5305,0.0,0.8529,0.2398,1.2398,1.4102,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.333657272560483,1.333657272560483,0.0,HIGH,1
cilostazol,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.5305,0.0,0.8529,0.2398,1.2398,1.356,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.2823759951301381,1.2823759951301381,0.0,HIGH,1
cilostazol,EFO_0000712,stroke,1.3885457739885985,0.5305,0.0,0.8529,0.1386,1.1386,1.3484,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,True,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.388545773988598,1.388545773988598,0.0,HIGH,1
cilostazol,EFO_0000319,cardiovascular disease,1.546855860642903,0.5305,0.0,0.8529,0.0,1.0,1.3193,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,True,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.546855860642903,1.546855860642903,0.0,HIGH,1
cilostazol,EFO_0000676,psoriasis,1.2386421513156345,0.5305,0.0,0.8529,0.2398,1.2398,1.3097,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.238642151315634,1.238642151315634,0.0,HIGH,1
cilostazol,MONDO_0004979,asthma,1.29385793995227,0.5305,0.0,0.8529,0.1792,1.1792,1.3012,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.29385793995227,1.29385793995227,0.0,HIGH,1
cilostazol,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,0.5305,0.0,0.8529,0.2398,1.2398,1.2805,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.2110423777158301,1.2110423777158301,0.0,HIGH,1
cilostazol,Orphanet_1276,Brachydactyly - arterial hypertension,1.1895599638523269,0.5305,0.0,0.8529,0.2079,1.2079,1.2255,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.189559963852326,1.189559963852326,0.0,HIGH,1
cilostazol,MONDO_0018852,achromatopsia,1.4306619453288874,0.5305,0.0,0.8529,0.0,1.0,1.2202,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.4306619453288871,1.4306619453288871,0.0,HIGH,1
cilostazol,EFO_0000274,atopic eczema,1.1385902761338402,0.5305,0.0,0.8529,0.2398,1.2398,1.2039,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.13859027613384,1.13859027613384,0.0,HIGH,1
cilostazol,MONDO_0005277,migraine disorder,1.1543191180082693,0.5305,0.0,0.8529,0.2079,1.2079,1.1892,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.154319118008269,1.154319118008269,0.0,HIGH,1
cilostazol,MONDO_0013437,retinitis pigmentosa 43,1.1227328916707495,0.5305,0.0,0.8529,0.2398,1.2398,1.1872,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.122732891670749,1.122732891670749,0.0,HIGH,1
cilostazol,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,1.0893989193580678,0.5305,0.0,0.8529,0.2398,1.2398,1.1519,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.089398919358067,1.089398919358067,0.0,HIGH,1
cilostazol,MONDO_0014835,"striatal degeneration, autosomal dominant 2",1.1151901705079166,0.5305,0.0,0.8529,0.2079,1.2079,1.1489,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.115190170507916,1.115190170507916,0.0,HIGH,1
cilostazol,EFO_0000341,chronic obstructive pulmonary disease,1.2583578032560725,0.5305,0.0,0.8529,0.0693,1.0693,1.1476,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.258357803256072,1.258357803256072,0.0,HIGH,1
cilostazol,MONDO_0007211,brachydactyly-arterial hypertension syndrome,1.1120001898216738,0.5305,0.0,0.8529,0.2079,1.2079,1.1456,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.112000189821673,1.112000189821673,0.0,HIGH,1
cilostazol,HP_0000556,Retinal dystrophy,1.073875011489864,0.5305,0.0,0.8529,0.2398,1.2398,1.1355,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.073875011489864,1.073875011489864,0.0,HIGH,1
cilostazol,Orphanet_2754,Joubert syndrome with orofaciodigital defect,1.0707563865225374,0.5305,0.0,0.8529,0.2398,1.2398,1.1322,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.070756386522537,1.070756386522537,0.0,HIGH,1
cilostazol,EFO_0004190,open-angle glaucoma,1.084330600044849,0.5305,0.0,0.8529,0.2079,1.2079,1.1171,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.084330600044849,1.084330600044849,0.0,HIGH,1
cilostazol,EFO_0003913,angina pectoris,1.2926834317608282,0.5305,0.0,0.8529,0.0,1.0,1.1025,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.292683431760828,1.292683431760828,0.0,HIGH,1
cilostazol,EFO_0000275,atrial fibrillation,1.0247870327030362,0.5305,0.0,0.8529,0.2398,1.2398,1.0836,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.024787032703036,1.024787032703036,0.0,HIGH,1
cilostazol,EFO_0001361,pulmonary arterial hypertension,1.240655745766478,0.5305,0.0,0.8529,0.0,1.0,1.0581,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.240655745766478,1.240655745766478,0.0,HIGH,1
cilostazol,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,0.984524524711656,0.5305,0.0,0.8529,0.2398,1.2398,1.041,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9845245247116561,0.9845245247116561,0.0,HIGH,1
cilostazol,EFO_0000479,essential thrombocythemia,0.9617083811407224,0.5305,0.0,0.8529,0.2398,1.2398,1.0169,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9617083811407221,0.9617083811407221,0.0,HIGH,1
cilostazol,EFO_0000612,myocardial infarction,1.1920683342916516,0.5305,0.0,0.8529,0.0,1.0,1.0167,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.192068334291651,1.192068334291651,0.0,HIGH,1
cilostazol,EFO_0003144,heart failure,1.1747090342831998,0.5305,0.0,0.8529,0.0,1.0,1.0019,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,True,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.174709034283199,1.174709034283199,0.0,HIGH,1
cilostazol,MONDO_0005148,type 2 diabetes mellitus,0.9945832614369317,0.5305,0.0,0.8529,0.1792,1.1792,1.0002,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9945832614369311,0.9945832614369311,0.0,HIGH,1
cilostazol,EFO_0000400,diabetes mellitus,0.9605574599143508,0.5305,0.0,0.8529,0.2197,1.2197,0.9992,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.96055745991435,0.96055745991435,0.0,HIGH,1
cilostazol,EFO_0004278,sudden cardiac arrest,0.9396752125518276,0.5305,0.0,0.8529,0.2398,1.2398,0.9936,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9396752125518271,0.9396752125518271,0.0,HIGH,1
cilostazol,EFO_0000284,benign prostatic hyperplasia,1.012492609176383,0.5305,0.0,0.8529,0.1386,1.1386,0.9832,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.012492609176383,1.012492609176383,0.0,HIGH,1
cilostazol,MONDO_0005041,glaucoma,1.1456348841935742,0.5305,0.0,0.8529,0.0,1.0,0.9771,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.145634884193574,1.145634884193574,0.0,HIGH,1
cilostazol,MONDO_0016293,congenital stationary night blindness,1.1393938299890096,0.5305,0.0,0.8529,0.0,1.0,0.9718,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.139393829989009,1.139393829989009,0.0,HIGH,1
cilostazol,MONDO_0005149,pulmonary hypertension,1.131366079877285,0.5305,0.0,0.8529,0.0,1.0,0.9649,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.131366079877285,1.131366079877285,0.0,HIGH,1
cilostazol,MONDO_0005090,schizophrenia,0.9090491626389512,0.5305,0.0,0.8529,0.2398,1.2398,0.9612,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9090491626389511,0.9090491626389511,0.0,HIGH,1
cilostazol,HP_0004419,Recurrent thrombophlebitis,1.1255530380326395,0.5305,0.0,0.8529,0.0,1.0,0.96,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,True,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.125553038032639,1.125553038032639,0.0,HIGH,1
cilostazol,HP_0006536,Airway obstruction,1.119374753690431,0.5305,0.0,0.8529,0.0,1.0,0.9547,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.119374753690431,1.119374753690431,0.0,HIGH,1
cilostazol,HP_0012531,Pain,1.1146136880566135,0.5305,0.0,0.8529,0.0,1.0,0.9506,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.114613688056613,1.114613688056613,0.0,HIGH,1
cilostazol,MONDO_0001134,essential hypertension,1.09990490954711,0.5305,0.0,0.8529,0.0,1.0,0.9381,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.09990490954711,1.09990490954711,0.0,HIGH,1
cilostazol,MONDO_0029137,"hearing loss, autosomal dominant 74",0.9440697062271116,0.5305,0.0,0.8529,0.1609,1.1609,0.9348,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.9440697062271111,0.9440697062271111,0.0,HIGH,1
cilostazol,HP_0100806,Sepsis,1.0850994798692406,0.5305,0.0,0.8529,0.0,1.0,0.9255,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.08509947986924,1.08509947986924,0.0,HIGH,1
cilostazol,Orphanet_228169,Autosomal dominant striatal neurodegeneration,0.8747684226426157,0.5305,0.0,0.8529,0.2398,1.2398,0.925,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.8747684226426151,0.8747684226426151,0.0,HIGH,1
cilostazol,EFO_0000373,congestive heart failure,1.069110912267493,0.5305,0.0,0.8529,0.0,1.0,0.9118,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.069110912267493,1.069110912267493,0.0,HIGH,1
cilostazol,MONDO_0005180,Parkinson disease,0.8584849000525133,0.5305,0.0,0.8529,0.2398,1.2398,0.9078,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.8584849000525131,0.8584849000525131,0.0,HIGH,1
cilostazol,MONDO_0004975,Alzheimer disease,0.851740443206587,0.5305,0.0,0.8529,0.2398,1.2398,0.9006,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.851740443206587,0.851740443206587,0.0,HIGH,1
cilostazol,EFO_0003778,psoriatic arthritis,1.050875687351308,0.5305,0.0,0.8529,0.0,1.0,0.8963,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.050875687351308,1.050875687351308,0.0,HIGH,1
cilostazol,MONDO_0012398,retinal cone dystrophy 3A,0.8420650580859055,0.5305,0.0,0.8529,0.2398,1.2398,0.8904,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,0.842065058085905,0.842065058085905,0.0,HIGH,1
cilostazol,MONDO_0019797,acrodysostosis,1.03386441620032,0.5305,0.0,0.8529,0.0,1.0,0.8818,1,TERMINATED,STOPPED,Peripheral Arterial Disease | Claudication (Finding),Original PI left institution,False,"Arthritis, Rheumatoid; Atherosclerosis; CADASIL; Cardiovascular Diseases; Cerebral Infarction",,,1.03386441620032,1.03386441620032,0.0,HIGH,1
colchicine,MONDO_0012703,lissencephaly due to TUBA1A mutation,13.136414449407498,0.7399,0.0,0.8009,0.2398,1.2398,13.0444,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.313641,1.313641,0.0,HIGH,10
colchicine,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,13.12919255867715,0.7399,0.0,0.8009,0.2398,1.2398,13.0372,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.312919,1.312919,0.0,HIGH,10
colchicine,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,12.977335361212427,0.7399,0.0,0.8009,0.2398,1.2398,12.8864,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.297734,1.297734,0.0,HIGH,10
colchicine,MONDO_0004976,amyotrophic lateral sclerosis,12.838683450861703,0.7399,0.0,0.8009,0.2398,1.2398,12.7488,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.24448,1.33652,0.09204,HIGH,10
colchicine,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",12.786414434034509,0.7399,0.0,0.8009,0.2398,1.2398,12.6969,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.278641,1.278641,0.0,HIGH,10
colchicine,Orphanet_183506,Genetic central nervous system malformation,12.763070556018697,0.7399,0.0,0.8009,0.2398,1.2398,12.6737,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.276307,1.276307,0.0,HIGH,10
colchicine,EFO_1001985,congenital fibrosis of the extraocular muscles,12.462325847941036,0.7399,0.0,0.8009,0.2398,1.2398,12.375,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.246233,1.246233,0.0,HIGH,10
colchicine,MONDO_0012905,hypomyelinating leukodystrophy 6,12.303472963501092,0.7399,0.0,0.8009,0.2398,1.2398,12.2173,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.230347,1.230347,0.0,HIGH,10
colchicine,EFO_0003060,non-small cell lung carcinoma,12.793850598546944,0.7399,0.0,0.8009,0.1792,1.1792,12.0831,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.26925,1.290634,0.021384,HIGH,10
colchicine,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,12.13336275379104,0.7399,0.0,0.8009,0.2398,1.2398,12.0484,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.213336,1.213336,0.0,HIGH,10
colchicine,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,12.090169792908508,0.7399,0.0,0.8009,0.2398,1.2398,12.0055,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.209017,1.209017,0.0,HIGH,10
colchicine,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,12.00098212718321,0.7399,0.0,0.8009,0.2398,1.2398,11.9169,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.200098,1.200098,0.0,HIGH,10
colchicine,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,12.000664971634906,0.7399,0.0,0.8009,0.2398,1.2398,11.9166,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.200066,1.200066,0.0,HIGH,10
colchicine,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,11.875585571904995,0.7399,0.0,0.8009,0.2398,1.2398,11.7924,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.187559,1.187559,0.0,HIGH,10
colchicine,Orphanet_98805,"Primary dystonia, DYT4 type",11.80562558543578,0.7399,0.0,0.8009,0.2398,1.2398,11.7229,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.180563,1.180563,0.0,HIGH,10
colchicine,Orphanet_404469,Female infertility due to fertilization defect,12.136046598229504,0.7399,0.0,0.8009,0.1792,1.1792,11.4619,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.213605,1.213605,0.0,HIGH,10
colchicine,MONDO_0007493,torsion dystonia 4,11.464047185131626,0.7399,0.0,0.8009,0.2398,1.2398,11.3838,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.146405,1.146405,0.0,HIGH,10
colchicine,EFO_0000305,breast carcinoma,12.185931951650362,0.7399,0.0,0.8009,0.1609,1.1609,11.331,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.214505,1.223742,0.009237,HIGH,10
colchicine,EFO_0001378,multiple myeloma,11.782262662766955,0.7399,0.0,0.8009,0.1792,1.1792,11.1277,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.168918,1.188783,0.019866,HIGH,10
colchicine,EFO_0003869,breast neoplasm,12.18812415110853,0.7399,0.0,0.8009,0.1386,1.1386,11.1152,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.215778,1.223364,0.007585,HIGH,10
colchicine,MONDO_0014341,complex cortical dysplasia with other brain malformations 6,10.765187665341704,0.7399,0.0,0.8009,0.2398,1.2398,10.6898,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.076519,1.076519,0.0,HIGH,10
colchicine,EFO_0000183,Hodgkins lymphoma,11.38533988619736,0.7399,0.0,0.8009,0.1609,1.1609,10.5866,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.128135,1.151946,0.023812,HIGH,10
colchicine,MONDO_0008170,ovarian cancer,11.16871534450116,0.7399,0.0,0.8009,0.1792,1.1792,10.5483,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.111619,1.124037,0.012417,HIGH,10
colchicine,EFO_0000616,neoplasm,13.131907804859832,0.7399,0.0,0.8009,0.0,1.0,10.5179,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.301573,1.326562,0.024989,HIGH,10
colchicine,HP_0001339,Lissencephaly,10.471078353307096,0.7399,0.0,0.8009,0.2398,1.2398,10.3977,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.047108,1.047108,0.0,HIGH,10
colchicine,MONDO_0007254,breast cancer,12.916087666167307,0.7399,0.0,0.8009,0.0,1.0,10.345,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.281377,1.302965,0.021588,HIGH,10
colchicine,MONDO_0008315,prostate cancer,12.79403355725126,0.7399,0.0,0.8009,0.0,1.0,10.2472,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.27003,1.290659,0.020629,HIGH,10
colchicine,MONDO_0060650,Leber congenital amaurosis with early-onset deafness,10.257955750077706,0.7399,0.0,0.8009,0.2398,1.2398,10.1861,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.025796,1.025796,0.0,HIGH,10
colchicine,EFO_0000574,lymphoma,11.800025529955716,0.7399,0.0,0.8009,0.0693,1.0693,10.1062,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.157157,1.209795,0.052638,HIGH,10
colchicine,EFO_0002618,pancreatic carcinoma,10.575884212228294,0.7399,0.0,0.8009,0.1792,1.1792,9.9884,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.053184,1.063805,0.010621,HIGH,10
colchicine,MONDO_0015372,autosomal dominant macrothrombocytopenia,12.442397045113934,0.7399,0.0,0.8009,0.0,1.0,9.9656,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.24424,1.24424,0.0,HIGH,10
colchicine,MONDO_0100153,tubulinopathy,12.419112806551189,0.7399,0.0,0.8009,0.0,1.0,9.947,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.241911,1.241911,0.0,HIGH,10
colchicine,EFO_0000673,prostate adenocarcinoma,10.894123861980978,0.7399,0.0,0.8009,0.1386,1.1386,9.9351,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.086007,1.092818,0.006811,HIGH,10
colchicine,MONDO_0004992,cancer,12.262479395961256,0.7399,0.0,0.8009,0.0,1.0,9.8215,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.210926,1.246538,0.035611,HIGH,10
colchicine,MONDO_0002974,cervical cancer,10.711343274447977,0.7399,0.0,0.8009,0.1386,1.1386,9.7685,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.067878,1.076791,0.008913,HIGH,10
colchicine,HP_0001249,Intellectual disability,9.721168921473195,0.7399,0.0,0.8009,0.2398,1.2398,9.6531,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.972117,0.972117,0.0,HIGH,10
colchicine,EFO_0004274,gout,11.581626799710406,0.7399,0.0,0.8009,0.0,1.0,9.2762,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.152455,1.166317,0.013862,HIGH,10
colchicine,EFO_0000403,diffuse large B-cell lymphoma,11.3066355276063,0.7399,0.0,0.8009,0.0,1.0,9.0559,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.120472,1.142747,0.022275,HIGH,10
colchicine,MONDO_0018088,familial Mediterranean fever,11.290054240048232,0.7399,0.0,0.8009,0.0,1.0,9.0426,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.129005,1.129005,0.0,HIGH,10
colchicine,EFO_1000359,Malignant Pancreatic Neoplasm,9.54904841681508,0.7399,0.0,0.8009,0.1386,1.1386,8.7085,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.954905,0.954905,0.0,HIGH,10
colchicine,EFO_0005952,non-Hodgkins lymphoma,10.83394780915244,0.7399,0.0,0.8009,0.0,1.0,8.6773,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.078943,1.090683,0.01174,HIGH,10
colchicine,MONDO_0007990,multiple benign circumferential skin creases on limbs,10.822626185927184,0.7399,0.0,0.8009,0.0,1.0,8.6683,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.082263,1.082263,0.0,HIGH,10
colchicine,EFO_0006859,head and neck malignant neoplasia,10.778062178781648,0.7399,0.0,0.8009,0.0,1.0,8.6326,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.076424,1.07988,0.003457,HIGH,10
colchicine,MONDO_0008903,lung cancer,9.08922134112784,0.7399,0.0,0.8009,0.1792,1.1792,8.5843,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.905653,0.913942,0.008289,HIGH,10
colchicine,EFO_0000621,neuroblastoma,8.64353503417389,0.7399,0.0,0.8009,0.2398,1.2398,8.583,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.860754,0.869434,0.00868,HIGH,10
colchicine,EFO_0000756,melanoma,8.784486662205612,0.7399,0.0,0.8009,0.2197,1.2197,8.5818,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.872439,0.885626,0.013187,HIGH,10
colchicine,MONDO_0018763,tubulinopathy-associated dysgyria,10.697868931290662,0.7399,0.0,0.8009,0.0,1.0,8.5683,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.069787,1.069787,0.0,HIGH,10
colchicine,MONDO_0012450,spinocerebellar ataxia type 28,8.584225978384074,0.7399,0.0,0.8009,0.2398,1.2398,8.5241,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,0.858423,0.858423,0.0,HIGH,10
colchicine,EFO_0005772,neurodegenerative disease,10.617656249963789,0.7399,0.0,0.8009,0.0,1.0,8.5041,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.047752,1.078928,0.031176,HIGH,10
colchicine,EFO_0003897,stomach neoplasm,10.613879807363434,0.7399,0.0,0.8009,0.0,1.0,8.5011,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Asthma; Atherosclerosis",,,1.060261,1.063641,0.00338,HIGH,10
dabigatran,MONDO_0013361,congenital prothrombin deficiency,13.214198615974531,0.7996,0.05,0.7789,0.2398,1.2398,12.7606,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.307097,1.342905,0.035808,HIGH,10
dabigatran,Orphanet_325,Congenital factor II deficiency,12.87408211242687,0.7996,0.05,0.7789,0.2398,1.2398,12.4322,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.273454,1.30834,0.034886,HIGH,10
dabigatran,MONDO_0008559,thrombophilia due to thrombin defect,11.798238408285806,0.7996,0.05,0.7789,0.2079,1.2079,11.1006,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.179824,1.179824,0.0,HIGH,10
dabigatran,EFO_0000712,stroke,11.311107791328386,0.7996,0.05,0.7789,0.1386,1.1386,10.0316,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.108785,1.157707,0.048923,HIGH,10
dabigatran,HP_0004936,Venous thrombosis,10.381129567775943,0.7996,0.05,0.7789,0.2398,1.2398,10.0248,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.003005,1.090775,0.08777,HIGH,10
dabigatran,EFO_0000275,atrial fibrillation,9.69180209013457,0.7996,0.05,0.7789,0.2398,1.2398,9.3591,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.943677,0.998331,0.054654,HIGH,10
dabigatran,HP_0001873,Thrombocytopenia,9.739604121892308,0.7996,0.05,0.7789,0.2079,1.2079,9.1637,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.958295,0.989626,0.031331,HIGH,10
dabigatran,EFO_0004286,venous thromboembolism,11.602923660116414,0.7996,0.05,0.7789,0.0,1.0,9.0375,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.143319,1.186154,0.042835,HIGH,10
dabigatran,EFO_1000954,habitual abortion,9.426231943358925,0.7996,0.05,0.7789,0.1792,1.1792,8.6576,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.932406,0.957949,0.025543,HIGH,10
dabigatran,EFO_0003907,deep vein thrombosis,11.012276190948173,0.7996,0.05,0.7789,0.0,1.0,8.5775,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.089291,1.119132,0.029841,HIGH,10
dabigatran,EFO_0003827,pulmonary embolism,10.627550521226969,0.7996,0.05,0.7789,0.0,1.0,8.2778,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.051236,1.080034,0.028799,HIGH,10
dabigatran,HP_0001907,Thromboembolism,10.589430495672437,0.7996,0.05,0.7789,0.0,1.0,8.2481,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.041819,1.076067,0.034249,HIGH,10
dabigatran,HP_0002140,Ischemic stroke,10.51562677425201,0.7996,0.05,0.7789,0.0,1.0,8.1906,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.030728,1.072397,0.04167,HIGH,10
dabigatran,MONDO_0024307,prothrombin deficiency,10.49402556648148,0.7996,0.05,0.7789,0.0,1.0,8.1738,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,1.049403,1.049403,0.0,HIGH,10
dabigatran,EFO_0000319,cardiovascular disease,10.031118203333463,0.7996,0.05,0.7789,0.0,1.0,7.8132,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.962471,1.072505,0.110034,MEDIUM,10
dabigatran,EFO_0003777,heart disease,9.87289999288842,0.7996,0.05,0.7789,0.0,1.0,7.69,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.967906,1.008864,0.040958,HIGH,10
dabigatran,MONDO_0000831,thrombotic disease,9.144569257145148,0.7996,0.05,0.7789,0.0,1.0,7.1227,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.904545,0.929325,0.02478,HIGH,10
dabigatran,HP_0004419,Recurrent thrombophlebitis,9.139430166927523,0.7996,0.05,0.7789,0.0,1.0,7.1187,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.904037,0.928803,0.024766,HIGH,10
dabigatran,EFO_0005672,acute coronary syndrome,8.787660906841603,0.7996,0.05,0.7789,0.0,1.0,6.8447,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.861355,0.896177,0.034822,HIGH,10
dabigatran,EFO_1001395,Phlebitis,8.606528252109753,0.7996,0.05,0.7789,0.0,1.0,6.7036,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.851324,0.874646,0.023322,HIGH,10
dabigatran,HP_0004418,Thrombophlebitis,8.578169386233197,0.7996,0.05,0.7789,0.0,1.0,6.6815,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.848519,0.871764,0.023245,HIGH,10
dabigatran,EFO_0009314,blood coagulation disease,8.565403884037416,0.7996,0.05,0.7789,0.0,1.0,6.6716,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.847256,0.870467,0.023211,HIGH,10
dabigatran,EFO_0000612,myocardial infarction,8.221947345653396,0.7996,0.05,0.7789,0.0,1.0,6.4041,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.681669,0.967482,0.285813,LOW,10
dabigatran,HP_0001976,Reduced antithrombin III activity,8.111784333809716,0.7996,0.05,0.7789,0.0,1.0,6.3183,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.6634,1.032846,0.369446,LOW,10
dabigatran,EFO_0001645,coronary artery disease,6.542505852881755,0.7996,0.05,0.7789,0.2303,1.2303,6.2694,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.577579,0.799768,0.222189,MEDIUM,10
dabigatran,EFO_0009315,thrombophilia,7.996263789080825,0.7996,0.05,0.7789,0.0,1.0,6.2283,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.790959,0.812627,0.021668,HIGH,10
dabigatran,MONDO_0004596,cor pulmonale,7.540131929732645,0.7996,0.05,0.7789,0.0,1.0,5.873,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.754013,0.754013,0.0,HIGH,10
dabigatran,EFO_1000985,intermediate coronary syndrome,7.191203995170174,0.7996,0.05,0.7789,0.0,1.0,5.6012,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.708601,0.735149,0.026548,HIGH,10
dabigatran,EFO_1001408,Pulmonary Infarction,6.907923553132634,0.7996,0.05,0.7789,0.0,1.0,5.3806,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.690792,0.690792,0.0,HIGH,10
dabigatran,HP_0001977,Abnormal thrombosis,6.894063750408842,0.7996,0.05,0.7789,0.0,1.0,5.3698,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.681934,0.700615,0.018682,HIGH,10
dabigatran,EFO_0000195,metabolic syndrome,5.1730715490870205,0.7996,0.05,0.7789,0.2398,1.2398,4.9955,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.466005,0.603264,0.137259,MEDIUM,10
dabigatran,HP_0008151,Prolonged prothrombin time,6.033437018130079,0.7996,0.05,0.7789,0.0,1.0,4.6994,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.603344,0.603344,0.0,HIGH,10
dabigatran,EFO_0000538,hypertrophic cardiomyopathy,4.778913703204888,0.7996,0.05,0.7789,0.2398,1.2398,4.6149,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.470205,0.485578,0.015373,HIGH,10
dabigatran,EFO_0010726,total joint arthroplasty,5.8862800176878824,0.7996,0.05,0.7789,0.0,1.0,4.5848,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.588628,0.588628,0.0,HIGH,10
dabigatran,MONDO_0013144,hereditary antithrombin deficiency,4.779498819493321,0.7996,0.05,0.7789,0.2303,1.2303,4.58,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.206657,0.884889,0.678232,LOW,10
dabigatran,HP_0005521,Disseminated intravascular coagulation,5.827911372732706,0.7996,0.05,0.7789,0.0,1.0,4.5394,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.576474,0.592267,0.015792,HIGH,10
dabigatran,EFO_0000668,preeclampsia,4.477981155949813,0.7996,0.05,0.7789,0.2398,1.2398,4.3243,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.439006,0.457583,0.018577,HIGH,10
dabigatran,EFO_0000266,aortic stenosis,4.475942784462324,0.7996,0.05,0.7789,0.2303,1.2303,4.2891,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.419962,0.481633,0.061671,HIGH,10
dabigatran,MONDO_0005148,type 2 diabetes mellitus,4.549390572149469,0.7996,0.05,0.7789,0.1792,1.1792,4.1784,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.236048,0.680011,0.443964,LOW,10
dabigatran,EFO_0008583,acute myocardial infarction,5.326417984863719,0.7996,0.05,0.7789,0.0,1.0,4.1487,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.500136,0.567587,0.067451,HIGH,10
dabigatran,MONDO_0002243,hemorrhagic disease,5.267198386152138,0.7996,0.05,0.7789,0.0,1.0,4.1026,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.521011,0.535284,0.014273,HIGH,10
dabigatran,MONDO_0002242,coagulation protein disease,5.254923446877424,0.7996,0.05,0.7789,0.0,1.0,4.0931,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.525492,0.525492,0.0,HIGH,10
dabigatran,EFO_0003818,lung disease,5.132807062522126,0.7996,0.05,0.7789,0.0,1.0,3.9979,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.497268,0.54265,0.045382,HIGH,10
dabigatran,MONDO_0002610,purpura,4.985165226923087,0.7996,0.05,0.7789,0.0,1.0,3.8829,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.493113,0.506622,0.013509,HIGH,10
dabigatran,EFO_0000546,injury,4.845981341018051,0.7996,0.05,0.7789,0.0,1.0,3.7745,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.434651,0.54553,0.110879,MEDIUM,10
dabigatran,EFO_0000400,diabetes mellitus,3.8729731915022607,0.7996,0.05,0.7789,0.2197,1.2197,3.6795,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.17863,0.631788,0.453158,LOW,10
dabigatran,HP_0002590,Paralytic ileus,4.693101124734878,0.7996,0.05,0.7789,0.0,1.0,3.6555,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.46931,0.46931,0.0,HIGH,10
dabigatran,EFO_0000713,subarachnoid hemorrhage,4.363494866783165,0.7996,0.05,0.7789,0.0,1.0,3.3987,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.427704,0.444995,0.017291,HIGH,10
dabigatran,MONDO_0100096,COVID-19,4.270914208684318,0.7996,0.05,0.7789,0.0,1.0,3.3266,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.256115,0.586454,0.330339,LOW,10
dabigatran,HP_0001871,Abnormality of blood and blood-forming tissues,4.267553012823713,0.7996,0.05,0.7789,0.0,1.0,3.324,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Atrial Fibrillation; CADASIL; Hematoma; Hemorrhage; Ischemic Stroke,,,0.426755,0.426755,0.0,HIGH,10
dipyridamole,MONDO_0019200,retinitis pigmentosa,15.641324579625012,0.6185,0.0,0.8307,0.2079,1.2079,15.6943,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.55637,1.577599,0.021229,HIGH,10
dipyridamole,EFO_0001645,coronary artery disease,14.439201364026214,0.6185,0.0,0.8307,0.2303,1.2303,14.7558,,,,,,True,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.437667,1.45583,0.018163,HIGH,10
dipyridamole,Orphanet_1872,Cone rod dystrophy,13.412481162742882,0.6185,0.0,0.8307,0.2398,1.2398,13.8127,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.333657,1.354397,0.020739,HIGH,10
dipyridamole,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,12.823759951301383,0.6185,0.0,0.8307,0.2398,1.2398,13.2064,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.282376,1.282376,0.0,HIGH,10
dipyridamole,EFO_0000712,stroke,13.820477704299568,0.6185,0.0,0.8307,0.1386,1.1386,13.0716,,,,,,True,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.377347,1.390357,0.01301,HIGH,10
dipyridamole,EFO_0000676,psoriasis,12.349526236969757,0.6185,0.0,0.8307,0.2398,1.2398,12.718,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.226921,1.247799,0.020878,HIGH,10
dipyridamole,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,12.17714223482543,0.6185,0.0,0.8307,0.2398,1.2398,12.5405,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.211042,1.231058,0.020016,HIGH,10
dipyridamole,MONDO_0004979,asthma,12.59878064533602,0.6185,0.0,0.8307,0.1792,1.1792,12.3404,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.248402,1.276123,0.02772,HIGH,10
dipyridamole,Orphanet_1276,Brachydactyly - arterial hypertension,11.895599638523269,0.6185,0.0,0.8307,0.2079,1.2079,11.9359,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.18956,1.18956,0.0,HIGH,10
dipyridamole,MONDO_0018852,achromatopsia,14.355278126521654,0.6185,0.0,0.8307,0.0,1.0,11.9243,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.430662,1.44526,0.014598,HIGH,10
dipyridamole,EFO_0000319,cardiovascular disease,14.266911178053556,0.6185,0.0,0.8307,0.0,1.0,11.8509,,,,,,True,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.39055,1.477446,0.086896,HIGH,10
dipyridamole,EFO_0000537,hypertension,12.077640842178829,0.6185,0.0,0.8307,0.1609,1.1609,11.647,,,,,,True,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.109169,1.353358,0.244189,MEDIUM,10
dipyridamole,MONDO_0013437,retinitis pigmentosa 43,11.289182249243812,0.6185,0.0,0.8307,0.2398,1.2398,11.6261,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.122733,1.141289,0.018556,HIGH,10
dipyridamole,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,10.996588770843443,0.6185,0.0,0.8307,0.2398,1.2398,11.3247,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.089399,1.120179,0.03078,HIGH,10
dipyridamole,EFO_0000274,atopic eczema,10.995354903518583,0.6185,0.0,0.8307,0.2398,1.2398,11.3235,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.093313,1.110315,0.017002,HIGH,10
dipyridamole,MONDO_0014835,"striatal degeneration, autosomal dominant 2",11.151901705079164,0.6185,0.0,0.8307,0.2079,1.2079,11.1897,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.11519,1.11519,0.0,HIGH,10
dipyridamole,MONDO_0007211,brachydactyly-arterial hypertension syndrome,11.12000189821674,0.6185,0.0,0.8307,0.2079,1.2079,11.1577,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.112,1.112,0.0,HIGH,10
dipyridamole,HP_0000556,Retinal dystrophy,10.78322278756278,0.6185,0.0,0.8307,0.2398,1.2398,11.105,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.073875,1.087217,0.013342,HIGH,10
dipyridamole,Orphanet_2754,Joubert syndrome with orofaciodigital defect,10.707563865225374,0.6185,0.0,0.8307,0.2398,1.2398,11.0271,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.070756,1.070756,0.0,HIGH,10
dipyridamole,EFO_0000341,chronic obstructive pulmonary disease,12.411827198694535,0.6185,0.0,0.8307,0.0693,1.0693,11.0246,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.234352,1.252073,0.017721,HIGH,10
dipyridamole,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,9.881719153241216,0.6185,0.0,0.8307,0.2398,1.2398,10.1766,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.984525,0.995467,0.010942,HIGH,10
dipyridamole,EFO_0001361,pulmonary arterial hypertension,12.101086574403976,0.6185,0.0,0.8307,0.0,1.0,10.0519,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.203602,1.219324,0.015722,HIGH,10
dipyridamole,EFO_0000479,essential thrombocythemia,9.652712442622173,0.6185,0.0,0.8307,0.2398,1.2398,9.9408,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.961708,0.972397,0.010689,HIGH,10
dipyridamole,MONDO_0005090,schizophrenia,9.354715689788913,0.6185,0.0,0.8307,0.2398,1.2398,9.6339,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.909049,0.987932,0.078882,HIGH,10
dipyridamole,MONDO_0016293,congenital stationary night blindness,11.50124639724121,0.6185,0.0,0.8307,0.0,1.0,9.5536,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.139394,1.171586,0.032192,HIGH,10
dipyridamole,EFO_0000284,benign prostatic hyperplasia,9.792364052541169,0.6185,0.0,0.8307,0.1386,1.1386,9.2617,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.964912,1.001063,0.036151,HIGH,10
dipyridamole,HP_0006536,Airway obstruction,11.097962362283225,0.6185,0.0,0.8307,0.0,1.0,9.2186,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.108732,1.111925,0.003193,HIGH,10
dipyridamole,MONDO_0005148,type 2 diabetes mellitus,9.396415524672433,0.6185,0.0,0.8307,0.1792,1.1792,9.2037,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.927424,0.956659,0.029235,HIGH,10
dipyridamole,EFO_0000400,diabetes mellitus,9.079490906837249,0.6185,0.0,0.8307,0.2197,1.2197,9.1991,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.836776,1.038756,0.20198,MEDIUM,10
dipyridamole,MONDO_0029137,"hearing loss, autosomal dominant 74",9.440697062271116,0.6185,0.0,0.8307,0.1609,1.1609,9.1041,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.94407,0.94407,0.0,HIGH,10
dipyridamole,Orphanet_228169,Autosomal dominant striatal neurodegeneration,8.825768126474724,0.6185,0.0,0.8307,0.2398,1.2398,9.0891,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.874768,0.898194,0.023425,HIGH,10
dipyridamole,HP_0004419,Recurrent thrombophlebitis,10.77080478782273,0.6185,0.0,0.8307,0.0,1.0,8.9468,,,,,,True,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.071695,1.087852,0.016158,HIGH,10
dipyridamole,MONDO_0005149,pulmonary hypertension,10.554870760004448,0.6185,0.0,0.8307,0.0,1.0,8.7675,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.037613,1.080092,0.042479,HIGH,10
dipyridamole,EFO_0003778,psoriatic arthritis,10.544498522227547,0.6185,0.0,0.8307,0.0,1.0,8.7589,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.050876,1.061598,0.010722,HIGH,10
dipyridamole,MONDO_0004975,Alzheimer disease,8.502545410124078,0.6185,0.0,0.8307,0.2398,1.2398,8.7563,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.842869,0.864064,0.021195,HIGH,10
dipyridamole,EFO_0003144,heart failure,10.508495381643543,0.6185,0.0,0.8307,0.0,1.0,8.729,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.997965,1.13814,0.140175,MEDIUM,10
dipyridamole,MONDO_0012398,retinal cone dystrophy 3A,8.420650580859055,0.6185,0.0,0.8307,0.2398,1.2398,8.6719,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.842065,0.842065,0.0,HIGH,10
dipyridamole,MONDO_0019797,acrodysostosis,10.3386441620032,0.6185,0.0,0.8307,0.0,1.0,8.5879,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,1.033864,1.033864,0.0,HIGH,10
dipyridamole,EFO_0005772,neurodegenerative disease,10.07328759971719,0.6185,0.0,0.8307,0.0,1.0,8.3675,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.985099,1.041296,0.056197,HIGH,10
dipyridamole,EFO_0000275,atrial fibrillation,8.035965181425158,0.6185,0.0,0.8307,0.2398,1.2398,8.2758,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.706053,0.963849,0.257796,LOW,10
dipyridamole,EFO_0004705,hypothyroidism,9.928579170755716,0.6185,0.0,0.8307,0.0,1.0,8.2472,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.991321,0.995932,0.004611,HIGH,10
dipyridamole,EFO_0004234,erectile dysfunction,9.889311596126555,0.6185,0.0,0.8307,0.0,1.0,8.2146,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.974386,1.011093,0.036707,HIGH,10
dipyridamole,MONDO_0002009,major depressive disorder,8.839801874029096,0.6185,0.0,0.8307,0.1099,1.1099,8.1495,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.8794,0.892776,0.013375,HIGH,10
dipyridamole,EFO_1001494,psoriasis vulgaris,9.78861703720962,0.6185,0.0,0.8307,0.0,1.0,8.131,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.974898,0.986789,0.011891,HIGH,10
dipyridamole,HP_0000924,Abnormality of the skeletal system,9.742822042204594,0.6185,0.0,0.8307,0.0,1.0,8.0929,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.967041,0.988765,0.021724,HIGH,10
dipyridamole,MONDO_0005180,Parkinson disease,7.7882453315223215,0.6185,0.0,0.8307,0.2398,1.2398,8.0206,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.765712,0.801912,0.036201,HIGH,10
dipyridamole,EFO_0000729,ulcerative colitis,7.781988002468127,0.6185,0.0,0.8307,0.2398,1.2398,8.0142,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.769603,0.793477,0.023874,HIGH,10
dipyridamole,HP_0000802,Impotence,9.549568639006026,0.6185,0.0,0.8307,0.0,1.0,7.9324,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.954957,0.954957,0.0,HIGH,10
dipyridamole,MONDO_0013616,"pigmented nodular adrenocortical disease, primary, 3",8.342984386181229,0.6185,0.0,0.8307,0.1386,1.1386,7.8909,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.834298,0.834298,0.0,HIGH,10
dipyridamole,EFO_0000508,genetic disorder,9.48382902901963,0.6185,0.0,0.8307,0.0,1.0,7.8778,,,,,,False,"Anemia, Sickle Cell; Angina, Stable; Arthritis, Rheumatoid; Cardiovascular Diseases; Carotid Stenosis",,,0.92326,0.998629,0.075369,HIGH,10
dipyridamole + aspirin,EFO_0000729,ulcerative colitis,3.028574628395389,0.0,0.0,1.0,0.2398,1.2398,3.7548,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.66332,0.687562,0.024242,HIGH,9
dipyridamole + aspirin,MONDO_0005178,osteoarthritis,2.9926984680923736,0.0,0.0,1.0,0.2303,1.2303,3.6818,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.657531,0.676756,0.019224,HIGH,9
dipyridamole + aspirin,EFO_0000685,rheumatoid arthritis,2.9461111980223893,0.0,0.0,1.0,0.2398,1.2398,3.6526,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.647296,0.666221,0.018925,HIGH,9
dipyridamole + aspirin,EFO_0001645,coronary artery disease,2.967346929094094,0.0,0.0,1.0,0.2303,1.2303,3.6506,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.651961,0.671023,0.019061,HIGH,9
dipyridamole + aspirin,MONDO_0005277,migraine disorder,3.02148961715847,0.0,0.0,1.0,0.2079,1.2079,3.6498,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.66869,0.676947,0.008258,HIGH,9
dipyridamole + aspirin,MONDO_0005129,cataract,2.843251731325658,0.0,0.0,1.0,0.2398,1.2398,3.525,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.631834,0.631834,0.0,HIGH,9
dipyridamole + aspirin,HP_0002014,Diarrhea,2.6681575248217166,0.0,0.0,1.0,0.2398,1.2398,3.308,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.58439,0.609991,0.025601,HIGH,9
dipyridamole + aspirin,EFO_0000712,stroke,2.885972540519022,0.0,0.0,1.0,0.1386,1.1386,3.2861,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.638698,0.646585,0.007887,HIGH,9
dipyridamole + aspirin,EFO_0004274,gout,3.0093225982323077,0.0,0.0,1.0,0.0,1.0,3.0093,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.663278,0.676929,0.013651,HIGH,9
dipyridamole + aspirin,HP_0012531,Pain,2.969642929743467,0.0,0.0,1.0,0.0,1.0,2.9696,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.645121,0.686864,0.041743,HIGH,9
dipyridamole + aspirin,EFO_0004253,nephrolithiasis,2.4799806585570447,0.0,0.0,1.0,0.1946,1.1946,2.9626,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.548848,0.555625,0.006778,HIGH,9
dipyridamole + aspirin,HP_0002315,Headache,2.9308249163677176,0.0,0.0,1.0,0.0,1.0,2.9308,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.651294,0.651294,0.0,HIGH,9
dipyridamole + aspirin,HP_0001945,Fever,2.925472504762223,0.0,0.0,1.0,0.0,1.0,2.9255,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.644797,0.658068,0.013271,HIGH,9
dipyridamole + aspirin,EFO_0002609,juvenile idiopathic arthritis,2.921816347047779,0.0,0.0,1.0,0.0,1.0,2.9218,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.643991,0.657245,0.013254,HIGH,9
dipyridamole + aspirin,HP_0100607,Dysmenorrhea,2.9139560307600765,0.0,0.0,1.0,0.0,1.0,2.914,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.647546,0.647546,0.0,HIGH,9
dipyridamole + aspirin,EFO_0003898,ankylosing spondylitis,2.905429966565633,0.0,0.0,1.0,0.0,1.0,2.9054,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.645651,0.645651,0.0,HIGH,9
dipyridamole + aspirin,HP_0001643,Patent ductus arteriosus,2.890566894016474,0.0,0.0,1.0,0.0,1.0,2.8906,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.639715,0.647615,0.0079,HIGH,9
dipyridamole + aspirin,MONDO_0002258,pharyngitis,2.887250937509944,0.0,0.0,1.0,0.0,1.0,2.8873,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.641611,0.641611,0.0,HIGH,9
dipyridamole + aspirin,EFO_0007214,common cold,2.880793704982034,0.0,0.0,1.0,0.0,1.0,2.8808,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.640176,0.640176,0.0,HIGH,9
dipyridamole + aspirin,EFO_0005755,rheumatic disease,2.874289323346027,0.0,0.0,1.0,0.0,1.0,2.8743,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.638731,0.638731,0.0,HIGH,9
dipyridamole + aspirin,EFO_0010072,toothache,2.8734582937879205,0.0,0.0,1.0,0.0,1.0,2.8735,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.635929,0.643782,0.007853,HIGH,9
dipyridamole + aspirin,HP_0003418,Back pain,2.8682794999675165,0.0,0.0,1.0,0.0,1.0,2.8683,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.634782,0.642621,0.007839,HIGH,9
dipyridamole + aspirin,EFO_0005856,arthritis,2.8340070095436296,0.0,0.0,1.0,0.0,1.0,2.834,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.629779,0.629779,0.0,HIGH,9
dipyridamole + aspirin,EFO_0000612,myocardial infarction,2.81749154989488,0.0,0.0,1.0,0.0,1.0,2.8175,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.620997,0.633778,0.012781,HIGH,9
dipyridamole + aspirin,HP_0003326,Myalgia,2.810477385346556,0.0,0.0,1.0,0.0,1.0,2.8105,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.624551,0.624551,0.0,HIGH,9
dipyridamole + aspirin,MONDO_0003937,spondylitis,2.8015330232913853,0.0,0.0,1.0,0.0,1.0,2.8015,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.622563,0.622563,0.0,HIGH,9
dipyridamole + aspirin,HP_0002829,Arthralgia,2.8010250848619966,0.0,0.0,1.0,0.0,1.0,2.801,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.62245,0.62245,0.0,HIGH,9
dipyridamole + aspirin,EFO_0009846,muscle cramp,2.7997697295245,0.0,0.0,1.0,0.0,1.0,2.7998,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.622171,0.622171,0.0,HIGH,9
dipyridamole + aspirin,EFO_0007328,influenza,2.7778821450698974,0.0,0.0,1.0,0.0,1.0,2.7779,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.610334,0.628178,0.017844,HIGH,9
dipyridamole + aspirin,EFO_0009582,sprain,2.7618875287683817,0.0,0.0,1.0,0.0,1.0,2.7619,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.613753,0.613753,0.0,HIGH,9
dipyridamole + aspirin,EFO_0002496,actinic keratosis,2.7565460899137566,0.0,0.0,1.0,0.0,1.0,2.7565,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.612566,0.612566,0.0,HIGH,9
dipyridamole + aspirin,EFO_0004142,colorectal neoplasm,2.281793953087186,0.0,0.0,1.0,0.2079,1.2079,2.7563,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.507065,0.507065,0.0,HIGH,9
dipyridamole + aspirin,EFO_0005752,eye inflammation,2.6932937839661144,0.0,0.0,1.0,0.0,1.0,2.6933,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.59851,0.59851,0.0,HIGH,9
dipyridamole + aspirin,EFO_0000319,cardiovascular disease,2.6712585017926527,0.0,0.0,1.0,0.0,1.0,2.6713,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.586907,0.604067,0.017159,HIGH,9
dipyridamole + aspirin,HP_0002018,Nausea,2.6658753558323465,0.0,0.0,1.0,0.0,1.0,2.6659,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.589988,0.597274,0.007286,HIGH,9
dipyridamole + aspirin,MONDO_0002471,bursitis,2.661093680727642,0.0,0.0,1.0,0.0,1.0,2.6611,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.591354,0.591354,0.0,HIGH,9
dipyridamole + aspirin,EFO_0009454,gastric ulcer,2.6303766755650777,0.0,0.0,1.0,0.0,1.0,2.6304,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.584528,0.584528,0.0,HIGH,9
dipyridamole + aspirin,HP_0200026,Ocular pain,2.6297567317792523,0.0,0.0,1.0,0.0,1.0,2.6298,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.58439,0.58439,0.0,HIGH,9
dipyridamole + aspirin,Orphanet_733,Familial adenomatous polyposis,2.5813070867962415,0.0,0.0,1.0,0.0,1.0,2.5813,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.573624,0.573624,0.0,HIGH,9
dipyridamole + aspirin,MONDO_0004857,tendinitis,2.576877591171307,0.0,0.0,1.0,0.0,1.0,2.5769,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.572639,0.572639,0.0,HIGH,9
dipyridamole + aspirin,EFO_0005628,proctitis,2.5730629187433083,0.0,0.0,1.0,0.0,1.0,2.5731,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.571792,0.571792,0.0,HIGH,9
dipyridamole + aspirin,MONDO_0005575,colorectal cancer,2.090659383789252,0.0,0.0,1.0,0.2079,1.2079,2.5254,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.460797,0.470281,0.009484,HIGH,9
dipyridamole + aspirin,MONDO_0000831,thrombotic disease,2.5018944920170685,0.0,0.0,1.0,0.0,1.0,2.5019,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.555977,0.555977,0.0,HIGH,9
dipyridamole + aspirin,EFO_0000384,Crohn's disease,1.9709176578464256,0.0,0.0,1.0,0.2398,1.2398,2.4435,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.431671,0.447447,0.015776,HIGH,9
dipyridamole + aspirin,EFO_0000668,preeclampsia,1.9563251555379089,0.0,0.0,1.0,0.2398,1.2398,2.4254,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.432957,0.438303,0.005347,HIGH,9
dipyridamole + aspirin,MONDO_0004975,Alzheimer disease,1.9541766374872376,0.0,0.0,1.0,0.2398,1.2398,2.4228,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.428005,0.443647,0.015642,HIGH,9
dipyridamole + aspirin,HP_0004398,Peptic ulcer,2.416461246653576,0.0,0.0,1.0,0.0,1.0,2.4165,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.532607,0.543569,0.010962,HIGH,9
dipyridamole + aspirin,EFO_0005757,vaginal inflammation,2.400038738260074,0.0,0.0,1.0,0.0,1.0,2.4,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.533342,0.533342,0.0,HIGH,9
dipyridamole + aspirin,EFO_0009364,non-allergic rhinitis,2.400038738260074,0.0,0.0,1.0,0.0,1.0,2.4,,,,,,False,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.533342,0.533342,0.0,HIGH,9
dipyridamole + aspirin,EFO_0000275,atrial fibrillation,1.9075273348442583,0.0,0.0,1.0,0.2398,1.2398,2.3649,,,,,,True,"Abortion, Habitual; Acute Chest Syndrome; Acute Coronary Syndrome; Acute Lung Injury; Adenocarcinoma of Lung",,,0.420434,0.429087,0.008653,HIGH,9
evolocumab,EFO_0004911,familial hypercholesterolemia,2.77804792833365,0.9232,0.0,0.7581,0.2303,1.2303,2.5909,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.678536,0.726464,0.047928,HIGH,4
evolocumab,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.6342867486984978,0.9232,0.0,0.7581,0.1946,1.1946,2.3856,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.649624,0.676466,0.026842,HIGH,4
evolocumab,EFO_0001645,coronary artery disease,2.44613693759838,0.9232,0.0,0.7581,0.2303,1.2303,2.2814,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.590022,0.63074,0.040718,HIGH,4
evolocumab,HP_0003124,Hypercholesterolemia,2.5837086872155477,0.9232,0.0,0.7581,0.0,1.0,1.9587,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.637152,0.663478,0.026326,HIGH,4
evolocumab,EFO_0000319,cardiovascular disease,2.415491241289434,0.9232,0.0,0.7581,0.0,1.0,1.8312,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.58263,0.622838,0.040207,HIGH,4
evolocumab,EFO_0000589,metabolic disease,2.3055488757387117,0.9232,0.0,0.7581,0.0,1.0,1.7478,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.568557,0.592049,0.023492,HIGH,4
evolocumab,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.9232,0.0,0.7581,0.0,1.0,1.6807,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.554263,0.554263,0.0,HIGH,4
evolocumab,EFO_0000612,myocardial infarction,2.1587039312067464,0.9232,0.0,0.7581,0.0,1.0,1.6365,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.520261,0.559091,0.03883,HIGH,4
evolocumab,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.9232,0.0,0.7581,0.2079,1.2079,1.6333,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.445905,0.445905,0.0,HIGH,4
evolocumab,MONDO_0018328,homozygous familial hypercholesterolemia,2.148464723176249,0.9232,0.0,0.7581,0.0,1.0,1.6287,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.524761,0.561827,0.037066,HIGH,4
evolocumab,MONDO_0021187,hyperlipidemia,2.1040568357817544,0.9232,0.0,0.7581,0.0,1.0,1.5951,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.526014,0.526014,0.0,HIGH,4
evolocumab,EFO_0003914,atherosclerosis,2.0172272109385148,0.9232,0.0,0.7581,0.0,1.0,1.5292,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.492706,0.527508,0.034802,HIGH,4
evolocumab,EFO_0000195,metabolic syndrome,1.5989738546727714,0.9232,0.0,0.7581,0.2398,1.2398,1.5028,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.389027,0.41046,0.021432,HIGH,4
evolocumab,EFO_1001375,Myocardial Ischemia,1.8354966537754889,0.9232,0.0,0.7581,0.0,1.0,1.3915,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.442366,0.475382,0.033016,HIGH,4
evolocumab,MONDO_0009387,familial lipoprotein lipase deficiency,1.4386859310417202,0.9232,0.0,0.7581,0.2398,1.2398,1.3522,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.351398,0.376219,0.024821,HIGH,4
evolocumab,EFO_0003777,heart disease,1.773792300626292,0.9232,0.0,0.7581,0.0,1.0,1.3447,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.410746,0.491881,0.081136,HIGH,4
evolocumab,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.9232,0.0,0.7581,0.0,1.0,1.3368,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.440834,0.440834,0.0,HIGH,4
evolocumab,EFO_0003913,angina pectoris,1.733713012728092,0.9232,0.0,0.7581,0.0,1.0,1.3143,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.421809,0.445047,0.023238,HIGH,4
evolocumab,EFO_0000712,stroke,1.5163324930556523,0.9232,0.0,0.7581,0.1386,1.1386,1.3089,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.300694,0.523436,0.222742,MEDIUM,4
evolocumab,HP_0003077,Hyperlipidemia,1.7264272674266656,0.9232,0.0,0.7581,0.0,1.0,1.3088,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.425743,0.443334,0.017591,HIGH,4
evolocumab,MONDO_0001336,familial hyperlipidemia,1.7148713527001924,0.9232,0.0,0.7581,0.0,1.0,1.3,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.428718,0.428718,0.0,HIGH,4
evolocumab,EFO_0000400,diabetes mellitus,1.4041737247377832,0.9232,0.0,0.7581,0.2197,1.2197,1.2984,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.341633,0.360454,0.018821,HIGH,4
evolocumab,MONDO_0013144,hereditary antithrombin deficiency,1.390206303767071,0.9232,0.0,0.7581,0.2303,1.2303,1.2966,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.676469,0.713737,0.037268,HIGH,2
evolocumab,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.9232,0.0,0.7581,0.0,1.0,1.1712,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.386247,0.386247,0.0,HIGH,4
evolocumab,HP_0003146,Hypocholesterolemia,1.519787603332834,0.9232,0.0,0.7581,0.0,1.0,1.1521,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.379947,0.379947,0.0,HIGH,4
evolocumab,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.9232,0.0,0.7581,0.0,1.0,1.1156,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.367893,0.367893,0.0,HIGH,4
evolocumab,EFO_0000275,atrial fibrillation,1.1767919069442716,0.9232,0.0,0.7581,0.2398,1.2398,1.106,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.072621,0.515775,0.443154,LOW,4
evolocumab,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.9232,0.0,0.7581,0.0,1.0,1.0832,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.357214,0.357214,0.0,HIGH,4
evolocumab,HP_0004936,Venous thrombosis,1.1306796423669063,0.9232,0.0,0.7581,0.2398,1.2398,1.0627,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.550185,0.580495,0.030311,HIGH,2
evolocumab,Orphanet_79211,Combined hyperlipidemia,1.1062756269960068,0.9232,0.0,0.7581,0.2303,1.2303,1.0318,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.270207,0.289293,0.019086,HIGH,4
evolocumab,EFO_0005672,acute coronary syndrome,1.3444152821346198,0.9232,0.0,0.7581,0.0,1.0,1.0192,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280993,0.421709,0.140716,MEDIUM,4
evolocumab,HP_0001976,Reduced antithrombin III activity,1.2937212142508865,0.9232,0.0,0.7581,0.0,1.0,0.9808,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.62952,0.664201,0.034681,HIGH,2
evolocumab,EFO_1000985,intermediate coronary syndrome,1.2710260283837655,0.9232,0.0,0.7581,0.0,1.0,0.9636,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.279558,0.359048,0.07949,HIGH,4
evolocumab,EFO_0004286,venous thromboembolism,1.2626208859932304,0.9232,0.0,0.7581,0.0,1.0,0.9572,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.046997,0.584314,0.537317,LOW,4
evolocumab,EFO_0008583,acute myocardial infarction,1.1953208910287108,0.9232,0.0,0.7581,0.0,1.0,0.9062,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.288221,0.308302,0.020082,HIGH,4
evolocumab,EFO_0003144,heart failure,1.1943910450436237,0.9232,0.0,0.7581,0.0,1.0,0.9055,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.298598,0.298598,0.0,HIGH,4
evolocumab,HP_0011428,Short fetal femur length,1.187066470233723,0.9232,0.0,0.7581,0.0,1.0,0.8999,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.296767,0.296767,0.0,HIGH,4
evolocumab,EFO_0004264,vascular disease,1.1630272440108385,0.9232,0.0,0.7581,0.0,1.0,0.8817,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.290757,0.290757,0.0,HIGH,4
evolocumab,EFO_0004329,alcohol drinking,1.153512135309475,0.9232,0.0,0.7581,0.0,1.0,0.8745,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.296109,0.015461,HIGH,4
evolocumab,MONDO_0100096,COVID-19,1.1404696119601427,0.9232,0.0,0.7581,0.0,1.0,0.8646,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.231762,0.338472,0.10671,MEDIUM,4
evolocumab,EFO_0003776,coronary artery bypass,1.1279602973638454,0.9232,0.0,0.7581,0.0,1.0,0.8551,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.28199,0.28199,0.0,HIGH,4
evolocumab,EFO_0003940,physical activity,1.1225894210654916,0.9232,0.0,0.7581,0.0,1.0,0.851,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.280647,0.0,HIGH,4
evolocumab,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.9232,0.0,0.7581,0.0,1.0,0.851,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.280647,0.0,HIGH,4
evolocumab,EFO_0003907,deep vein thrombosis,1.0937238054191556,0.9232,0.0,0.7581,0.0,1.0,0.8291,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.522221,0.571503,0.049281,HIGH,2
evolocumab,EFO_0003086,kidney disease,1.0396200487798937,0.9232,0.0,0.7581,0.0,1.0,0.7881,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.25303,0.263343,0.010313,HIGH,4
evolocumab,EFO_0003827,pulmonary embolism,1.0315689372997063,0.9232,0.0,0.7581,0.0,1.0,0.782,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.480032,0.551537,0.071504,HIGH,2
evolocumab,EFO_0003884,chronic kidney disease,1.018479956512245,0.9232,0.0,0.7581,0.0,1.0,0.7721,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.214524,0.294716,0.080193,HIGH,4
evolocumab,HP_0001907,Thromboembolism,0.9830566798637128,0.9232,0.0,0.7581,0.0,1.0,0.7452,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.436461,0.546596,0.110135,MEDIUM,2
evolocumab,HP_0003040,Arthropathy,0.9594178191147148,0.9232,0.0,0.7581,0.0,1.0,0.7273,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.239854,0.239854,0.0,HIGH,4
evolocumab,EFO_0009578,placental retention,0.9588206730453008,0.9232,0.0,0.7581,0.0,1.0,0.7269,2,TERMINATED,STOPPED,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Funding withdrawn,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.239705,0.239705,0.0,HIGH,4
ezetimibe,EFO_0004911,familial hypercholesterolemia,0.9811824336261872,0.832,0.1,0.7637,0.2303,1.2303,0.9219,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.9811824336261871,0.9811824336261871,0.0,HIGH,1
ezetimibe,HP_0003124,Hypercholesterolemia,1.1542297813935771,0.832,0.1,0.7637,0.0,1.0,0.8815,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,1.154229781393577,1.154229781393577,0.0,HIGH,1
ezetimibe,MONDO_0021187,hyperlipidemia,1.101764190881846,0.832,0.1,0.7637,0.0,1.0,0.8414,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,1.101764190881846,1.101764190881846,0.0,HIGH,1
ezetimibe,EFO_0000319,cardiovascular disease,0.8306891947084494,0.832,0.1,0.7637,0.0,1.0,0.6344,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.830689194708449,0.830689194708449,0.0,HIGH,1
ezetimibe,EFO_0001645,coronary artery disease,0.6510540466490428,0.832,0.1,0.7637,0.2303,1.2303,0.6117,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.6510540466490421,0.6510540466490421,0.0,HIGH,1
ezetimibe,Orphanet_309005,Disorder of lipid metabolism,0.7597204497794091,0.832,0.1,0.7637,0.0,1.0,0.5802,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.7597204497794091,0.7597204497794091,0.0,HIGH,1
ezetimibe,EFO_0000589,metabolic disease,0.7567782745272026,0.832,0.1,0.7637,0.0,1.0,0.5779,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.756778274527202,0.756778274527202,0.0,HIGH,1
ezetimibe,MONDO_0005148,type 2 diabetes mellitus,0.5400146586842938,0.832,0.1,0.7637,0.1792,1.1792,0.4863,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.540014658684293,0.540014658684293,0.0,HIGH,1
ezetimibe,EFO_0003914,atherosclerosis,0.5701983144655997,0.832,0.1,0.7637,0.0,1.0,0.4355,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.5701983144655991,0.5701983144655991,0.0,HIGH,1
ezetimibe,EFO_0004211,Hypertriglyceridemia,0.561669656826669,0.832,0.1,0.7637,0.0,1.0,0.4289,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.561669656826669,0.561669656826669,0.0,HIGH,1
ezetimibe,EFO_0000195,metabolic syndrome,0.426721400669677,0.832,0.1,0.7637,0.2398,1.2398,0.404,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.426721400669677,0.426721400669677,0.0,HIGH,1
ezetimibe,HP_0001650,Aortic valve stenosis,0.5150495015476898,0.832,0.1,0.7637,0.0,1.0,0.3933,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.515049501547689,0.515049501547689,0.0,HIGH,1
ezetimibe,MONDO_0001336,familial hyperlipidemia,0.5076893443384163,0.832,0.1,0.7637,0.0,1.0,0.3877,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.5076893443384161,0.5076893443384161,0.0,HIGH,1
ezetimibe,EFO_0000400,diabetes mellitus,0.4153346238873279,0.832,0.1,0.7637,0.2197,1.2197,0.3869,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.41533462388732706,0.41533462388732706,0.0,HIGH,1
ezetimibe,EFO_0000537,hypertension,0.4120396012381517,0.832,0.1,0.7637,0.1609,1.1609,0.3653,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
ezetimibe,EFO_0000612,myocardial infarction,0.4126282292399205,0.832,0.1,0.7637,0.0,1.0,0.3151,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.41262822923992004,0.41262822923992004,0.0,HIGH,1
ezetimibe,MONDO_0019052,inborn errors of metabolism,0.4120396012381517,0.832,0.1,0.7637,0.0,1.0,0.3147,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
ezetimibe,EFO_0003913,angina pectoris,0.4097018129698564,0.832,0.1,0.7637,0.0,1.0,0.3129,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.409701812969856,0.409701812969856,0.0,HIGH,1
ezetimibe,EFO_0003776,coronary artery bypass,0.237488359962275,0.832,0.1,0.7637,0.0,1.0,0.1814,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.23748835996227502,0.23748835996227502,0.0,HIGH,1
ezetimibe,EFO_0000182,hepatocellular carcinoma,0.1448920988848256,0.832,0.1,0.7637,0.1609,1.1609,0.1285,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.14489209888482502,0.14489209888482502,0.0,HIGH,1
ezetimibe,EFO_0000616,neoplasm,0.1604550422350072,0.832,0.1,0.7637,0.0,1.0,0.1225,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.160455042235007,0.160455042235007,0.0,HIGH,1
ezetimibe,EFO_0003095,non-alcoholic fatty liver disease,0.1407433713945828,0.832,0.1,0.7637,0.1099,1.1099,0.1193,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.140743371394582,0.140743371394582,0.0,HIGH,1
ezetimibe,EFO_0007304,hepatitis D virus infection,0.1471570004421969,0.832,0.1,0.7637,0.0,1.0,0.1124,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.147157000442196,0.147157000442196,0.0,HIGH,1
ezetimibe,EFO_0008527,steatosis,0.1430460678595945,0.832,0.1,0.7637,0.0,1.0,0.1092,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.143046067859594,0.143046067859594,0.0,HIGH,1
ezetimibe,MONDO_0018328,homozygous familial hypercholesterolemia,0.1354330022169672,0.832,0.1,0.7637,0.0,1.0,0.1034,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.135433002216967,0.135433002216967,0.0,HIGH,1
ezetimibe,EFO_1001951,colorectal carcinoma,0.1332403482651239,0.832,0.1,0.7637,0.0,1.0,0.1018,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.13324034826512302,0.13324034826512302,0.0,HIGH,1
ezetimibe,EFO_0004220,chronic hepatitis C virus infection,0.1324413003979773,0.832,0.1,0.7637,0.0,1.0,0.1011,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,True,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.132441300397977,0.132441300397977,0.0,HIGH,1
ezetimibe,EFO_1000044,pancreatic adenocarcinoma,0.1177256003537575,0.832,0.1,0.7637,0.0,1.0,0.0899,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.11772560035375701,0.11772560035375701,0.0,HIGH,1
ezetimibe,MONDO_0009294,glycogen storage disease VI,0.0883824944655834,0.832,0.1,0.7637,0.2398,1.2398,0.0837,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.08838249446558301,0.08838249446558301,0.0,HIGH,1
ezetimibe,MONDO_0859149,hypertriglyceridemia 2,0.0941304469028556,0.832,0.1,0.7637,0.1609,1.1609,0.0835,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.094130446902855,0.094130446902855,0.0,HIGH,1
ezetimibe,MONDO_0013700,pancreatic triacylglycerol lipase deficiency,0.0836057782312298,0.832,0.1,0.7637,0.1946,1.1946,0.0763,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.083605778231229,0.083605778231229,0.0,HIGH,1
ezetimibe,Orphanet_79211,Combined hyperlipidemia,0.0796001646791932,0.832,0.1,0.7637,0.2303,1.2303,0.0748,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.07960016467919301,0.07960016467919301,0.0,HIGH,1
ezetimibe,MONDO_0011601,neonatal intrahepatic cholestasis due to citrin deficiency,0.0758388317478905,0.832,0.1,0.7637,0.2398,1.2398,0.0718,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.07583883174789001,0.07583883174789001,0.0,HIGH,1
ezetimibe,MONDO_0004992,cancer,0.0920413897228009,0.832,0.1,0.7637,0.0,1.0,0.0703,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.0920413897228,0.0920413897228,0.0,HIGH,1
ezetimibe,MONDO_0008863,sitosterolemia,0.0741519169941481,0.832,0.1,0.7637,0.2398,1.2398,0.0702,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.07415191699414801,0.07415191699414801,0.0,HIGH,1
ezetimibe,EFO_1001979,Adrenocorticotropic hormone deficiency,0.073793349441744,0.832,0.1,0.7637,0.2303,1.2303,0.0693,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.07379334944174401,0.07379334944174401,0.0,HIGH,1
ezetimibe,MONDO_0009528,chylomicron retention disease,0.0732223802800283,0.832,0.1,0.7637,0.2398,1.2398,0.0693,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.073222380280028,0.073222380280028,0.0,HIGH,1
ezetimibe,Orphanet_411,Hyperlipoproteinemia type 1,0.0727661935786575,0.832,0.1,0.7637,0.2398,1.2398,0.0689,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.072766193578657,0.072766193578657,0.0,HIGH,1
ezetimibe,MONDO_0020748,sitosterolemia 2,0.0699407791701673,0.832,0.1,0.7637,0.1792,1.1792,0.063,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.069940779170167,0.069940779170167,0.0,HIGH,1
ezetimibe,EFO_0005546,congenital disorder of glycosylation type II,0.0665473387399702,0.832,0.1,0.7637,0.2398,1.2398,0.063,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.06654733873997,0.06654733873997,0.0,HIGH,1
ezetimibe,MONDO_0010939,gallbladder disease 1,0.0645724917940359,0.832,0.1,0.7637,0.2398,1.2398,0.0611,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.064572491794035,0.064572491794035,0.0,HIGH,1
ezetimibe,MONDO_0011906,congenital bile acid synthesis defect 1,0.0615704889850152,0.832,0.1,0.7637,0.2398,1.2398,0.0583,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.06157048898501501,0.06157048898501501,0.0,HIGH,1
ezetimibe,Orphanet_79301,Congenital bile acid synthesis defect type 1,0.0615704889850152,0.832,0.1,0.7637,0.2398,1.2398,0.0583,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.06157048898501501,0.06157048898501501,0.0,HIGH,1
ezetimibe,MONDO_0001056,gastric cancer,0.0662206501989886,0.832,0.1,0.7637,0.1386,1.1386,0.0576,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.066220650198988,0.066220650198988,0.0,HIGH,1
ezetimibe,MONDO_0010598,glycogen storage disease IXa1,0.0606522293022558,0.832,0.1,0.7637,0.2398,1.2398,0.0574,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.06065222930225501,0.06065222930225501,0.0,HIGH,1
ezetimibe,MONDO_0008810,familial apolipoprotein C-II deficiency,0.058556713615959,0.832,0.1,0.7637,0.2398,1.2398,0.0554,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.058556713615959,0.058556713615959,0.0,HIGH,1
ezetimibe,MONDO_0013091,glycogen storage disease IXc,0.0585213959358528,0.832,0.1,0.7637,0.2398,1.2398,0.0554,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.058521395935852004,0.058521395935852004,0.0,HIGH,1
ezetimibe,MONDO_0012586,"coronary artery disease, autosomal dominant 2",0.0570733710515015,0.832,0.1,0.7637,0.2398,1.2398,0.054,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.057073371051501,0.057073371051501,0.0,HIGH,1
ezetimibe,MONDO_0009387,familial lipoprotein lipase deficiency,0.0568379198507941,0.832,0.1,0.7637,0.2398,1.2398,0.0538,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.056837919850794005,0.056837919850794005,0.0,HIGH,1
ezetimibe,Orphanet_2089,Glycogen storage disease due to hepatic glycogen synthase deficiency,0.0573205948122445,0.832,0.1,0.7637,0.2079,1.2079,0.0529,2,TERMINATED,STOPPED,Hypercholesterolemia | Atherosclerosis,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,False,Aortic Valve Stenosis; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus,,,0.057320594812244004,0.057320594812244004,0.0,HIGH,1
fasudil hydrochloride,EFO_0004190,open-angle glaucoma,8.774846306016991,0.0,0.0,1.0,0.2079,1.2079,10.5995,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.869721,0.893011,0.02329,HIGH,10
fasudil hydrochloride,EFO_0005772,neurodegenerative disease,10.006403504175138,0.0,0.0,1.0,0.0,1.0,10.0064,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.949291,1.053743,0.104452,MEDIUM,10
fasudil hydrochloride,EFO_1001069,ocular hypertension,8.701188608417162,0.0,0.0,1.0,0.0,1.0,8.7012,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.870119,0.870119,0.0,HIGH,10
fasudil hydrochloride,EFO_0000540,immune system disease,6.844483637951535,0.0,0.0,1.0,0.1386,1.1386,7.7933,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.65565,0.727394,0.071744,HIGH,10
fasudil hydrochloride,EFO_0003060,non-small cell lung carcinoma,6.496417323332726,0.0,0.0,1.0,0.1792,1.1792,7.6604,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.449102,0.92886,0.479757,LOW,10
fasudil hydrochloride,Orphanet_98974,Fuchs endothelial corneal dystrophy,5.977841859227438,0.0,0.0,1.0,0.2398,1.2398,7.4113,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.597784,0.597784,0.0,HIGH,10
fasudil hydrochloride,MONDO_0004976,amyotrophic lateral sclerosis,5.739176509749865,0.0,0.0,1.0,0.2398,1.2398,7.1154,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.274636,0.929696,0.655061,LOW,10
fasudil hydrochloride,EFO_0001378,multiple myeloma,5.928616756970187,0.0,0.0,1.0,0.1792,1.1792,6.9909,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.4166,0.852968,0.436369,LOW,10
fasudil hydrochloride,EFO_0000305,breast carcinoma,6.01371778126074,0.0,0.0,1.0,0.1609,1.1609,6.9816,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.388274,0.859055,0.470781,LOW,10
fasudil hydrochloride,MONDO_0013730,graft versus host disease,6.729399773674001,0.0,0.0,1.0,0.0,1.0,6.7294,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.655525,0.701779,0.046254,HIGH,10
fasudil hydrochloride,EFO_0000183,Hodgkins lymphoma,5.549123046257672,0.0,0.0,1.0,0.1609,1.1609,6.4422,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.379304,0.814935,0.435631,LOW,10
fasudil hydrochloride,EFO_0002618,pancreatic carcinoma,5.367895084807706,0.0,0.0,1.0,0.1792,1.1792,6.3297,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.370809,0.763114,0.392304,LOW,10
fasudil hydrochloride,EFO_0000756,melanoma,5.15222506211292,0.0,0.0,1.0,0.2197,1.2197,6.2843,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.397802,0.677194,0.279392,LOW,10
fasudil hydrochloride,EFO_0000616,neoplasm,6.179788264274068,0.0,0.0,1.0,0.0,1.0,6.1798,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.335986,0.948168,0.612182,LOW,10
fasudil hydrochloride,EFO_0000319,cardiovascular disease,6.1420996873929115,0.0,0.0,1.0,0.0,1.0,6.1421,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,True,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.487325,0.836762,0.349437,LOW,10
fasudil hydrochloride,EFO_0000673,prostate adenocarcinoma,5.359825164539428,0.0,0.0,1.0,0.1386,1.1386,6.1029,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.374111,0.775381,0.401271,LOW,10
fasudil hydrochloride,EFO_0004193,basal cell carcinoma,5.296955041153855,0.0,0.0,1.0,0.1386,1.1386,6.0313,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.526793,0.5355,0.008707,HIGH,10
fasudil hydrochloride,MONDO_0005041,glaucoma,5.989116605160558,0.0,0.0,1.0,0.0,1.0,5.9891,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.58472,0.617593,0.032874,HIGH,10
fasudil hydrochloride,EFO_0001645,coronary artery disease,4.82826342350118,0.0,0.0,1.0,0.2303,1.2303,5.94,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.236841,0.795227,0.558386,LOW,10
fasudil hydrochloride,EFO_0000389,cutaneous melanoma,4.791012354359415,0.0,0.0,1.0,0.2398,1.2398,5.9398,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.350021,0.630209,0.280188,LOW,10
fasudil hydrochloride,MONDO_0004986,urinary bladder carcinoma,4.9755430951722275,0.0,0.0,1.0,0.1609,1.1609,5.7763,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.38807,0.656999,0.268929,LOW,10
fasudil hydrochloride,MONDO_0019200,retinitis pigmentosa,4.778211314444381,0.0,0.0,1.0,0.2079,1.2079,5.7718,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.209601,0.865539,0.655938,LOW,10
fasudil hydrochloride,EFO_0000403,diffuse large B-cell lymphoma,5.706939874410271,0.0,0.0,1.0,0.0,1.0,5.7069,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.399087,0.822942,0.423854,LOW,10
fasudil hydrochloride,EFO_0000660,polycystic ovary syndrome,4.612151174084871,0.0,0.0,1.0,0.2079,1.2079,5.5712,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.452028,0.47144,0.019412,HIGH,10
fasudil hydrochloride,MONDO_0004992,cancer,5.563937728442699,0.0,0.0,1.0,0.0,1.0,5.5639,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.265421,0.880565,0.615144,LOW,10
fasudil hydrochloride,EFO_0000571,lung adenocarcinoma,4.708937954815022,0.0,0.0,1.0,0.1792,1.1792,5.5527,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.357882,0.63212,0.274238,LOW,10
fasudil hydrochloride,EFO_0005922,esophageal squamous cell carcinoma,4.920452553021326,0.0,0.0,1.0,0.1099,1.1099,5.461,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.38214,0.65056,0.26842,LOW,10
fasudil hydrochloride,EFO_0000222,acute myeloid leukemia,4.693788577663987,0.0,0.0,1.0,0.1386,1.1386,5.3445,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.367979,0.590421,0.222442,MEDIUM,10
fasudil hydrochloride,MONDO_0002009,major depressive disorder,4.799491148284592,0.0,0.0,1.0,0.1099,1.1099,5.3268,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.399914,0.595467,0.195553,MEDIUM,10
fasudil hydrochloride,EFO_0000731,uterine fibroid,4.643347555409027,0.0,0.0,1.0,0.1386,1.1386,5.2871,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.464335,0.464335,0.0,HIGH,10
fasudil hydrochloride,MONDO_0020547,chronic graft versus host disease,5.267925327022646,0.0,0.0,1.0,0.0,1.0,5.2679,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.50213,0.571747,0.069616,HIGH,10
fasudil hydrochloride,MONDO_0008315,prostate cancer,5.145423055799315,0.0,0.0,1.0,0.0,1.0,5.1454,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.211409,0.874861,0.663452,LOW,10
fasudil hydrochloride,EFO_0000178,gastric carcinoma,4.517192360755129,0.0,0.0,1.0,0.1386,1.1386,5.1434,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.351204,0.602143,0.250939,LOW,10
fasudil hydrochloride,EFO_0000181,head and neck squamous cell carcinoma,4.608209157710309,0.0,0.0,1.0,0.1099,1.1099,5.1145,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.347646,0.621329,0.273684,LOW,10
fasudil hydrochloride,EFO_0000275,atrial fibrillation,4.110263349973136,0.0,0.0,1.0,0.2398,1.2398,5.0959,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.186953,0.646486,0.459533,LOW,10
fasudil hydrochloride,MONDO_0007254,breast cancer,5.032767770999148,0.0,0.0,1.0,0.0,1.0,5.0328,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.254115,0.849227,0.595112,LOW,10
fasudil hydrochloride,EFO_0000182,hepatocellular carcinoma,4.288383563702532,0.0,0.0,1.0,0.1609,1.1609,4.9786,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.357058,0.527368,0.17031,MEDIUM,10
fasudil hydrochloride,EFO_0007355,male reproductive organ cancer,4.970457049754359,0.0,0.0,1.0,0.0,1.0,4.9705,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.450872,0.556288,0.105417,MEDIUM,10
fasudil hydrochloride,EFO_0000095,chronic lymphocytic leukemia,4.338091235143479,0.0,0.0,1.0,0.1386,1.1386,4.9395,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.337791,0.566537,0.228745,MEDIUM,10
fasudil hydrochloride,MONDO_0012703,lissencephaly due to TUBA1A mutation,3.94092433482225,0.0,0.0,1.0,0.2398,1.2398,4.8859,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.313641,1.313641,0.0,HIGH,3
fasudil hydrochloride,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,3.938757767603145,0.0,0.0,1.0,0.2398,1.2398,4.8832,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.312919,1.312919,0.0,HIGH,3
fasudil hydrochloride,MONDO_0005321,Fuchs' endothelial dystrophy,4.8828846493196,0.0,0.0,1.0,0.0,1.0,4.8829,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.488288,0.488288,0.0,HIGH,10
fasudil hydrochloride,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,3.893200608363729,0.0,0.0,1.0,0.2398,1.2398,4.8267,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.297734,1.297734,0.0,HIGH,3
fasudil hydrochloride,EFO_1001469,Mantle cell lymphoma,4.8241011424622195,0.0,0.0,1.0,0.0,1.0,4.8241,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.368476,0.644758,0.276281,LOW,10
fasudil hydrochloride,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",3.835924330210352,0.0,0.0,1.0,0.2398,1.2398,4.7557,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.278641,1.278641,0.0,HIGH,3
fasudil hydrochloride,Orphanet_183506,Genetic central nervous system malformation,3.8289211668056087,0.0,0.0,1.0,0.2398,1.2398,4.7471,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.276307,1.276307,0.0,HIGH,3
fasudil hydrochloride,EFO_0000702,small cell lung carcinoma,4.243887125498265,0.0,0.0,1.0,0.1099,1.1099,4.7101,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.34166,0.53953,0.19787,MEDIUM,10
fasudil hydrochloride,EFO_1000879,corneal edema,4.675003219047195,0.0,0.0,1.0,0.0,1.0,4.675,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,0.4675,0.4675,0.0,HIGH,10
fasudil hydrochloride,EFO_1001985,congenital fibrosis of the extraocular muscles,3.7386977543823106,0.0,0.0,1.0,0.2398,1.2398,4.6352,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.246233,1.246233,0.0,HIGH,3
fasudil hydrochloride,MONDO_0012905,hypomyelinating leukodystrophy 6,3.691041889050328,0.0,0.0,1.0,0.2398,1.2398,4.5761,1,TERMINATED,STOPPED,Carotid Stenosis,Slow enrollment,False,Cardiovascular Diseases; Carotid Stenosis; Parkinson Disease,,,1.230347,1.230347,0.0,HIGH,3
fentanyl,HP_0002014,Diarrhea,5.836776608821151,0.0,0.0,1.0,0.2398,1.2398,7.2364,,,,,,False,"Pain; Pain, Postoperative",,,0.957762,1.002863,0.045101,HIGH,6
fentanyl,EFO_0010702,opioid use disorder,7.002267594670959,0.0,0.0,1.0,0.0,1.0,7.0023,,,,,,False,"Pain; Pain, Postoperative",,,1.156426,1.188281,0.031855,HIGH,6
fentanyl,HP_0012531,Pain,6.822850335585274,0.0,0.0,1.0,0.0,1.0,6.8229,,,,,,False,"Pain; Pain, Postoperative",,,1.102835,1.171448,0.068613,HIGH,6
fentanyl,EFO_0005611,opioid dependence,6.628745440215823,0.0,0.0,1.0,0.0,1.0,6.6287,,,,,,False,"Pain; Pain, Postoperative",,,1.094739,1.124895,0.030156,HIGH,6
fentanyl,MONDO_0007079,alcohol dependence,5.918031358432361,0.0,0.0,1.0,0.1099,1.1099,6.5682,,,,,,False,"Pain; Pain, Postoperative",,,0.977364,1.004287,0.026922,HIGH,6
fentanyl,MONDO_0004992,cancer,6.287251728962576,0.0,0.0,1.0,0.0,1.0,6.2873,,,,,,False,"Pain; Pain, Postoperative",,,1.003039,1.096769,0.093731,HIGH,6
fentanyl,HP_0012532,Chronic pain,5.946467785371659,0.0,0.0,1.0,0.0,1.0,5.9465,,,,,,False,"Pain; Pain, Postoperative",,,0.96702,1.021436,0.054416,HIGH,6
fentanyl,MONDO_0005277,migraine disorder,4.890844180750492,0.0,0.0,1.0,0.2079,1.2079,5.9079,,,,,,False,"Pain; Pain, Postoperative",,,0.742286,0.937906,0.19562,MEDIUM,6
fentanyl,EFO_0003890,drug dependence,5.892207549950015,0.0,0.0,1.0,0.0,1.0,5.8922,,,,,,False,"Pain; Pain, Postoperative",,,0.9731,0.999905,0.026805,HIGH,6
fentanyl,HP_0002019,Constipation,5.746297578522295,0.0,0.0,1.0,0.0,1.0,5.7463,,,,,,False,"Pain; Pain, Postoperative",,,0.957716,0.957716,0.0,HIGH,6
fentanyl,EFO_0005762,neuropathic pain,5.5709639812287906,0.0,0.0,1.0,0.0,1.0,5.571,,,,,,False,"Pain; Pain, Postoperative",,,0.905955,0.956935,0.05098,HIGH,6
fentanyl,MONDO_0005178,osteoarthritis,4.49055432618939,0.0,0.0,1.0,0.2303,1.2303,5.5245,,,,,,False,"Pain; Pain, Postoperative",,,0.667465,0.898202,0.230737,MEDIUM,6
fentanyl,EFO_0000555,irritable bowel syndrome,5.472027545095557,0.0,0.0,1.0,0.0,1.0,5.472,,,,,,False,"Pain; Pain, Postoperative",,,0.8855,0.948753,0.063253,HIGH,6
fentanyl,EFO_0001645,coronary artery disease,4.324549264554854,0.0,0.0,1.0,0.2303,1.2303,5.3203,,,,,,False,"Pain; Pain, Postoperative",,,0.528644,0.91877,0.390126,LOW,6
fentanyl,EFO_0022041,response to tramadol,5.2217151658732845,0.0,0.0,1.0,0.0,1.0,5.2217,,,,,,False,"Pain; Pain, Postoperative",,,0.870286,0.870286,0.0,HIGH,6
fentanyl,EFO_0000712,stroke,4.463804811499806,0.0,0.0,1.0,0.1386,1.1386,5.0826,,,,,,False,"Pain; Pain, Postoperative",,,0.507607,0.99293,0.485323,LOW,6
fentanyl,MONDO_0005090,schizophrenia,4.083794756992949,0.0,0.0,1.0,0.2398,1.2398,5.063,,,,,,False,"Pain; Pain, Postoperative",,,0.661027,0.707815,0.046789,HIGH,6
fentanyl,EFO_0001073,obesity,4.2114549731280935,0.0,0.0,1.0,0.1946,1.1946,5.031,,,,,,False,"Pain; Pain, Postoperative",,,0.624867,0.836378,0.211511,MEDIUM,6
fentanyl,EFO_0801084,cancer pain,5.016904778616746,0.0,0.0,1.0,0.0,1.0,5.0169,,,,,,False,"Pain; Pain, Postoperative",,,0.836151,0.836151,0.0,HIGH,6
fentanyl,EFO_0006834,septic shock,4.80606898105521,0.0,0.0,1.0,0.0,1.0,4.8061,,,,,,False,"Pain; Pain, Postoperative",,,0.781567,0.825547,0.04398,HIGH,6
fentanyl,HP_0000924,Abnormality of the skeletal system,4.566519677634116,0.0,0.0,1.0,0.0,1.0,4.5665,,,,,,False,"Pain; Pain, Postoperative",,,0.754162,0.774936,0.020774,HIGH,6
fentanyl,HP_0012735,Cough,4.499962968855424,0.0,0.0,1.0,0.0,1.0,4.5,,,,,,False,"Pain; Pain, Postoperative",,,0.749994,0.749994,0.0,HIGH,6
fentanyl,EFO_0004253,nephrolithiasis,3.737185891578381,0.0,0.0,1.0,0.1946,1.1946,4.4644,,,,,,False,"Pain; Pain, Postoperative",,,0.560832,0.736631,0.175799,MEDIUM,6
fentanyl,EFO_0003918,obstructive sleep apnea,3.7097877821505687,0.0,0.0,1.0,0.1946,1.1946,4.4317,,,,,,False,"Pain; Pain, Postoperative",,,0.596556,0.643055,0.046499,HIGH,6
fentanyl,EFO_0020911,overdose,4.427880564805489,0.0,0.0,1.0,0.0,1.0,4.4279,,,,,,False,"Pain; Pain, Postoperative",,,0.73798,0.73798,0.0,HIGH,6
fentanyl,MONDO_0002203,constipation disorder,4.414710013265912,0.0,0.0,1.0,0.0,1.0,4.4147,,,,,,False,"Pain; Pain, Postoperative",,,0.735785,0.735785,0.0,HIGH,6
fentanyl,EFO_0000768,idiopathic pulmonary fibrosis,3.532077292170385,0.0,0.0,1.0,0.2398,1.2398,4.379,,,,,,False,"Pain; Pain, Postoperative",,,0.578159,0.5992,0.021041,HIGH,6
fentanyl,MONDO_0002046,alcohol abuse,4.3340440675088505,0.0,0.0,1.0,0.0,1.0,4.334,,,,,,False,"Pain; Pain, Postoperative",,,0.715769,0.735485,0.019716,HIGH,6
fentanyl,EFO_0000764,HIV infection,4.25507867930633,0.0,0.0,1.0,0.0,1.0,4.2551,,,,,,False,"Pain; Pain, Postoperative",,,0.630581,0.846888,0.216307,MEDIUM,6
fentanyl,HP_0003418,Back pain,4.241072920864486,0.0,0.0,1.0,0.0,1.0,4.2411,,,,,,False,"Pain; Pain, Postoperative",,,0.639539,0.841459,0.201921,MEDIUM,6
fentanyl,MONDO_0011382,sickle cell disease,3.403919361361311,0.0,0.0,1.0,0.2398,1.2398,4.2201,,,,,,False,"Pain; Pain, Postoperative",,,0.547401,0.597196,0.049795,HIGH,6
fentanyl,EFO_0002618,pancreatic carcinoma,3.5768644692910163,0.0,0.0,1.0,0.1792,1.1792,4.2178,,,,,,False,"Pain; Pain, Postoperative",,,0.578159,0.614129,0.03597,HIGH,6
fentanyl,MONDO_0005180,Parkinson disease,3.3135074692009105,0.0,0.0,1.0,0.2398,1.2398,4.1081,,,,,,False,"Pain; Pain, Postoperative",,,0.538965,0.569017,0.030053,HIGH,6
fentanyl,HP_0003419,Low back pain,4.091649849938992,0.0,0.0,1.0,0.0,1.0,4.0916,,,,,,False,"Pain; Pain, Postoperative",,,0.671403,0.703019,0.031616,HIGH,6
fentanyl,EFO_0000616,neoplasm,4.088267772431372,0.0,0.0,1.0,0.0,1.0,4.0883,,,,,,False,"Pain; Pain, Postoperative",,,0.637171,0.727018,0.089848,HIGH,6
fentanyl,EFO_0004616,"osteoarthritis, knee",4.048714742710546,0.0,0.0,1.0,0.0,1.0,4.0487,,,,,,False,"Pain; Pain, Postoperative",,,0.645325,0.713449,0.068124,HIGH,6
fentanyl,EFO_0010072,toothache,3.957849395366877,0.0,0.0,1.0,0.0,1.0,3.9578,,,,,,False,"Pain; Pain, Postoperative",,,0.576169,0.816007,0.239838,MEDIUM,6
fentanyl,EFO_0000546,injury,3.956254653265064,0.0,0.0,1.0,0.0,1.0,3.9563,,,,,,False,"Pain; Pain, Postoperative",,,0.642639,0.681155,0.038516,HIGH,6
fentanyl,EFO_0000222,acute myeloid leukemia,3.46589966204925,0.0,0.0,1.0,0.1386,1.1386,3.9464,,,,,,False,"Pain; Pain, Postoperative",,,0.563628,0.595344,0.031716,HIGH,6
fentanyl,EFO_0004240,heroin dependence,3.9449113262244335,0.0,0.0,1.0,0.0,1.0,3.9449,,,,,,False,"Pain; Pain, Postoperative",,,0.657485,0.657485,0.0,HIGH,6
fentanyl,EFO_0004244,interstitial lung disease,3.1470469777394268,0.0,0.0,1.0,0.2398,1.2398,3.9017,,,,,,False,"Pain; Pain, Postoperative",,,0.51505,0.533966,0.018917,HIGH,6
fentanyl,EFO_0004329,alcohol drinking,3.8769086827947854,0.0,0.0,1.0,0.0,1.0,3.8769,,,,,,False,"Pain; Pain, Postoperative",,,0.630466,0.665944,0.035478,HIGH,6
fentanyl,MONDO_0004567,ileus,3.8734114962433894,0.0,0.0,1.0,0.0,1.0,3.8734,,,,,,False,"Pain; Pain, Postoperative",,,0.645569,0.645569,0.0,HIGH,6
fentanyl,MONDO_0015626,Charcot-Marie-Tooth disease,3.0902970092861386,0.0,0.0,1.0,0.2398,1.2398,3.8313,,,,,,False,"Pain; Pain, Postoperative",,,0.51505,0.51505,0.0,HIGH,6
fentanyl,EFO_1000786,"osteoarthritis, hip",3.822712718692463,0.0,0.0,1.0,0.0,1.0,3.8227,,,,,,False,"Pain; Pain, Postoperative",,,0.62395,0.663456,0.039505,HIGH,6
fentanyl,EFO_1000783,diabetic neuropathy,3.8201786107528575,0.0,0.0,1.0,0.0,1.0,3.8202,,,,,,False,"Pain; Pain, Postoperative",,,0.621241,0.656199,0.034958,HIGH,6
fentanyl,EFO_0003884,chronic kidney disease,3.814728475087989,0.0,0.0,1.0,0.0,1.0,3.8147,,,,,,False,"Pain; Pain, Postoperative",,,0.529341,0.784442,0.255102,LOW,6
fentanyl,HP_0000175,Cleft palate,3.0902970092861386,0.0,0.0,1.0,0.2303,1.2303,3.8019,,,,,,False,"Pain; Pain, Postoperative",,,0.51505,0.51505,0.0,HIGH,6
fentanyl,MONDO_0002009,major depressive disorder,3.418021261872368,0.0,0.0,1.0,0.1099,1.1099,3.7935,,,,,,False,"Pain; Pain, Postoperative",,,0.555964,0.586965,0.031001,HIGH,6
fentanyl,EFO_0002610,cocaine dependence,3.770823266824613,0.0,0.0,1.0,0.0,1.0,3.7708,,,,,,False,"Pain; Pain, Postoperative",,,0.622752,0.639907,0.017154,HIGH,6
gemfibrozil,MONDO_0005148,type 2 diabetes mellitus,7.837992335340784,0.6491,0.0,0.823,0.1792,1.1792,7.6069,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.696803,0.870795,0.173992,MEDIUM,10
gemfibrozil,EFO_0000400,diabetes mellitus,6.803715946129082,0.6491,0.0,0.823,0.2197,1.2197,6.8302,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.597212,0.763535,0.166322,MEDIUM,10
gemfibrozil,EFO_0001645,coronary artery disease,6.071841149152083,0.6491,0.0,0.823,0.2303,1.2303,6.1481,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.557746,0.6703,0.112554,MEDIUM,10
gemfibrozil,HP_0003124,Hypercholesterolemia,6.423956816306698,0.6491,0.0,0.823,0.0,1.0,5.2872,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.597113,0.701253,0.10414,MEDIUM,10
gemfibrozil,EFO_0000319,cardiovascular disease,6.2704419081008735,0.6491,0.0,0.823,0.0,1.0,5.1609,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.593852,0.666079,0.072228,HIGH,10
gemfibrozil,MONDO_0011448,PPARG-related familial partial lipodystrophy,4.591598549494713,0.6491,0.0,0.823,0.2398,1.2398,4.6853,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.217285,0.701035,0.48375,LOW,10
gemfibrozil,EFO_0000537,hypertension,4.792973778444817,0.6491,0.0,0.823,0.1609,1.1609,4.5797,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.34997,0.619184,0.269215,LOW,10
gemfibrozil,HP_0003119,Abnormal circulating lipid concentration,5.503534078363644,0.6491,0.0,0.823,0.0,1.0,4.5297,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.528705,0.582826,0.054121,HIGH,10
gemfibrozil,Orphanet_79211,Combined hyperlipidemia,4.359780940524052,0.6491,0.0,0.823,0.2303,1.2303,4.4145,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.426314,0.447164,0.02085,HIGH,10
gemfibrozil,EFO_0000729,ulcerative colitis,4.282324746257909,0.6491,0.0,0.823,0.2398,1.2398,4.3697,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.249611,0.590915,0.341305,LOW,10
gemfibrozil,EFO_0001073,obesity,4.113635364154506,0.6491,0.0,0.823,0.1946,1.1946,4.0445,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.256244,0.563003,0.306758,LOW,10
gemfibrozil,MONDO_0021187,hyperlipidemia,4.86137110822923,0.6491,0.0,0.823,0.0,1.0,4.0011,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.407528,0.598252,0.190724,MEDIUM,10
gemfibrozil,Orphanet_309005,Disorder of lipid metabolism,4.592936956841971,0.6491,0.0,0.823,0.0,1.0,3.7802,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.429981,0.49779,0.06781,HIGH,10
gemfibrozil,EFO_0000195,metabolic syndrome,3.63821133271639,0.6491,0.0,0.823,0.2398,1.2398,3.7124,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.253633,0.472316,0.218683,MEDIUM,10
gemfibrozil,EFO_1001486,primary biliary cirrhosis,4.437461186046076,0.6491,0.0,0.823,0.0,1.0,3.6522,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.436609,0.450884,0.014275,HIGH,10
gemfibrozil,MONDO_0004975,Alzheimer disease,3.472067524174794,0.6491,0.0,0.823,0.2398,1.2398,3.5429,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.218696,0.48004,0.261344,LOW,10
gemfibrozil,EFO_0000612,myocardial infarction,4.2822343211435125,0.6491,0.0,0.823,0.0,1.0,3.5245,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.313248,0.543991,0.230743,MEDIUM,10
gemfibrozil,EFO_0003770,diabetic retinopathy,4.180956798289074,0.6491,0.0,0.823,0.0,1.0,3.4411,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.374667,0.474423,0.099757,HIGH,10
gemfibrozil,EFO_0004211,Hypertriglyceridemia,4.122533474358606,0.6491,0.0,0.823,0.0,1.0,3.393,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.40776,0.418993,0.011232,HIGH,10
gemfibrozil,EFO_0003914,atherosclerosis,4.100104553534541,0.6491,0.0,0.823,0.0,1.0,3.3746,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.337847,0.495925,0.158078,MEDIUM,10
gemfibrozil,EFO_0004705,hypothyroidism,4.0350371122340265,0.6491,0.0,0.823,0.0,1.0,3.321,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.384323,0.42874,0.044417,HIGH,10
gemfibrozil,EFO_0000589,metabolic disease,4.0142682782789105,0.6491,0.0,0.823,0.0,1.0,3.3039,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.350801,0.472512,0.121711,MEDIUM,10
gemfibrozil,EFO_1000727,lipodystrophy,3.852092884139857,0.6491,0.0,0.823,0.0,1.0,3.1704,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.314312,0.449679,0.135367,MEDIUM,10
gemfibrozil,EFO_0004268,sclerosing cholangitis,3.0444839405389423,0.6491,0.0,0.823,0.2398,1.2398,3.1066,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.293151,0.322785,0.029634,HIGH,10
gemfibrozil,HP_0002027,Abdominal pain,3.71382920101241,0.6491,0.0,0.823,0.0,1.0,3.0567,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.371383,0.371383,0.0,HIGH,10
gemfibrozil,EFO_0000384,Crohn's disease,2.993107770956096,0.6491,0.0,0.823,0.2398,1.2398,3.0542,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.290961,0.55353,0.262568,LOW,7
gemfibrozil,MONDO_0005301,multiple sclerosis,2.9516808661785343,0.6491,0.0,0.823,0.2398,1.2398,3.0119,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.09761,0.492726,0.395116,LOW,10
gemfibrozil,EFO_0001074,morbid obesity,3.5475227811069536,0.6491,0.0,0.823,0.0,1.0,2.9198,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.182054,0.512905,0.330852,LOW,10
gemfibrozil,MONDO_0005180,Parkinson disease,2.8496558571521673,0.6491,0.0,0.823,0.2398,1.2398,2.9078,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.18363,0.40281,0.21918,MEDIUM,10
gemfibrozil,EFO_1001249,non-alcoholic steatohepatitis,3.420159042923246,0.6491,0.0,0.823,0.0,1.0,2.8149,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.334731,0.349477,0.014745,HIGH,10
gemfibrozil,EFO_0000275,atrial fibrillation,2.709518033505665,0.6491,0.0,0.823,0.2398,1.2398,2.7648,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.1375,0.418892,0.281392,LOW,10
gemfibrozil,EFO_0003095,non-alcoholic fatty liver disease,3.0067386780125336,0.6491,0.0,0.823,0.1099,1.1099,2.7466,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.207587,0.394526,0.186939,MEDIUM,10
gemfibrozil,EFO_0000341,chronic obstructive pulmonary disease,3.073657286118092,0.6491,0.0,0.823,0.0693,1.0693,2.7051,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.158957,0.491815,0.332858,LOW,10
gemfibrozil,MONDO_0002009,major depressive disorder,2.9479932319360547,0.6491,0.0,0.823,0.1099,1.1099,2.6929,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.210008,0.387656,0.177648,MEDIUM,10
gemfibrozil,HP_0001397,Hepatic steatosis,3.254286511047467,0.6491,0.0,0.823,0.0,1.0,2.6784,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.296643,0.355579,0.058936,HIGH,10
gemfibrozil,MONDO_0018473,hyperlipoproteinemia type 3,3.24376271713937,0.6491,0.0,0.823,0.0,1.0,2.6698,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.268176,0.408677,0.140502,MEDIUM,10
gemfibrozil,MONDO_0004979,asthma,2.727969072159747,0.6491,0.0,0.823,0.1792,1.1792,2.6475,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.345348,0.563975,0.218628,MEDIUM,6
gemfibrozil,EFO_0009321,diabetic macular edema,3.197156002742531,0.6491,0.0,0.823,0.0,1.0,2.6314,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.289544,0.364974,0.07543,HIGH,10
gemfibrozil,EFO_1001375,Myocardial Ischemia,3.168624607999939,0.6491,0.0,0.823,0.0,1.0,2.6079,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",True,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.288938,0.355618,0.066681,HIGH,10
gemfibrozil,EFO_0000660,polycystic ovary syndrome,2.569757361627562,0.6491,0.0,0.823,0.2079,1.2079,2.5548,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.173529,0.338633,0.165105,MEDIUM,10
gemfibrozil,EFO_0000182,hepatocellular carcinoma,2.6667970962337613,0.6491,0.0,0.823,0.1609,1.1609,2.5482,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.19144,0.345523,0.154083,MEDIUM,10
gemfibrozil,EFO_0003767,inflammatory bowel disease,2.581397831756751,0.6491,0.0,0.823,0.1792,1.1792,2.5053,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.173315,0.34329,0.169976,MEDIUM,10
gemfibrozil,MONDO_0019182,inherited obesity,2.5418189817569132,0.6491,0.0,0.823,0.1946,1.1946,2.4991,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.508364,0.508364,0.0,HIGH,5
gemfibrozil,MONDO_0015515,carnitine palmitoyltransferase II deficiency,2.9452508932403907,0.6491,0.0,0.823,0.0,1.0,2.4241,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.289788,0.299262,0.009475,HIGH,10
gemfibrozil,EFO_0000616,neoplasm,2.941449194334525,0.6491,0.0,0.823,0.0,1.0,2.4209,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.190219,0.423913,0.233695,MEDIUM,10
gemfibrozil,EFO_0000685,rheumatoid arthritis,2.3678236697461905,0.6491,0.0,0.823,0.2398,1.2398,2.4161,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.230959,0.558315,0.327356,LOW,6
gemfibrozil,EFO_0005422,skin aging,2.902942752307782,0.6491,0.0,0.823,0.0,1.0,2.3893,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.290294,0.290294,0.0,HIGH,10
gemfibrozil,EFO_0001378,multiple myeloma,2.4084425699594405,0.6491,0.0,0.823,0.1792,1.1792,2.3374,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.151331,0.346955,0.195624,MEDIUM,10
gemfibrozil,MONDO_0018883,Berardinelli-Seip congenital lipodystrophy,2.265426281484382,0.6491,0.0,0.823,0.2398,1.2398,2.3116,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.117844,0.335242,0.217398,MEDIUM,10
gemfibrozil,EFO_0000676,psoriasis,2.2607732984535858,0.6491,0.0,0.823,0.2398,1.2398,2.3069,1,WITHDRAWN,STOPPED,Atherosclerosis,"The study chair changed his employment, the realization of the study was not possible",False,Abdominal Pain; Alcoholism; Alzheimer Disease; Anemia; Cardiovascular Diseases,,,0.299343,0.604966,0.305624,LOW,5
glimepiride,MONDO_0005148,type 2 diabetes mellitus,8.992926732471343,0.7426,0.0,0.8003,0.1792,1.1792,8.4865,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.453089,1.590285,0.137195,MEDIUM,6
glimepiride,MONDO_0009734,"hyperinsulinemic hypoglycemia, familial, 1",8.638473284858772,0.7426,0.0,0.8003,0.2197,1.2197,8.4323,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.43091,1.457416,0.026506,HIGH,6
glimepiride,EFO_0000400,diabetes mellitus,8.383837185431043,0.7426,0.0,0.8003,0.2197,1.2197,8.1838,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.35065,1.490618,0.139968,MEDIUM,6
glimepiride,MONDO_0011153,"hyperinsulinemic hypoglycemia, familial, 2",8.401339339074367,0.7426,0.0,0.8003,0.2079,1.2079,8.1217,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.391631,1.417409,0.025778,HIGH,6
glimepiride,MONDO_0012522,"diabetes mellitus, transient neonatal, 3",8.03771104630478,0.7426,0.0,0.8003,0.2398,1.2398,7.975,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.331398,1.35606,0.024662,HIGH,6
glimepiride,MONDO_0030087,"diabetes mellitus, permanent neonatal 2",7.693803343614539,0.7426,0.0,0.8003,0.2398,1.2398,7.6338,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.282301,1.282301,0.0,HIGH,6
glimepiride,MONDO_0030088,"diabetes mellitus, permanent neonatal 3",7.650638124799745,0.7426,0.0,0.8003,0.2398,1.2398,7.5909,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.263505,1.298309,0.034804,HIGH,6
glimepiride,EFO_0006856,leucine-induced hypoglycemia,7.392975130714184,0.7426,0.0,0.8003,0.2398,1.2398,7.3353,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.220952,1.254584,0.033632,HIGH,6
glimepiride,Orphanet_552,MODY,7.308455492563018,0.7426,0.0,0.8003,0.2398,1.2398,7.2514,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.20022,1.253787,0.053567,HIGH,6
glimepiride,MONDO_0100164,permanent neonatal diabetes mellitus,7.29141318322883,0.7426,0.0,0.8003,0.2197,1.2197,7.1174,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.215236,1.215236,0.0,HIGH,6
glimepiride,MONDO_0012480,"diabetes mellitus, transient neonatal, 2",7.597348736482813,0.7426,0.0,0.8003,0.1386,1.1386,6.923,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.254704,1.289266,0.034562,HIGH,6
glimepiride,MONDO_0014589,maturity-onset diabetes of the young type 13,6.798640867582447,0.7426,0.0,0.8003,0.2398,1.2398,6.7456,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.120818,1.157684,0.036866,HIGH,6
glimepiride,HP_0001943,Hypoglycemia,6.7652339943517195,0.7426,0.0,0.8003,0.2398,1.2398,6.7124,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.12062,1.141378,0.020758,HIGH,6
glimepiride,MONDO_0100165,permanent neonatal diabetes mellitus 1,6.836401944616036,0.7426,0.0,0.8003,0.2197,1.2197,6.6733,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.127044,1.164114,0.03707,HIGH,6
glimepiride,EFO_0000537,hypertension,6.301248765966036,0.7426,0.0,0.8003,0.1609,1.1609,5.8545,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.967576,1.215472,0.247896,MEDIUM,6
glimepiride,MONDO_0020525,transient neonatal diabetes mellitus,6.642782591217897,0.7426,0.0,0.8003,0.0,1.0,5.3162,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.100336,1.120719,0.020382,HIGH,6
glimepiride,MONDO_0019010,congenital isolated hyperinsulinism,6.593869726411448,0.7426,0.0,0.8003,0.0,1.0,5.277,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.098978,1.098978,0.0,HIGH,6
glimepiride,MONDO_0017182,familial hyperinsulinism,6.458965359452502,0.7426,0.0,0.8003,0.0,1.0,5.1691,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,1.076494,1.076494,0.0,HIGH,6
glimepiride,MONDO_0019207,DEND syndrome,5.054317364123001,0.7426,0.0,0.8003,0.2197,1.2197,4.9337,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.842386,0.842386,0.0,HIGH,6
glimepiride,MONDO_0018911,maturity-onset diabetes of the young,5.7214266387895725,0.7426,0.0,0.8003,0.0,1.0,4.5788,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.953571,0.953571,0.0,HIGH,6
glimepiride,EFO_0001645,coronary artery disease,4.601342629379285,0.7426,0.0,0.8003,0.2303,1.2303,4.5303,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.678319,0.944033,0.265714,LOW,6
glimepiride,MONDO_0016391,neonatal diabetes mellitus,5.527921967524209,0.7426,0.0,0.8003,0.0,1.0,4.424,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.92132,0.92132,0.0,HIGH,6
glimepiride,EFO_0000508,genetic disorder,5.48359703428641,0.7426,0.0,0.8003,0.0,1.0,4.3885,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.872065,0.997669,0.125604,MEDIUM,6
glimepiride,HP_0000819,Diabetes mellitus,5.20376267068713,0.7426,0.0,0.8003,0.0,1.0,4.1645,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.861972,0.877938,0.015967,HIGH,6
glimepiride,EFO_1001511,monogenic diabetes,4.840512297951561,0.7426,0.0,0.8003,0.0,1.0,3.8738,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.806752,0.806752,0.0,HIGH,6
glimepiride,HP_0000857,Neonatal insulin-dependent diabetes mellitus,4.8262394702358655,0.7426,0.0,0.8003,0.0,1.0,3.8624,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.804373,0.804373,0.0,HIGH,6
glimepiride,EFO_0001073,obesity,3.894434256681351,0.7426,0.0,0.8003,0.1946,1.1946,3.7232,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.63569,0.675837,0.040147,HIGH,6
glimepiride,MONDO_0017184,autosomal dominant hyperinsulinism due to SUR1 deficiency,4.611697739664539,0.7426,0.0,0.8003,0.0,1.0,3.6907,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.7639,0.77805,0.01415,HIGH,6
glimepiride,EFO_0003770,diabetic retinopathy,4.578514526648051,0.7426,0.0,0.8003,0.0,1.0,3.6642,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.758403,0.772451,0.014048,HIGH,6
glimepiride,EFO_0000407,dilated cardiomyopathy,3.605051709594544,0.7426,0.0,0.8003,0.2398,1.2398,3.5769,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.588628,0.62527,0.036642,HIGH,6
glimepiride,EFO_0005571,osteochondrodysplasia,3.53176801061273,0.7426,0.0,0.8003,0.2398,1.2398,3.5042,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.588628,0.588628,0.0,HIGH,6
glimepiride,EFO_0000676,psoriasis,3.4102459517036117,0.7426,0.0,0.8003,0.2398,1.2398,3.3836,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.558223,0.588678,0.030455,HIGH,6
glimepiride,EFO_0009486,diabetic eye disease,4.215937356404928,0.7426,0.0,0.8003,0.0,1.0,3.374,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.702656,0.702656,0.0,HIGH,6
glimepiride,EFO_0001361,pulmonary arterial hypertension,4.197160628627147,0.7426,0.0,0.8003,0.0,1.0,3.359,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.699527,0.699527,0.0,HIGH,6
glimepiride,MONDO_0019280,hypertrichosis,4.152181924477032,0.7426,0.0,0.8003,0.0,1.0,3.323,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.69203,0.69203,0.0,HIGH,6
glimepiride,EFO_0004997,type 2 diabetes nephropathy,4.135084863155084,0.7426,0.0,0.8003,0.0,1.0,3.3093,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.689181,0.689181,0.0,HIGH,6
glimepiride,HP_0000924,Abnormality of the skeletal system,4.126166454453618,0.7426,0.0,0.8003,0.0,1.0,3.3022,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.627213,0.808657,0.181444,MEDIUM,6
glimepiride,MONDO_0002177,hyperinsulinism,3.9809596737214736,0.7426,0.0,0.8003,0.0,1.0,3.1859,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.663493,0.663493,0.0,HIGH,6
glimepiride,HP_0032263,Increased blood pressure,3.845519156573808,0.7426,0.0,0.8003,0.0,1.0,3.0776,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.602373,0.718014,0.115641,MEDIUM,6
glimepiride,EFO_0007318,hyperinsulinemic hypoglycemia,3.783410854648728,0.7426,0.0,0.8003,0.0,1.0,3.0278,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.630568,0.630568,0.0,HIGH,6
glimepiride,MONDO_0019334,autosomal recessive hyperinsulinism due to Kir6.2 deficiency,3.749347755824828,0.7426,0.0,0.8003,0.0,1.0,3.0006,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.621057,0.632561,0.011504,HIGH,6
glimepiride,EFO_0005772,neurodegenerative disease,3.7232976930020807,0.7426,0.0,0.8003,0.0,1.0,2.9797,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.579696,0.702256,0.12256,MEDIUM,6
glimepiride,EFO_1000783,diabetic neuropathy,3.678165811615171,0.7426,0.0,0.8003,0.0,1.0,2.9436,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.582773,0.673538,0.090765,HIGH,6
glimepiride,EFO_0003914,atherosclerosis,3.666990263213694,0.7426,0.0,0.8003,0.0,1.0,2.9347,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.594338,0.64482,0.050482,HIGH,6
glimepiride,HP_0003124,Hypercholesterolemia,3.660809782556773,0.7426,0.0,0.8003,0.0,1.0,2.9297,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,True,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.544046,0.742314,0.198268,MEDIUM,6
glimepiride,MONDO_0017185,autosomal dominant hyperinsulinism due to Kir6.2 deficiency,3.641397061591164,0.7426,0.0,0.8003,0.0,1.0,2.9142,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.601378,0.617943,0.016565,HIGH,6
glimepiride,MONDO_0005129,cataract,2.934492223181401,0.7426,0.0,0.8003,0.2398,1.2398,2.9116,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.489082,0.489082,0.0,HIGH,6
glimepiride,MONDO_0018054,familial atrial fibrillation,3.6196335422173136,0.7426,0.0,0.8003,0.0,1.0,2.8968,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.588628,0.632561,0.043933,HIGH,6
glimepiride,EFO_0000284,benign prostatic hyperplasia,3.1086345549399166,0.7426,0.0,0.8003,0.1386,1.1386,2.8327,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.514926,0.524465,0.009538,HIGH,6
glimepiride,MONDO_0017187,diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,3.53176801061273,0.7426,0.0,0.8003,0.0,1.0,2.8265,1,COMPLETED,COMPLETED_NEGATIVE,Diabetes Mellitus,,False,"Atherosclerosis; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypercholesterolemia",,,0.588628,0.588628,0.0,HIGH,6
heparin,MONDO_0013144,hereditary antithrombin deficiency,5.6353609758213175,0.6407,0.0,0.8251,0.2303,1.2303,5.7206,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.371572,1.427474,0.055902,HIGH,4
heparin,HP_0004936,Venous thrombosis,4.583339836313719,0.6407,0.0,0.8251,0.2398,1.2398,4.6887,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.115524,1.16099,0.045466,HIGH,4
heparin,HP_0001976,Reduced antithrombin III activity,5.2442475801081905,0.6407,0.0,0.8251,0.0,1.0,4.3272,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.276381,1.328403,0.052022,HIGH,4
heparin,MONDO_0013361,congenital prothrombin deficiency,4.165309916058633,0.6407,0.0,0.8251,0.2398,1.2398,4.261,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.380881,1.371551,0.99067,LOW,4
heparin,EFO_0000275,atrial fibrillation,4.088677756776423,0.6407,0.0,0.8251,0.2398,1.2398,4.1827,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.012789,1.04093,0.028141,HIGH,4
heparin,Orphanet_325,Congenital factor II deficiency,4.07953217668001,0.6407,0.0,0.8251,0.2398,1.2398,4.1733,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.387151,1.336249,0.949098,LOW,4
heparin,EFO_0004286,venous thromboembolism,4.736649625883835,0.6407,0.0,0.8251,0.0,1.0,3.9083,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.119758,1.233032,0.113273,MEDIUM,4
heparin,EFO_0000712,stroke,4.135213829414169,0.6407,0.0,0.8251,0.1386,1.1386,3.8851,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.764056,1.184691,0.420634,LOW,4
heparin,EFO_0001645,coronary artery disease,3.6704139881200586,0.6407,0.0,0.8251,0.2303,1.2303,3.7259,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.59626,1.238947,0.642688,LOW,4
heparin,EFO_0003907,deep vein thrombosis,4.473457887622285,0.6407,0.0,0.8251,0.0,1.0,3.6912,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.069083,1.143005,0.073922,HIGH,4
heparin,EFO_0000319,cardiovascular disease,4.43716746082967,0.6407,0.0,0.8251,0.0,1.0,3.6612,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.995158,1.223426,0.228267,MEDIUM,4
heparin,MONDO_0008559,thrombophilia due to thrombin defect,3.5394715224857416,0.6407,0.0,0.8251,0.2079,1.2079,3.5278,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.179824,1.179824,0.0,HIGH,3
heparin,EFO_0003827,pulmonary embolism,4.269283932626489,0.6407,0.0,0.8251,0.0,1.0,3.5227,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.995817,1.103073,0.107256,MEDIUM,4
heparin,EFO_0000612,myocardial infarction,4.239856005875197,0.6407,0.0,0.8251,0.0,1.0,3.4984,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.001746,1.118182,0.116436,MEDIUM,4
heparin,HP_0001873,Thrombocytopenia,3.487654049390363,0.6407,0.0,0.8251,0.2079,1.2079,3.4762,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.615601,1.00007,0.384469,LOW,4
heparin,HP_0001907,Thromboembolism,4.152496847480675,0.6407,0.0,0.8251,0.0,1.0,3.4263,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.927989,1.093192,0.165203,MEDIUM,4
heparin,EFO_1000954,habitual abortion,3.463281229751357,0.6407,0.0,0.8251,0.1792,1.1792,3.3697,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.640694,0.978384,0.33769,LOW,4
heparin,EFO_0003777,heart disease,3.906156032165031,0.6407,0.0,0.8251,0.0,1.0,3.2231,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.900256,1.028584,0.128328,MEDIUM,4
heparin,HP_0004419,Recurrent thrombophlebitis,3.718814462186552,0.6407,0.0,0.8251,0.0,1.0,3.0685,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.89188,0.948615,0.056736,HIGH,4
heparin,MONDO_0000831,thrombotic disease,3.430141424254297,0.6407,0.0,0.8251,0.0,1.0,2.8303,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.674308,0.949149,0.274841,LOW,4
heparin,HP_0002140,Ischemic stroke,3.4093661962789614,0.6407,0.0,0.8251,0.0,1.0,2.8132,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.375816,1.105548,0.729732,LOW,4
heparin,EFO_0005672,acute coronary syndrome,3.362668725457109,0.6407,0.0,0.8251,0.0,1.0,2.7746,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.699217,0.923881,0.224664,MEDIUM,4
heparin,EFO_0004911,familial hypercholesterolemia,2.7141434293629603,0.6407,0.0,0.8251,0.2303,1.2303,2.7552,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.357072,1.357072,0.0,HIGH,2
heparin,EFO_0009314,blood coagulation disease,3.230836880369251,0.6407,0.0,0.8251,0.0,1.0,2.6659,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.645057,0.889035,0.243978,MEDIUM,4
heparin,EFO_1001395,Phlebitis,3.162121862839942,0.6407,0.0,0.8251,0.0,1.0,2.6092,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.584984,0.893304,0.308319,LOW,4
heparin,HP_0004418,Thrombophlebitis,3.155611886750928,0.6407,0.0,0.8251,0.0,1.0,2.6038,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.585989,0.89036,0.304371,LOW,4
heparin,MONDO_0024307,prothrombin deficiency,3.148207669944444,0.6407,0.0,0.8251,0.0,1.0,2.5977,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.049403,1.049403,0.0,HIGH,3
heparin,EFO_0000195,metabolic syndrome,2.5067837081936615,0.6407,0.0,0.8251,0.2398,1.2398,2.5644,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.453905,0.799487,0.345582,LOW,4
heparin,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.598497793614942,0.6407,0.0,0.8251,0.1946,1.1946,2.5613,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.299249,1.299249,0.0,HIGH,2
heparin,EFO_0009315,thrombophilia,3.068449727438642,0.6407,0.0,0.8251,0.0,1.0,2.5319,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.641413,0.829962,0.188549,MEDIUM,4
heparin,EFO_1000985,intermediate coronary syndrome,2.9109047642755614,0.6407,0.0,0.8251,0.0,1.0,2.4019,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.675434,0.764202,0.088769,HIGH,4
heparin,MONDO_0005575,colorectal cancer,2.397987960195757,0.6407,0.0,0.8251,0.2079,1.2079,2.3901,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.593996,0.6105,0.016504,HIGH,4
heparin,MONDO_0010602,hemophilia A,2.260721254692319,0.6407,0.0,0.8251,0.2398,1.2398,2.3127,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.55023,0.572656,0.022426,HIGH,4
heparin,EFO_1001375,Myocardial Ischemia,2.7841488467761875,0.6407,0.0,0.8251,0.0,1.0,2.2973,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.44131,0.950765,0.509455,LOW,4
heparin,MONDO_0010604,hemophilia B,2.245297732973694,0.6407,0.0,0.8251,0.2398,1.2398,2.2969,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.546476,0.568749,0.022273,HIGH,4
heparin,MONDO_0005148,type 2 diabetes mellitus,2.33680816885102,0.6407,0.0,0.8251,0.1792,1.1792,2.2736,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.578841,0.594924,0.016083,HIGH,4
heparin,MONDO_0100096,COVID-19,2.683155886628304,0.6407,0.0,0.8251,0.0,1.0,2.2139,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.664633,0.6831,0.018467,HIGH,4
heparin,MONDO_0008903,lung cancer,2.2510787751447787,0.6407,0.0,0.8251,0.1792,1.1792,2.1902,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.557605,0.573099,0.015493,HIGH,4
heparin,EFO_0003913,angina pectoris,2.6196014650970807,0.6407,0.0,0.8251,0.0,1.0,2.1615,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.419706,0.890095,0.470389,LOW,4
heparin,HP_0001977,Abnormal thrombosis,2.5704937794469904,0.6407,0.0,0.8251,0.0,1.0,2.121,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.496749,0.715561,0.218811,MEDIUM,4
heparin,HP_0003124,Hypercholesterolemia,2.548606876753404,0.6407,0.0,0.8251,0.0,1.0,2.1029,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.274303,1.274303,0.0,HIGH,2
heparin,EFO_0000544,infection,2.496532767191808,0.6407,0.0,0.8251,0.0,1.0,2.06,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.618406,0.635588,0.017183,HIGH,4
heparin,EFO_0000365,colorectal adenocarcinoma,2.060198006190759,0.6407,0.0,0.8251,0.2079,1.2079,2.0534,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.51505,0.51505,0.0,HIGH,4
heparin,EFO_0008583,acute myocardial infarction,2.3781900825131927,0.6407,0.0,0.8251,0.0,1.0,1.9623,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.578047,0.611133,0.033086,HIGH,4
heparin,MONDO_0018660,hemophilia,2.36055031929459,0.6407,0.0,0.8251,0.0,1.0,1.9478,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.590138,0.590138,0.0,HIGH,4
heparin,EFO_0004875,mathematical ability,2.344212270435009,0.6407,0.0,0.8251,0.0,1.0,1.9343,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.586053,0.586053,0.0,HIGH,4
heparin,EFO_0003884,chronic kidney disease,2.3362917956080436,0.6407,0.0,0.8251,0.0,1.0,1.9277,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.578713,0.594793,0.01608,HIGH,4
heparin,HP_0100806,Sepsis,2.2946312091606256,0.6407,0.0,0.8251,0.0,1.0,1.8934,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,True,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.55828,0.589036,0.030757,HIGH,4
heparin,EFO_0000589,metabolic disease,2.2742260954083156,0.6407,0.0,0.8251,0.0,1.0,1.8765,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,1.137113,1.137113,0.0,HIGH,2
heparin,MONDO_0004596,cor pulmonale,2.2620395789197936,0.6407,0.0,0.8251,0.0,1.0,1.8665,1,WITHDRAWN,STOPPED,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Sponsor decision,False,"Acute Coronary Syndrome; Acute Lung Injury; Angina, Stable; Angina, Unstable; Aortic Valve Stenosis",,,0.754013,0.754013,0.0,HIGH,3
jardiance,MONDO_0009297,familial renal glucosuria,2.3140916382472043,0.0,0.0,1.0,0.2197,1.2197,2.8225,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,1.157046,1.157046,0.0,HIGH,2
jardiance,EFO_0000400,diabetes mellitus,2.0068965622288326,0.0,0.0,1.0,0.2197,1.2197,2.4479,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,1.003448,1.003448,0.0,HIGH,2
jardiance,Orphanet_69076,Renal glucosuria,1.9824489793541893,0.0,0.0,1.0,0.2197,1.2197,2.418,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.991224,0.991224,0.0,HIGH,2
jardiance,MONDO_0005148,type 2 diabetes mellitus,2.022101849765444,0.0,0.0,1.0,0.1792,1.1792,2.3844,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,1.011051,1.011051,0.0,HIGH,2
jardiance,MONDO_0005147,type 1 diabetes mellitus,1.7724402484276884,0.0,0.0,1.0,0.2398,1.2398,2.1975,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.88622,0.88622,0.0,HIGH,2
jardiance,EFO_0003144,heart failure,1.985098971500723,0.0,0.0,1.0,0.0,1.0,1.9851,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.992549,0.992549,0.0,HIGH,2
jardiance,EFO_0003884,chronic kidney disease,1.911341490139564,0.0,0.0,1.0,0.0,1.0,1.9113,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.955671,0.955671,0.0,HIGH,2
jardiance,Orphanet_79161,Disorder of carbohydrate metabolism,1.814580585462054,0.0,0.0,1.0,0.0,1.0,1.8146,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.90729,0.90729,0.0,HIGH,2
jardiance,MONDO_0037792,carbohydrate metabolism disease,1.6543456943153243,0.0,0.0,1.0,0.0,1.0,1.6543,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.827173,0.827173,0.0,HIGH,2
jardiance,EFO_0000275,atrial fibrillation,1.1489732111582296,0.0,0.0,1.0,0.2398,1.2398,1.4245,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.574487,0.574487,0.0,HIGH,2
jardiance,EFO_0000660,polycystic ovary syndrome,1.1281259600451865,0.0,0.0,1.0,0.2079,1.2079,1.3627,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.564063,0.564063,0.0,HIGH,2
jardiance,EFO_0004252,nasopharyngeal neoplasm,1.1772560035375763,0.0,0.0,1.0,0.1099,1.1099,1.3066,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.588628,0.588628,0.0,HIGH,2
jardiance,EFO_0000407,dilated cardiomyopathy,1.0300990030953796,0.0,0.0,1.0,0.2398,1.2398,1.2771,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.51505,0.51505,0.0,HIGH,2
jardiance,HP_0003076,Glycosuria,1.2681771465222074,0.0,0.0,1.0,0.0,1.0,1.2682,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.634089,0.634089,0.0,HIGH,2
jardiance,EFO_0000401,diabetic nephropathy,1.229615275206217,0.0,0.0,1.0,0.0,1.0,1.2296,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.614808,0.614808,0.0,HIGH,2
jardiance,EFO_1000647,renal tubular transport disease,1.1772560035375763,0.0,0.0,1.0,0.0,1.0,1.1773,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.588628,0.588628,0.0,HIGH,2
jardiance,HP_0001943,Hypoglycemia,0.9466830333911628,0.0,0.0,1.0,0.2398,1.2398,1.1737,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.473342,0.473342,0.0,HIGH,2
jardiance,HP_0000855,Insulin resistance,1.1539204013135362,0.0,0.0,1.0,0.0,1.0,1.1539,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.57696,0.57696,0.0,HIGH,2
jardiance,EFO_0000195,metabolic syndrome,0.9298855363464574,0.0,0.0,1.0,0.2398,1.2398,1.1529,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.464943,0.464943,0.0,HIGH,2
jardiance,EFO_0000612,myocardial infarction,1.1288817068864183,0.0,0.0,1.0,0.0,1.0,1.1289,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.564441,0.564441,0.0,HIGH,2
jardiance,EFO_0003095,non-alcoholic fatty liver disease,0.9951077690069184,0.0,0.0,1.0,0.1099,1.1099,1.1044,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.497554,0.497554,0.0,HIGH,2
jardiance,EFO_0001645,coronary artery disease,0.8903189143857508,0.0,0.0,1.0,0.2303,1.2303,1.0953,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.445159,0.445159,0.0,HIGH,2
jardiance,HP_0012664,Reduced left ventricular ejection fraction,1.0594875641459125,0.0,0.0,1.0,0.0,1.0,1.0595,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.529744,0.529744,0.0,HIGH,2
jardiance,EFO_0008585,ST Elevation Myocardial Infarction,1.057936202345695,0.0,0.0,1.0,0.0,1.0,1.0579,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.528968,0.528968,0.0,HIGH,2
jardiance,EFO_0000538,hypertrophic cardiomyopathy,0.8499966388226707,0.0,0.0,1.0,0.2398,1.2398,1.0538,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.424998,0.424998,0.0,HIGH,2
jardiance,EFO_0004194,IGA glomerulonephritis,0.8461375117486516,0.0,0.0,1.0,0.2398,1.2398,1.049,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.423069,0.423069,0.0,HIGH,2
jardiance,EFO_0004593,gestational diabetes,1.0364671678015611,0.0,0.0,1.0,0.0,1.0,1.0365,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.518234,0.518234,0.0,HIGH,2
jardiance,EFO_1001249,non-alcoholic steatohepatitis,0.9719916296912632,0.0,0.0,1.0,0.0,1.0,0.972,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.485996,0.485996,0.0,HIGH,2
jardiance,HP_0001919,Acute kidney injury,0.9413066161549296,0.0,0.0,1.0,0.0,1.0,0.9413,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.470653,0.470653,0.0,HIGH,2
jardiance,MONDO_0100096,COVID-19,0.9341420742803124,0.0,0.0,1.0,0.0,1.0,0.9341,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.467071,0.467071,0.0,HIGH,2
jardiance,EFO_0008583,acute myocardial infarction,0.9048916753783904,0.0,0.0,1.0,0.0,1.0,0.9049,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.452446,0.452446,0.0,HIGH,2
jardiance,MONDO_0024327,chronic renal failure syndrome,0.8829420026531822,0.0,0.0,1.0,0.0,1.0,0.8829,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.441471,0.441471,0.0,HIGH,2
jardiance,HP_0001397,Hepatic steatosis,0.8494899532315877,0.0,0.0,1.0,0.0,1.0,0.8495,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.424745,0.424745,0.0,HIGH,2
jardiance,EFO_0003770,diabetic retinopathy,0.846531548326213,0.0,0.0,1.0,0.0,1.0,0.8465,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.423266,0.423266,0.0,HIGH,2
jardiance,EFO_1002048,kidney failure,0.8424332649106879,0.0,0.0,1.0,0.0,1.0,0.8424,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.421217,0.421217,0.0,HIGH,2
jardiance,HP_0001653,Mitral regurgitation,0.8274638134864739,0.0,0.0,1.0,0.0,1.0,0.8275,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.413732,0.413732,0.0,HIGH,2
jardiance,EFO_0000694,severe acute respiratory syndrome,0.8258450864816099,0.0,0.0,1.0,0.0,1.0,0.8258,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.412923,0.412923,0.0,HIGH,2
jardiance,HP_0031273,Shock,0.825256458479841,0.0,0.0,1.0,0.0,1.0,0.8253,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.412628,0.412628,0.0,HIGH,2
jardiance,EFO_1001482,cardiotoxicity,0.8240792024763034,0.0,0.0,1.0,0.0,1.0,0.8241,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.41204,0.41204,0.0,HIGH,2
jardiance,EFO_0000508,genetic disorder,0.6194352281385914,0.0,0.0,1.0,0.0,1.0,0.6194,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.309718,0.309718,0.0,HIGH,2
jardiance,EFO_0001073,obesity,0.3882727245773457,0.0,0.0,1.0,0.1946,1.1946,0.4638,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.194136,0.194136,0.0,HIGH,2
jardiance,MONDO_0008315,prostate cancer,0.4476029205335426,0.0,0.0,1.0,0.0,1.0,0.4476,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.223801,0.223801,0.0,HIGH,2
jardiance,MONDO_0004975,Alzheimer disease,0.3295138578215085,0.0,0.0,1.0,0.2398,1.2398,0.4085,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.164757,0.164757,0.0,HIGH,2
jardiance,MONDO_0009067,cystinuria,0.3312138367556458,0.0,0.0,1.0,0.2303,1.2303,0.4075,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.165607,0.165607,0.0,HIGH,2
jardiance,Orphanet_1331,Familial prostate cancer,0.3531768010612728,0.0,0.0,1.0,0.1386,1.1386,0.4021,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.176588,0.176588,0.0,HIGH,2
jardiance,EFO_0001422,cirrhosis of liver,0.3231905794556913,0.0,0.0,1.0,0.2398,1.2398,0.4007,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.161595,0.161595,0.0,HIGH,2
jardiance,EFO_0004253,nephrolithiasis,0.3281882573797608,0.0,0.0,1.0,0.1946,1.1946,0.3921,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.164094,0.164094,0.0,HIGH,2
jardiance,MONDO_0007254,breast cancer,0.3749525064397286,0.0,0.0,1.0,0.0,1.0,0.375,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.187476,0.187476,0.0,HIGH,2
jardiance,EFO_0003767,inflammatory bowel disease,0.3131223914563442,0.0,0.0,1.0,0.1792,1.1792,0.3692,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.156561,0.156561,0.0,HIGH,2
jardiance,EFO_0003086,kidney disease,0.3686870643489662,0.0,0.0,1.0,0.0,1.0,0.3687,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Acute Kidney Injury; Ascites; Cardiotoxicity; Colitis, Ulcerative; Crohn Disease",,,0.184344,0.184344,0.0,HIGH,2
midazolam,MONDO_0016532,Lennox-Gastaut syndrome,3.045942588794542,0.7148,0.0,0.807,0.2398,1.2398,3.0475,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.522971,1.522971,0.0,HIGH,2
midazolam,MONDO_0100062,genetic developmental and epileptic encephalopathy,2.979790600954522,0.7148,0.0,0.807,0.2398,1.2398,2.9813,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.489895,1.489895,0.0,HIGH,2
midazolam,Orphanet_36387,Generalized epilepsy with febrile seizures-plus,2.904062211011726,0.7148,0.0,0.807,0.2398,1.2398,2.9055,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.452031,1.452031,0.0,HIGH,2
midazolam,MONDO_0014921,"developmental and epileptic encephalopathy, 43",2.6559432651992494,0.7148,0.0,0.807,0.2398,1.2398,2.6573,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.327972,1.327972,0.0,HIGH,2
midazolam,MONDO_0009696,juvenile myoclonic epilepsy,2.5845852399396416,0.7148,0.0,0.807,0.2303,1.2303,2.566,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.292293,1.292293,0.0,HIGH,2
midazolam,MONDO_0007079,alcohol dependence,2.835473269949567,0.7148,0.0,0.807,0.1099,1.1099,2.5396,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.417737,1.417737,0.0,HIGH,2
midazolam,MONDO_0014328,"developmental and epileptic encephalopathy, 19",2.4626773005157037,0.7148,0.0,0.807,0.2398,1.2398,2.4639,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.231339,1.231339,0.0,HIGH,2
midazolam,EFO_0000474,epilepsy,3.0400320518172066,0.7148,0.0,0.807,0.0,1.0,2.4533,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.520016,1.520016,0.0,HIGH,2
midazolam,MONDO_0005277,migraine disorder,2.5134073099688248,0.7148,0.0,0.807,0.2079,1.2079,2.4501,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.256704,1.256704,0.0,HIGH,2
midazolam,HP_0001249,Intellectual disability,2.3446657252363825,0.7148,0.0,0.807,0.2398,1.2398,2.3458,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.172333,1.172333,0.0,HIGH,2
midazolam,HP_0001250,Seizure,2.9017285979391674,0.7148,0.0,0.807,0.0,1.0,2.3417,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.450864,1.450864,0.0,HIGH,2
midazolam,MONDO_0010826,childhood absence epilepsy,2.804190906947988,0.7148,0.0,0.807,0.0,1.0,2.2629,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.402095,1.402095,0.0,HIGH,2
midazolam,EFO_0004698,insomnia,2.512783067810264,0.7148,0.0,0.807,0.1099,1.1099,2.2506,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.256392,1.256392,0.0,HIGH,2
midazolam,MONDO_0014942,"developmental and epileptic encephalopathy, 45",2.1820122453061703,0.7148,0.0,0.807,0.2398,1.2398,2.1831,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.091006,1.091006,0.0,HIGH,2
midazolam,MONDO_0002009,major depressive disorder,2.399172825902771,0.7148,0.0,0.807,0.1099,1.1099,2.1488,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.199586,1.199586,0.0,HIGH,2
midazolam,EFO_0005917,generalised epilepsy,2.0665999739823713,0.7148,0.0,0.807,0.2398,1.2398,2.0676,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.0333,1.0333,0.0,HIGH,2
midazolam,EFO_0004262,panic disorder,2.4888361056626342,0.7148,0.0,0.807,0.0,1.0,2.0085,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.244418,1.244418,0.0,HIGH,2
midazolam,MONDO_0005180,Parkinson disease,1.9982907874894609,0.7148,0.0,0.807,0.2398,1.2398,1.9993,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.999145,0.999145,0.0,HIGH,2
midazolam,EFO_0007498,Stiff-Person syndrome,1.9916375198015384,0.7148,0.0,0.807,0.2398,1.2398,1.9926,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.995819,0.995819,0.0,HIGH,2
midazolam,HP_0000739,Anxiety,2.468040557561326,0.7148,0.0,0.807,0.0,1.0,1.9917,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.23402,1.23402,0.0,HIGH,2
midazolam,MONDO_0005090,schizophrenia,1.981905232756611,0.7148,0.0,0.807,0.2398,1.2398,1.9829,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.990953,0.990953,0.0,HIGH,2
midazolam,MONDO_0004975,Alzheimer disease,1.9726184082884104,0.7148,0.0,0.807,0.2398,1.2398,1.9736,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.986309,0.986309,0.0,HIGH,2
midazolam,MONDO_0005301,multiple sclerosis,1.96109496283973,0.7148,0.0,0.807,0.2398,1.2398,1.9621,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.980547,0.980547,0.0,HIGH,2
midazolam,EFO_0006788,anxiety disorder,2.4059193305222184,0.7148,0.0,0.807,0.0,1.0,1.9415,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.20296,1.20296,0.0,HIGH,2
midazolam,Orphanet_1945,Rolandic epilepsy,1.9292933675440629,0.7148,0.0,0.807,0.2398,1.2398,1.9302,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.964647,0.964647,0.0,HIGH,2
midazolam,HP_0000713,Agitation,2.3874086208124616,0.7148,0.0,0.807,0.0,1.0,1.9266,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.193704,1.193704,0.0,HIGH,2
midazolam,HP_0012531,Pain,2.376469993744589,0.7148,0.0,0.807,0.0,1.0,1.9178,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.188235,1.188235,0.0,HIGH,2
midazolam,EFO_0001073,obesity,1.9255899098156417,0.7148,0.0,0.807,0.1946,1.1946,1.8563,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.962795,0.962795,0.0,HIGH,2
midazolam,EFO_0007453,postpartum depression,2.2883821313631625,0.7148,0.0,0.807,0.0,1.0,1.8467,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.144191,1.144191,0.0,HIGH,2
midazolam,EFO_1001892,generalized anxiety disorder,2.2840198133731717,0.7148,0.0,0.807,0.0,1.0,1.8432,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.14201,1.14201,0.0,HIGH,2
midazolam,EFO_0008526,status epilepticus,2.2537239965300326,0.7148,0.0,0.807,0.0,1.0,1.8187,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.126862,1.126862,0.0,HIGH,2
midazolam,MONDO_0007295,self-limited epilepsy with centrotemporal spikes,1.8548192150963116,0.7148,0.0,0.807,0.1792,1.1792,1.765,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.92741,0.92741,0.0,HIGH,2
midazolam,MONDO_0018097,infantile spasms,1.7559961720634654,0.7148,0.0,0.807,0.2398,1.2398,1.7569,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.877998,0.877998,0.0,HIGH,2
midazolam,MONDO_0002050,depressive disorder,2.162647751194014,0.7148,0.0,0.807,0.0,1.0,1.7452,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.081324,1.081324,0.0,HIGH,2
midazolam,EFO_0000508,genetic disorder,2.051227645348812,0.7148,0.0,0.807,0.0,1.0,1.6553,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,1.025614,1.025614,0.0,HIGH,2
midazolam,HP_0200134,Epileptic encephalopathy,1.99456155270906,0.7148,0.0,0.807,0.0,1.0,1.6096,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.997281,0.997281,0.0,HIGH,2
midazolam,EFO_1001454,amnesia,1.9361498874926,0.7148,0.0,0.807,0.0,1.0,1.5625,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.968075,0.968075,0.0,HIGH,2
midazolam,MONDO_0859564,"epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features",1.5391093207529136,0.7148,0.0,0.807,0.2398,1.2398,1.5399,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.769555,0.769555,0.0,HIGH,2
midazolam,HP_0007359,Focal-onset seizure,1.7923389767099955,0.7148,0.0,0.807,0.0,1.0,1.4464,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.896169,0.896169,0.0,HIGH,2
midazolam,EFO_0000537,hypertension,1.542803061305701,0.7148,0.0,0.807,0.1609,1.1609,1.4454,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.771402,0.771402,0.0,HIGH,2
midazolam,EFO_0000400,diabetes mellitus,1.4652476265937042,0.7148,0.0,0.807,0.2197,1.2197,1.4422,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.732624,0.732624,0.0,HIGH,2
midazolam,EFO_0005772,neurodegenerative disease,1.7798205650636114,0.7148,0.0,0.807,0.0,1.0,1.4363,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.88991,0.88991,0.0,HIGH,2
midazolam,MONDO_0005148,type 2 diabetes mellitus,1.4903315825656684,0.7148,0.0,0.807,0.1792,1.1792,1.4182,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.745166,0.745166,0.0,HIGH,2
midazolam,EFO_1000632,cerebral palsy,1.748754895435497,0.7148,0.0,0.807,0.0,1.0,1.4112,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.874377,0.874377,0.0,HIGH,2
midazolam,EFO_0004263,partial epilepsy,1.7312239224880692,0.7148,0.0,0.807,0.0,1.0,1.3971,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.865612,0.865612,0.0,HIGH,2
midazolam,MONDO_0004985,bipolar disorder,1.7206525170426117,0.7148,0.0,0.807,0.0,1.0,1.3885,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.860326,0.860326,0.0,HIGH,2
midazolam,EFO_0001645,coronary artery disease,1.394547951404663,0.7148,0.0,0.807,0.2303,1.2303,1.3845,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.697274,0.697274,0.0,HIGH,2
midazolam,EFO_0004895,Tourette syndrome,1.3765679996708922,0.7148,0.0,0.807,0.2303,1.2303,1.3667,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.688284,0.688284,0.0,HIGH,2
midazolam,HP_0000726,Dementia,1.6770663278187117,0.7148,0.0,0.807,0.0,1.0,1.3534,,,,,,True,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.838533,0.838533,0.0,HIGH,2
midazolam,MONDO_0007113,Angelman syndrome,1.342355139308598,0.7148,0.0,0.807,0.2398,1.2398,1.343,,,,,,False,Aggression; Alzheimer Disease; Amnesia; Amyotrophic Lateral Sclerosis; Anemia,,,0.671178,0.671178,0.0,HIGH,2
mln1202,MONDO_0009060,cystic disease of lung,3.9526043303217593,0.0,0.0,1.0,0.1609,1.1609,4.5888,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.988151,0.988151,0.0,HIGH,4
mln1202,Orphanet_51636,WHIM syndrome,2.5923572442017973,0.0,0.0,1.0,0.2398,1.2398,3.214,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,1.296179,1.296179,0.0,HIGH,2
mln1202,EFO_0000685,rheumatoid arthritis,2.529982721267432,0.0,0.0,1.0,0.2398,1.2398,3.1366,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.470216,0.937626,0.46741,LOW,4
mln1202,EFO_0001645,coronary artery disease,2.511083141661756,0.0,0.0,1.0,0.2303,1.2303,3.0893,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.373538,1.071616,0.698078,LOW,3
mln1202,EFO_0001378,multiple myeloma,2.6129511876148617,0.0,0.0,1.0,0.1792,1.1792,3.0811,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.597573,1.007689,0.410116,LOW,3
mln1202,MONDO_0100096,COVID-19,2.8048568550438784,0.0,0.0,1.0,0.0,1.0,2.8049,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.659033,0.743395,0.084362,HIGH,4
mln1202,EFO_0000764,HIV infection,2.7147149047368675,0.0,0.0,1.0,0.0,1.0,2.7147,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.335818,0.991594,0.655776,LOW,4
mln1202,EFO_0000180,HIV-1 infection,2.6371626405232744,0.0,0.0,1.0,0.0,1.0,2.6372,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.635572,0.683009,0.047437,HIGH,4
mln1202,MONDO_8000006,WHIM syndrome 1,2.106659271438093,0.0,0.0,1.0,0.2398,1.2398,2.6118,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,1.05333,1.05333,0.0,HIGH,2
mln1202,EFO_0000612,myocardial infarction,2.5670295818262066,0.0,0.0,1.0,0.0,1.0,2.567,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.228019,1.055496,0.827477,LOW,4
mln1202,HP_0012531,Pain,2.498224997334896,0.0,0.0,1.0,0.0,1.0,2.4982,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.121065,1.128047,1.006982,LOW,4
mln1202,EFO_0001060,celiac disease,1.97037244314478,0.0,0.0,1.0,0.2398,1.2398,2.4428,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.492593,0.492593,0.0,HIGH,4
mln1202,EFO_0000616,neoplasm,2.4241729340601355,0.0,0.0,1.0,0.0,1.0,2.4242,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,True,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.352852,0.75684,0.403988,LOW,4
mln1202,MONDO_0005301,multiple sclerosis,1.9380704292347872,0.0,0.0,1.0,0.2398,1.2398,2.4028,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,True,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.243648,0.641015,0.397367,LOW,4
mln1202,MONDO_0005148,type 2 diabetes mellitus,2.0119447834279685,0.0,0.0,1.0,0.1792,1.1792,2.3724,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.252472,0.7535,0.501028,LOW,4
mln1202,HP_0002014,Diarrhea,1.88399927157864,0.0,0.0,1.0,0.2398,1.2398,2.3358,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.926237,0.957762,0.031526,HIGH,2
mln1202,EFO_0000712,stroke,1.9904015137601443,0.0,0.0,1.0,0.1386,1.1386,2.2663,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.978089,1.012313,0.034224,HIGH,2
mln1202,MONDO_0005277,migraine disorder,1.859491161032664,0.0,0.0,1.0,0.2079,1.2079,2.2462,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.799643,1.059848,0.260205,LOW,2
mln1202,MONDO_0005178,osteoarthritis,1.778601172387413,0.0,0.0,1.0,0.2303,1.2303,2.1881,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.697829,1.080772,0.382943,LOW,2
mln1202,EFO_0000729,ulcerative colitis,1.7544759926653737,0.0,0.0,1.0,0.2398,1.2398,2.1752,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.204894,0.891597,0.686703,LOW,4
mln1202,EFO_0003060,non-small cell lung carcinoma,1.8299316486614523,0.0,0.0,1.0,0.1792,1.1792,2.1578,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.184763,0.663711,0.478947,LOW,4
mln1202,EFO_0000182,hepatocellular carcinoma,1.8018016797011165,0.0,0.0,1.0,0.1609,1.1609,2.0918,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.27116,0.553919,0.282759,LOW,4
mln1202,MONDO_0004992,cancer,2.082730998490102,0.0,0.0,1.0,0.0,1.0,2.0827,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.188807,0.896379,0.707572,LOW,4
mln1202,EFO_0002609,juvenile idiopathic arthritis,2.0368384810170506,0.0,0.0,1.0,0.0,1.0,2.0368,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.489162,1.058515,0.569354,LOW,3
mln1202,EFO_0002496,actinic keratosis,1.96807800411517,0.0,0.0,1.0,0.0,1.0,1.9681,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.498592,0.970894,0.472302,LOW,3
mln1202,EFO_0004329,alcohol drinking,1.9631151700916347,0.0,0.0,1.0,0.0,1.0,1.9631,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.424424,0.623489,0.199065,MEDIUM,4
mln1202,EFO_0000275,atrial fibrillation,1.5715952934073136,0.0,0.0,1.0,0.2398,1.2398,1.9484,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.181301,0.699236,0.517935,LOW,3
mln1202,EFO_0007328,influenza,1.8594006635186715,0.0,0.0,1.0,0.0,1.0,1.8594,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.117253,0.812447,0.695194,LOW,4
mln1202,EFO_0000574,lymphoma,1.71720816299742,0.0,0.0,1.0,0.0693,1.0693,1.8362,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.858604,0.858604,0.0,HIGH,2
mln1202,EFO_0008583,acute myocardial infarction,1.8014796592398277,0.0,0.0,1.0,0.0,1.0,1.8015,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.816542,0.984938,0.168396,MEDIUM,2
mln1202,EFO_0001073,obesity,1.5008347209464603,0.0,0.0,1.0,0.1946,1.1946,1.7929,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.472563,1.028272,0.555709,LOW,2
mln1202,MONDO_0000831,thrombotic disease,1.74453935289923,0.0,0.0,1.0,0.0,1.0,1.7445,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.863337,0.881202,0.017865,HIGH,2
mln1202,EFO_0000319,cardiovascular disease,1.7443391264746944,0.0,0.0,1.0,0.0,1.0,1.7443,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,True,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.142484,0.78014,0.637656,LOW,4
mln1202,EFO_0002618,pancreatic carcinoma,1.4719197021755992,0.0,0.0,1.0,0.1792,1.1792,1.7357,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.329732,0.626854,0.297122,LOW,3
mln1202,EFO_0005543,glioma,1.399070999567262,0.0,0.0,1.0,0.2398,1.2398,1.7346,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.169439,0.530096,0.360657,LOW,4
mln1202,EFO_0005952,non-Hodgkins lymphoma,1.718946580781714,0.0,0.0,1.0,0.0,1.0,1.7189,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.859473,0.859473,0.0,HIGH,2
mln1202,HP_0002018,Nausea,1.715699540035712,0.0,0.0,1.0,0.0,1.0,1.7157,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.78059,0.935109,0.154519,MEDIUM,2
mln1202,EFO_0004253,nephrolithiasis,1.4307344798926596,0.0,0.0,1.0,0.1946,1.1946,1.7091,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.560832,0.869903,0.309071,LOW,2
mln1202,EFO_0004616,"osteoarthritis, knee",1.7063990393037252,0.0,0.0,1.0,0.0,1.0,1.7064,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.119491,0.733708,0.614217,LOW,4
mln1202,EFO_0000222,acute myeloid leukemia,1.4906265178594018,0.0,0.0,1.0,0.1386,1.1386,1.6973,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.16893,0.576383,0.407453,LOW,4
mln1202,EFO_0005772,neurodegenerative disease,1.6931601492614687,0.0,0.0,1.0,0.0,1.0,1.6932,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.537575,0.604503,0.066928,HIGH,3
mln1202,EFO_0000756,melanoma,1.3858131474456434,0.0,0.0,1.0,0.2197,1.2197,1.6903,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,True,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.165553,0.527353,0.3618,LOW,4
mln1202,MONDO_0007254,breast cancer,1.658811726676202,0.0,0.0,1.0,0.0,1.0,1.6588,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.233114,0.601697,0.368583,LOW,4
mln1202,HP_0004419,Recurrent thrombophlebitis,1.6576976935959404,0.0,0.0,1.0,0.0,1.0,1.6577,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.776321,0.881377,0.105056,MEDIUM,2
mln1202,HP_0012532,Chronic pain,1.653990331421101,0.0,0.0,1.0,0.0,1.0,1.654,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.633696,1.020295,0.386599,LOW,2
mln1202,HP_0003418,Back pain,1.6456449994630873,0.0,0.0,1.0,0.0,1.0,1.6456,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.639539,1.006106,0.366568,LOW,2
mln1202,HP_0002140,Ischemic stroke,1.6207630711832273,0.0,0.0,1.0,0.0,1.0,1.6208,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.103031,0.70735,0.604319,LOW,4
mln1202,EFO_0005672,acute coronary syndrome,1.6204253397741806,0.0,0.0,1.0,0.0,1.0,1.6204,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.647255,0.97317,0.325915,LOW,2
mln1202,EFO_0010072,toothache,1.6158338062184927,0.0,0.0,1.0,0.0,1.0,1.6158,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.607911,1.007923,0.400012,LOW,2
mln1202,EFO_0000341,chronic obstructive pulmonary disease,1.4983124574868811,0.0,0.0,1.0,0.0693,1.0693,1.6022,1,WITHDRAWN,STOPPED,Atherosclerotic Cardiovascular Disease,Study has withdrawn.,False,Atherosclerosis; Cardiovascular Diseases; Diabetic Nephropathies; Melanoma; Multiple Sclerosis,,,0.163545,0.585611,0.422066,LOW,4
montelukast sodium,MONDO_0004979,asthma,3.988642863859339,0.897,0.0,0.7641,0.1792,1.1792,3.5936,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.965799,1.059885,0.094086,HIGH,4
montelukast sodium,EFO_0005854,allergic rhinitis,3.90366354999091,0.897,0.0,0.7641,0.0,1.0,2.9827,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.9613,1.005147,0.043847,HIGH,4
montelukast sodium,EFO_0003956,seasonal allergic rhinitis,3.843928732175375,0.897,0.0,0.7641,0.0,1.0,2.937,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.944567,0.993813,0.049247,HIGH,4
montelukast sodium,HP_0006536,Airway obstruction,3.486499369549252,0.897,0.0,0.7641,0.0,1.0,2.6639,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.841951,0.930973,0.089023,HIGH,4
montelukast sodium,MONDO_0005301,multiple sclerosis,2.802104658802175,0.897,0.0,0.7641,0.2398,1.2398,2.6544,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.507306,1.066005,0.558699,LOW,4
montelukast sodium,EFO_1001417,"Rhinitis, Allergic, Perennial",3.4212056040308068,0.897,0.0,0.7641,0.0,1.0,2.614,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.805947,0.954011,0.148064,MEDIUM,4
montelukast sodium,EFO_0001378,multiple myeloma,2.846350955415471,0.897,0.0,0.7641,0.1792,1.1792,2.5645,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.544668,1.045426,0.500758,LOW,4
montelukast sodium,EFO_0000685,rheumatoid arthritis,2.5111067449056126,0.897,0.0,0.7641,0.2398,1.2398,2.3787,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.454045,0.975241,0.521196,LOW,4
montelukast sodium,EFO_0000341,chronic obstructive pulmonary disease,2.8463583460212134,0.897,0.0,0.7641,0.0693,1.0693,2.3255,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.518977,1.075372,0.556395,LOW,4
montelukast sodium,MONDO_0004975,Alzheimer disease,2.441088474024762,0.897,0.0,0.7641,0.2398,1.2398,2.3124,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.552603,0.686578,0.133975,MEDIUM,4
montelukast sodium,EFO_0005772,neurodegenerative disease,2.983083427708858,0.897,0.0,0.7641,0.0,1.0,2.2793,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.613877,0.984193,0.370316,LOW,4
montelukast sodium,MONDO_0005180,Parkinson disease,2.280690164441833,0.897,0.0,0.7641,0.2398,1.2398,2.1605,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.539769,0.608677,0.068908,HIGH,4
montelukast sodium,MONDO_0100096,COVID-19,2.741295190974967,0.897,0.0,0.7641,0.0,1.0,2.0945,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.588411,0.808393,0.219981,MEDIUM,4
montelukast sodium,EFO_0003918,obstructive sleep apnea,2.129102233127135,0.897,0.0,0.7641,0.1946,1.1946,1.9433,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.520031,0.556764,0.036732,HIGH,4
montelukast sodium,EFO_0000275,atrial fibrillation,2.0298926624907816,0.897,0.0,0.7641,0.2398,1.2398,1.9229,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.974198,1.055695,0.081497,HIGH,2
montelukast sodium,HP_0001873,Thrombocytopenia,2.019125247149076,0.897,0.0,0.7641,0.2079,1.2079,1.8635,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.00007,1.019055,0.018986,HIGH,2
montelukast sodium,EFO_0000401,diabetic nephropathy,2.2895470877696633,0.897,0.0,0.7641,0.0,1.0,1.7494,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.846952,0.434912,LOW,4
montelukast sodium,HP_0012531,Pain,2.214068220850706,0.897,0.0,0.7641,0.0,1.0,1.6917,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.819447,0.407407,LOW,4
montelukast sodium,HP_0011950,Bronchiolitis,2.1856411736788184,0.897,0.0,0.7641,0.0,1.0,1.67,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.54641,0.54641,0.0,HIGH,4
montelukast sodium,EFO_0003894,acne,2.1173894297161433,0.897,0.0,0.7641,0.0,1.0,1.6178,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.763963,0.351923,LOW,4
montelukast sodium,MONDO_0007254,breast cancer,2.0762804543129123,0.897,0.0,0.7641,0.0,1.0,1.5864,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.127951,1.024205,0.896253,LOW,4
montelukast sodium,EFO_0004194,IGA glomerulonephritis,1.6574628057333165,0.897,0.0,0.7641,0.2398,1.2398,1.5701,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.0143,0.814432,0.800132,LOW,4
montelukast sodium,MONDO_0002561,lysosomal storage disease,2.050994234630195,0.897,0.0,0.7641,0.0,1.0,1.5671,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.505782,0.526681,0.020898,HIGH,4
montelukast sodium,EFO_0000694,severe acute respiratory syndrome,2.0345392130577102,0.897,0.0,0.7641,0.0,1.0,1.5545,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.6848,0.272761,LOW,4
montelukast sodium,EFO_0004232,eosinophilic esophagitis,1.9885612835067057,0.897,0.0,0.7641,0.0,1.0,1.5194,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,True,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.433296,0.606926,0.173631,MEDIUM,4
montelukast sodium,EFO_0003060,non-small cell lung carcinoma,1.6700979993825618,0.897,0.0,0.7641,0.1792,1.1792,1.5047,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.117726,1.012258,0.894532,LOW,4
montelukast sodium,EFO_0007486,sinusitis,1.9215046885527272,0.897,0.0,0.7641,0.0,1.0,1.4682,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.617049,0.20501,MEDIUM,4
montelukast sodium,EFO_0000676,psoriasis,1.5184364777304658,0.897,0.0,0.7641,0.2398,1.2398,1.4384,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.118609,0.90161,0.783002,LOW,4
montelukast sodium,MONDO_0008315,prostate cancer,1.867175753323488,0.897,0.0,0.7641,0.0,1.0,1.4266,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.18197,1.028923,0.846953,LOW,4
montelukast sodium,EFO_0000616,neoplasm,1.8560493988519329,0.897,0.0,0.7641,0.0,1.0,1.4181,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.152312,1.050525,0.898213,LOW,4
montelukast sodium,MONDO_0008170,ovarian cancer,1.5465979344926624,0.897,0.0,0.7641,0.1792,1.1792,1.3934,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.117726,0.882307,0.764581,LOW,4
montelukast sodium,MONDO_0004976,amyotrophic lateral sclerosis,1.4427232316887475,0.897,0.0,0.7641,0.2398,1.2398,1.3667,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.442723231688747,1.442723231688747,0.0,HIGH,1
montelukast sodium,EFO_0000612,myocardial infarction,1.7613961897928392,0.897,0.0,0.7641,0.0,1.0,1.3458,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.013342,0.867356,0.854014,LOW,4
montelukast sodium,EFO_0003144,heart failure,1.7083286674164948,0.897,0.0,0.7641,0.0,1.0,1.3053,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.731993,0.976336,0.244343,MEDIUM,2
montelukast sodium,EFO_0003086,kidney disease,1.6887452327406154,0.897,0.0,0.7641,0.0,1.0,1.2903,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.70914,0.979605,0.270464,LOW,2
montelukast sodium,EFO_0001645,coronary artery disease,1.3681450247383475,0.897,0.0,0.7641,0.2303,1.2303,1.2861,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.59626,0.771885,0.175626,MEDIUM,2
montelukast sodium,EFO_0003884,chronic kidney disease,1.6574916699484707,0.897,0.0,0.7641,0.0,1.0,1.2664,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.722195,0.935297,0.213103,MEDIUM,2
montelukast sodium,HP_0030828,Wheezing,1.6481584049526068,0.897,0.0,0.7641,0.0,1.0,1.2593,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.41204,0.41204,0.0,HIGH,4
montelukast sodium,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.897,0.0,0.7641,0.2398,1.2398,1.2444,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.313641444940749,1.313641444940749,0.0,HIGH,1
montelukast sodium,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.897,0.0,0.7641,0.2398,1.2398,1.2437,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.312919255867715,1.312919255867715,0.0,HIGH,1
montelukast sodium,MONDO_0013361,congenital prothrombin deficiency,1.299935146535446,0.897,0.0,0.7641,0.2398,1.2398,1.2314,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.299935146535446,1.299935146535446,0.0,HIGH,1
montelukast sodium,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,0.897,0.0,0.7641,0.2398,1.2398,1.2293,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.297733536121243,1.297733536121243,0.0,HIGH,1
montelukast sodium,MONDO_0014421,glucocorticoid resistance,1.2868789558114788,0.897,0.0,0.7641,0.2398,1.2398,1.219,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.286878955811478,1.286878955811478,0.0,HIGH,1
montelukast sodium,EFO_0000319,cardiovascular disease,1.593269128365999,0.897,0.0,0.7641,0.0,1.0,1.2174,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.013289,0.783345,0.770056,LOW,4
montelukast sodium,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",1.2786414434034508,0.897,0.0,0.7641,0.2398,1.2398,1.2112,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.27864144340345,1.27864144340345,0.0,HIGH,1
montelukast sodium,Orphanet_183506,Genetic central nervous system malformation,1.2763070556018696,0.897,0.0,0.7641,0.2398,1.2398,1.209,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.276307055601869,1.276307055601869,0.0,HIGH,1
montelukast sodium,Orphanet_325,Congenital factor II deficiency,1.266476485157081,0.897,0.0,0.7641,0.2398,1.2398,1.1997,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.26647648515708,1.26647648515708,0.0,HIGH,1
montelukast sodium,MONDO_0004992,cancer,1.5698271176320542,0.897,0.0,0.7641,0.0,1.0,1.1994,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.089946,0.991126,0.90118,LOW,4
montelukast sodium,MONDO_0019200,retinitis pigmentosa,1.2850784056268851,0.897,0.0,0.7641,0.2079,1.2079,1.1861,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,1.285078405626885,1.285078405626885,0.0,HIGH,1
montelukast sodium,MONDO_0005147,type 1 diabetes mellitus,1.2469685231427174,0.897,0.0,0.7641,0.2398,1.2398,1.1812,1,TERMINATED,STOPPED,Coronary Artery Disease | Acute Coronary Syndrome,Diffic;ulty recruiting,False,"Asthma; Asthma, Exercise-Induced; Bronchiolitis; Bronchiolitis Obliterans; Eosinophilic Esophagitis",,,0.540447,0.706521,0.166074,MEDIUM,2
mycophenolate mofetil,MONDO_0019200,retinitis pigmentosa,5.006112531300893,0.8713,0.0,0.77,0.2079,1.2079,4.6561,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.217978,1.285078,0.067101,HIGH,4
mycophenolate mofetil,MONDO_0018998,Leber congenital amaurosis,4.305878191303444,0.8713,0.0,0.77,0.2398,1.2398,4.1104,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.047612,1.105327,0.057715,HIGH,4
mycophenolate mofetil,EFO_0001422,cirrhosis of liver,3.868012532503309,0.8713,0.0,0.77,0.2398,1.2398,3.6924,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.944759,1.011492,0.066733,HIGH,4
mycophenolate mofetil,EFO_0000616,neoplasm,4.130366452780571,0.8713,0.0,0.77,0.0,1.0,3.1803,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.715254,1.349929,0.634676,LOW,4
mycophenolate mofetil,MONDO_0005301,multiple sclerosis,3.3044855931666026,0.8713,0.0,0.77,0.2398,1.2398,3.1545,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.669404,1.106529,0.437125,LOW,4
mycophenolate mofetil,EFO_0000183,Hodgkins lymphoma,3.525895161032805,0.8713,0.0,0.77,0.1609,1.1609,3.1518,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.590001,1.172946,0.582945,LOW,4
mycophenolate mofetil,EFO_0001378,multiple myeloma,3.433291607144546,0.8713,0.0,0.77,0.1792,1.1792,3.1172,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.509926,1.20672,0.696794,LOW,4
mycophenolate mofetil,EFO_0000574,lymphoma,3.7537124615941777,0.8713,0.0,0.77,0.0693,1.0693,3.0906,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.646566,1.23029,0.583723,LOW,4
mycophenolate mofetil,EFO_0004220,chronic hepatitis C virus infection,3.9120475532234766,0.8713,0.0,0.77,0.0,1.0,3.0122,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.964725,1.004586,0.039861,HIGH,4
mycophenolate mofetil,MONDO_0004976,amyotrophic lateral sclerosis,3.108046759360795,0.8713,0.0,0.77,0.2398,1.2398,2.9669,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.124211,1.429812,1.305601,LOW,4
mycophenolate mofetil,MONDO_0008379,retinitis pigmentosa 10,3.0579177810654707,0.8713,0.0,0.77,0.2398,1.2398,2.9191,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.743986,0.784973,0.040987,HIGH,4
mycophenolate mofetil,EFO_0004255,nephrotic syndrome,3.0404116468978115,0.8713,0.0,0.77,0.2398,1.2398,2.9024,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.641007,0.980483,0.339476,LOW,4
mycophenolate mofetil,EFO_0000565,leukemia,3.5973511578575215,0.8713,0.0,0.77,0.0,1.0,2.7699,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.715536,1.139217,0.423681,LOW,4
mycophenolate mofetil,MONDO_0007915,systemic lupus erythematosus,2.8389943557169333,0.8713,0.0,0.77,0.2398,1.2398,2.7101,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.590445,0.932102,0.341657,LOW,4
mycophenolate mofetil,EFO_0000763,viral disease,3.497522123244733,0.8713,0.0,0.77,0.0,1.0,2.693,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.790701,0.95806,0.167359,MEDIUM,4
mycophenolate mofetil,EFO_0000222,acute myeloid leukemia,3.036927563166176,0.8713,0.0,0.77,0.1386,1.1386,2.6625,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.694852,0.823612,0.128759,MEDIUM,4
mycophenolate mofetil,EFO_0007160,autoimmune thrombocytopenic purpura,2.958260787038684,0.8713,0.0,0.77,0.1609,1.1609,2.6444,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.591729,0.995623,0.403895,LOW,4
mycophenolate mofetil,MONDO_0013454,Leber congenital amaurosis 11,2.9462412790419017,0.8713,0.0,0.77,0.1609,1.1609,2.6336,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.73656,0.73656,0.0,HIGH,4
mycophenolate mofetil,HP_0000556,Retinal dystrophy,2.6975754112839385,0.8713,0.0,0.77,0.2398,1.2398,2.5751,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.674394,0.674394,0.0,HIGH,4
mycophenolate mofetil,EFO_0000403,diffuse large B-cell lymphoma,3.335900836542727,0.8713,0.0,0.77,0.0,1.0,2.5685,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.503296,1.164654,0.661358,LOW,4
mycophenolate mofetil,MONDO_0005147,type 1 diabetes mellitus,2.6307199866295616,0.8713,0.0,0.77,0.2398,1.2398,2.5113,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.626887,0.689463,0.062576,HIGH,4
mycophenolate mofetil,MONDO_0012703,lissencephaly due to TUBA1A mutation,2.6272828898814997,0.8713,0.0,0.77,0.2398,1.2398,2.508,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.313641,1.313641,0.0,HIGH,2
mycophenolate mofetil,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,2.62583851173543,0.8713,0.0,0.77,0.2398,1.2398,2.5066,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.312919,1.312919,0.0,HIGH,2
mycophenolate mofetil,EFO_0003060,non-small cell lung carcinoma,2.7394624008213864,0.8713,0.0,0.77,0.1792,1.1792,2.4872,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.059296,1.310435,1.25114,LOW,4
mycophenolate mofetil,EFO_0005952,non-Hodgkins lymphoma,3.218077467411304,0.8713,0.0,0.77,0.0,1.0,2.4778,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.508529,1.100509,0.59198,LOW,4
mycophenolate mofetil,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,2.595467072242486,0.8713,0.0,0.77,0.2398,1.2398,2.4776,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.297734,1.297734,0.0,HIGH,2
mycophenolate mofetil,EFO_0000685,rheumatoid arthritis,2.5845635985505857,0.8713,0.0,0.77,0.2398,1.2398,2.4672,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.472693,0.979903,0.50721,LOW,4
mycophenolate mofetil,MONDO_0004992,cancer,3.174035392852724,0.8713,0.0,0.77,0.0,1.0,2.4439,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.314925,1.272093,0.957167,LOW,4
mycophenolate mofetil,EFO_0000198,myelodysplastic syndrome,2.8572494096746026,0.8713,0.0,0.77,0.1099,1.1099,2.4417,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.665687,0.762937,0.09725,HIGH,4
mycophenolate mofetil,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",2.5572828868069015,0.8713,0.0,0.77,0.2398,1.2398,2.4412,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.278641,1.278641,0.0,HIGH,2
mycophenolate mofetil,Orphanet_183506,Genetic central nervous system malformation,2.5526141112037393,0.8713,0.0,0.77,0.2398,1.2398,2.4367,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.276307,1.276307,0.0,HIGH,2
mycophenolate mofetil,EFO_0000220,acute lymphoblastic leukemia,3.1254425043772693,0.8713,0.0,0.77,0.0,1.0,2.4065,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.663271,0.899451,0.23618,MEDIUM,4
mycophenolate mofetil,EFO_0004194,IGA glomerulonephritis,2.5167702235883644,0.8713,0.0,0.77,0.2398,1.2398,2.4025,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.569129,0.72124,0.15211,MEDIUM,4
mycophenolate mofetil,EFO_1001985,congenital fibrosis of the extraocular muscles,2.492465169588207,0.8713,0.0,0.77,0.2398,1.2398,2.3793,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.246233,1.246233,0.0,HIGH,2
mycophenolate mofetil,EFO_0004719,pemphigus vulgaris,2.6096550636419615,0.8713,0.0,0.77,0.1792,1.1792,2.3694,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.543424,0.870392,0.326968,LOW,4
mycophenolate mofetil,EFO_0006890,fibrosis,3.0597563054015593,0.8713,0.0,0.77,0.0,1.0,2.3559,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.73742,0.792458,0.055038,HIGH,4
mycophenolate mofetil,EFO_0000540,immune system disease,2.68314339487127,0.8713,0.0,0.77,0.1386,1.1386,2.3523,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.621678,0.719894,0.098216,HIGH,4
mycophenolate mofetil,MONDO_0012905,hypomyelinating leukodystrophy 6,2.4606945927002184,0.8713,0.0,0.77,0.2398,1.2398,2.349,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.230347,1.230347,0.0,HIGH,2
mycophenolate mofetil,EFO_0000544,infection,3.0450519082447776,0.8713,0.0,0.77,0.0,1.0,2.3446,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.591049,1.044961,0.453912,LOW,4
mycophenolate mofetil,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,2.426672550758208,0.8713,0.0,0.77,0.2398,1.2398,2.3165,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.213336,1.213336,0.0,HIGH,2
mycophenolate mofetil,EFO_0005772,neurodegenerative disease,2.999628651275224,0.8713,0.0,0.77,0.0,1.0,2.3096,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.392182,1.107632,0.71545,LOW,4
mycophenolate mofetil,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,2.4180339585817014,0.8713,0.0,0.77,0.2398,1.2398,2.3083,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.209017,1.209017,0.0,HIGH,2
mycophenolate mofetil,EFO_0001645,coronary artery disease,2.431344041409973,0.8713,0.0,0.77,0.2303,1.2303,2.3031,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.771885,0.881377,0.109492,MEDIUM,3
mycophenolate mofetil,EFO_0004991,Myasthenia gravis,2.401373627118635,0.8713,0.0,0.77,0.2398,1.2398,2.2924,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.594834,0.611362,0.016528,HIGH,4
mycophenolate mofetil,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,2.400196425436642,0.8713,0.0,0.77,0.2398,1.2398,2.2912,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.200098,1.200098,0.0,HIGH,2
mycophenolate mofetil,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,2.400132994326982,0.8713,0.0,0.77,0.2398,1.2398,2.2912,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.200066,1.200066,0.0,HIGH,2
mycophenolate mofetil,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,2.3751171143809993,0.8713,0.0,0.77,0.2398,1.2398,2.2673,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.187559,1.187559,0.0,HIGH,2
mycophenolate mofetil,Orphanet_98805,"Primary dystonia, DYT4 type",2.3611251170871563,0.8713,0.0,0.77,0.2398,1.2398,2.2539,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,1.180563,1.180563,0.0,HIGH,2
mycophenolate mofetil,EFO_0005297,Granulomatosis with Polyangiitis,2.359210652618052,0.8713,0.0,0.77,0.2398,1.2398,2.2521,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.567473,0.634462,0.066988,HIGH,4
mycophenolate mofetil,EFO_0003047,hepatitis C virus infection,2.8951289078407174,0.8713,0.0,0.77,0.0,1.0,2.2292,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Arthritis, Rheumatoid; Autoimmune Diseases; Burkitt Lymphoma",,,0.710619,0.736945,0.026326,HIGH,4
nexlizet,EFO_0004911,familial hypercholesterolemia,2.4094996729070544,0.0,0.0,1.0,0.2303,1.2303,2.9643,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.803167,0.803167,0.0,HIGH,3
nexlizet,EFO_0001645,coronary artery disease,1.9651991884968671,0.0,0.0,1.0,0.2303,1.2303,2.4177,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.593559,0.778082,0.184523,MEDIUM,3
nexlizet,EFO_0003914,atherosclerosis,2.330969528142969,0.0,0.0,1.0,0.0,1.0,2.331,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.74603,0.83891,0.09288,HIGH,3
nexlizet,HP_0003124,Hypercholesterolemia,2.250676658103041,0.0,0.0,1.0,0.0,1.0,2.2507,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.736697,0.777283,0.040586,HIGH,3
nexlizet,EFO_0000319,cardiovascular disease,2.2062950641346704,0.0,0.0,1.0,0.0,1.0,2.2063,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.695945,0.814406,0.118461,MEDIUM,3
nexlizet,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.444406828106269,0.0,0.0,1.0,0.2398,1.2398,1.7908,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.444406828106269,1.444406828106269,0.0,HIGH,1
nexlizet,HP_0003119,Abnormal circulating lipid concentration,1.765884005306365,0.0,0.0,1.0,0.0,1.0,1.7659,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.588628,0.588628,0.0,HIGH,3
nexlizet,MONDO_0004976,amyotrophic lateral sclerosis,1.416900905603781,0.0,0.0,1.0,0.2398,1.2398,1.7567,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.41690090560378,1.41690090560378,0.0,HIGH,1
nexlizet,EFO_0000616,neoplasm,1.70314825139072,0.0,0.0,1.0,0.0,1.0,1.7031,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.176609,1.349929,1.17332,LOW,3
nexlizet,EFO_0003060,non-small cell lung carcinoma,1.4401585783194346,0.0,0.0,1.0,0.1792,1.1792,1.6982,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.064862,1.310435,1.245574,LOW,3
nexlizet,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.0,0.0,1.0,0.2398,1.2398,1.6286,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.313641444940749,1.313641444940749,0.0,HIGH,1
nexlizet,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.0,0.0,1.0,0.2398,1.2398,1.6277,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.312919255867715,1.312919255867715,0.0,HIGH,1
nexlizet,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,0.0,0.0,1.0,0.2398,1.2398,1.6089,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.297733536121243,1.297733536121243,0.0,HIGH,1
nexlizet,MONDO_0004992,cancer,1.5896022029011343,0.0,0.0,1.0,0.0,1.0,1.5896,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.168468,1.252666,1.084198,LOW,3
nexlizet,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",1.2786414434034508,0.0,0.0,1.0,0.2398,1.2398,1.5852,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.27864144340345,1.27864144340345,0.0,HIGH,1
nexlizet,Orphanet_183506,Genetic central nervous system malformation,1.2763070556018696,0.0,0.0,1.0,0.2398,1.2398,1.5824,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.276307055601869,1.276307055601869,0.0,HIGH,1
nexlizet,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,1.0,0.1792,1.1792,1.5571,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.320513540780355,1.320513540780355,0.0,HIGH,1
nexlizet,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,1.0,0.1792,1.1792,1.5548,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.318525014371726,1.318525014371726,0.0,HIGH,1
nexlizet,MONDO_0019200,retinitis pigmentosa,1.2850784056268851,0.0,0.0,1.0,0.2079,1.2079,1.5523,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.285078405626885,1.285078405626885,0.0,HIGH,1
nexlizet,EFO_1001985,congenital fibrosis of the extraocular muscles,1.2462325847941036,0.0,0.0,1.0,0.2398,1.2398,1.5451,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.246232584794103,1.246232584794103,0.0,HIGH,1
nexlizet,MONDO_0012905,hypomyelinating leukodystrophy 6,1.2303472963501092,0.0,0.0,1.0,0.2398,1.2398,1.5254,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.230347296350109,1.230347296350109,0.0,HIGH,1
nexlizet,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,1.213336275379104,0.0,0.0,1.0,0.2398,1.2398,1.5043,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.213336275379104,1.213336275379104,0.0,HIGH,1
nexlizet,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,1.2090169792908507,0.0,0.0,1.0,0.2398,1.2398,1.4989,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.20901697929085,1.20901697929085,0.0,HIGH,1
nexlizet,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,1.200098212718321,0.0,0.0,1.0,0.2398,1.2398,1.4879,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.200098212718321,1.200098212718321,0.0,HIGH,1
nexlizet,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,1.200066497163491,0.0,0.0,1.0,0.2398,1.2398,1.4878,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.20006649716349,1.20006649716349,0.0,HIGH,1
nexlizet,MONDO_0007254,breast cancer,1.4847437408586182,0.0,0.0,1.0,0.0,1.0,1.4847,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.080894,1.322956,1.242062,LOW,3
nexlizet,MONDO_0008170,ovarian cancer,1.254727734441751,0.0,0.0,1.0,0.1792,1.1792,1.4795,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.05878,1.137167,1.078387,LOW,3
nexlizet,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,1.1875585571904996,0.0,0.0,1.0,0.2398,1.2398,1.4723,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.187558557190499,1.187558557190499,0.0,HIGH,1
nexlizet,Orphanet_98805,"Primary dystonia, DYT4 type",1.1805625585435782,0.0,0.0,1.0,0.2398,1.2398,1.4636,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.180562558543578,1.180562558543578,0.0,HIGH,1
nexlizet,EFO_0003869,breast neoplasm,1.2785871195246965,0.0,0.0,1.0,0.1386,1.1386,1.4558,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.023819,1.230949,1.20713,LOW,3
nexlizet,EFO_0000305,breast carcinoma,1.2338834445116622,0.0,0.0,1.0,0.1609,1.1609,1.4325,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.233883444511662,1.233883444511662,0.0,HIGH,1
nexlizet,Orphanet_404469,Female infertility due to fertilization defect,1.2136046598229504,0.0,0.0,1.0,0.1792,1.1792,1.4311,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.21360465982295,1.21360465982295,0.0,HIGH,1
nexlizet,EFO_0000756,melanoma,1.1655832082937605,0.0,0.0,1.0,0.2197,1.2197,1.4217,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.132417,0.900749,0.768332,LOW,3
nexlizet,MONDO_0007493,torsion dystonia 4,1.1464047185131627,0.0,0.0,1.0,0.2398,1.2398,1.4213,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.146404718513162,1.146404718513162,0.0,HIGH,1
nexlizet,EFO_0001378,multiple myeloma,1.2010941271735935,0.0,0.0,1.0,0.1792,1.1792,1.4163,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.201094127173593,1.201094127173593,0.0,HIGH,1
nexlizet,MONDO_0008903,lung cancer,1.1916070209727154,0.0,0.0,1.0,0.1792,1.1792,1.4051,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.13257,0.926468,0.793898,LOW,3
nexlizet,MONDO_0008315,prostate cancer,1.4046619790596202,0.0,0.0,1.0,0.0,1.0,1.4047,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.046711,1.311241,1.26453,LOW,3
nexlizet,MONDO_0018998,Leber congenital amaurosis,1.105326947068426,0.0,0.0,1.0,0.2398,1.2398,1.3704,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.105326947068426,1.105326947068426,0.0,HIGH,1
nexlizet,EFO_0001422,cirrhosis of liver,1.097798509367867,0.0,0.0,1.0,0.2398,1.2398,1.361,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.032031,1.033736,1.001705,LOW,3
nexlizet,EFO_0000183,Hodgkins lymphoma,1.1599017756147956,0.0,0.0,1.0,0.1609,1.1609,1.3466,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.159901775614795,1.159901775614795,0.0,HIGH,1
nexlizet,MONDO_0014341,complex cortical dysplasia with other brain malformations 6,1.0765187665341702,0.0,0.0,1.0,0.2398,1.2398,1.3347,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.07651876653417,1.07651876653417,0.0,HIGH,1
nexlizet,MONDO_0011136,Quebec platelet disorder,1.1034736948883288,0.0,0.0,1.0,0.2079,1.2079,1.3329,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.103473694888328,1.103473694888328,0.0,HIGH,1
nexlizet,MONDO_0002974,cervical cancer,1.1705094279555937,0.0,0.0,1.0,0.1386,1.1386,1.3328,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.039744,1.091021,1.051277,LOW,3
nexlizet,MONDO_0021187,hyperlipidemia,1.3261788879850798,0.0,0.0,1.0,0.0,1.0,1.3262,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",True,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.44206,0.44206,0.0,HIGH,3
nexlizet,EFO_0000574,lymphoma,1.2311884754791962,0.0,0.0,1.0,0.0693,1.0693,1.3165,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.024735,1.181719,1.156984,LOW,3
nexlizet,HP_0001339,Lissencephaly,1.0471078353307095,0.0,0.0,1.0,0.2398,1.2398,1.2982,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.047107835330709,1.047107835330709,0.0,HIGH,1
nexlizet,MONDO_0060650,Leber congenital amaurosis with early-onset deafness,1.0257955750077703,0.0,0.0,1.0,0.2398,1.2398,1.2718,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.02579557500777,1.02579557500777,0.0,HIGH,1
nexlizet,EFO_0002618,pancreatic carcinoma,1.0716699961263496,0.0,0.0,1.0,0.1792,1.1792,1.2637,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.071669996126349,1.071669996126349,0.0,HIGH,1
nexlizet,EFO_0000222,acute myeloid leukemia,1.1004955954464906,0.0,0.0,1.0,0.1386,1.1386,1.2531,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,0.138442,0.823612,0.68517,LOW,3
nexlizet,MONDO_0015372,autosomal dominant macrothrombocytopenia,1.244239704511393,0.0,0.0,1.0,0.0,1.0,1.2442,1,WITHDRAWN,STOPPED,Coronary Artery Disease | Atherosclerosis | Heart Attack,"study withdrawn, no participants enrolled, changes in the study design planned",False,"Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dyslipidemias",,,1.244239704511393,1.244239704511393,0.0,HIGH,1
niacin/laropiprant,EFO_0001361,pulmonary arterial hypertension,2.261291119689942,0.0,0.0,1.0,0.0,1.0,2.2613,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.020635,1.240656,0.22002,MEDIUM,2
niacin/laropiprant,EFO_0000537,hypertension,1.9315509169333824,0.0,0.0,1.0,0.1609,1.1609,2.2424,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.35239,1.579161,1.226772,LOW,2
niacin/laropiprant,MONDO_0005149,pulmonary hypertension,2.0707552839807266,0.0,0.0,1.0,0.0,1.0,2.0708,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.939389,1.131366,0.191977,MEDIUM,2
niacin/laropiprant,HP_0004419,Recurrent thrombophlebitis,1.9635304016618176,0.0,0.0,1.0,0.0,1.0,1.9635,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.837977,1.125553,0.287576,LOW,2
niacin/laropiprant,MONDO_0019200,retinitis pigmentosa,1.556369626340392,0.0,0.0,1.0,0.2079,1.2079,1.88,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.556369626340391,1.556369626340391,0.0,HIGH,1
niacin/laropiprant,EFO_0001645,coronary artery disease,1.4430304047823457,0.0,0.0,1.0,0.2303,1.2303,1.7753,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.443030404782345,1.443030404782345,0.0,HIGH,1
niacin/laropiprant,EFO_0005772,neurodegenerative disease,1.742062329870481,0.0,0.0,1.0,0.0,1.0,1.7421,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.749852,0.99221,0.242358,MEDIUM,2
niacin/laropiprant,MONDO_0005148,type 2 diabetes mellitus,1.4508773888431972,0.0,0.0,1.0,0.1792,1.1792,1.7108,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,True,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.456294,0.994583,0.538289,LOW,2
niacin/laropiprant,MONDO_0004979,asthma,1.441281239735907,0.0,0.0,1.0,0.1792,1.1792,1.6995,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.147423,1.293858,1.146435,LOW,2
niacin/laropiprant,Orphanet_1872,Cone rod dystrophy,1.3336572725604836,0.0,0.0,1.0,0.2398,1.2398,1.6535,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.333657272560483,1.333657272560483,0.0,HIGH,1
niacin/laropiprant,EFO_0000729,ulcerative colitis,1.318520778996192,0.0,0.0,1.0,0.2398,1.2398,1.6347,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.529283,0.789238,0.259955,LOW,2
niacin/laropiprant,EFO_0000712,stroke,1.396492252012477,0.0,0.0,1.0,0.1386,1.1386,1.5901,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.007946,1.388546,1.380599,LOW,2
niacin/laropiprant,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.0,0.0,1.0,0.2398,1.2398,1.5899,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.2823759951301381,1.2823759951301381,0.0,HIGH,1
niacin/laropiprant,EFO_0000319,cardiovascular disease,1.578320933066566,0.0,0.0,1.0,0.0,1.0,1.5783,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.031465,1.546856,1.515391,LOW,2
niacin/laropiprant,EFO_0000676,psoriasis,1.244528431333322,0.0,0.0,1.0,0.2398,1.2398,1.543,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.005886,1.238642,1.232756,LOW,2
niacin/laropiprant,HP_0012531,Pain,1.5266532892947653,0.0,0.0,1.0,0.0,1.0,1.5267,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.41204,1.114614,0.702574,LOW,2
niacin/laropiprant,EFO_0000341,chronic obstructive pulmonary disease,1.4161094460679076,0.0,0.0,1.0,0.0693,1.0693,1.5143,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.157752,1.258358,1.100606,LOW,2
niacin/laropiprant,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,0.0,0.0,1.0,0.2398,1.2398,1.5014,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.2110423777158301,1.2110423777158301,0.0,HIGH,1
niacin/laropiprant,MONDO_0005277,migraine disorder,1.223327575826746,0.0,0.0,1.0,0.2079,1.2079,1.4777,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.069008,1.154319,1.085311,LOW,2
niacin/laropiprant,EFO_0006834,septic shock,1.4682007750607964,0.0,0.0,1.0,0.0,1.0,1.4682,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.454552,1.013649,0.559098,LOW,2
niacin/laropiprant,Orphanet_1276,Brachydactyly - arterial hypertension,1.1895599638523269,0.0,0.0,1.0,0.2079,1.2079,1.4369,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.189559963852326,1.189559963852326,0.0,HIGH,1
niacin/laropiprant,MONDO_0018852,achromatopsia,1.4306619453288874,0.0,0.0,1.0,0.0,1.0,1.4307,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.4306619453288871,1.4306619453288871,0.0,HIGH,1
niacin/laropiprant,EFO_0000274,atopic eczema,1.1530418960168691,0.0,0.0,1.0,0.2398,1.2398,1.4295,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.014452,1.13859,1.124139,LOW,2
niacin/laropiprant,MONDO_0013437,retinitis pigmentosa 43,1.1227328916707495,0.0,0.0,1.0,0.2398,1.2398,1.392,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.122732891670749,1.122732891670749,0.0,HIGH,1
niacin/laropiprant,Orphanet_79211,Combined hyperlipidemia,1.12166335892608,0.0,0.0,1.0,0.2303,1.2303,1.3799,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,True,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.560832,0.560832,0.0,HIGH,2
niacin/laropiprant,EFO_0000768,idiopathic pulmonary fibrosis,1.1069813432493905,0.0,0.0,1.0,0.2398,1.2398,1.3724,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.51505,0.591932,0.076882,HIGH,2
niacin/laropiprant,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,1.0893989193580678,0.0,0.0,1.0,0.2398,1.2398,1.3506,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.089398919358067,1.089398919358067,0.0,HIGH,1
niacin/laropiprant,MONDO_0014835,"striatal degeneration, autosomal dominant 2",1.1151901705079166,0.0,0.0,1.0,0.2079,1.2079,1.3471,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.115190170507916,1.115190170507916,0.0,HIGH,1
niacin/laropiprant,MONDO_0007211,brachydactyly-arterial hypertension syndrome,1.1120001898216738,0.0,0.0,1.0,0.2079,1.2079,1.3432,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.112000189821673,1.112000189821673,0.0,HIGH,1
niacin/laropiprant,HP_0000556,Retinal dystrophy,1.073875011489864,0.0,0.0,1.0,0.2398,1.2398,1.3314,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.073875011489864,1.073875011489864,0.0,HIGH,1
niacin/laropiprant,Orphanet_2754,Joubert syndrome with orofaciodigital defect,1.0707563865225374,0.0,0.0,1.0,0.2398,1.2398,1.3275,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.070756386522537,1.070756386522537,0.0,HIGH,1
niacin/laropiprant,EFO_0004190,open-angle glaucoma,1.084330600044849,0.0,0.0,1.0,0.2079,1.2079,1.3098,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.084330600044849,1.084330600044849,0.0,HIGH,1
niacin/laropiprant,EFO_0000275,atrial fibrillation,1.0519620254513615,0.0,0.0,1.0,0.2398,1.2398,1.3042,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.027175,1.024787,0.997612,LOW,2
niacin/laropiprant,EFO_0003913,angina pectoris,1.2926834317608282,0.0,0.0,1.0,0.0,1.0,1.2927,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.292683431760828,1.292683431760828,0.0,HIGH,1
niacin/laropiprant,MONDO_0017147,idiopathic pulmonary arterial hypertension,1.2916282916487385,0.0,0.0,1.0,0.0,1.0,1.2916,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.625249,0.66638,0.041131,HIGH,2
niacin/laropiprant,EFO_0000612,myocardial infarction,1.2569687443069864,0.0,0.0,1.0,0.0,1.0,1.257,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.0649,1.192068,1.127168,LOW,2
niacin/laropiprant,HP_0003124,Hypercholesterolemia,1.241698488801329,0.0,0.0,1.0,0.0,1.0,1.2417,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,True,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.592928,0.64877,0.055842,HIGH,2
niacin/laropiprant,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,0.984524524711656,0.0,0.0,1.0,0.2398,1.2398,1.2206,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.9845245247116561,0.9845245247116561,0.0,HIGH,1
niacin/laropiprant,EFO_1001145,Raynaud disease,1.0550464721857336,0.0,0.0,1.0,0.1386,1.1386,1.2013,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.419986,0.63506,0.215074,MEDIUM,2
niacin/laropiprant,EFO_0000479,essential thrombocythemia,0.9617083811407224,0.0,0.0,1.0,0.2398,1.2398,1.1923,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.9617083811407221,0.9617083811407221,0.0,HIGH,1
niacin/laropiprant,EFO_0000400,diabetes mellitus,0.9755347724038008,0.0,0.0,1.0,0.2197,1.2197,1.1899,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.014977,0.960557,0.94558,LOW,2
niacin/laropiprant,EFO_0003144,heart failure,1.1747090342831998,0.0,0.0,1.0,0.0,1.0,1.1747,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.174709034283199,1.174709034283199,0.0,HIGH,1
niacin/laropiprant,EFO_0004278,sudden cardiac arrest,0.9396752125518276,0.0,0.0,1.0,0.2398,1.2398,1.165,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.9396752125518271,0.9396752125518271,0.0,HIGH,1
niacin/laropiprant,EFO_0000284,benign prostatic hyperplasia,1.0183788891940708,0.0,0.0,1.0,0.1386,1.1386,1.1596,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.005886,1.012493,1.006606,LOW,2
niacin/laropiprant,MONDO_0005041,glaucoma,1.1456348841935742,0.0,0.0,1.0,0.0,1.0,1.1456,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.145634884193574,1.145634884193574,0.0,HIGH,1
niacin/laropiprant,Orphanet_309005,Disorder of lipid metabolism,1.1410880829844496,0.0,0.0,1.0,0.0,1.0,1.1411,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,True,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.570544,0.570544,0.0,HIGH,2
niacin/laropiprant,MONDO_0004975,Alzheimer disease,0.9196346091044664,0.0,0.0,1.0,0.2398,1.2398,1.1402,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.067894,0.85174,0.783846,LOW,2
niacin/laropiprant,MONDO_0016293,congenital stationary night blindness,1.1393938299890096,0.0,0.0,1.0,0.0,1.0,1.1394,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,1.139393829989009,1.139393829989009,0.0,HIGH,1
niacin/laropiprant,MONDO_0005090,schizophrenia,0.9090491626389512,0.0,0.0,1.0,0.2398,1.2398,1.127,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,False,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.9090491626389511,0.9090491626389511,0.0,HIGH,1
niacin/laropiprant,MONDO_0021187,hyperlipidemia,1.12166335892608,0.0,0.0,1.0,0.0,1.0,1.1217,1,TERMINATED,STOPPED,HIV | Atherosclerosis,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,True,"Diabetes Mellitus, Type 2; Flushing; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias",,,0.560832,0.560832,0.0,HIGH,2
nitroglycerin,EFO_0000537,hypertension,2.7863243348036506,0.8068,0.0,0.785,0.1609,1.1609,2.5394,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.161197,1.625127,0.463931,LOW,2
nitroglycerin,EFO_0001645,coronary artery disease,2.6221858066791164,0.8068,0.0,0.785,0.2303,1.2303,2.5325,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.134271,1.487915,0.353644,LOW,2
nitroglycerin,EFO_0000319,cardiovascular disease,2.6734181487871767,0.8068,0.0,0.785,0.0,1.0,2.0987,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.080023,1.593395,0.513372,LOW,2
nitroglycerin,EFO_0003913,angina pectoris,2.6613710901836094,0.8068,0.0,0.785,0.0,1.0,2.0893,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.156743,1.504628,0.347886,LOW,2
nitroglycerin,MONDO_0014331,Moyamoya disease with early-onset achalasia,2.142764537198834,0.8068,0.0,0.785,0.2398,1.2398,2.0855,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.071382,1.071382,0.0,HIGH,2
nitroglycerin,EFO_0000400,diabetes mellitus,1.9614914890215056,0.8068,0.0,0.785,0.2197,1.2197,1.8782,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.538002,1.423489,0.885486,LOW,2
nitroglycerin,EFO_0003144,heart failure,2.3804086531441406,0.8068,0.0,0.785,0.0,1.0,1.8687,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.032713,1.347696,0.314983,LOW,2
nitroglycerin,EFO_0001361,pulmonary arterial hypertension,2.239299612823114,0.8068,0.0,0.785,0.0,1.0,1.7579,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.009613,1.229686,0.220073,MEDIUM,2
nitroglycerin,EFO_0000612,myocardial infarction,2.195319051533388,0.8068,0.0,0.785,0.0,1.0,1.7234,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.987259,1.20806,0.220801,MEDIUM,2
nitroglycerin,EFO_0000712,stroke,1.8750636172460544,0.8068,0.0,0.785,0.1386,1.1386,1.676,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.461909,1.413154,0.951245,LOW,2
nitroglycerin,MONDO_0005149,pulmonary hypertension,2.08229381291436,0.8068,0.0,0.785,0.0,1.0,1.6347,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.962908,1.119386,0.156478,MEDIUM,2
nitroglycerin,MONDO_0019200,retinitis pigmentosa,1.7112906534313308,0.8068,0.0,0.785,0.2079,1.2079,1.6228,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.098252,1.613038,1.514786,LOW,2
nitroglycerin,MONDO_0001134,essential hypertension,2.0436552938932326,0.8068,0.0,0.785,0.0,1.0,1.6043,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.831053,1.212602,0.381549,LOW,2
nitroglycerin,MONDO_0005148,type 2 diabetes mellitus,1.6684612259024405,0.8068,0.0,0.785,0.1792,1.1792,1.5445,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.687298,0.981164,0.293866,LOW,2
nitroglycerin,EFO_1001375,Myocardial Ischemia,1.956516043628991,0.8068,0.0,0.785,0.0,1.0,1.5359,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.851947,1.104569,0.252622,LOW,2
nitroglycerin,HP_0012531,Pain,1.9444528275976876,0.8068,0.0,0.785,0.0,1.0,1.5265,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.892084,1.052369,0.160285,MEDIUM,2
nitroglycerin,MONDO_0016820,Moyamoya disease,1.5107198606377614,0.8068,0.0,0.785,0.2197,1.2197,1.4465,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.735111,0.775609,0.040499,HIGH,2
nitroglycerin,Orphanet_1872,Cone rod dystrophy,1.4434071029094817,0.8068,0.0,0.785,0.2398,1.2398,1.4048,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.054519,1.388888,1.33437,LOW,2
nitroglycerin,EFO_0000373,congestive heart failure,1.7697838274347624,0.8068,0.0,0.785,0.0,1.0,1.3893,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.832597,0.937187,0.10459,MEDIUM,2
nitroglycerin,MONDO_0014917,"developmental and epileptic encephalopathy, 42",1.4190796429750936,0.8068,0.0,0.785,0.2398,1.2398,1.3812,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.419079642975093,1.419079642975093,0.0,HIGH,1
nitroglycerin,MONDO_0021661,coronary atherosclerosis,1.7472245268268098,0.8068,0.0,0.785,0.0,1.0,1.3716,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.837566,0.909658,0.072092,HIGH,2
nitroglycerin,EFO_0004329,alcohol drinking,1.7374177311241965,0.8068,0.0,0.785,0.0,1.0,1.3639,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.712322,1.025096,0.312774,LOW,2
nitroglycerin,Orphanet_97,Familial paroxysmal ataxia,1.3927430514561254,0.8068,0.0,0.785,0.2398,1.2398,1.3555,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.392743051456125,1.392743051456125,0.0,HIGH,1
nitroglycerin,MONDO_0010979,Timothy syndrome,1.3920745479517749,0.8068,0.0,0.785,0.2398,1.2398,1.3549,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.392074547951774,1.392074547951774,0.0,HIGH,1
nitroglycerin,EFO_0000668,preeclampsia,1.3760847136692056,0.8068,0.0,0.785,0.2398,1.2398,1.3393,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.602874,0.77321,0.170336,MEDIUM,2
nitroglycerin,MONDO_0004979,asthma,1.4354285154174948,0.8068,0.0,0.785,0.1792,1.1792,1.3288,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.117726,1.317703,1.199977,LOW,2
nitroglycerin,EFO_0000275,atrial fibrillation,1.3603906233601872,0.8068,0.0,0.785,0.2398,1.2398,1.324,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.004709,1.355682,1.350973,LOW,2
nitroglycerin,MONDO_0005090,schizophrenia,1.3470219266488117,0.8068,0.0,0.785,0.2398,1.2398,1.311,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.177696,1.169326,0.991631,LOW,2
nitroglycerin,MONDO_0100062,genetic developmental and epileptic encephalopathy,1.3412716203822586,0.8068,0.0,0.785,0.2398,1.2398,1.3054,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.3412716203822581,1.3412716203822581,0.0,HIGH,1
nitroglycerin,MONDO_0007163,episodic ataxia type 2,1.317267405997716,0.8068,0.0,0.785,0.2398,1.2398,1.2821,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.317267405997715,1.317267405997715,0.0,HIGH,1
nitroglycerin,MONDO_0020756,"migraine, familial hemiplegic, 1",1.3099016060132944,0.8068,0.0,0.785,0.2398,1.2398,1.2749,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.309901606013294,1.309901606013294,0.0,HIGH,1
nitroglycerin,EFO_0000676,psoriasis,1.2960220291335984,0.8068,0.0,0.785,0.2398,1.2398,1.2614,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.014998,1.281024,1.266026,LOW,2
nitroglycerin,EFO_0009552,hemorrhoid,1.5968128736952951,0.8068,0.0,0.785,0.0,1.0,1.2535,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.735785,0.861028,0.125243,MEDIUM,2
nitroglycerin,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.8068,0.0,0.785,0.2398,1.2398,1.2481,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.2823759951301381,1.2823759951301381,0.0,HIGH,1
nitroglycerin,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2777608353829566,0.8068,0.0,0.785,0.2398,1.2398,1.2436,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.277760835382956,1.277760835382956,0.0,HIGH,1
nitroglycerin,MONDO_0010241,congenital stationary night blindness 2A,1.2823162524001888,0.8068,0.0,0.785,0.2197,1.2197,1.2278,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.282316252400188,1.282316252400188,0.0,HIGH,1
nitroglycerin,HP_0032263,Increased blood pressure,1.5636876568901874,0.8068,0.0,0.785,0.0,1.0,1.2275,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.690071,0.873616,0.183545,MEDIUM,2
nitroglycerin,MONDO_0002009,major depressive disorder,1.4059209005892734,0.8068,0.0,0.785,0.1099,1.1099,1.2249,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.488234,0.917686,0.429452,LOW,2
nitroglycerin,MONDO_0013960,sinoatrial node dysfunction and deafness,1.290406885393879,0.8068,0.0,0.785,0.2079,1.2079,1.2237,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.290406885393879,1.290406885393879,0.0,HIGH,1
nitroglycerin,MONDO_0042979,"hypokalemic periodic paralysis, type 1",1.2514884307370369,0.8068,0.0,0.785,0.2398,1.2398,1.218,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.251488430737036,1.251488430737036,0.0,HIGH,1
nitroglycerin,MONDO_0008457,spinocerebellar ataxia type 6,1.2493213730799673,0.8068,0.0,0.785,0.2398,1.2398,1.2159,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.249321373079967,1.249321373079967,0.0,HIGH,1
nitroglycerin,EFO_0009059,Spinocerebellar ataxia type 42,1.237540150094074,0.8068,0.0,0.785,0.2398,1.2398,1.2045,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.237540150094074,1.237540150094074,0.0,HIGH,1
nitroglycerin,MONDO_0013437,retinitis pigmentosa 43,1.2362795353223983,0.8068,0.0,0.785,0.2398,1.2398,1.2032,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.051693,1.184586,1.132893,LOW,2
nitroglycerin,MONDO_0013464,episodic ataxia type 5,1.2328237228973804,0.8068,0.0,0.785,0.2398,1.2398,1.1999,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.23282372289738,1.23282372289738,0.0,HIGH,1
nitroglycerin,EFO_1001145,Raynaud disease,1.337277142397786,0.8068,0.0,0.785,0.1386,1.1386,1.1953,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,True,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.629958,0.70732,0.077362,HIGH,2
nitroglycerin,MONDO_0859514,congenital myopathy 18,1.2127841546608158,0.8068,0.0,0.785,0.2398,1.2398,1.1804,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.212784154660815,1.212784154660815,0.0,HIGH,1
nitroglycerin,MONDO_0014200,aldosterone-producing adenoma with seizures and neurological abnormalities,1.2049779722981362,0.8068,0.0,0.785,0.2398,1.2398,1.1728,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.204977972298136,1.204977972298136,0.0,HIGH,1
nitroglycerin,MONDO_0018852,achromatopsia,1.479320618561668,0.8068,0.0,0.785,0.0,1.0,1.1613,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.479320618561667,1.479320618561667,0.0,HIGH,1
nitroglycerin,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,1.191998496620833,0.8068,0.0,0.785,0.2398,1.2398,1.1601,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,1.191998496620833,1.191998496620833,0.0,HIGH,1
nitroglycerin,HP_0002093,Respiratory insufficiency,1.4748401599873526,0.8068,0.0,0.785,0.0,1.0,1.1578,1,TERMINATED,STOPPED,Non-Obstructive Coronary Atherosclerosis,Study was terminated due to funding expiration.,False,"Angina Pectoris; Anus Diseases; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Carcinoma, Non-Small-Cell Lung",,,0.73742,0.73742,0.0,HIGH,2
olmesartan medoxomil,MONDO_0009970,renal tubular dysgenesis of genetic origin,4.603030194668649,0.7674,0.0,0.7944,0.2398,1.2398,4.5333,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.150758,1.150758,0.0,HIGH,4
olmesartan medoxomil,EFO_0000537,hypertension,4.874861044666751,0.7674,0.0,0.7944,0.1609,1.1609,4.4957,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.174871,1.262559,0.087688,HIGH,4
olmesartan medoxomil,EFO_0000712,stroke,4.2593722432762,0.7674,0.0,0.7944,0.1386,1.1386,3.8526,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.955671,1.174015,0.218344,MEDIUM,4
olmesartan medoxomil,MONDO_0017609,renal tubular dysgenesis,4.8070045513337725,0.7674,0.0,0.7944,0.0,1.0,3.8185,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.201751,1.201751,0.0,HIGH,4
olmesartan medoxomil,EFO_0000400,diabetes mellitus,3.939237980208024,0.7674,0.0,0.7944,0.2197,1.2197,3.8168,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.949381,1.020238,0.070858,HIGH,4
olmesartan medoxomil,MONDO_0007781,"essential hypertension, genetic",4.099940983287322,0.7674,0.0,0.7944,0.1609,1.1609,3.781,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.024985,1.024985,0.0,HIGH,4
olmesartan medoxomil,MONDO_0005148,type 2 diabetes mellitus,3.6521401725268623,0.7674,0.0,0.7944,0.1792,1.1792,3.421,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.880188,0.945882,0.065694,HIGH,4
olmesartan medoxomil,EFO_0004194,IGA glomerulonephritis,3.338193878991166,0.7674,0.0,0.7944,0.2398,1.2398,3.2876,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.812176,0.856921,0.044744,HIGH,4
olmesartan medoxomil,EFO_0000612,myocardial infarction,4.083065907267751,0.7674,0.0,0.7944,0.0,1.0,3.2435,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.97486,1.066673,0.091812,HIGH,4
olmesartan medoxomil,EFO_0000275,atrial fibrillation,3.243363688001501,0.7674,0.0,0.7944,0.2398,1.2398,3.1942,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.647484,0.974198,0.326714,LOW,4
olmesartan medoxomil,EFO_0003086,kidney disease,3.9723875248795526,0.7674,0.0,0.7944,0.0,1.0,3.1555,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.979605,1.020081,0.040476,HIGH,4
olmesartan medoxomil,EFO_0003144,heart failure,3.959131572227173,0.7674,0.0,0.7944,0.0,1.0,3.145,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.976336,1.016677,0.040341,HIGH,4
olmesartan medoxomil,MONDO_0001134,essential hypertension,3.906886789900324,0.7674,0.0,0.7944,0.0,1.0,3.1035,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.963452,1.003261,0.039809,HIGH,4
olmesartan medoxomil,EFO_0000319,cardiovascular disease,3.9048513899280737,0.7674,0.0,0.7944,0.0,1.0,3.1019,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.938834,1.013592,0.074759,HIGH,4
olmesartan medoxomil,EFO_0000401,diabetic nephropathy,3.8123095524465738,0.7674,0.0,0.7944,0.0,1.0,3.0284,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.940129,0.978974,0.038845,HIGH,4
olmesartan medoxomil,EFO_0000373,congestive heart failure,3.810514575802316,0.7674,0.0,0.7944,0.0,1.0,3.0269,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.952629,0.952629,0.0,HIGH,4
olmesartan medoxomil,EFO_0003884,chronic kidney disease,3.7050419334180544,0.7674,0.0,0.7944,0.0,1.0,2.9432,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.88646,0.969233,0.082773,HIGH,4
olmesartan medoxomil,HP_0000093,Proteinuria,3.5734566920440636,0.7674,0.0,0.7944,0.0,1.0,2.8386,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.893364,0.893364,0.0,HIGH,4
olmesartan medoxomil,EFO_0003913,angina pectoris,3.3714486340198695,0.7674,0.0,0.7944,0.0,1.0,2.6782,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.842862,0.842862,0.0,HIGH,4
olmesartan medoxomil,MONDO_0013361,congenital prothrombin deficiency,2.599870293070892,0.7674,0.0,0.7944,0.2398,1.2398,2.5605,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.299935,1.299935,0.0,HIGH,2
olmesartan medoxomil,MONDO_0007947,Marfan syndrome,2.5334838058491904,0.7674,0.0,0.7944,0.2398,1.2398,2.4951,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.633371,0.633371,0.0,HIGH,4
olmesartan medoxomil,Orphanet_325,Congenital factor II deficiency,2.5329529703141613,0.7674,0.0,0.7944,0.2398,1.2398,2.4946,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.266476,1.266476,0.0,HIGH,2
olmesartan medoxomil,EFO_0003777,heart disease,3.075128734203501,0.7674,0.0,0.7944,0.0,1.0,2.4428,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.518249,1.019315,0.501066,LOW,4
olmesartan medoxomil,EFO_0006834,septic shock,2.930417242859929,0.7674,0.0,0.7944,0.0,1.0,2.3278,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.701931,0.793951,0.092021,HIGH,4
olmesartan medoxomil,EFO_0001645,coronary artery disease,2.3355815248305927,0.7674,0.0,0.7944,0.2303,1.2303,2.2825,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.551919,0.615872,0.063953,HIGH,4
olmesartan medoxomil,EFO_0004236,focal segmental glomerulosclerosis,2.304651014947832,0.7674,0.0,0.7944,0.2398,1.2398,2.2697,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.568335,0.591818,0.023483,HIGH,4
olmesartan medoxomil,MONDO_0008559,thrombophilia due to thrombin defect,2.359647681657161,0.7674,0.0,0.7944,0.2079,1.2079,2.2642,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.179824,1.179824,0.0,HIGH,2
olmesartan medoxomil,EFO_0000195,metabolic syndrome,2.2395854537796485,0.7674,0.0,0.7944,0.2398,1.2398,2.2057,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.544887,0.574906,0.030019,HIGH,4
olmesartan medoxomil,MONDO_0005147,type 1 diabetes mellitus,2.191563407180455,0.7674,0.0,0.7944,0.2398,1.2398,2.1584,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.540447,0.562778,0.022331,HIGH,4
olmesartan medoxomil,MONDO_0100096,COVID-19,2.632395744953165,0.7674,0.0,0.7944,0.0,1.0,2.0911,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.623986,0.692212,0.068226,HIGH,4
olmesartan medoxomil,EFO_0000266,aortic stenosis,2.129050381800149,0.7674,0.0,0.7944,0.2303,1.2303,2.0807,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.517994,0.546531,0.028537,HIGH,4
olmesartan medoxomil,HP_0001873,Thrombocytopenia,2.144683098747747,0.7674,0.0,0.7944,0.2079,1.2079,2.0579,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.072272,1.00007,0.927798,LOW,4
olmesartan medoxomil,MONDO_0005180,Parkinson disease,2.0156107609237104,0.7674,0.0,0.7944,0.2398,1.2398,1.9851,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.441311,0.566494,0.125184,MEDIUM,4
olmesartan medoxomil,HP_0003124,Hypercholesterolemia,2.492207378826713,0.7674,0.0,0.7944,0.0,1.0,1.9797,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.623052,0.623052,0.0,HIGH,4
olmesartan medoxomil,EFO_0003914,atherosclerosis,2.485329280440919,0.7674,0.0,0.7944,0.0,1.0,1.9743,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,True,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.612891,0.638215,0.025324,HIGH,4
olmesartan medoxomil,HP_0004936,Venous thrombosis,1.9709024972588811,0.7674,0.0,0.7944,0.2398,1.2398,1.941,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.985451,0.985451,0.0,HIGH,2
olmesartan medoxomil,MONDO_0004975,Alzheimer disease,1.9635341948474376,0.7674,0.0,0.7944,0.2398,1.2398,1.9338,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.439175,0.563279,0.124104,MEDIUM,4
olmesartan medoxomil,EFO_0005251,hypotension,2.386940560477032,0.7674,0.0,0.7944,0.0,1.0,1.8961,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.588628,0.612949,0.024321,HIGH,4
olmesartan medoxomil,MONDO_0019719,congenital anomaly of kidney and urinary tract,2.362164171098147,0.7674,0.0,0.7944,0.0,1.0,1.8764,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.590541,0.590541,0.0,HIGH,4
olmesartan medoxomil,HP_0031273,Shock,2.358632403087534,0.7674,0.0,0.7944,0.0,1.0,1.8736,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.589658,0.589658,0.0,HIGH,4
olmesartan medoxomil,EFO_0003896,left ventricular hypertrophy,2.2791145131946595,0.7674,0.0,0.7944,0.0,1.0,1.8105,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.569779,0.569779,0.0,HIGH,4
olmesartan medoxomil,EFO_0004286,venous thromboembolism,2.2741102172256564,0.7674,0.0,0.7944,0.0,1.0,1.8065,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.137055,1.137055,0.0,HIGH,2
olmesartan medoxomil,Orphanet_309005,Disorder of lipid metabolism,2.2474471138645407,0.7674,0.0,0.7944,0.0,1.0,1.7853,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.561862,0.561862,0.0,HIGH,4
olmesartan medoxomil,EFO_0008583,acute myocardial infarction,2.2181377051456588,0.7674,0.0,0.7944,0.0,1.0,1.762,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.534585,0.574484,0.039899,HIGH,4
olmesartan medoxomil,MONDO_0005301,multiple sclerosis,1.7752082644312672,0.7674,0.0,0.7944,0.2398,1.2398,1.7483,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.401831,0.501899,0.100068,MEDIUM,4
olmesartan medoxomil,EFO_1000954,habitual abortion,1.8545945249762243,0.7674,0.0,0.7944,0.1792,1.1792,1.7372,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.927297,0.927297,0.0,HIGH,2
olmesartan medoxomil,EFO_0003907,deep vein thrombosis,2.166645935934917,0.7674,0.0,0.7944,0.0,1.0,1.7211,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.083323,1.083323,0.0,HIGH,2
olmesartan medoxomil,MONDO_0012833,Crouzon syndrome-acanthosis nigricans syndrome,1.7465083335814755,0.7674,0.0,0.7944,0.2398,1.2398,1.72,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.436627,0.436627,0.0,HIGH,4
olmesartan medoxomil,HP_0002140,Ischemic stroke,2.151321068963328,0.7674,0.0,0.7944,0.0,1.0,1.7089,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,1.075661,1.075661,0.0,HIGH,2
olmesartan medoxomil,EFO_0000407,dilated cardiomyopathy,1.7330712643633202,0.7674,0.0,0.7944,0.2398,1.2398,1.7068,1,TERMINATED,STOPPED,Essential Hypertension | Carotid Plaque,Low recruitment,False,Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Essential Hypertension,AGTR1,1.0,0.433268,0.433268,0.0,HIGH,4
pactimibe sulfate,EFO_0004911,familial hypercholesterolemia,2.9697614252457183,0.0,0.0,1.0,0.2303,1.2303,3.6536,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.484881,1.484881,0.0,HIGH,2
pactimibe sulfate,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.741653613949166,0.0,0.0,1.0,0.1946,1.1946,3.2752,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.370827,1.370827,0.0,HIGH,2
pactimibe sulfate,EFO_0001645,coronary artery disease,2.522959374402546,0.0,0.0,1.0,0.2303,1.2303,3.1039,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.26148,1.26148,0.0,HIGH,2
pactimibe sulfate,HP_0003124,Hypercholesterolemia,2.6890141186019783,0.0,0.0,1.0,0.0,1.0,2.689,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.344507,1.344507,0.0,HIGH,2
pactimibe sulfate,EFO_0000319,cardiovascular disease,2.4913512311300523,0.0,0.0,1.0,0.0,1.0,2.4914,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.245676,1.245676,0.0,HIGH,2
pactimibe sulfate,EFO_0000589,metabolic disease,2.3995172167298993,0.0,0.0,1.0,0.0,1.0,2.3995,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.199759,1.199759,0.0,HIGH,2
pactimibe sulfate,MONDO_0018328,homozygous familial hypercholesterolemia,2.296730590323977,0.0,0.0,1.0,0.0,1.0,2.2967,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.148365,1.148365,0.0,HIGH,2
pactimibe sulfate,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.0,0.0,1.0,0.0,1.0,2.2171,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.108526,1.108526,0.0,HIGH,2
pactimibe sulfate,EFO_0003914,atherosclerosis,2.1564363580273382,0.0,0.0,1.0,0.0,1.0,2.1564,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.078218,1.078218,0.0,HIGH,2
pactimibe sulfate,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.0,0.0,1.0,0.2079,1.2079,2.1545,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.891811,0.891811,0.0,HIGH,2
pactimibe sulfate,MONDO_0021187,hyperlipidemia,2.1040568357817544,0.0,0.0,1.0,0.0,1.0,2.1041,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.052028,1.052028,0.0,HIGH,2
pactimibe sulfate,EFO_0000612,myocardial infarction,2.0810436737369216,0.0,0.0,1.0,0.0,1.0,2.081,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,1.040522,1.040522,0.0,HIGH,2
pactimibe sulfate,EFO_0000195,metabolic syndrome,1.641838259890651,0.0,0.0,1.0,0.2398,1.2398,2.0355,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.820919,0.820919,0.0,HIGH,2
pactimibe sulfate,MONDO_0009387,familial lipoprotein lipase deficiency,1.5379698591500608,0.0,0.0,1.0,0.2398,1.2398,1.9068,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.768985,0.768985,0.0,HIGH,2
pactimibe sulfate,HP_0003077,Hyperlipidemia,1.7967920763748404,0.0,0.0,1.0,0.0,1.0,1.7968,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.898396,0.898396,0.0,HIGH,2
pactimibe sulfate,EFO_1001375,Myocardial Ischemia,1.7694639103980672,0.0,0.0,1.0,0.0,1.0,1.7695,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.884732,0.884732,0.0,HIGH,2
pactimibe sulfate,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.0,0.0,1.0,0.0,1.0,1.7633,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.881668,0.881668,0.0,HIGH,2
pactimibe sulfate,EFO_0000400,diabetes mellitus,1.4418160359973236,0.0,0.0,1.0,0.2197,1.2197,1.7586,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.720908,0.720908,0.0,HIGH,2
pactimibe sulfate,MONDO_0001336,familial hyperlipidemia,1.7148713527001924,0.0,0.0,1.0,0.0,1.0,1.7149,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.857436,0.857436,0.0,HIGH,2
pactimibe sulfate,EFO_0003913,angina pectoris,1.687236594810492,0.0,0.0,1.0,0.0,1.0,1.6872,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.843618,0.843618,0.0,HIGH,2
pactimibe sulfate,EFO_0003777,heart disease,1.642982730620368,0.0,0.0,1.0,0.0,1.0,1.643,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.821491,0.821491,0.0,HIGH,2
pactimibe sulfate,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.0,0.0,1.0,0.0,1.0,1.545,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.772495,0.772495,0.0,HIGH,2
pactimibe sulfate,HP_0003146,Hypocholesterolemia,1.519787603332834,0.0,0.0,1.0,0.0,1.0,1.5198,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.759894,0.759894,0.0,HIGH,2
pactimibe sulfate,HP_0000924,Abnormality of the skeletal system,1.5023777048523923,0.0,0.0,1.0,0.0,1.0,1.5024,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.751189,0.751189,0.0,HIGH,2
pactimibe sulfate,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.0,0.0,1.0,0.0,1.0,1.4716,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.735785,0.735785,0.0,HIGH,2
pactimibe sulfate,Orphanet_79211,Combined hyperlipidemia,1.1826198710376177,0.0,0.0,1.0,0.2303,1.2303,1.4549,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.59131,0.59131,0.0,HIGH,2
pactimibe sulfate,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.0,0.0,1.0,0.0,1.0,1.4289,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.714428,0.714428,0.0,HIGH,2
pactimibe sulfate,EFO_0000712,stroke,1.20277799938547,0.0,0.0,1.0,0.1386,1.1386,1.3695,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.601389,0.601389,0.0,HIGH,2
pactimibe sulfate,MONDO_0021511,benign neoplasm of adrenal gland,1.3547010903713852,0.0,0.0,1.0,0.0,1.0,1.3547,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.677351,0.677351,0.0,HIGH,2
pactimibe sulfate,EFO_0008583,acute myocardial infarction,1.1998707733605194,0.0,0.0,1.0,0.0,1.0,1.1999,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.599935,0.599935,0.0,HIGH,2
pactimibe sulfate,EFO_0005772,neurodegenerative disease,1.1945285932663348,0.0,0.0,1.0,0.0,1.0,1.1945,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.597264,0.597264,0.0,HIGH,2
pactimibe sulfate,EFO_0003144,heart failure,1.1943910450436237,0.0,0.0,1.0,0.0,1.0,1.1944,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.597196,0.597196,0.0,HIGH,2
pactimibe sulfate,HP_0011428,Short fetal femur length,1.187066470233723,0.0,0.0,1.0,0.0,1.0,1.1871,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.593533,0.593533,0.0,HIGH,2
pactimibe sulfate,EFO_0004264,vascular disease,1.1630272440108385,0.0,0.0,1.0,0.0,1.0,1.163,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.581514,0.581514,0.0,HIGH,2
pactimibe sulfate,EFO_0005672,acute coronary syndrome,1.1541008061604114,0.0,0.0,1.0,0.0,1.0,1.1541,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.57705,0.57705,0.0,HIGH,2
pactimibe sulfate,EFO_0003776,coronary artery bypass,1.1279602973638454,0.0,0.0,1.0,0.0,1.0,1.128,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.56398,0.56398,0.0,HIGH,2
pactimibe sulfate,EFO_0003940,physical activity,1.1225894210654916,0.0,0.0,1.0,0.0,1.0,1.1226,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.561295,0.561295,0.0,HIGH,2
pactimibe sulfate,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.0,0.0,1.0,0.0,1.0,1.1226,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.561295,0.561295,0.0,HIGH,2
pactimibe sulfate,EFO_0004329,alcohol drinking,1.1225894210654916,0.0,0.0,1.0,0.0,1.0,1.1226,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.561295,0.561295,0.0,HIGH,2
pactimibe sulfate,EFO_1000985,intermediate coronary syndrome,1.118232710706178,0.0,0.0,1.0,0.0,1.0,1.1182,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.559116,0.559116,0.0,HIGH,2
pactimibe sulfate,EFO_0003086,kidney disease,1.053370520411149,0.0,0.0,1.0,0.0,1.0,1.0534,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.526685,0.526685,0.0,HIGH,2
pactimibe sulfate,EFO_0003769,endocrine neoplasm,0.9968458962306624,0.0,0.0,1.0,0.0,1.0,0.9968,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.498423,0.498423,0.0,HIGH,2
pactimibe sulfate,EFO_0003894,acne,0.9955008356694512,0.0,0.0,1.0,0.0,1.0,0.9955,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.49775,0.49775,0.0,HIGH,2
pactimibe sulfate,MONDO_0000627,benign endocrine neoplasm,0.9933934657064296,0.0,0.0,1.0,0.0,1.0,0.9934,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.496697,0.496697,0.0,HIGH,2
pactimibe sulfate,HP_0003040,Arthropathy,0.9594178191147148,0.0,0.0,1.0,0.0,1.0,0.9594,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.479709,0.479709,0.0,HIGH,2
pactimibe sulfate,EFO_0009578,placental retention,0.9588206730453008,0.0,0.0,1.0,0.0,1.0,0.9588,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.47941,0.47941,0.0,HIGH,2
pactimibe sulfate,MONDO_0100096,COVID-19,0.9519017092954246,0.0,0.0,1.0,0.0,1.0,0.9519,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.475951,0.475951,0.0,HIGH,2
pactimibe sulfate,EFO_0003884,chronic kidney disease,0.858094158148282,0.0,0.0,1.0,0.0,1.0,0.8581,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.429047,0.429047,0.0,HIGH,2
pactimibe sulfate,EFO_0020092,neuroinflammatory disorder,0.8564903946660308,0.0,0.0,1.0,0.0,1.0,0.8565,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.428245,0.428245,0.0,HIGH,2
pactimibe sulfate,MONDO_0017774,hypobetalipoproteinemia,0.6251496691785116,0.0,0.0,1.0,0.0,1.0,0.6251,1,TERMINATED,STOPPED,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,,False,,,,0.312575,0.312575,0.0,HIGH,2
phenprocoumon,Orphanet_98434,Hereditary combined deficiency of vitamin K-dependent clotting factors,1.137205086918541,0.0,0.05,0.99,0.2398,1.2398,1.3959,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,1.137205086918541,1.137205086918541,0.0,HIGH,1
phenprocoumon,MONDO_0011837,"vitamin K-dependent clotting factors, combined deficiency of, type 2",1.135399722413151,0.0,0.05,0.99,0.1946,1.1946,1.3428,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,1.135399722413151,1.135399722413151,0.0,HIGH,1
phenprocoumon,EFO_0000275,atrial fibrillation,0.9731456905021372,0.0,0.05,0.99,0.2398,1.2398,1.1945,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.9731456905021371,0.9731456905021371,0.0,HIGH,1
phenprocoumon,HP_0004936,Venous thrombosis,0.8593592866938459,0.0,0.05,0.99,0.2398,1.2398,1.0548,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Melanoma; Thrombosis; Venous Thrombosis,,,0.8593592866938451,0.8593592866938451,0.0,HIGH,1
phenprocoumon,EFO_0000712,stroke,0.8596690711260174,0.0,0.05,0.99,0.1386,1.1386,0.9691,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.8596690711260171,0.8596690711260171,0.0,HIGH,1
phenprocoumon,EFO_0005801,cholesterol embolism,0.9018076323847418,0.0,0.05,0.99,0.0,1.0,0.8928,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.901807632384741,0.901807632384741,0.0,HIGH,1
phenprocoumon,HP_0004419,Recurrent thrombophlebitis,0.8615224836999292,0.0,0.05,0.99,0.0,1.0,0.853,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Melanoma; Thrombosis; Venous Thrombosis,,,0.8615224836999291,0.8615224836999291,0.0,HIGH,1
phenprocoumon,EFO_0003827,pulmonary embolism,0.8467460521952096,0.0,0.05,0.99,0.0,1.0,0.8383,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.846746052195209,0.846746052195209,0.0,HIGH,1
phenprocoumon,MONDO_0000831,thrombotic disease,0.8227915968899653,0.0,0.05,0.99,0.0,1.0,0.8146,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.8227915968899651,0.8227915968899651,0.0,HIGH,1
phenprocoumon,HP_0001907,Thromboembolism,0.8183659561338297,0.0,0.05,0.99,0.0,1.0,0.8102,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.818365956133829,0.818365956133829,0.0,HIGH,1
phenprocoumon,EFO_0000612,myocardial infarction,0.7967897542831893,0.0,0.05,0.99,0.0,1.0,0.7889,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.7967897542831891,0.7967897542831891,0.0,HIGH,1
phenprocoumon,EFO_0004286,venous thromboembolism,0.70557853461004,0.0,0.05,0.99,0.0,1.0,0.6986,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.70557853461004,0.70557853461004,0.0,HIGH,1
phenprocoumon,EFO_0005772,neurodegenerative disease,0.6944708770939099,0.0,0.05,0.99,0.0,1.0,0.6876,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.6944708770939091,0.6944708770939091,0.0,HIGH,1
phenprocoumon,EFO_0003907,deep vein thrombosis,0.6396732471632461,0.0,0.05,0.99,0.0,1.0,0.6333,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,True,Melanoma; Thrombosis; Venous Thrombosis,,,0.639673247163246,0.639673247163246,0.0,HIGH,1
phenprocoumon,MONDO_0015722,congenital vitamin K-dependent coagulation factors deficiency,0.5886280017687883,0.0,0.05,0.99,0.0,1.0,0.5828,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.588628001768788,0.588628001768788,0.0,HIGH,1
phenprocoumon,HP_0001873,Thrombocytopenia,0.4414710013265911,0.0,0.05,0.99,0.2079,1.2079,0.528,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.44147100132659106,0.44147100132659106,0.0,HIGH,1
phenprocoumon,EFO_0003777,heart disease,0.530116743315188,0.0,0.05,0.99,0.0,1.0,0.5248,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.530116743315188,0.530116743315188,0.0,HIGH,1
phenprocoumon,EFO_0001645,coronary artery disease,0.4248354288215399,0.0,0.05,0.99,0.2303,1.2303,0.5175,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.424835428821539,0.424835428821539,0.0,HIGH,1
phenprocoumon,EFO_1001375,Myocardial Ischemia,0.5201264180629455,0.0,0.05,0.99,0.0,1.0,0.515,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.520126418062945,0.520126418062945,0.0,HIGH,1
phenprocoumon,EFO_0002950,pregnancy,0.5150495015476898,0.0,0.05,0.99,0.0,1.0,0.5099,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.515049501547689,0.515049501547689,0.0,HIGH,1
phenprocoumon,EFO_0003875,peripheral vascular disease,0.5150495015476898,0.0,0.05,0.99,0.0,1.0,0.5099,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.515049501547689,0.515049501547689,0.0,HIGH,1
phenprocoumon,EFO_1000059,cervical artery dissection,0.5150495015476898,0.0,0.05,0.99,0.0,1.0,0.5099,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.515049501547689,0.515049501547689,0.0,HIGH,1
phenprocoumon,EFO_0000768,idiopathic pulmonary fibrosis,0.4120396012381517,0.0,0.05,0.99,0.2398,1.2398,0.5058,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
phenprocoumon,EFO_0003144,heart failure,0.4431551314427629,0.0,0.05,0.99,0.0,1.0,0.4387,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.44315513144276203,0.44315513144276203,0.0,HIGH,1
phenprocoumon,MONDO_0008315,prostate cancer,0.4416948434750415,0.0,0.05,0.99,0.0,1.0,0.4373,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.441694843475041,0.441694843475041,0.0,HIGH,1
phenprocoumon,EFO_0000319,cardiovascular disease,0.4342785879046796,0.0,0.05,0.99,0.0,1.0,0.43,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.43427858790467905,0.43427858790467905,0.0,HIGH,1
phenprocoumon,EFO_0003914,atherosclerosis,0.4142431905605443,0.0,0.05,0.99,0.0,1.0,0.4101,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41424319056054404,0.41424319056054404,0.0,HIGH,1
phenprocoumon,EFO_1001161,rheumatic heart disease,0.4131432787414683,0.0,0.05,0.99,0.0,1.0,0.409,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41314327874146806,0.41314327874146806,0.0,HIGH,1
phenprocoumon,EFO_0003764,transient ischemic attack,0.4126282292399205,0.0,0.05,0.99,0.0,1.0,0.4085,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41262822923992004,0.41262822923992004,0.0,HIGH,1
phenprocoumon,EFO_0003911,atrial flutter,0.4120396012381517,0.0,0.05,0.99,0.0,1.0,0.4079,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
phenprocoumon,EFO_0003929,relapsing-remitting multiple sclerosis,0.4120396012381517,0.0,0.05,0.99,0.0,1.0,0.4079,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
phenprocoumon,EFO_0004277,brain infarction,0.4120396012381517,0.0,0.05,0.99,0.0,1.0,0.4079,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
phenprocoumon,MONDO_0002679,cerebral infarction,0.4120396012381517,0.0,0.05,0.99,0.0,1.0,0.4079,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.41203960123815103,0.41203960123815103,0.0,HIGH,1
phenprocoumon,EFO_0001073,obesity,0.2277134420449796,0.0,0.05,0.99,0.1946,1.1946,0.2693,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.227713442044979,0.227713442044979,0.0,HIGH,1
phenprocoumon,EFO_0000266,aortic stenosis,0.2060198006190758,0.0,0.05,0.99,0.2303,1.2303,0.2509,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.20601980061907502,0.20601980061907502,0.0,HIGH,1
phenprocoumon,EFO_0000699,Sjogren syndrome,0.1686185424488071,0.0,0.05,0.99,0.2398,1.2398,0.207,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.168618542448807,0.168618542448807,0.0,HIGH,1
phenprocoumon,EFO_0001422,cirrhosis of liver,0.1177256003537575,0.0,0.05,0.99,0.2398,1.2398,0.1445,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.11772560035375701,0.11772560035375701,0.0,HIGH,1
phenprocoumon,EFO_0003095,non-alcoholic fatty liver disease,0.126260706379405,0.0,0.05,0.99,0.1099,1.1099,0.1387,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.126260706379405,0.126260706379405,0.0,HIGH,1
phenprocoumon,HP_0001297,Stroke,0.1341559579371095,0.0,0.05,0.99,0.0,1.0,0.1328,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.13415595793710902,0.13415595793710902,0.0,HIGH,1
phenprocoumon,EFO_0001361,pulmonary arterial hypertension,0.1324413003979773,0.0,0.05,0.99,0.0,1.0,0.1311,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.132441300397977,0.132441300397977,0.0,HIGH,1
phenprocoumon,Orphanet_903,Von Willebrand disease,0.10542327511679,0.0,0.05,0.99,0.2398,1.2398,0.1294,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.10542327511679,0.10542327511679,0.0,HIGH,1
phenprocoumon,MONDO_0005148,type 2 diabetes mellitus,0.1021310460013414,0.0,0.05,0.99,0.1792,1.1792,0.1192,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.10213104600134101,0.10213104600134101,0.0,HIGH,1
phenprocoumon,MONDO_0005149,pulmonary hypertension,0.1177256003537575,0.0,0.05,0.99,0.0,1.0,0.1166,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.11772560035375701,0.11772560035375701,0.0,HIGH,1
phenprocoumon,MONDO_0017278,autoimmune polyendocrinopathy,0.1177256003537575,0.0,0.05,0.99,0.0,1.0,0.1166,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.11772560035375701,0.11772560035375701,0.0,HIGH,1
phenprocoumon,Orphanet_2098,"Acromesomelic dysplasia, Grebe type",0.0872964758023201,0.0,0.05,0.99,0.2398,1.2398,0.1072,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.08729647580232,0.08729647580232,0.0,HIGH,1
phenprocoumon,EFO_0000685,rheumatoid arthritis,0.0861522483699928,0.0,0.05,0.99,0.2398,1.2398,0.1057,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.08615224836999201,0.08615224836999201,0.0,HIGH,1
phenprocoumon,MONDO_0005180,Parkinson disease,0.0850769155652421,0.0,0.05,0.99,0.2398,1.2398,0.1044,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.08507691556524201,0.08507691556524201,0.0,HIGH,1
phenprocoumon,MONDO_0031332,Glanzmann thrombasthenia 1,0.085022246114375,0.0,0.05,0.99,0.2398,1.2398,0.1044,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.085022246114375,0.085022246114375,0.0,HIGH,1
phenprocoumon,EFO_0000676,psoriasis,0.0837977363629177,0.0,0.05,0.99,0.2398,1.2398,0.1029,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.083797736362917,0.083797736362917,0.0,HIGH,1
phenprocoumon,Orphanet_931,Acheiropodia,0.0824844418878602,0.0,0.05,0.99,0.2398,1.2398,0.1012,1,TERMINATED,STOPPED,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Slow recruitment; Study was terminated for futility reasons,False,Melanoma; Thrombosis; Venous Thrombosis,,,0.08248444188786001,0.08248444188786001,0.0,HIGH,1
plerixafor,Orphanet_51636,WHIM syndrome,9.07325035470629,0.4412,0.1,0.8587,0.2398,1.2398,9.6591,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,1.296179,1.296179,0.0,HIGH,7
plerixafor,MONDO_8000006,WHIM syndrome 1,7.373307450033325,0.4412,0.1,0.8587,0.2398,1.2398,7.8494,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,1.05333,1.05333,0.0,HIGH,7
plerixafor,EFO_0001378,multiple myeloma,7.053824480424494,0.4412,0.1,0.8587,0.1792,1.1792,7.1422,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,1.007689,1.007689,0.0,HIGH,7
plerixafor,EFO_0000764,HIV infection,6.481510052516344,0.4412,0.1,0.8587,0.0,1.0,5.5655,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.899664,0.9643,0.064635,HIGH,7
plerixafor,EFO_0000574,lymphoma,6.01022857049097,0.4412,0.1,0.8587,0.0693,1.0693,5.5185,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.858604,0.858604,0.0,HIGH,7
plerixafor,EFO_0005952,non-Hodgkins lymphoma,6.016313032735999,0.4412,0.1,0.8587,0.0,1.0,5.166,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.859473,0.859473,0.0,HIGH,7
plerixafor,MONDO_0018542,severe congenital neutropenia,5.156675609495469,0.4412,0.1,0.8587,0.0,1.0,4.4279,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.736668,0.736668,0.0,HIGH,7
plerixafor,EFO_0000220,acute lymphoblastic leukemia,4.762021678421457,0.4412,0.1,0.8587,0.0,1.0,4.089,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.680289,0.680289,0.0,HIGH,7
plerixafor,EFO_0000616,neoplasm,4.717396291768068,0.4412,0.1,0.8587,0.0,1.0,4.0507,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.654797,0.70184,0.047043,HIGH,7
plerixafor,MONDO_0005301,multiple sclerosis,3.7185243816185793,0.4412,0.1,0.8587,0.2398,1.2398,3.9586,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.516149,0.553231,0.037082,HIGH,7
plerixafor,EFO_0004198,skin neoplasm,4.473714593391981,0.4412,0.1,0.8587,0.0,1.0,3.8415,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.639102,0.639102,0.0,HIGH,7
plerixafor,EFO_0005543,glioma,3.492281651562726,0.4412,0.1,0.8587,0.2398,1.2398,3.7178,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.486418,0.5162,0.029782,HIGH,7
plerixafor,EFO_0000756,melanoma,3.474211528861283,0.4412,0.1,0.8587,0.2197,1.2197,3.6387,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.483901,0.513529,0.029628,HIGH,7
plerixafor,EFO_1001938,B-cell non-Hodgkins lymphoma,4.22462599909181,0.4412,0.1,0.8587,0.0,1.0,3.6276,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.603518,0.603518,0.0,HIGH,7
plerixafor,EFO_0000222,acute myeloid leukemia,3.693098372556645,0.4412,0.1,0.8587,0.1386,1.1386,3.6108,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.508066,0.558627,0.05056,HIGH,7
plerixafor,EFO_0001642,lymphoid neoplasm,4.1633494239789215,0.4412,0.1,0.8587,0.0,1.0,3.575,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.594764,0.594764,0.0,HIGH,7
plerixafor,MONDO_0000432,lymphoplasmacytic lymphoma,4.151215123840861,0.4412,0.1,0.8587,0.0,1.0,3.5645,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.593031,0.593031,0.0,HIGH,7
plerixafor,EFO_1000836,benign monoclonal gammopathy,4.1203960123815175,0.4412,0.1,0.8587,0.0,1.0,3.5381,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.588628,0.588628,0.0,HIGH,7
plerixafor,EFO_0003060,non-small cell lung carcinoma,3.4858674204310396,0.4412,0.1,0.8587,0.1792,1.1792,3.5295,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.487584,0.511129,0.023546,HIGH,7
plerixafor,EFO_0000182,hepatocellular carcinoma,3.508402478823273,0.4412,0.1,0.8587,0.1609,1.1609,3.4974,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.488663,0.518583,0.029919,HIGH,7
plerixafor,EFO_0001645,coronary artery disease,3.307158851750603,0.4412,0.1,0.8587,0.2303,1.2303,3.4936,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.373538,0.670277,0.296738,LOW,7
plerixafor,EFO_0000183,Hodgkins lymphoma,3.495721216059206,0.4412,0.1,0.8587,0.1609,1.1609,3.4848,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.495489,0.507188,0.011699,HIGH,7
plerixafor,EFO_0000571,lung adenocarcinoma,3.425184061391566,0.4412,0.1,0.8587,0.1792,1.1792,3.4681,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.479096,0.502231,0.023136,HIGH,7
plerixafor,EFO_0000095,chronic lymphocytic leukemia,3.4762466439257933,0.4412,0.1,0.8587,0.1386,1.1386,3.3988,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.496607,0.496607,0.0,HIGH,7
plerixafor,EFO_0000637,osteosarcoma,3.467936098129116,0.4412,0.1,0.8587,0.1386,1.1386,3.3906,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.487742,0.503097,0.015355,HIGH,7
plerixafor,EFO_0000389,cutaneous melanoma,3.1438298026884883,0.4412,0.1,0.8587,0.2398,1.2398,3.3468,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.449119,0.449119,0.0,HIGH,7
plerixafor,EFO_0000305,breast carcinoma,3.3557331260224257,0.4412,0.1,0.8587,0.1609,1.1609,3.3452,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.469381,0.492048,0.022667,HIGH,7
plerixafor,EFO_0005772,neurodegenerative disease,3.82995415708995,0.4412,0.1,0.8587,0.0,1.0,3.2887,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.537575,0.566258,0.028683,HIGH,7
plerixafor,MONDO_0021094,immunodeficiency disease,3.81562400144296,0.4412,0.1,0.8587,0.0,1.0,3.2764,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.545089,0.545089,0.0,HIGH,7
plerixafor,EFO_0000181,head and neck squamous cell carcinoma,3.4023801998716245,0.4412,0.1,0.8587,0.1099,1.1099,3.2425,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.482259,0.493645,0.011386,HIGH,7
plerixafor,EFO_0005922,esophageal squamous cell carcinoma,3.39801763617469,0.4412,0.1,0.8587,0.1099,1.1099,3.2383,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.485431,0.485431,0.0,HIGH,7
plerixafor,EFO_0000365,colorectal adenocarcinoma,3.1133883952721924,0.4412,0.1,0.8587,0.2079,1.2079,3.2293,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.44477,0.44477,0.0,HIGH,7
plerixafor,EFO_0000403,diffuse large B-cell lymphoma,3.7319593383200433,0.4412,0.1,0.8587,0.0,1.0,3.2045,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,True,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.524875,0.541399,0.016524,HIGH,7
plerixafor,EFO_0000478,esophageal adenocarcinoma,3.1619722300745754,0.4412,0.1,0.8587,0.1792,1.1792,3.2016,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.45171,0.45171,0.0,HIGH,7
plerixafor,MONDO_0004986,urinary bladder carcinoma,3.211042912334291,0.4412,0.1,0.8587,0.1609,1.1609,3.201,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.45872,0.45872,0.0,HIGH,7
plerixafor,EFO_0000309,Burkitts lymphoma,3.2020929162815395,0.4412,0.1,0.8587,0.1609,1.1609,3.1921,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.457442,0.457442,0.0,HIGH,7
plerixafor,EFO_0000178,gastric carcinoma,3.2380840737548864,0.4412,0.1,0.8587,0.1386,1.1386,3.1659,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.462583,0.462583,0.0,HIGH,7
plerixafor,EFO_0000349,clear cell renal carcinoma,3.2753288321539267,0.4412,0.1,0.8587,0.1099,1.1099,3.1214,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.467904,0.467904,0.0,HIGH,7
plerixafor,MONDO_0002898,skin cancer,3.6247623402783855,0.4412,0.1,0.8587,0.0,1.0,3.1125,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.517823,0.517823,0.0,HIGH,7
plerixafor,EFO_0002496,actinic keratosis,3.4901446490520027,0.4412,0.1,0.8587,0.0,1.0,2.9969,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.498592,0.498592,0.0,HIGH,7
plerixafor,EFO_0002609,juvenile idiopathic arthritis,3.4241311186634023,0.4412,0.1,0.8587,0.0,1.0,2.9402,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.489162,0.489162,0.0,HIGH,7
plerixafor,EFO_0000503,gastric adenocarcinoma,3.328612668267925,0.4412,0.1,0.8587,0.0,1.0,2.8582,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.475516,0.475516,0.0,HIGH,7
plerixafor,EFO_0000612,myocardial infarction,3.2629447078603264,0.4412,0.1,0.8587,0.0,1.0,2.8018,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.358818,0.675122,0.316304,LOW,7
plerixafor,MONDO_0005341,skin basal cell carcinoma,3.2561062885243,0.4412,0.1,0.8587,0.0,1.0,2.7959,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.461526,0.472423,0.010897,HIGH,7
plerixafor,MONDO_0005184,pancreatic ductal adenocarcinoma,3.2024269534038767,0.4412,0.1,0.8587,0.0,1.0,2.7498,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.4504,0.464579,0.014179,HIGH,7
plerixafor,MONDO_0005148,type 2 diabetes mellitus,2.6842981448265,0.4412,0.1,0.8587,0.1792,1.1792,2.7179,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.311867,0.52177,0.209903,MEDIUM,7
plerixafor,EFO_0006544,bladder transitional cell carcinoma,3.16104016784078,0.4412,0.1,0.8587,0.0,1.0,2.7143,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.451577,0.451577,0.0,HIGH,7
plerixafor,EFO_1001471,Merkel cell skin cancer,3.1523439516117415,0.4412,0.1,0.8587,0.0,1.0,2.7068,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.446818,0.457368,0.01055,HIGH,7
plerixafor,EFO_1001949,colon adenocarcinoma,3.1501625651523244,0.4412,0.1,0.8587,0.0,1.0,2.705,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.446509,0.457052,0.010542,HIGH,7
plerixafor,EFO_1000172,cervical squamous cell carcinoma,3.1425173059708347,0.4412,0.1,0.8587,0.0,1.0,2.6984,1,TERMINATED,STOPPED,Diabetes | Wounds | Critical Limb Ischemia,Safety reasons,False,"Anemia, Sickle Cell; Blood Platelet Disorders; Diabetes Mellitus, Type 1; Diabetic Foot; End Stage Liver Disease",,,0.448931,0.448931,0.0,HIGH,7
prednisone,MONDO_0014421,glucocorticoid resistance,6.495441779731445,1.0,0.0,0.7408,0.2398,1.2398,5.9658,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.81193,0.81193,0.0,HIGH,8
prednisone,MONDO_0005301,multiple sclerosis,5.769630224981402,1.0,0.0,0.7408,0.2398,1.2398,5.2992,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.695549,0.748876,0.053327,HIGH,8
prednisone,EFO_0000729,ulcerative colitis,5.384594901613732,1.0,0.0,0.7408,0.2398,1.2398,4.9455,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.634776,0.71164,0.076864,HIGH,8
prednisone,EFO_0000685,rheumatoid arthritis,5.293840166535629,1.0,0.0,0.7408,0.2398,1.2398,4.8622,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.638191,0.687121,0.048929,HIGH,8
prednisone,EFO_0000341,chronic obstructive pulmonary disease,6.011699148918847,1.0,0.0,0.7408,0.0693,1.0693,4.7623,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.718435,0.78449,0.066055,HIGH,8
prednisone,EFO_0000676,psoriasis,5.141847650089903,1.0,0.0,0.7408,0.2398,1.2398,4.7226,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.616017,0.676615,0.060597,HIGH,8
prednisone,EFO_0000384,Crohn's disease,5.092388136534779,1.0,0.0,0.7408,0.2398,1.2398,4.6771,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.612592,0.660265,0.047673,HIGH,8
prednisone,EFO_0004255,nephrotic syndrome,5.086741172886628,1.0,0.0,0.7408,0.2398,1.2398,4.672,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.617842,0.656039,0.038197,HIGH,8
prednisone,EFO_0000274,atopic eczema,5.02494319747302,1.0,0.0,0.7408,0.2398,1.2398,4.6152,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.612472,0.644989,0.032517,HIGH,8
prednisone,MONDO_0005178,osteoarthritis,5.007130592217461,1.0,0.0,0.7408,0.2303,1.2303,4.5635,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.617388,0.638646,0.021258,HIGH,8
prednisone,MONDO_0004979,asthma,5.123467190512259,1.0,0.0,0.7408,0.1792,1.1792,4.4756,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.619481,0.662482,0.043001,HIGH,8
prednisone,EFO_0000275,atrial fibrillation,4.842546367020402,1.0,0.0,0.7408,0.2398,1.2398,4.4477,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.544198,0.660607,0.116409,MEDIUM,8
prednisone,MONDO_0007915,systemic lupus erythematosus,4.807724101192033,1.0,0.0,0.7408,0.2398,1.2398,4.4157,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.583838,0.620182,0.036344,HIGH,8
prednisone,EFO_0000768,idiopathic pulmonary fibrosis,4.791382690858795,1.0,0.0,0.7408,0.2398,1.2398,4.4007,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.591954,0.61286,0.020906,HIGH,8
prednisone,EFO_0007160,autoimmune thrombocytopenic purpura,5.114978570722469,1.0,0.0,0.7408,0.1609,1.1609,4.3991,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.62049,0.666801,0.046311,HIGH,8
prednisone,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,4.754418100182987,1.0,0.0,0.7408,0.2398,1.2398,4.3667,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.582273,0.606332,0.024059,HIGH,8
prednisone,EFO_0000574,lymphoma,5.332582395652496,1.0,0.0,0.7408,0.0693,1.0693,4.2243,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.619925,0.731236,0.11131,MEDIUM,8
prednisone,MONDO_0010679,Duchenne muscular dystrophy,4.595607950506558,1.0,0.0,0.7408,0.2398,1.2398,4.2209,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.55734,0.596332,0.038993,HIGH,8
prednisone,HP_0001873,Thrombocytopenia,4.699175972579517,1.0,0.0,0.7408,0.2079,1.2079,4.2051,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.571768,0.609757,0.03799,HIGH,8
prednisone,EFO_1001051,mycosis fungoides,4.4831749535441645,1.0,0.0,0.7408,0.2197,1.2197,4.051,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.553876,0.573438,0.019562,HIGH,8
prednisone,MONDO_0004992,cancer,5.43262880505514,1.0,0.0,0.7408,0.0,1.0,4.0246,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.630867,0.739358,0.108491,MEDIUM,8
prednisone,EFO_0004719,pemphigus vulgaris,4.571061261048193,1.0,0.0,0.7408,0.1792,1.1792,3.9931,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.564734,0.584679,0.019945,HIGH,8
prednisone,EFO_0000565,leukemia,5.373536654186764,1.0,0.0,0.7408,0.0,1.0,3.9808,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.624553,0.732821,0.108269,MEDIUM,8
prednisone,EFO_0000544,infection,5.3207097687005325,1.0,0.0,0.7408,0.0,1.0,3.9417,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.628992,0.701863,0.072871,HIGH,8
prednisone,EFO_0003099,Cushing syndrome,4.266598409128347,1.0,0.0,0.7408,0.2398,1.2398,3.9187,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.533325,0.533325,0.0,HIGH,8
prednisone,EFO_0000616,neoplasm,5.144062447348249,1.0,0.0,0.7408,0.0,1.0,3.8108,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.570153,0.738051,0.167898,MEDIUM,8
prednisone,HP_0001915,Aplastic anemia,4.627162902185715,1.0,0.0,0.7408,0.1099,1.1099,3.8045,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.569532,0.596122,0.02659,HIGH,8
prednisone,EFO_0001378,multiple myeloma,4.3054262486977555,1.0,0.0,0.7408,0.1792,1.1792,3.761,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.461151,0.643441,0.18229,MEDIUM,8
prednisone,EFO_0004274,gout,5.074157787139434,1.0,0.0,0.7408,0.0,1.0,3.759,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.596051,0.686054,0.090003,HIGH,8
prednisone,EFO_1000941,frozen shoulder,4.991449104283251,1.0,0.0,0.7408,0.0,1.0,3.6978,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.615455,0.636646,0.021192,HIGH,8
prednisone,MONDO_0019338,sarcoidosis,4.989553233941294,1.0,0.0,0.7408,0.0,1.0,3.6964,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.615221,0.636404,0.021183,HIGH,8
prednisone,EFO_0005854,allergic rhinitis,4.979215560250098,1.0,0.0,0.7408,0.0,1.0,3.6887,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.609804,0.635,0.025196,HIGH,8
prednisone,EFO_0003060,non-small cell lung carcinoma,4.222581376874784,1.0,0.0,0.7408,0.1792,1.1792,3.6887,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.425893,0.66989,0.243997,MEDIUM,8
prednisone,EFO_1001494,psoriasis vulgaris,4.950106015937351,1.0,0.0,0.7408,0.0,1.0,3.6671,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.60335,0.635383,0.032033,HIGH,8
prednisone,EFO_0000701,skin disease,4.924053145670712,1.0,0.0,0.7408,0.0,1.0,3.6478,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.607144,0.62805,0.020905,HIGH,8
prednisone,EFO_0002609,juvenile idiopathic arthritis,4.919896665028634,1.0,0.0,0.7408,0.0,1.0,3.6447,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.606632,0.62752,0.020888,HIGH,8
prednisone,EFO_0007141,allergic conjunctivitis,4.880997642450778,1.0,0.0,0.7408,0.0,1.0,3.6159,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.603026,0.624323,0.021297,HIGH,8
prednisone,EFO_0003106,pneumonia,4.8702847697414855,1.0,0.0,0.7408,0.0,1.0,3.608,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.608786,0.608786,0.0,HIGH,8
prednisone,EFO_0003956,seasonal allergic rhinitis,4.8661001427113515,1.0,0.0,0.7408,0.0,1.0,3.6049,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.604102,0.616583,0.01248,HIGH,8
prednisone,EFO_1001417,"Rhinitis, Allergic, Perennial",4.833039434006054,1.0,0.0,0.7408,0.0,1.0,3.5804,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.599998,0.612394,0.012396,HIGH,8
prednisone,EFO_1001194,subacute thyroiditis,4.825946468499257,1.0,0.0,0.7408,0.0,1.0,3.5751,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.603243,0.603243,0.0,HIGH,8
prednisone,EFO_0003778,psoriatic arthritis,4.796980216320147,1.0,0.0,0.7408,0.0,1.0,3.5537,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.599623,0.599623,0.0,HIGH,8
prednisone,EFO_1001435,tenosynovitis,4.7898001465315225,1.0,0.0,0.7408,0.0,1.0,3.5484,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.598725,0.598725,0.0,HIGH,8
prednisone,EFO_1001119,posterior uveitis,4.784285223251841,1.0,0.0,0.7408,0.0,1.0,3.5443,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.589911,0.610223,0.020312,HIGH,8
prednisone,MONDO_0018479,congenital adrenal hyperplasia,4.764627557416927,1.0,0.0,0.7408,0.0,1.0,3.5297,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.583523,0.607634,0.02411,HIGH,8
prednisone,HP_0001742,Nasal congestion,4.734874473459477,1.0,0.0,0.7408,0.0,1.0,3.5077,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.591859,0.591859,0.0,HIGH,8
prednisone,EFO_0005752,eye inflammation,4.7266443810472625,1.0,0.0,0.7408,0.0,1.0,3.5016,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.590831,0.590831,0.0,HIGH,8
prednisone,EFO_1001231,uveitis,4.715681013773472,1.0,0.0,0.7408,0.0,1.0,3.4935,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.582601,0.603177,0.020576,HIGH,8
prednisone,EFO_1000764,seborrheic dermatitis,4.710049725798246,1.0,0.0,0.7408,0.0,1.0,3.4893,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.584729,0.59681,0.01208,HIGH,8
prednisone,EFO_1000906,dry eye syndrome,4.7029990638561685,1.0,0.0,0.7408,0.0,1.0,3.4841,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Hemolytic; Arthritis; Arthritis, Gouty; Arthritis, Juvenile",,,0.578866,0.605892,0.027026,HIGH,8
pregabalin,MONDO_0014917,"developmental and epileptic encephalopathy, 42",14.230118422001803,0.9601,0.0,0.7497,0.2398,1.2398,13.227,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.41908,1.430876,0.011797,HIGH,10
pregabalin,Orphanet_97,Familial paroxysmal ataxia,13.927430514561255,0.9601,0.0,0.7497,0.2398,1.2398,12.9456,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.392743,1.392743,0.0,HIGH,10
pregabalin,MONDO_0010979,Timothy syndrome,13.920745479517748,0.9601,0.0,0.7497,0.2398,1.2398,12.9394,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.392075,1.392075,0.0,HIGH,10
pregabalin,EFO_0000537,hypertension,14.59137072854839,0.9601,0.0,0.7497,0.1609,1.1609,12.7002,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.43713,1.500308,0.063177,HIGH,10
pregabalin,EFO_0000275,atrial fibrillation,13.490562009127204,0.9601,0.0,0.7497,0.2398,1.2398,12.5396,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.321011,1.402601,0.08159,HIGH,10
pregabalin,MONDO_0100062,genetic developmental and epileptic encephalopathy,13.43351159075376,0.9601,0.0,0.7497,0.2398,1.2398,12.4865,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.341272,1.34751,0.006239,HIGH,10
pregabalin,EFO_0000400,diabetes mellitus,13.551676660164834,0.9601,0.0,0.7497,0.2197,1.2197,12.3925,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,True,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.311693,1.432897,0.121204,MEDIUM,10
pregabalin,MONDO_0007163,episodic ataxia type 2,13.172674059977158,0.9601,0.0,0.7497,0.2398,1.2398,12.2441,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.317267,1.317267,0.0,HIGH,10
pregabalin,MONDO_0020756,"migraine, familial hemiplegic, 1",13.099016060132945,0.9601,0.0,0.7497,0.2398,1.2398,12.1756,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.309902,1.309902,0.0,HIGH,10
pregabalin,MONDO_0010241,congenital stationary night blindness 2A,12.823162524001887,0.9601,0.0,0.7497,0.2197,1.2197,11.7263,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.282316,1.282316,0.0,HIGH,10
pregabalin,MONDO_0042979,"hypokalemic periodic paralysis, type 1",12.583831009338398,0.9601,0.0,0.7497,0.2398,1.2398,11.6968,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.251488,1.272172,0.020684,HIGH,10
pregabalin,MONDO_0013960,sinoatrial node dysfunction and deafness,12.90406885393879,0.9601,0.0,0.7497,0.2079,1.2079,11.6863,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.290407,1.290407,0.0,HIGH,10
pregabalin,MONDO_0008457,spinocerebellar ataxia type 6,12.493213730799672,0.9601,0.0,0.7497,0.2398,1.2398,11.6125,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.249321,1.249321,0.0,HIGH,10
pregabalin,EFO_0009059,Spinocerebellar ataxia type 42,12.37540150094074,0.9601,0.0,0.7497,0.2398,1.2398,11.503,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.23754,1.23754,0.0,HIGH,10
pregabalin,MONDO_0013464,episodic ataxia type 5,12.35539618259297,0.9601,0.0,0.7497,0.2398,1.2398,11.4844,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.232824,1.240971,0.008148,HIGH,10
pregabalin,EFO_0000319,cardiovascular disease,15.040812576987223,0.9601,0.0,0.7497,0.0,1.0,11.2765,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.492908,1.525884,0.032977,HIGH,10
pregabalin,MONDO_0859514,congenital myopathy 18,12.127841546608158,0.9601,0.0,0.7497,0.2398,1.2398,11.2729,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.212784,1.212784,0.0,HIGH,10
pregabalin,EFO_0001645,coronary artery disease,12.164966073843704,0.9601,0.0,0.7497,0.2303,1.2303,11.2205,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.18266,1.281234,0.098574,HIGH,10
pregabalin,MONDO_0014200,aldosterone-producing adenoma with seizures and neurological abnormalities,12.049779722981365,0.9601,0.0,0.7497,0.2398,1.2398,11.2003,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.204978,1.204978,0.0,HIGH,10
pregabalin,Orphanet_1872,Cone rod dystrophy,11.969059125232071,0.9601,0.0,0.7497,0.2398,1.2398,11.1253,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.175575,1.239569,0.063994,HIGH,10
pregabalin,MONDO_0012742,Brugada syndrome 3,12.135806199592674,0.9601,0.0,0.7497,0.2079,1.2079,10.9906,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.213581,1.213581,0.0,HIGH,10
pregabalin,MONDO_0859286,"neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures",11.734855711915673,0.9601,0.0,0.7497,0.2398,1.2398,10.9076,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.173486,1.173486,0.0,HIGH,10
pregabalin,MONDO_0010371,Aland island eye disease,11.797338000505183,0.9601,0.0,0.7497,0.2303,1.2303,10.8814,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.179734,1.179734,0.0,HIGH,10
pregabalin,MONDO_0060551,"cerebellar atrophy, developmental delay, and seizures",11.758156821019693,0.9601,0.0,0.7497,0.2303,1.2303,10.8453,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.169373,1.1887,0.019327,HIGH,10
pregabalin,MONDO_0060758,"spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits",11.64892685839759,0.9601,0.0,0.7497,0.2398,1.2398,10.8278,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.164893,1.164893,0.0,HIGH,10
pregabalin,EFO_0010276,neurodevelopmental disorder with seizures and non-epileptic hyperkinetic movements,11.378964327659697,0.9601,0.0,0.7497,0.2398,1.2398,10.5768,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.137896,1.137896,0.0,HIGH,10
pregabalin,HP_0001250,Seizure,13.86307241947452,0.9601,0.0,0.7497,0.0,1.0,10.3936,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,True,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.383176,1.39257,0.009394,HIGH,10
pregabalin,EFO_0005138,acquired long QT syndrome,13.555769053233355,0.9601,0.0,0.7497,0.0,1.0,10.1632,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.355577,1.355577,0.0,HIGH,10
pregabalin,MONDO_0005090,schizophrenia,10.798914951854856,0.9601,0.0,0.7497,0.2398,1.2398,10.0377,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,True,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.068473,1.101429,0.032956,HIGH,10
pregabalin,Orphanet_178333,land Islands eye disease,10.83059346465463,0.9601,0.0,0.7497,0.2303,1.2303,9.9897,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.077125,1.094927,0.017802,HIGH,10
pregabalin,MONDO_0010335,X-linked cone-rod dystrophy 3,10.72195607953484,0.9601,0.0,0.7497,0.2398,1.2398,9.9661,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.066321,1.083945,0.017624,HIGH,10
pregabalin,EFO_0000474,epilepsy,13.184299688547425,0.9601,0.0,0.7497,0.0,1.0,9.8847,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,True,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.307683,1.338788,0.031105,HIGH,10
pregabalin,MONDO_0015263,Brugada syndrome,10.41117504125509,0.9601,0.0,0.7497,0.2398,1.2398,9.6773,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.996969,1.129414,0.132445,MEDIUM,10
pregabalin,EFO_0000712,stroke,11.083345972002162,0.9601,0.0,0.7497,0.1386,1.1386,9.4615,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.070658,1.18065,0.109991,MEDIUM,10
pregabalin,MONDO_0012507,retinal cone dystrophy 4,10.28628656745096,0.9601,0.0,0.7497,0.2197,1.2197,9.4064,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.024832,1.036222,0.01139,HIGH,10
pregabalin,EFO_0003144,heart failure,12.416616758280588,0.9601,0.0,0.7497,0.0,1.0,9.3091,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.226403,1.269127,0.042724,HIGH,10
pregabalin,MONDO_0032756,long QT syndrome 8,9.963264336487912,0.9601,0.0,0.7497,0.2398,1.2398,9.2609,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.996326,0.996326,0.0,HIGH,10
pregabalin,MONDO_0859313,neurodevelopmental disorder with speech impairment and with or without seizures,9.955791449638454,0.9601,0.0,0.7497,0.2398,1.2398,9.254,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.995579,0.995579,0.0,HIGH,10
pregabalin,HP_0000556,Retinal dystrophy,9.828947489688758,0.9601,0.0,0.7497,0.2398,1.2398,9.1361,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.967844,1.012995,0.045151,HIGH,10
pregabalin,MONDO_0033361,"developmental and epileptic encephalopathy, 52",9.816988474389984,0.9601,0.0,0.7497,0.2398,1.2398,9.125,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.981699,0.981699,0.0,HIGH,10
pregabalin,HP_0001249,Intellectual disability,9.34888808385626,0.9601,0.0,0.7497,0.2398,1.2398,8.6899,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.932371,0.939925,0.007554,HIGH,10
pregabalin,EFO_0000538,hypertrophic cardiomyopathy,9.32042353810469,0.9601,0.0,0.7497,0.2398,1.2398,8.6634,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.928072,0.939359,0.011287,HIGH,10
pregabalin,MONDO_0016293,congenital stationary night blindness,11.52864299588503,0.9601,0.0,0.7497,0.0,1.0,8.6434,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.142438,1.173717,0.031279,HIGH,10
pregabalin,EFO_0003913,angina pectoris,11.47803043523616,0.9601,0.0,0.7497,0.0,1.0,8.6054,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.103584,1.232594,0.12901,MEDIUM,10
pregabalin,MONDO_0005148,type 2 diabetes mellitus,9.666053746438733,0.9601,0.0,0.7497,0.1792,1.1792,8.5454,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.869277,1.151717,0.282441,LOW,10
pregabalin,EFO_0004269,cardiac arrhythmia,11.352431429391295,0.9601,0.0,0.7497,0.0,1.0,8.5112,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.090539,1.223003,0.132464,MEDIUM,10
pregabalin,MONDO_0016525,familial hyperaldosteronism,9.372644181803128,0.9601,0.0,0.7497,0.2079,1.2079,8.4882,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,0.937264,0.937264,0.0,HIGH,10
pregabalin,MONDO_0001134,essential hypertension,11.31312377216832,0.9601,0.0,0.7497,0.0,1.0,8.4818,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.12228,1.149377,0.027097,HIGH,10
pregabalin,EFO_0000612,myocardial infarction,11.303373812902514,0.9601,0.0,0.7497,0.0,1.0,8.4745,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,False,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.118076,1.151658,0.033582,HIGH,10
pregabalin,EFO_0005762,neuropathic pain,11.273038144423364,0.9601,0.0,0.7497,0.0,1.0,8.4517,1,TERMINATED,STOPPED,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,low inclusion rate,True,Alcoholism; Anxiety; Anxiety Disorders; Breast Neoplasms; Burning Mouth Syndrome,,,1.122289,1.135388,0.013099,HIGH,10
ranolazine,EFO_0000275,atrial fibrillation,4.651673339689716,0.6784,0.0,0.8158,0.2398,1.2398,4.7051,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.899756,1.42608,0.526324,LOW,4
ranolazine,MONDO_0011001,Brugada syndrome 1,4.6589333260179835,0.6784,0.0,0.8158,0.2303,1.2303,4.6762,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.901161,1.428306,0.527145,LOW,4
ranolazine,MONDO_0011377,long QT syndrome 3,4.388628180372573,0.6784,0.0,0.8158,0.2398,1.2398,4.439,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.848877,1.345438,0.496561,LOW,4
ranolazine,MONDO_0015263,Brugada syndrome,4.387318930168344,0.6784,0.0,0.8158,0.2398,1.2398,4.4377,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.848623,1.345036,0.496413,LOW,4
ranolazine,MONDO_0008195,paramyotonia congenita of Von Eulenburg,4.36740117513351,0.6784,0.0,0.8158,0.2398,1.2398,4.4175,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.844771,1.33893,0.494159,LOW,4
ranolazine,Orphanet_871,Familial progressive cardiac conduction defect,4.2794011742458125,0.6784,0.0,0.8158,0.2398,1.2398,4.3285,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.827749,1.311951,0.484202,LOW,4
ranolazine,MONDO_0007240,"progressive familial heart block, type 1A",4.276407385028826,0.6784,0.0,0.8158,0.2398,1.2398,4.3255,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.82717,1.311034,0.483863,LOW,4
ranolazine,MONDO_0008224,hyperkalemic periodic paralysis,4.324333347273584,0.6784,0.0,0.8158,0.2079,1.2079,4.2616,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.83644,1.325726,0.489286,LOW,4
ranolazine,MONDO_0018959,potassium-aggravated myotonia,4.1866895178572845,0.6784,0.0,0.8158,0.2398,1.2398,4.2347,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.809816,1.283528,0.473712,LOW,4
ranolazine,MONDO_0011003,dilated cardiomyopathy 1E,4.178719012333092,0.6784,0.0,0.8158,0.2398,1.2398,4.2267,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.808275,1.281085,0.47281,LOW,4
ranolazine,MONDO_0013530,"atrial fibrillation, familial, 10",4.145583533757567,0.6784,0.0,0.8158,0.2398,1.2398,4.1932,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.801865,1.270926,0.469061,LOW,4
ranolazine,MONDO_0024562,sick sinus syndrome 1,4.135990513270874,0.6784,0.0,0.8158,0.2398,1.2398,4.1835,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.80001,1.267985,0.467976,LOW,4
ranolazine,EFO_0004138,bundle branch block,4.029504242102426,0.6784,0.0,0.8158,0.2398,1.2398,4.0757,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.779413,1.23534,0.455927,LOW,4
ranolazine,Orphanet_101016,Romano-Ward syndrome,3.9389122726487926,0.6784,0.0,0.8158,0.2398,1.2398,3.9841,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.76189,1.207567,0.445677,LOW,4
ranolazine,Orphanet_590,Congenital myasthenic syndromes,3.932336320473132,0.6784,0.0,0.8158,0.2398,1.2398,3.9775,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.760618,1.20555,0.444933,LOW,4
ranolazine,EFO_0005303,sudden infant death syndrome,4.124794423198214,0.6784,0.0,0.8158,0.1792,1.1792,3.9682,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.797844,1.264553,0.466709,LOW,4
ranolazine,MONDO_0957265,"congenital myopathy 22B, severe fetal",3.8164079042353336,0.6784,0.0,0.8158,0.2398,1.2398,3.8602,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.738194,1.17001,0.431816,LOW,4
ranolazine,EFO_0004269,cardiac arrhythmia,4.652830275029573,0.6784,0.0,0.8158,0.0,1.0,3.796,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.89998,1.426435,0.526455,LOW,4
ranolazine,MONDO_0011376,"ventricular fibrillation, paroxysmal familial, type 1",4.042329456289963,0.6784,0.0,0.8158,0.1386,1.1386,3.7551,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.781893,1.239271,0.457378,LOW,4
ranolazine,EFO_0000407,dilated cardiomyopathy,3.635416842068156,0.6784,0.0,0.8158,0.2398,1.2398,3.6771,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.703186,1.114523,0.411337,LOW,4
ranolazine,MONDO_0005277,migraine disorder,3.698645857299927,0.6784,0.0,0.8158,0.2079,1.2079,3.645,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.715416,1.133907,0.418491,LOW,4
ranolazine,MONDO_0042979,"hypokalemic periodic paralysis, type 1",3.5919988390120254,0.6784,0.0,0.8158,0.2398,1.2398,3.6332,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.637852,1.198602,0.56075,LOW,4
ranolazine,MONDO_0013620,congenital myasthenic syndrome 16,3.5709945605709237,0.6784,0.0,0.8158,0.2398,1.2398,3.612,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.690725,1.094773,0.404048,LOW,4
ranolazine,HP_0001250,Seizure,4.195067397154598,0.6784,0.0,0.8158,0.0,1.0,3.4225,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.811437,1.286097,0.47466,LOW,4
ranolazine,MONDO_0004976,amyotrophic lateral sclerosis,3.329897302780791,0.6784,0.0,0.8158,0.2398,1.2398,3.3681,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.64409,1.020859,0.376769,LOW,4
ranolazine,MONDO_0005178,osteoarthritis,3.3550097113216055,0.6784,0.0,0.8158,0.2303,1.2303,3.3674,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.648947,1.028557,0.37961,LOW,4
ranolazine,MONDO_0957247,"congenital myopathy 22A, classic",3.3289857848600892,0.6784,0.0,0.8158,0.2398,1.2398,3.3672,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.643914,1.020579,0.376665,LOW,4
ranolazine,Orphanet_98913,Postsynaptic congenital myasthenic syndromes,3.322553098378698,0.6784,0.0,0.8158,0.2398,1.2398,3.3607,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.642669,1.018607,0.375938,LOW,4
ranolazine,MONDO_0008223,hypokalemic periodic paralysis,4.102973912971556,0.6784,0.0,0.8158,0.0,1.0,3.3474,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.793623,1.257863,0.46424,LOW,4
ranolazine,MONDO_0016532,Lennox-Gastaut syndrome,3.2702807180823017,0.6784,0.0,0.8158,0.2398,1.2398,3.3078,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.632559,1.002582,0.370023,LOW,4
ranolazine,HP_0012531,Pain,3.980105327970079,0.6784,0.0,0.8158,0.0,1.0,3.2471,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.769857,1.220195,0.450338,LOW,4
ranolazine,MONDO_0013234,"hypokalemic periodic paralysis, type 2",3.2158988681792633,0.6784,0.0,0.8158,0.2303,1.2303,3.2278,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.62204,0.98591,0.36387,LOW,4
ranolazine,Orphanet_228140,"Idiopathic ventricular fibrillation, not Brugada type",3.3066836624279814,0.6784,0.0,0.8158,0.1946,1.1946,3.2227,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.6396,1.013742,0.374142,LOW,4
ranolazine,EFO_0000319,cardiovascular disease,3.8374519884344904,0.6784,0.0,0.8158,0.0,1.0,3.1308,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.639232,1.339764,0.700532,LOW,4
ranolazine,EFO_0000474,epilepsy,3.8294530342350246,0.6784,0.0,0.8158,0.0,1.0,3.1242,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.740717,1.196544,0.455827,LOW,4
ranolazine,EFO_0000537,hypertension,3.2905241369614644,0.6784,0.0,0.8158,0.1609,1.1609,3.1166,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.451936,1.236078,0.784142,LOW,4
ranolazine,EFO_0000400,diabetes mellitus,3.0863500263459263,0.6784,0.0,0.8158,0.2197,1.2197,3.0712,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.458636,1.138079,0.679442,LOW,4
ranolazine,HP_0001657,Prolonged QT interval,3.748223372213716,0.6784,0.0,0.8158,0.0,1.0,3.058,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.725005,1.149106,0.424101,LOW,4
ranolazine,MONDO_0004985,bipolar disorder,3.727291863426278,0.6784,0.0,0.8158,0.0,1.0,3.0409,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.720957,1.150168,0.429212,LOW,4
ranolazine,Orphanet_1344,Atrial stand still,2.960218457091266,0.6784,0.0,0.8158,0.2398,1.2398,2.9942,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.572584,0.907525,0.33494,LOW,4
ranolazine,MONDO_0019171,familial long QT syndrome,3.644673051383392,0.6784,0.0,0.8158,0.0,1.0,2.9735,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.704976,1.117361,0.412385,LOW,4
ranolazine,EFO_1001219,trigeminal neuralgia,3.235435713861071,0.6784,0.0,0.8158,0.1099,1.1099,2.9296,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.625819,0.991899,0.36608,LOW,4
ranolazine,MONDO_0005090,schizophrenia,2.863067053020501,0.6784,0.0,0.8158,0.2398,1.2398,2.8959,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.489418,0.979773,0.490355,LOW,4
ranolazine,EFO_0004263,partial epilepsy,3.528129936885023,0.6784,0.0,0.8158,0.0,1.0,2.8784,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.682433,1.081631,0.399198,LOW,4
ranolazine,EFO_0003913,angina pectoris,3.4400614818465667,0.6784,0.0,0.8158,0.0,1.0,2.8066,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,True,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.665399,1.054632,0.389233,LOW,4
ranolazine,HP_0007359,Focal-onset seizure,3.409674602930993,0.6784,0.0,0.8158,0.0,1.0,2.7818,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.659521,1.045316,0.385795,LOW,4
ranolazine,EFO_0009552,hemorrhoid,3.392347026341813,0.6784,0.0,0.8158,0.0,1.0,2.7676,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.656169,1.040004,0.383835,LOW,4
ranolazine,HP_0000989,Pruritus,3.383641123024894,0.6784,0.0,0.8158,0.0,1.0,2.7605,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.654486,1.037335,0.382849,LOW,4
ranolazine,EFO_0005762,neuropathic pain,3.382606246744884,0.6784,0.0,0.8158,0.0,1.0,2.7597,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.654285,1.048465,0.394179,LOW,4
ranolazine,HP_0004308,Ventricular arrhythmia,3.339294839922208,0.6784,0.0,0.8158,0.0,1.0,2.7243,2,"TERMINATED,WITHDRAWN",STOPPED,Peripheral Arterial Disease,Insufficient enrollment,False,"Acute Coronary Syndrome; Amyotrophic Lateral Sclerosis; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Dilated",,,0.645908,1.02374,0.377832,LOW,4
remodulin (treprostinil sodium),EFO_0001361,pulmonary arterial hypertension,3.2286338772621814,0.0,0.0,1.0,0.0,1.0,3.2286,,,,,,True,"Hypertension, Pulmonary",,,0.967343,1.240656,0.273313,LOW,3
remodulin (treprostinil sodium),MONDO_0005149,pulmonary hypertension,3.010144488084168,0.0,0.0,1.0,0.0,1.0,3.0101,,,,,,True,"Hypertension, Pulmonary",,,0.939389,1.131366,0.191977,MEDIUM,3
remodulin (treprostinil sodium),HP_0004419,Recurrent thrombophlebitis,2.801507765290995,0.0,0.0,1.0,0.0,1.0,2.8015,,,,,,False,"Hypertension, Pulmonary",,,0.837977,1.125553,0.287576,LOW,3
remodulin (treprostinil sodium),EFO_0005772,neurodegenerative disease,2.4919144810506837,0.0,0.0,1.0,0.0,1.0,2.4919,,,,,,False,"Hypertension, Pulmonary",,,0.749852,0.99221,0.242358,MEDIUM,3
remodulin (treprostinil sodium),EFO_0000729,ulcerative colitis,1.8201671846555445,0.0,0.0,1.0,0.2398,1.2398,2.2566,,,,,,False,"Hypertension, Pulmonary",,,0.501646,0.789238,0.287591,LOW,3
remodulin (treprostinil sodium),EFO_0000537,hypertension,1.9315509169333824,0.0,0.0,1.0,0.1609,1.1609,2.2424,,,,,,False,"Hypertension, Pulmonary",,,0.35239,1.579161,1.226772,LOW,2
remodulin (treprostinil sodium),EFO_0000768,idiopathic pulmonary fibrosis,1.6220308447970804,0.0,0.0,1.0,0.2398,1.2398,2.011,,,,,,False,"Hypertension, Pulmonary",,,0.51505,0.591932,0.076882,HIGH,3
remodulin (treprostinil sodium),HP_0012531,Pain,1.9386928905329168,0.0,0.0,1.0,0.0,1.0,1.9387,,,,,,False,"Hypertension, Pulmonary",,,0.41204,1.114614,0.702574,LOW,3
remodulin (treprostinil sodium),EFO_0006834,septic shock,1.9227523986489163,0.0,0.0,1.0,0.0,1.0,1.9228,,,,,,False,"Hypertension, Pulmonary",,,0.454552,1.013649,0.559098,LOW,3
remodulin (treprostinil sodium),MONDO_0017147,idiopathic pulmonary arterial hypertension,1.8842295324294656,0.0,0.0,1.0,0.0,1.0,1.8842,,,,,,False,"Hypertension, Pulmonary",,,0.592601,0.66638,0.073778,HIGH,3
remodulin (treprostinil sodium),MONDO_0019200,retinitis pigmentosa,1.556369626340392,0.0,0.0,1.0,0.2079,1.2079,1.88,,,,,,False,"Hypertension, Pulmonary",,,1.556369626340391,1.556369626340391,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0001645,coronary artery disease,1.4430304047823457,0.0,0.0,1.0,0.2303,1.2303,1.7753,,,,,,False,"Hypertension, Pulmonary",,,1.443030404782345,1.443030404782345,0.0,HIGH,1
remodulin (treprostinil sodium),MONDO_0004979,asthma,1.4738219567532151,0.0,0.0,1.0,0.1792,1.1792,1.7379,,,,,,False,"Hypertension, Pulmonary",,,0.032541,1.293858,1.261317,LOW,3
remodulin (treprostinil sodium),MONDO_0005148,type 2 diabetes mellitus,1.462649948878573,0.0,0.0,1.0,0.1792,1.1792,1.7247,,,,,,False,"Hypertension, Pulmonary",,,0.011773,0.994583,0.982811,LOW,3
remodulin (treprostinil sodium),EFO_1001145,Raynaud disease,1.475032551447764,0.0,0.0,1.0,0.1386,1.1386,1.6795,,,,,,False,"Hypertension, Pulmonary",,,0.419986,0.63506,0.215074,MEDIUM,3
remodulin (treprostinil sodium),EFO_0000341,chronic obstructive pulmonary disease,1.5656240651649669,0.0,0.0,1.0,0.0693,1.0693,1.6741,,,,,,False,"Hypertension, Pulmonary",,,0.149515,1.258358,1.108843,LOW,3
remodulin (treprostinil sodium),Orphanet_1872,Cone rod dystrophy,1.3336572725604836,0.0,0.0,1.0,0.2398,1.2398,1.6535,,,,,,False,"Hypertension, Pulmonary",,,1.333657272560483,1.333657272560483,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0000319,cardiovascular disease,1.6081430524082758,0.0,0.0,1.0,0.0,1.0,1.6081,,,,,,False,"Hypertension, Pulmonary",,,0.029822,1.546856,1.517034,LOW,3
remodulin (treprostinil sodium),EFO_0000712,stroke,1.4044387300363554,0.0,0.0,1.0,0.1386,1.1386,1.5991,,,,,,False,"Hypertension, Pulmonary",,,0.007946,1.388546,1.380599,LOW,3
remodulin (treprostinil sodium),MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.0,0.0,1.0,0.2398,1.2398,1.5899,,,,,,False,"Hypertension, Pulmonary",,,1.2823759951301381,1.2823759951301381,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0004244,interstitial lung disease,1.270304327729045,0.0,0.0,1.0,0.2398,1.2398,1.5749,,,,,,False,"Hypertension, Pulmonary",,,0.412628,0.445048,0.03242,HIGH,3
remodulin (treprostinil sodium),MONDO_0005277,migraine disorder,1.2923360336452232,0.0,0.0,1.0,0.2079,1.2079,1.5611,,,,,,False,"Hypertension, Pulmonary",,,0.069008,1.154319,1.085311,LOW,3
remodulin (treprostinil sodium),EFO_0000676,psoriasis,1.25041471135101,0.0,0.0,1.0,0.2398,1.2398,1.5503,,,,,,False,"Hypertension, Pulmonary",,,0.005886,1.238642,1.232756,LOW,3
remodulin (treprostinil sodium),MONDO_0001999,primary pulmonary hypertension,1.5469143886483754,0.0,0.0,1.0,0.0,1.0,1.5469,,,,,,False,"Hypertension, Pulmonary",,,0.515638,0.515638,0.0,HIGH,3
remodulin (treprostinil sodium),MONDO_0012833,Crouzon syndrome-acanthosis nigricans syndrome,1.236118803714455,0.0,0.0,1.0,0.2398,1.2398,1.5325,,,,,,False,"Hypertension, Pulmonary",,,0.41204,0.41204,0.0,HIGH,3
remodulin (treprostinil sodium),MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,0.0,0.0,1.0,0.2398,1.2398,1.5014,,,,,,False,"Hypertension, Pulmonary",,,1.2110423777158301,1.2110423777158301,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0009658,adverse effect,1.4747478819106987,0.0,0.0,1.0,0.0,1.0,1.4747,,,,,,False,"Hypertension, Pulmonary",,,0.468282,0.538183,0.069901,HIGH,3
remodulin (treprostinil sodium),EFO_0000274,atopic eczema,1.164814456052245,0.0,0.0,1.0,0.2398,1.2398,1.4441,,,,,,False,"Hypertension, Pulmonary",,,0.011773,1.13859,1.126818,LOW,3
remodulin (treprostinil sodium),Orphanet_1276,Brachydactyly - arterial hypertension,1.1895599638523269,0.0,0.0,1.0,0.2079,1.2079,1.4369,,,,,,False,"Hypertension, Pulmonary",,,1.189559963852326,1.189559963852326,0.0,HIGH,1
remodulin (treprostinil sodium),MONDO_0018852,achromatopsia,1.4306619453288874,0.0,0.0,1.0,0.0,1.0,1.4307,,,,,,False,"Hypertension, Pulmonary",,,1.4306619453288871,1.4306619453288871,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_1001459,diabetic foot,1.407717320199678,0.0,0.0,1.0,0.0,1.0,1.4077,,,,,,False,"Hypertension, Pulmonary",,,0.426755,0.554207,0.127451,MEDIUM,3
remodulin (treprostinil sodium),MONDO_0013437,retinitis pigmentosa 43,1.1227328916707495,0.0,0.0,1.0,0.2398,1.2398,1.392,,,,,,False,"Hypertension, Pulmonary",,,1.122732891670749,1.122732891670749,0.0,HIGH,1
remodulin (treprostinil sodium),MONDO_0100130,adult acute respiratory distress syndrome,1.3903121526832112,0.0,0.0,1.0,0.0,1.0,1.3903,,,,,,False,"Hypertension, Pulmonary",,,0.441471,0.50737,0.065899,HIGH,3
remodulin (treprostinil sodium),Orphanet_79211,Combined hyperlipidemia,1.12166335892608,0.0,0.0,1.0,0.2303,1.2303,1.3799,,,,,,False,"Hypertension, Pulmonary",,,0.560832,0.560832,0.0,HIGH,2
remodulin (treprostinil sodium),EFO_0000556,ischemia,1.370546723618402,0.0,0.0,1.0,0.0,1.0,1.3705,,,,,,False,"Hypertension, Pulmonary",,,0.456849,0.456849,0.0,HIGH,3
remodulin (treprostinil sodium),MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,1.0893989193580678,0.0,0.0,1.0,0.2398,1.2398,1.3506,,,,,,False,"Hypertension, Pulmonary",,,1.089398919358067,1.089398919358067,0.0,HIGH,1
remodulin (treprostinil sodium),MONDO_0014835,"striatal degeneration, autosomal dominant 2",1.1151901705079166,0.0,0.0,1.0,0.2079,1.2079,1.3471,,,,,,False,"Hypertension, Pulmonary",,,1.115190170507916,1.115190170507916,0.0,HIGH,1
remodulin (treprostinil sodium),MONDO_0007211,brachydactyly-arterial hypertension syndrome,1.1120001898216738,0.0,0.0,1.0,0.2079,1.2079,1.3432,,,,,,False,"Hypertension, Pulmonary",,,1.112000189821673,1.112000189821673,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0000275,atrial fibrillation,1.0791370181996875,0.0,0.0,1.0,0.2398,1.2398,1.3379,,,,,,False,"Hypertension, Pulmonary",,,0.027175,1.024787,0.997612,LOW,3
remodulin (treprostinil sodium),HP_0000556,Retinal dystrophy,1.073875011489864,0.0,0.0,1.0,0.2398,1.2398,1.3314,,,,,,False,"Hypertension, Pulmonary",,,1.073875011489864,1.073875011489864,0.0,HIGH,1
remodulin (treprostinil sodium),Orphanet_2754,Joubert syndrome with orofaciodigital defect,1.0707563865225374,0.0,0.0,1.0,0.2398,1.2398,1.3275,,,,,,False,"Hypertension, Pulmonary",,,1.070756386522537,1.070756386522537,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0000612,myocardial infarction,1.3184803704918246,0.0,0.0,1.0,0.0,1.0,1.3185,,,,,,False,"Hypertension, Pulmonary",,,0.061512,1.192068,1.130557,LOW,3
remodulin (treprostinil sodium),EFO_0004190,open-angle glaucoma,1.084330600044849,0.0,0.0,1.0,0.2079,1.2079,1.3098,,,,,,False,"Hypertension, Pulmonary",,,1.084330600044849,1.084330600044849,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0003913,angina pectoris,1.2926834317608282,0.0,0.0,1.0,0.0,1.0,1.2927,,,,,,False,"Hypertension, Pulmonary",,,1.292683431760828,1.292683431760828,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0009448,pulmonary fibrosis,1.2892565607060134,0.0,0.0,1.0,0.0,1.0,1.2893,,,,,,False,"Hypertension, Pulmonary",,,0.412628,0.464,0.051372,HIGH,3
remodulin (treprostinil sodium),HP_0003124,Hypercholesterolemia,1.241698488801329,0.0,0.0,1.0,0.0,1.0,1.2417,,,,,,False,"Hypertension, Pulmonary",,,0.592928,0.64877,0.055842,HIGH,2
remodulin (treprostinil sodium),MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,0.984524524711656,0.0,0.0,1.0,0.2398,1.2398,1.2206,,,,,,False,"Hypertension, Pulmonary",,,0.9845245247116561,0.9845245247116561,0.0,HIGH,1
remodulin (treprostinil sodium),EFO_0000400,diabetes mellitus,0.9905120848932512,0.0,0.0,1.0,0.2197,1.2197,1.2081,,,,,,False,"Hypertension, Pulmonary",,,0.014977,0.960557,0.94558,LOW,3
remodulin (treprostinil sodium),MONDO_0004975,Alzheimer disease,0.9687049270113676,0.0,0.0,1.0,0.2398,1.2398,1.201,,,,,,False,"Hypertension, Pulmonary",,,0.04907,0.85174,0.80267,LOW,3
remodulin (treprostinil sodium),EFO_0000479,essential thrombocythemia,0.9617083811407224,0.0,0.0,1.0,0.2398,1.2398,1.1923,,,,,,False,"Hypertension, Pulmonary",,,0.9617083811407221,0.9617083811407221,0.0,HIGH,1
repatha,EFO_0004911,familial hypercholesterolemia,2.77804792833365,0.0,0.0,1.0,0.2303,1.2303,3.4177,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.678536,0.726464,0.047928,HIGH,4
repatha,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.6342867486984978,0.0,0.0,1.0,0.1946,1.1946,3.1469,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.649624,0.676466,0.026842,HIGH,4
repatha,EFO_0001645,coronary artery disease,2.44613693759838,0.0,0.0,1.0,0.2303,1.2303,3.0094,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.590022,0.63074,0.040718,HIGH,4
repatha,HP_0003124,Hypercholesterolemia,2.5837086872155477,0.0,0.0,1.0,0.0,1.0,2.5837,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.637152,0.663478,0.026326,HIGH,4
repatha,EFO_0000319,cardiovascular disease,2.415491241289434,0.0,0.0,1.0,0.0,1.0,2.4155,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.58263,0.622838,0.040207,HIGH,4
repatha,EFO_0000589,metabolic disease,2.3055488757387117,0.0,0.0,1.0,0.0,1.0,2.3055,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.568557,0.592049,0.023492,HIGH,4
repatha,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.0,0.0,1.0,0.0,1.0,2.2171,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.554263,0.554263,0.0,HIGH,4
repatha,EFO_0000612,myocardial infarction,2.1587039312067464,0.0,0.0,1.0,0.0,1.0,2.1587,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.520261,0.559091,0.03883,HIGH,4
repatha,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.0,0.0,1.0,0.2079,1.2079,2.1545,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.445905,0.445905,0.0,HIGH,4
repatha,MONDO_0018328,homozygous familial hypercholesterolemia,2.148464723176249,0.0,0.0,1.0,0.0,1.0,2.1485,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.524761,0.561827,0.037066,HIGH,4
repatha,MONDO_0021187,hyperlipidemia,2.1040568357817544,0.0,0.0,1.0,0.0,1.0,2.1041,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.526014,0.526014,0.0,HIGH,4
repatha,EFO_0003914,atherosclerosis,2.0172272109385148,0.0,0.0,1.0,0.0,1.0,2.0172,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.492706,0.527508,0.034802,HIGH,4
repatha,EFO_0000195,metabolic syndrome,1.5989738546727714,0.0,0.0,1.0,0.2398,1.2398,1.9824,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.389027,0.41046,0.021432,HIGH,4
repatha,EFO_1001375,Myocardial Ischemia,1.8354966537754889,0.0,0.0,1.0,0.0,1.0,1.8355,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.442366,0.475382,0.033016,HIGH,4
repatha,MONDO_0009387,familial lipoprotein lipase deficiency,1.4386859310417202,0.0,0.0,1.0,0.2398,1.2398,1.7837,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.351398,0.376219,0.024821,HIGH,4
repatha,EFO_0003777,heart disease,1.773792300626292,0.0,0.0,1.0,0.0,1.0,1.7738,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.410746,0.491881,0.081136,HIGH,4
repatha,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.0,0.0,1.0,0.0,1.0,1.7633,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.440834,0.440834,0.0,HIGH,4
repatha,EFO_0003913,angina pectoris,1.733713012728092,0.0,0.0,1.0,0.0,1.0,1.7337,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.421809,0.445047,0.023238,HIGH,4
repatha,EFO_0000712,stroke,1.5163324930556523,0.0,0.0,1.0,0.1386,1.1386,1.7265,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.300694,0.523436,0.222742,MEDIUM,4
repatha,HP_0003077,Hyperlipidemia,1.7264272674266656,0.0,0.0,1.0,0.0,1.0,1.7264,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.425743,0.443334,0.017591,HIGH,4
repatha,MONDO_0001336,familial hyperlipidemia,1.7148713527001924,0.0,0.0,1.0,0.0,1.0,1.7149,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.428718,0.428718,0.0,HIGH,4
repatha,EFO_0000400,diabetes mellitus,1.4041737247377832,0.0,0.0,1.0,0.2197,1.2197,1.7127,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.341633,0.360454,0.018821,HIGH,4
repatha,MONDO_0013144,hereditary antithrombin deficiency,1.390206303767071,0.0,0.0,1.0,0.2303,1.2303,1.7103,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.676469,0.713737,0.037268,HIGH,2
repatha,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.0,0.0,1.0,0.0,1.0,1.545,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.386247,0.386247,0.0,HIGH,4
repatha,HP_0003146,Hypocholesterolemia,1.519787603332834,0.0,0.0,1.0,0.0,1.0,1.5198,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.379947,0.379947,0.0,HIGH,4
repatha,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.0,0.0,1.0,0.0,1.0,1.4716,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.367893,0.367893,0.0,HIGH,4
repatha,EFO_0000275,atrial fibrillation,1.1767919069442716,0.0,0.0,1.0,0.2398,1.2398,1.459,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.072621,0.515775,0.443154,LOW,4
repatha,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.0,0.0,1.0,0.0,1.0,1.4289,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.357214,0.357214,0.0,HIGH,4
repatha,HP_0004936,Venous thrombosis,1.1306796423669063,0.0,0.0,1.0,0.2398,1.2398,1.4018,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.550185,0.580495,0.030311,HIGH,2
repatha,Orphanet_79211,Combined hyperlipidemia,1.1062756269960068,0.0,0.0,1.0,0.2303,1.2303,1.361,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.270207,0.289293,0.019086,HIGH,4
repatha,EFO_0005672,acute coronary syndrome,1.3444152821346198,0.0,0.0,1.0,0.0,1.0,1.3444,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280993,0.421709,0.140716,MEDIUM,4
repatha,HP_0001976,Reduced antithrombin III activity,1.2937212142508865,0.0,0.0,1.0,0.0,1.0,1.2937,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.62952,0.664201,0.034681,HIGH,2
repatha,EFO_1000985,intermediate coronary syndrome,1.2710260283837655,0.0,0.0,1.0,0.0,1.0,1.271,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.279558,0.359048,0.07949,HIGH,4
repatha,EFO_0004286,venous thromboembolism,1.2626208859932304,0.0,0.0,1.0,0.0,1.0,1.2626,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.046997,0.584314,0.537317,LOW,4
repatha,EFO_0008583,acute myocardial infarction,1.1953208910287108,0.0,0.0,1.0,0.0,1.0,1.1953,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.288221,0.308302,0.020082,HIGH,4
repatha,EFO_0003144,heart failure,1.1943910450436237,0.0,0.0,1.0,0.0,1.0,1.1944,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.298598,0.298598,0.0,HIGH,4
repatha,HP_0011428,Short fetal femur length,1.187066470233723,0.0,0.0,1.0,0.0,1.0,1.1871,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.296767,0.296767,0.0,HIGH,4
repatha,EFO_0004264,vascular disease,1.1630272440108385,0.0,0.0,1.0,0.0,1.0,1.163,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.290757,0.290757,0.0,HIGH,4
repatha,EFO_0004329,alcohol drinking,1.153512135309475,0.0,0.0,1.0,0.0,1.0,1.1535,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.296109,0.015461,HIGH,4
repatha,MONDO_0100096,COVID-19,1.1404696119601427,0.0,0.0,1.0,0.0,1.0,1.1405,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,True,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.231762,0.338472,0.10671,MEDIUM,4
repatha,EFO_0003776,coronary artery bypass,1.1279602973638454,0.0,0.0,1.0,0.0,1.0,1.128,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.28199,0.28199,0.0,HIGH,4
repatha,EFO_0003940,physical activity,1.1225894210654916,0.0,0.0,1.0,0.0,1.0,1.1226,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.280647,0.0,HIGH,4
repatha,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.0,0.0,1.0,0.0,1.0,1.1226,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.280647,0.280647,0.0,HIGH,4
repatha,EFO_0003907,deep vein thrombosis,1.0937238054191556,0.0,0.0,1.0,0.0,1.0,1.0937,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.522221,0.571503,0.049281,HIGH,2
repatha,EFO_0003086,kidney disease,1.0396200487798937,0.0,0.0,1.0,0.0,1.0,1.0396,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.25303,0.263343,0.010313,HIGH,4
repatha,EFO_0003827,pulmonary embolism,1.0315689372997063,0.0,0.0,1.0,0.0,1.0,1.0316,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.480032,0.551537,0.071504,HIGH,2
repatha,EFO_0003884,chronic kidney disease,1.018479956512245,0.0,0.0,1.0,0.0,1.0,1.0185,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.214524,0.294716,0.080193,HIGH,4
repatha,HP_0001907,Thromboembolism,0.9830566798637128,0.0,0.0,1.0,0.0,1.0,0.9831,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.436461,0.546596,0.110135,MEDIUM,2
repatha,HP_0003040,Arthropathy,0.9594178191147148,0.0,0.0,1.0,0.0,1.0,0.9594,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.239854,0.239854,0.0,HIGH,4
repatha,EFO_0009578,placental retention,0.9588206730453008,0.0,0.0,1.0,0.0,1.0,0.9588,1,TERMINATED,STOPPED,Ischemic Stroke,Funding Discontinued,False,"Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cardiovascular Diseases",,,0.239705,0.239705,0.0,HIGH,4
rimonabant,EFO_0001073,obesity,2.0028528271570245,0.0,0.0,1.0,0.1946,1.1946,2.3926,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.974581,1.028272,0.053691,HIGH,2
rimonabant,MONDO_0016532,Lennox-Gastaut syndrome,1.6900817993008064,0.0,0.0,1.0,0.2398,1.2398,2.0953,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.845041,0.845041,0.0,HIGH,2
rimonabant,MONDO_0004992,cancer,1.9080011564712211,0.0,0.0,1.0,0.0,1.0,1.908,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.778671,1.12933,0.35066,LOW,2
rimonabant,HP_0012531,Pain,1.743318750296837,0.0,0.0,1.0,0.0,1.0,1.7433,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.547598,1.195721,0.648123,LOW,2
rimonabant,EFO_0000474,epilepsy,1.692202673458652,0.0,0.0,1.0,0.0,1.0,1.6922,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.80805,0.884152,0.076102,HIGH,2
rimonabant,MONDO_0005148,type 2 diabetes mellitus,1.434376631594282,0.0,0.0,1.0,0.1792,1.1792,1.6914,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.638462,0.795914,0.157452,MEDIUM,2
rimonabant,Orphanet_51636,WHIM syndrome,1.2961786221008986,0.0,0.0,1.0,0.2398,1.2398,1.607,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.296178622100898,1.296178622100898,0.0,HIGH,1
rimonabant,HP_0002017,Nausea and vomiting,1.602376227037257,0.0,0.0,1.0,0.0,1.0,1.6024,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.801188,0.801188,0.0,HIGH,2
rimonabant,HP_0002018,Nausea,1.5204222775032776,0.0,0.0,1.0,0.0,1.0,1.5204,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.739832,0.78059,0.040759,HIGH,2
rimonabant,HP_0001250,Seizure,1.491305393259052,0.0,0.0,1.0,0.0,1.0,1.4913,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.745653,0.745653,0.0,HIGH,2
rimonabant,EFO_0010702,opioid use disorder,1.3990456127819952,0.0,0.0,1.0,0.0,1.0,1.399,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.17891,1.220136,1.041226,LOW,2
rimonabant,MONDO_0012354,platelet-type bleeding disorder 8,1.1463122862682256,0.0,0.0,1.0,0.2197,1.2197,1.3982,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.146312286268225,1.146312286268225,0.0,HIGH,1
rimonabant,MONDO_0007079,alcohol dependence,1.2176576160625712,0.0,0.0,1.0,0.1099,1.1099,1.3514,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.186448,1.031209,0.844761,LOW,2
rimonabant,EFO_0005611,opioid dependence,1.3225270886515077,0.0,0.0,1.0,0.0,1.0,1.3225,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.167477,1.15505,0.987573,LOW,2
rimonabant,MONDO_0005180,Parkinson disease,1.0644649374714663,0.0,0.0,1.0,0.2398,1.2398,1.3197,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.480106,0.584359,0.104252,MEDIUM,2
rimonabant,EFO_0001645,coronary artery disease,1.065928202970798,0.0,0.0,1.0,0.2303,1.2303,1.3114,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.065928202970798,1.065928202970798,0.0,HIGH,1
rimonabant,EFO_0000195,metabolic syndrome,1.0556211372509705,0.0,0.0,1.0,0.2398,1.2398,1.3087,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.527811,0.527811,0.0,HIGH,2
rimonabant,MONDO_8000006,WHIM syndrome 1,1.0533296357190465,0.0,0.0,1.0,0.2398,1.2398,1.3059,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.053329635719046,1.053329635719046,0.0,HIGH,1
rimonabant,Orphanet_36355,P2Y12 defect,1.0682290169877355,0.0,0.0,1.0,0.2197,1.2197,1.3029,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.068229016987735,1.068229016987735,0.0,HIGH,1
rimonabant,EFO_0004616,"osteoarthritis, knee",1.289629200330651,0.0,0.0,1.0,0.0,1.0,1.2896,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.583528,0.706101,0.122573,MEDIUM,2
rimonabant,MONDO_0010726,Rett syndrome,1.0300990030953796,0.0,0.0,1.0,0.2398,1.2398,1.2771,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.51505,0.51505,0.0,HIGH,2
rimonabant,MONDO_0018097,infantile spasms,1.0300990030953796,0.0,0.0,1.0,0.2398,1.2398,1.2771,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.51505,0.51505,0.0,HIGH,2
rimonabant,EFO_0004319,smoking cessation,1.2460759006940505,0.0,0.0,1.0,0.0,1.0,1.2461,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.606336,0.63974,0.033404,HIGH,2
rimonabant,EFO_0000764,HIV infection,1.2032917298099557,0.0,0.0,1.0,0.0,1.0,1.2033,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.169333,1.033959,0.864626,LOW,2
rimonabant,HP_0012532,Chronic pain,1.1959524121990142,0.0,0.0,1.0,0.0,1.0,1.196,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.175658,1.020295,0.844637,LOW,2
rimonabant,HP_0002039,Anorexia,1.1889177770424944,0.0,0.0,1.0,0.0,1.0,1.1889,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.594459,0.594459,0.0,HIGH,2
rimonabant,EFO_0001378,multiple myeloma,1.0076892114892133,0.0,0.0,1.0,0.1792,1.1792,1.1882,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.007689211489213,1.007689211489213,0.0,HIGH,1
rimonabant,HP_0002014,Diarrhea,0.957762425825498,0.0,0.0,1.0,0.2398,1.2398,1.1874,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.9577624258254971,0.9577624258254971,0.0,HIGH,1
rimonabant,EFO_1000634,hamartoma,1.1772560035375763,0.0,0.0,1.0,0.0,1.0,1.1773,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.588628,0.588628,0.0,HIGH,2
rimonabant,EFO_0005762,neuropathic pain,1.1652867312011783,0.0,0.0,1.0,0.0,1.0,1.1653,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.174009,0.991278,0.817269,LOW,2
rimonabant,MONDO_0008300,Prader-Willi syndrome,0.9363109414802192,0.0,0.0,1.0,0.2398,1.2398,1.1608,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.468155,0.468155,0.0,HIGH,2
rimonabant,MONDO_0009060,cystic disease of lung,0.9881510825804398,0.0,0.0,1.0,0.1609,1.1609,1.1472,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.988151082580439,0.988151082580439,0.0,HIGH,1
rimonabant,MONDO_0010383,fragile X syndrome,0.913543354470815,0.0,0.0,1.0,0.2398,1.2398,1.1326,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.456772,0.456772,0.0,HIGH,2
rimonabant,MONDO_0005090,schizophrenia,0.9132958184855778,0.0,0.0,1.0,0.2398,1.2398,1.1323,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.222198,0.691098,0.468901,LOW,2
rimonabant,MONDO_0005277,migraine disorder,0.9352075658594664,0.0,0.0,1.0,0.2079,1.2079,1.1297,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.135564,0.799643,0.664079,LOW,2
rimonabant,MONDO_0004976,amyotrophic lateral sclerosis,0.9091032471762396,0.0,0.0,1.0,0.2398,1.2398,1.1271,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.454552,0.454552,0.0,HIGH,2
rimonabant,EFO_0000712,stroke,0.9780889433785664,0.0,0.0,1.0,0.1386,1.1386,1.1137,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.9780889433785661,0.9780889433785661,0.0,HIGH,1
rimonabant,EFO_0003890,drug dependence,1.1029516947082771,0.0,0.0,1.0,0.0,1.0,1.103,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.076242,1.026709,0.950467,LOW,2
rimonabant,EFO_1000783,diabetic neuropathy,1.101741454968901,0.0,0.0,1.0,0.0,1.0,1.1017,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.446275,0.655466,0.209191,MEDIUM,2
rimonabant,EFO_0000555,irritable bowel syndrome,1.098760742239176,0.0,0.0,1.0,0.0,1.0,1.0988,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.164477,0.934284,0.769807,LOW,2
rimonabant,EFO_0005772,neurodegenerative disease,1.0917888036396333,0.0,0.0,1.0,0.0,1.0,1.0918,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.487286,0.604503,0.117217,MEDIUM,2
rimonabant,EFO_0000612,myocardial infarction,1.0902715454259535,0.0,0.0,1.0,0.0,1.0,1.0903,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,1.090271545425953,1.090271545425953,0.0,HIGH,1
rimonabant,MONDO_0004985,bipolar disorder,1.088466822293406,0.0,0.0,1.0,0.0,1.0,1.0885,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.544233,0.544233,0.0,HIGH,2
rimonabant,HP_0001397,Hepatic steatosis,1.0858811574787106,0.0,0.0,1.0,0.0,1.0,1.0859,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.542941,0.542941,0.0,HIGH,2
rimonabant,Orphanet_309005,Disorder of lipid metabolism,1.0300990030953796,0.0,0.0,1.0,0.0,1.0,1.0301,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,True,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.51505,0.51505,0.0,HIGH,2
rimonabant,MONDO_0100062,genetic developmental and epileptic encephalopathy,0.8240792024763034,0.0,0.0,1.0,0.2398,1.2398,1.0217,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.41204,0.41204,0.0,HIGH,2
rimonabant,MONDO_0005178,osteoarthritis,0.8258270392938437,0.0,0.0,1.0,0.2303,1.2303,1.016,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.127998,0.697829,0.569832,LOW,2
rimonabant,HP_0001249,Intellectual disability,0.8164142249207578,0.0,0.0,1.0,0.2398,1.2398,1.0122,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.117726,0.698689,0.580963,LOW,2
rimonabant,EFO_0004698,insomnia,0.911066867565702,0.0,0.0,1.0,0.1099,1.1099,1.0112,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.443322,0.467745,0.024423,HIGH,2
rimonabant,EFO_0005687,fibromyalgia,1.006727144689814,0.0,0.0,1.0,0.0,1.0,1.0067,1,TERMINATED,STOPPED,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Company decision taken in light of demands by certain national health authorities,False,"Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2",,,0.48987,0.516857,0.026988,HIGH,2
rosiglitazone,MONDO_0005148,type 2 diabetes mellitus,11.392484754012074,0.0,0.0,1.0,0.1792,1.1792,13.4337,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,1.375529,1.472592,0.097063,HIGH,8
rosiglitazone,MONDO_0011448,PPARG-related familial partial lipodystrophy,10.719432586702112,0.0,0.0,1.0,0.2398,1.2398,13.2898,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,1.313168,1.36669,0.053521,HIGH,8
rosiglitazone,EFO_0000400,diabetes mellitus,10.04596734349902,0.0,0.0,1.0,0.2197,1.2197,12.2533,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,1.212951,1.298541,0.08559,HIGH,8
rosiglitazone,EFO_0000729,ulcerative colitis,8.550656730099506,0.0,0.0,1.0,0.2398,1.2398,10.601,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,1.026391,1.111273,0.084882,HIGH,8
rosiglitazone,EFO_0001073,obesity,8.117190128209684,0.0,0.0,1.0,0.1946,1.1946,9.6967,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.98007,1.049228,0.069157,HIGH,8
rosiglitazone,EFO_0001645,coronary artery disease,7.302039499347698,0.0,0.0,1.0,0.2303,1.2303,8.9834,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.823059,1.035871,0.212812,MEDIUM,8
rosiglitazone,EFO_0001074,morbid obesity,7.807404420911833,0.0,0.0,1.0,0.0,1.0,7.8074,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.956435,0.995416,0.038982,HIGH,8
rosiglitazone,MONDO_0019182,inherited obesity,6.445900431529504,0.0,0.0,1.0,0.1946,1.1946,7.7002,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.805738,0.805738,0.0,HIGH,8
rosiglitazone,EFO_0000537,hypertension,6.365177354548177,0.0,0.0,1.0,0.1609,1.1609,7.3896,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.555363,1.043369,0.488006,LOW,8
rosiglitazone,EFO_0000195,metabolic syndrome,5.943990497934736,0.0,0.0,1.0,0.2398,1.2398,7.3693,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.700184,0.807194,0.10701,MEDIUM,8
rosiglitazone,HP_0003124,Hypercholesterolemia,7.364449728224574,0.0,0.0,1.0,0.0,1.0,7.3644,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.77968,1.070413,0.290732,LOW,8
rosiglitazone,EFO_0000384,Crohn's disease,5.928811580388484,0.0,0.0,1.0,0.2398,1.2398,7.3505,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.628241,0.899576,0.271335,LOW,8
rosiglitazone,EFO_0000319,cardiovascular disease,7.303115954140583,0.0,0.0,1.0,0.0,1.0,7.3031,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.797993,1.035783,0.23779,MEDIUM,8
rosiglitazone,MONDO_0004975,Alzheimer disease,5.846153514029663,0.0,0.0,1.0,0.2398,1.2398,7.248,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.668037,0.826248,0.158211,MEDIUM,8
rosiglitazone,EFO_0005628,proctitis,6.773538625687371,0.0,0.0,1.0,0.0,1.0,6.7735,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.846692,0.846692,0.0,HIGH,8
rosiglitazone,EFO_1001950,colon carcinoma,6.7097397889120485,0.0,0.0,1.0,0.0,1.0,6.7097,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.838717,0.838717,0.0,HIGH,8
rosiglitazone,MONDO_0004979,asthma,5.406840859893012,0.0,0.0,1.0,0.1792,1.1792,6.3756,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.542049,0.866908,0.32486,LOW,8
rosiglitazone,MONDO_0018883,Berardinelli-Seip congenital lipodystrophy,5.068388507131118,0.0,0.0,1.0,0.2398,1.2398,6.2837,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.620895,0.646202,0.025306,HIGH,8
rosiglitazone,EFO_0003095,non-alcoholic fatty liver disease,5.627513481544331,0.0,0.0,1.0,0.1099,1.1099,6.2458,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.684376,0.722503,0.038127,HIGH,8
rosiglitazone,HP_0000924,Abnormality of the skeletal system,6.134713846684055,0.0,0.0,1.0,0.0,1.0,6.1347,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.766839,0.766839,0.0,HIGH,8
rosiglitazone,EFO_0000685,rheumatoid arthritis,4.939341108399458,0.0,0.0,1.0,0.2398,1.2398,6.1237,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.454419,0.854092,0.399672,LOW,8
rosiglitazone,EFO_1000727,lipodystrophy,6.123156979901725,0.0,0.0,1.0,0.0,1.0,6.1232,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.746582,0.782734,0.036152,HIGH,8
rosiglitazone,EFO_0005140,autoimmune disease,4.891271727926962,0.0,0.0,1.0,0.2398,1.2398,6.0641,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.603102,0.623869,0.020766,HIGH,8
rosiglitazone,MONDO_0011962,endometrial cancer,5.2548100302061265,0.0,0.0,1.0,0.1386,1.1386,5.9833,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.640782,0.672966,0.032184,HIGH,8
rosiglitazone,HP_0009125,Lipodystrophy,5.945319124702832,0.0,0.0,1.0,0.0,1.0,5.9453,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.743165,0.743165,0.0,HIGH,8
rosiglitazone,EFO_0000501,follicular thyroid carcinoma,4.822967468248123,0.0,0.0,1.0,0.2303,1.2303,5.9335,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.602871,0.602871,0.0,HIGH,8
rosiglitazone,Orphanet_79211,Combined hyperlipidemia,4.777492315708812,0.0,0.0,1.0,0.2303,1.2303,5.8776,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.483919,0.699556,0.215637,MEDIUM,8
rosiglitazone,EFO_0000641,papillary thyroid carcinoma,5.040434817760611,0.0,0.0,1.0,0.1609,1.1609,5.8517,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.615561,0.651794,0.036233,HIGH,8
rosiglitazone,EFO_0003767,inflammatory bowel disease,4.910333606046287,0.0,0.0,1.0,0.1792,1.1792,5.7901,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.592874,0.634709,0.041835,HIGH,8
rosiglitazone,HP_0000855,Insulin resistance,5.783674498429141,0.0,0.0,1.0,0.0,1.0,5.7837,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.713137,0.737692,0.024555,HIGH,8
rosiglitazone,EFO_0004274,gout,5.728458046726883,0.0,0.0,1.0,0.0,1.0,5.7285,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.627002,0.84964,0.222638,MEDIUM,8
rosiglitazone,MONDO_0005180,Parkinson disease,4.524335082020007,0.0,0.0,1.0,0.2398,1.2398,5.6092,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.502351,0.670829,0.168479,MEDIUM,8
rosiglitazone,EFO_1000783,diabetic neuropathy,5.596503202136758,0.0,0.0,1.0,0.0,1.0,5.5965,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.690059,0.713819,0.02376,HIGH,8
rosiglitazone,EFO_0003914,atherosclerosis,5.595051142595219,0.0,0.0,1.0,0.0,1.0,5.5951,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.639599,0.799366,0.159767,MEDIUM,8
rosiglitazone,MONDO_0020088,familial partial lipodystrophy,5.59323604965712,0.0,0.0,1.0,0.0,1.0,5.5932,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.699155,0.699155,0.0,HIGH,8
rosiglitazone,EFO_0003770,diabetic retinopathy,5.530676739471858,0.0,0.0,1.0,0.0,1.0,5.5307,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.6088,0.799709,0.190909,MEDIUM,8
rosiglitazone,EFO_0000673,prostate adenocarcinoma,4.845648898182869,0.0,0.0,1.0,0.1386,1.1386,5.5174,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.551385,0.677695,0.12631,MEDIUM,8
rosiglitazone,EFO_0000660,polycystic ovary syndrome,4.521052488083965,0.0,0.0,1.0,0.2079,1.2079,5.4612,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.527713,0.607886,0.080174,HIGH,8
rosiglitazone,EFO_1001486,primary biliary cirrhosis,5.445515545795706,0.0,0.0,1.0,0.0,1.0,5.4455,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.639204,0.722175,0.082972,HIGH,8
rosiglitazone,EFO_0003060,non-small cell lung carcinoma,4.610332162755795,0.0,0.0,1.0,0.1792,1.1792,5.4364,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.512369,0.659191,0.146821,MEDIUM,8
rosiglitazone,EFO_0001378,multiple myeloma,4.517808914765204,0.0,0.0,1.0,0.1792,1.1792,5.3273,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.480955,0.678194,0.197239,MEDIUM,8
rosiglitazone,EFO_0000616,neoplasm,5.271840364013161,0.0,0.0,1.0,0.0,1.0,5.2718,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.537845,0.827053,0.289208,LOW,8
rosiglitazone,HP_0001513,Obesity,5.269490438865254,0.0,0.0,1.0,0.0,1.0,5.2695,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.639194,0.679379,0.040185,HIGH,8
rosiglitazone,EFO_0004705,hypothyroidism,5.249193605684485,0.0,0.0,1.0,0.0,1.0,5.2492,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.621756,0.699349,0.077594,HIGH,8
rosiglitazone,Orphanet_309005,Disorder of lipid metabolism,5.13527969146932,0.0,0.0,1.0,0.0,1.0,5.1353,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,True,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.52613,0.757658,0.231527,MEDIUM,8
rosiglitazone,EFO_0000182,hepatocellular carcinoma,4.418934974798498,0.0,0.0,1.0,0.1609,1.1609,5.1301,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.49865,0.617704,0.119054,MEDIUM,8
rosiglitazone,EFO_1000941,frozen shoulder,5.074153567457077,0.0,0.0,1.0,0.0,1.0,5.0742,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.502621,0.831741,0.32912,LOW,8
rosiglitazone,EFO_0002618,pancreatic carcinoma,4.26591128037215,0.0,0.0,1.0,0.1792,1.1792,5.0303,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.522445,0.544032,0.021587,HIGH,8
rosiglitazone,EFO_0005543,glioma,4.047119526682352,0.0,0.0,1.0,0.2398,1.2398,5.0176,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.493514,0.518301,0.024787,HIGH,8
rosiglitazone,EFO_0000756,melanoma,4.102969993337658,0.0,0.0,1.0,0.2197,1.2197,5.0045,1,SUSPENDED,STOPPED,"Diabetes Mellitus, Atherosclerosis",no fund,False,"Alzheimer Disease; Anemia; Arthritis, Rheumatoid; Asthma; Atherosclerosis",,,0.495393,0.53035,0.034957,HIGH,8
serine proteinase-1 (serp-1),MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",10.684977764053016,0.0,0.0,1.0,0.2398,1.2398,13.2471,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.320082,1.366704,0.046622,HIGH,8
serine proteinase-1 (serp-1),MONDO_0008090,cyclic hematopoiesis,10.564108326242849,0.0,0.0,1.0,0.1792,1.1792,12.4569,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.320514,1.320514,0.0,HIGH,8
serine proteinase-1 (serp-1),Orphanet_2686,Cyclic neutropenia,10.548200114973811,0.0,0.0,1.0,0.1792,1.1792,12.4382,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.318525,1.318525,0.0,HIGH,8
serine proteinase-1 (serp-1),MONDO_0001475,neutropenia,7.061207416418718,0.0,0.0,1.0,0.0,1.0,7.0612,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.851694,0.944564,0.09287,HIGH,8
serine proteinase-1 (serp-1),MONDO_0018542,severe congenital neutropenia,6.857353726922563,0.0,0.0,1.0,0.0,1.0,6.8574,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.847196,0.877116,0.029921,HIGH,8
serine proteinase-1 (serp-1),HP_0001875,Decreased total neutrophil count,6.786226829281052,0.0,0.0,1.0,0.0,1.0,6.7862,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.848278,0.848278,0.0,HIGH,8
serine proteinase-1 (serp-1),MONDO_0019751,autoinflammatory syndrome,5.91911488585729,0.0,0.0,1.0,0.0,1.0,5.9191,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.739889,0.739889,0.0,HIGH,8
serine proteinase-1 (serp-1),EFO_0003026,minimally differentiated acute myeloblastic leukemia,5.8862800176878824,0.0,0.0,1.0,0.0,1.0,5.8863,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.735785,0.735785,0.0,HIGH,8
serine proteinase-1 (serp-1),EFO_0000508,genetic disorder,5.854943049773426,0.0,0.0,1.0,0.0,1.0,5.8549,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.666666,0.836827,0.17016,MEDIUM,8
serine proteinase-1 (serp-1),Orphanet_60,Alpha-1-antitrypsin deficiency,4.633847935671903,0.0,0.0,1.0,0.2398,1.2398,5.745,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.575269,0.587154,0.011885,HIGH,8
serine proteinase-1 (serp-1),MONDO_0010294,X-linked severe congenital neutropenia,4.566597016351963,0.0,0.0,1.0,0.2197,1.2197,5.57,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.566921,0.578633,0.011712,HIGH,8
serine proteinase-1 (serp-1),MONDO_0008742,autosomal dominant severe congenital neutropenia,5.55664833669736,0.0,0.0,1.0,0.0,1.0,5.5566,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.694581,0.694581,0.0,HIGH,8
serine proteinase-1 (serp-1),EFO_0005772,neurodegenerative disease,5.38825631675346,0.0,0.0,1.0,0.0,1.0,5.3883,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.574281,0.831642,0.257361,LOW,8
serine proteinase-1 (serp-1),EFO_0003818,lung disease,4.7900701216769335,0.0,0.0,1.0,0.0,1.0,4.7901,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.594664,0.606949,0.012285,HIGH,8
serine proteinase-1 (serp-1),MONDO_0017953,hereditary periodic fever syndrome,4.709024014150306,0.0,0.0,1.0,0.0,1.0,4.709,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.588628,0.588628,0.0,HIGH,8
serine proteinase-1 (serp-1),EFO_0000341,chronic obstructive pulmonary disease,4.066319209684402,0.0,0.0,1.0,0.0693,1.0693,4.3482,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.49152,0.530079,0.038559,HIGH,8
serine proteinase-1 (serp-1),EFO_0003777,heart disease,3.946560161556678,0.0,0.0,1.0,0.0,1.0,3.9466,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.41204,0.648193,0.236153,MEDIUM,8
serine proteinase-1 (serp-1),EFO_0000694,severe acute respiratory syndrome,3.6317758197915775,0.0,0.0,1.0,0.0,1.0,3.6318,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.419201,0.523513,0.104312,MEDIUM,8
serine proteinase-1 (serp-1),HP_0100806,Sepsis,3.573188161416335,0.0,0.0,1.0,0.0,1.0,3.5732,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.435523,0.465901,0.030378,HIGH,8
serine proteinase-1 (serp-1),EFO_0003060,non-small cell lung carcinoma,2.2311707278709716,0.0,0.0,1.0,0.1792,1.1792,2.6309,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.045556,0.65176,0.606205,LOW,8
serine proteinase-1 (serp-1),EFO_0000616,neoplasm,2.5048299664695373,0.0,0.0,1.0,0.0,1.0,2.5048,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.156705,0.61597,0.459265,LOW,8
serine proteinase-1 (serp-1),EFO_0000275,atrial fibrillation,1.938801457131233,0.0,0.0,1.0,0.2398,1.2398,2.4037,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.211125,0.92333,0.712205,LOW,3
serine proteinase-1 (serp-1),MONDO_0005147,type 1 diabetes mellitus,1.9082806232803349,0.0,0.0,1.0,0.2398,1.2398,2.3659,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.168364,0.371464,0.2031,MEDIUM,8
serine proteinase-1 (serp-1),MONDO_0100096,COVID-19,2.354606716969193,0.0,0.0,1.0,0.0,1.0,2.3546,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.166874,0.50274,0.335866,LOW,8
serine proteinase-1 (serp-1),MONDO_0001056,gastric cancer,1.9935742606843312,0.0,0.0,1.0,0.1386,1.1386,2.2699,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.150497,0.443509,0.293012,LOW,8
serine proteinase-1 (serp-1),EFO_0000756,melanoma,1.78322979860181,0.0,0.0,1.0,0.2197,1.2197,2.175,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.068909,0.449424,0.380515,LOW,8
serine proteinase-1 (serp-1),HP_0001873,Thrombocytopenia,1.7842111946007653,0.0,0.0,1.0,0.2079,1.2079,2.1552,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.83636,0.947851,0.111491,MEDIUM,2
serine proteinase-1 (serp-1),MONDO_0008903,lung cancer,1.7216716356456103,0.0,0.0,1.0,0.1792,1.1792,2.0302,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.049793,0.486029,0.436236,LOW,8
serine proteinase-1 (serp-1),EFO_0004274,gout,2.012455110095758,0.0,0.0,1.0,0.0,1.0,2.0125,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.837822,1.174633,0.336811,LOW,2
serine proteinase-1 (serp-1),HP_0004936,Venous thrombosis,1.5761169201382326,0.0,0.0,1.0,0.2398,1.2398,1.9541,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.0439,0.985451,0.941551,LOW,3
serine proteinase-1 (serp-1),EFO_0002618,pancreatic carcinoma,1.643535636580847,0.0,0.0,1.0,0.1792,1.1792,1.938,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.147157,1.07167,0.924513,LOW,3
serine proteinase-1 (serp-1),EFO_0001645,coronary artery disease,1.5742938239209314,0.0,0.0,1.0,0.2303,1.2303,1.9368,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.115543,0.671604,0.556061,LOW,4
serine proteinase-1 (serp-1),MONDO_0004992,cancer,1.9227775694699936,0.0,0.0,1.0,0.0,1.0,1.9228,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.079558,0.547192,0.467634,LOW,8
serine proteinase-1 (serp-1),EFO_0000319,cardiovascular disease,1.9008741837668064,0.0,0.0,1.0,0.0,1.0,1.9009,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.143272,0.943196,0.799924,LOW,3
serine proteinase-1 (serp-1),EFO_0000712,stroke,1.655059297691864,0.0,0.0,1.0,0.1386,1.1386,1.8845,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.562582,1.092477,0.529895,LOW,2
serine proteinase-1 (serp-1),EFO_0000222,acute myeloid leukemia,1.6283546684867056,0.0,0.0,1.0,0.1386,1.1386,1.8541,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.061586,0.411535,0.349948,LOW,8
serine proteinase-1 (serp-1),MONDO_0013730,graft versus host disease,1.8449731744295317,0.0,0.0,1.0,0.0,1.0,1.845,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.161562,0.368741,0.207179,MEDIUM,8
serine proteinase-1 (serp-1),MONDO_0007254,breast cancer,1.814020247980626,0.0,0.0,1.0,0.0,1.0,1.814,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.046329,0.566754,0.520426,LOW,8
serine proteinase-1 (serp-1),MONDO_0018088,familial Mediterranean fever,1.7930815386887535,0.0,0.0,1.0,0.0,1.0,1.7931,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.664076,1.129005,0.464929,LOW,2
serine proteinase-1 (serp-1),EFO_0000546,injury,1.7814751419069446,0.0,0.0,1.0,0.0,1.0,1.7815,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.192012,0.284028,0.092016,HIGH,8
serine proteinase-1 (serp-1),EFO_0000305,breast carcinoma,1.533344174727293,0.0,0.0,1.0,0.1609,1.1609,1.7801,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.299461,1.233883,0.934423,LOW,2
serine proteinase-1 (serp-1),EFO_0001378,multiple myeloma,1.4983512680668316,0.0,0.0,1.0,0.1792,1.1792,1.7668,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.297257,1.201094,0.903837,LOW,2
serine proteinase-1 (serp-1),MONDO_0004976,amyotrophic lateral sclerosis,1.416900905603781,0.0,0.0,1.0,0.2398,1.2398,1.7567,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.41690090560378,1.41690090560378,0.0,HIGH,1
serine proteinase-1 (serp-1),MONDO_0009061,cystic fibrosis,1.3982402049485712,0.0,0.0,1.0,0.2398,1.2398,1.7335,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,True,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.173585,0.177171,0.003586,HIGH,8
serine proteinase-1 (serp-1),EFO_0000571,lung adenocarcinoma,1.4682669999309443,0.0,0.0,1.0,0.1792,1.1792,1.7313,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.024495,0.410923,0.386427,LOW,8
serine proteinase-1 (serp-1),MONDO_0008315,prostate cancer,1.7161009174763195,0.0,0.0,1.0,0.0,1.0,1.7161,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.022272,0.547568,0.525295,LOW,8
serine proteinase-1 (serp-1),EFO_0000540,immune system disease,1.4490415273052766,0.0,0.0,1.0,0.1386,1.1386,1.6499,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.707857,0.741185,0.033328,HIGH,2
serine proteinase-1 (serp-1),EFO_0000673,prostate adenocarcinoma,1.445457102030201,0.0,0.0,1.0,0.1386,1.1386,1.6458,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,0.058863,1.09228,1.033418,LOW,3
serine proteinase-1 (serp-1),MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.0,0.0,1.0,0.2398,1.2398,1.6286,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.313641444940749,1.313641444940749,0.0,HIGH,1
serine proteinase-1 (serp-1),Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.0,0.0,1.0,0.2398,1.2398,1.6277,1,TERMINATED,STOPPED,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Third dose group not recruited due to slow enrollment.,False,"Bronchiolitis Obliterans Syndrome; Cystic Fibrosis; Diabetes Mellitus, Type 1; Genetic Diseases, Inborn; Graft vs Host Disease",,,1.312919255867715,1.312919255867715,0.0,HIGH,1
simvastatin,EFO_0001645,coronary artery disease,4.790190738379875,0.9314,0.05,0.7487,0.2303,1.2303,4.4122,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.154465,1.24063,0.086165,HIGH,4
simvastatin,EFO_0004911,familial hypercholesterolemia,4.503957057819439,0.9314,0.05,0.7487,0.2303,1.2303,4.1486,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.125989,1.125989,0.0,HIGH,4
simvastatin,MONDO_0957270,"muscular dystrophy, limb-girdle, autosomal recessive 28",4.139181387657921,0.9314,0.05,0.7487,0.2398,1.2398,3.8421,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.034795,1.034795,0.0,HIGH,4
simvastatin,EFO_0000712,stroke,4.363053505116997,0.9314,0.05,0.7487,0.1386,1.1386,3.7195,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.090763,1.090763,0.0,HIGH,4
simvastatin,HP_0003124,Hypercholesterolemia,4.933217740180516,0.9314,0.05,0.7487,0.0,1.0,3.6935,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.188936,1.277673,0.088737,HIGH,4
simvastatin,MONDO_0005148,type 2 diabetes mellitus,4.112784979850193,0.9314,0.05,0.7487,0.1792,1.1792,3.631,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.795328,1.304791,0.509463,LOW,4
simvastatin,MONDO_0021187,hyperlipidemia,4.845499374382493,0.9314,0.05,0.7487,0.0,1.0,3.6278,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.167795,1.254955,0.087159,HIGH,4
simvastatin,MONDO_0004975,Alzheimer disease,3.868476294930664,0.9314,0.05,0.7487,0.2398,1.2398,3.5908,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.932327,1.001912,0.069585,HIGH,4
simvastatin,MONDO_0005301,multiple sclerosis,3.6886049872558786,0.9314,0.05,0.7487,0.2398,1.2398,3.4239,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.897431,0.946872,0.049441,HIGH,4
simvastatin,EFO_0000319,cardiovascular disease,4.462884304617532,0.9314,0.05,0.7487,0.0,1.0,3.3414,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,1.075583,1.15586,0.080277,HIGH,4
simvastatin,EFO_0000537,hypertension,3.827293118600767,0.9314,0.05,0.7487,0.1609,1.1609,3.3267,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.922401,0.991245,0.068844,HIGH,4
simvastatin,EFO_0000400,diabetes mellitus,3.6416669282093506,0.9314,0.05,0.7487,0.2197,1.2197,3.3256,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.726469,1.156859,0.43039,LOW,4
simvastatin,EFO_0000195,metabolic syndrome,3.5536216770031643,0.9314,0.05,0.7487,0.2398,1.2398,3.2986,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.856445,0.920366,0.063921,HIGH,4
simvastatin,MONDO_0005180,Parkinson disease,3.445586101873285,0.9314,0.05,0.7487,0.2398,1.2398,3.1983,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.830407,0.892386,0.061978,HIGH,4
simvastatin,EFO_0000612,myocardial infarction,4.0349585125306335,0.9314,0.05,0.7487,0.0,1.0,3.021,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.981698,1.035781,0.054083,HIGH,4
simvastatin,HP_0003119,Abnormal circulating lipid concentration,3.9327261105025513,0.9314,0.05,0.7487,0.0,1.0,2.9444,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.956825,1.009538,0.052713,HIGH,4
simvastatin,EFO_0003914,atherosclerosis,3.873268201585155,0.9314,0.05,0.7487,0.0,1.0,2.8999,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.933481,1.003153,0.069671,HIGH,4
simvastatin,EFO_0003913,angina pectoris,3.863629413422242,0.9314,0.05,0.7487,0.0,1.0,2.8927,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.965907,0.965907,0.0,HIGH,4
simvastatin,EFO_0000373,congestive heart failure,3.8369037769256056,0.9314,0.05,0.7487,0.0,1.0,2.8727,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.959226,0.959226,0.0,HIGH,4
simvastatin,EFO_0005772,neurodegenerative disease,3.682190813719466,0.9314,0.05,0.7487,0.0,1.0,2.7569,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.908041,0.945561,0.037519,HIGH,4
simvastatin,EFO_0000589,metabolic disease,3.649567887688011,0.9314,0.05,0.7487,0.0,1.0,2.7324,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.879568,0.945216,0.065647,HIGH,4
simvastatin,Orphanet_79211,Combined hyperlipidemia,2.818124869401234,0.9314,0.05,0.7487,0.2303,1.2303,2.5958,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.679185,0.729877,0.050692,HIGH,4
simvastatin,Orphanet_309005,Disorder of lipid metabolism,3.451584924544929,0.9314,0.05,0.7487,0.0,1.0,2.5842,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.831853,0.893939,0.062086,HIGH,4
simvastatin,MONDO_0018473,hyperlipoproteinemia type 3,3.3908130177989007,0.9314,0.05,0.7487,0.0,1.0,2.5387,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.824978,0.870428,0.04545,HIGH,4
simvastatin,MONDO_0021661,coronary atherosclerosis,3.267835882400563,0.9314,0.05,0.7487,0.0,1.0,2.4466,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.816959,0.816959,0.0,HIGH,4
simvastatin,MONDO_0005147,type 1 diabetes mellitus,2.5963853546596805,0.9314,0.05,0.7487,0.2398,1.2398,2.41,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.631696,0.666497,0.034801,HIGH,4
simvastatin,MONDO_0002561,lysosomal storage disease,3.1221168810178797,0.9314,0.05,0.7487,0.0,1.0,2.3375,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.780529,0.780529,0.0,HIGH,4
simvastatin,EFO_0008583,acute myocardial infarction,3.0371903135417453,0.9314,0.05,0.7487,0.0,1.0,2.2739,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.759298,0.759298,0.0,HIGH,4
simvastatin,EFO_0003144,heart failure,3.03366373053073,0.9314,0.05,0.7487,0.0,1.0,2.2713,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.738085,0.778747,0.040662,HIGH,4
simvastatin,EFO_0000275,atrial fibrillation,2.3659595467973276,0.9314,0.05,0.7487,0.2398,1.2398,2.1962,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.570211,0.612769,0.042558,HIGH,4
simvastatin,EFO_0001073,obesity,2.392857400626029,0.9314,0.05,0.7487,0.1946,1.1946,2.1401,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.439329,0.897832,0.458503,LOW,4
simvastatin,MONDO_0001336,familial hyperlipidemia,2.7727416637700424,0.9314,0.05,0.7487,0.0,1.0,2.076,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.693185,0.693185,0.0,HIGH,4
simvastatin,EFO_0000668,preeclampsia,2.2206239898550506,0.9314,0.05,0.7487,0.2398,1.2398,2.0613,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.555156,0.555156,0.0,HIGH,4
simvastatin,MONDO_0005575,colorectal cancer,2.2498931727742955,0.9314,0.05,0.7487,0.2079,1.2079,2.0348,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.562473,0.562473,0.0,HIGH,4
simvastatin,MONDO_0100096,COVID-19,2.712483131831161,0.9314,0.05,0.7487,0.0,1.0,2.0308,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.659942,0.696299,0.036357,HIGH,4
simvastatin,EFO_0004211,Hypertriglyceridemia,2.6531207653257143,0.9314,0.05,0.7487,0.0,1.0,1.9864,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.64467,0.68189,0.03722,HIGH,4
simvastatin,MONDO_0008903,lung cancer,2.229148188765344,0.9314,0.05,0.7487,0.1792,1.1792,1.968,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.557287,0.557287,0.0,HIGH,4
simvastatin,EFO_1001375,Myocardial Ischemia,2.6170798235550556,0.9314,0.05,0.7487,0.0,1.0,1.9594,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.636731,0.671809,0.035079,HIGH,4
simvastatin,HP_0003077,Hyperlipidemia,2.6096540692120263,0.9314,0.05,0.7487,0.0,1.0,1.9538,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.64355,0.670141,0.026591,HIGH,4
simvastatin,MONDO_0004979,asthma,2.2020500931853872,0.9314,0.05,0.7487,0.1792,1.1792,1.9441,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.543033,0.565471,0.022437,HIGH,4
simvastatin,HP_0002140,Ischemic stroke,2.54837978994417,0.9314,0.05,0.7487,0.0,1.0,1.908,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.637095,0.637095,0.0,HIGH,4
simvastatin,EFO_0005672,acute coronary syndrome,2.5099170764918135,0.9314,0.05,0.7487,0.0,1.0,1.8792,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.627479,0.627479,0.0,HIGH,4
simvastatin,MONDO_0016971,limb-girdle muscular dystrophy,2.4969739995092692,0.9314,0.05,0.7487,0.0,1.0,1.8695,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.624243,0.624243,0.0,HIGH,4
simvastatin,EFO_0003884,chronic kidney disease,2.477294596111572,0.9314,0.05,0.7487,0.0,1.0,1.8548,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.602721,0.635926,0.033205,HIGH,4
simvastatin,EFO_0000341,chronic obstructive pulmonary disease,2.3163513320411333,0.9314,0.05,0.7487,0.0693,1.0693,1.8545,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.563564,0.594612,0.031048,HIGH,4
simvastatin,EFO_0000660,polycystic ovary syndrome,2.0169458410690657,0.9314,0.05,0.7487,0.2079,1.2079,1.8241,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.475017,0.543048,0.068031,HIGH,4
simvastatin,EFO_0000182,hepatocellular carcinoma,2.061718470645353,0.9314,0.05,0.7487,0.1609,1.1609,1.792,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.496887,0.533972,0.037086,HIGH,4
simvastatin,EFO_0003929,relapsing-remitting multiple sclerosis,2.3900258965152026,0.9314,0.05,0.7487,0.0,1.0,1.7894,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.597506,0.597506,0.0,HIGH,4
simvastatin,MONDO_0008315,prostate cancer,2.3850703244687725,0.9314,0.05,0.7487,0.0,1.0,1.7857,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,True,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.580283,0.612252,0.031969,HIGH,4
simvastatin,EFO_1000727,lipodystrophy,2.379320341589604,0.9314,0.05,0.7487,0.0,1.0,1.7814,2,TERMINATED,STOPPED,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,False,"Acute Coronary Syndrome; Alopecia Areata; Alzheimer Disease; Anemia, Sickle Cell; Arthritis, Rheumatoid",,,0.51505,0.73311,0.218061,MEDIUM,4
sirolimus,EFO_0000274,atopic eczema,3.3818918782979153,0.635,0.0,0.8265,0.2398,1.2398,3.4656,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.475134,0.499113,0.023979,HIGH,7
sirolimus,EFO_0000681,renal cell carcinoma,3.3613289125629713,0.635,0.0,0.8265,0.1386,1.1386,3.1634,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.470164,0.500242,0.030078,HIGH,7
sirolimus,EFO_0000305,breast carcinoma,3.0201979841254167,0.635,0.0,0.8265,0.1609,1.1609,2.8981,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.400543,0.493285,0.092742,HIGH,7
sirolimus,MONDO_0007254,breast cancer,3.4644924314953145,0.635,0.0,0.8265,0.0,1.0,2.8636,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.467169,0.550444,0.083275,HIGH,7
sirolimus,EFO_0000616,neoplasm,3.415959547447897,0.635,0.0,0.8265,0.0,1.0,2.8234,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.456832,0.550318,0.093485,HIGH,7
sirolimus,EFO_1001901,neuroendocrine neoplasm,2.9981665004263323,0.635,0.0,0.8265,0.0,1.0,2.4781,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.417086,0.450756,0.03367,HIGH,7
sirolimus,EFO_1000634,hamartoma,2.9329207727021225,0.635,0.0,0.8265,0.0,1.0,2.4242,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.418989,0.418989,0.0,HIGH,7
sirolimus,EFO_0000676,psoriasis,2.292937549807291,0.635,0.0,0.8265,0.2398,1.2398,2.3497,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.285272,0.412143,0.126871,MEDIUM,7
sirolimus,EFO_0000729,ulcerative colitis,2.2855929201983556,0.635,0.0,0.8265,0.2398,1.2398,2.3421,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.284904,0.409732,0.124827,MEDIUM,7
sirolimus,MONDO_0004992,cancer,2.797646777477134,0.635,0.0,0.8265,0.0,1.0,2.3124,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.358648,0.481696,0.123048,MEDIUM,7
sirolimus,MONDO_0005147,type 1 diabetes mellitus,2.2381563143674272,0.635,0.0,0.8265,0.2398,1.2398,2.2935,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.314149,0.330911,0.016762,HIGH,7
sirolimus,EFO_0004255,nephrotic syndrome,2.2341720640670215,0.635,0.0,0.8265,0.2398,1.2398,2.2894,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.281225,0.395052,0.113827,MEDIUM,7
sirolimus,MONDO_0001734,tuberous sclerosis,2.7526063093333946,0.635,0.0,0.8265,0.0,1.0,2.2751,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.390159,0.399371,0.009212,HIGH,7
sirolimus,EFO_0001645,coronary artery disease,2.2085541859220275,0.635,0.0,0.8265,0.2303,1.2303,2.2458,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.303769,0.338986,0.035217,HIGH,7
sirolimus,EFO_0000685,rheumatoid arthritis,2.158876619667233,0.635,0.0,0.8265,0.2398,1.2398,2.2123,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.264065,0.397103,0.133038,MEDIUM,7
sirolimus,EFO_1001469,Mantle cell lymphoma,2.6495635097827455,0.635,0.0,0.8265,0.0,1.0,2.19,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.363413,0.408701,0.045288,HIGH,7
sirolimus,MONDO_0004555,kidney angiomyolipoma,2.6210296856537987,0.635,0.0,0.8265,0.0,1.0,2.1664,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.374433,0.374433,0.0,HIGH,7
sirolimus,EFO_0000183,Hodgkins lymphoma,2.2566061390415357,0.635,0.0,0.8265,0.1609,1.1609,2.1654,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.277268,0.41258,0.135311,MEDIUM,7
sirolimus,EFO_0005772,neurodegenerative disease,2.6172578355598444,0.635,0.0,0.8265,0.0,1.0,2.1633,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.343907,0.433868,0.089961,HIGH,7
sirolimus,HP_0000964,Eczematoid dermatitis,2.5752475077384487,0.635,0.0,0.8265,0.0,1.0,2.1286,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.367893,0.367893,0.0,HIGH,7
sirolimus,MONDO_0002603,angiomyolipoma,2.5752475077384487,0.635,0.0,0.8265,0.0,1.0,2.1286,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.367893,0.367893,0.0,HIGH,7
sirolimus,EFO_0000182,hepatocellular carcinoma,2.2061254949015647,0.635,0.0,0.8265,0.1609,1.1609,2.1169,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.30369,0.338102,0.034412,HIGH,7
sirolimus,EFO_1000045,pancreatic neuroendocrine tumor,2.5259555421377504,0.635,0.0,0.8265,0.0,1.0,2.0878,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.358033,0.366486,0.008453,HIGH,7
sirolimus,EFO_0004991,Myasthenia gravis,1.990930601019913,0.635,0.0,0.8265,0.2398,1.2398,2.0402,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.280416,0.292424,0.012008,HIGH,7
sirolimus,EFO_1001496,Autosomal dominant polycystic kidney disease,1.984027907684095,0.635,0.0,0.8265,0.2398,1.2398,2.0331,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.283433,0.283433,0.0,HIGH,7
sirolimus,EFO_0000540,immune system disease,2.131849828396141,0.635,0.0,0.8265,0.1386,1.1386,2.0063,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.294314,0.325022,0.030708,HIGH,7
sirolimus,EFO_0003869,breast neoplasm,2.0698868498402567,0.635,0.0,0.8265,0.1386,1.1386,1.948,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.242402,0.40229,0.159888,MEDIUM,7
sirolimus,MONDO_0001056,gastric cancer,2.06815413692482,0.635,0.0,0.8265,0.1386,1.1386,1.9464,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.268198,0.349956,0.081759,HIGH,7
sirolimus,MONDO_0013730,graft versus host disease,2.348256349485143,0.635,0.0,0.8265,0.0,1.0,1.9409,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.327113,0.35217,0.025057,HIGH,7
sirolimus,EFO_0000272,astrocytoma,2.322437396824964,0.635,0.0,0.8265,0.0,1.0,1.9196,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.319289,0.356752,0.037462,HIGH,7
sirolimus,EFO_0007141,allergic conjunctivitis,2.3065838161266887,0.635,0.0,0.8265,0.0,1.0,1.9065,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.297282,0.393973,0.096691,HIGH,7
sirolimus,EFO_1002048,kidney failure,2.2880240813616792,0.635,0.0,0.8265,0.0,1.0,1.8912,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.322521,0.335539,0.013018,HIGH,7
sirolimus,EFO_0004599,acute graft vs. host disease,2.2765621694635065,0.635,0.0,0.8265,0.0,1.0,1.8817,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.318749,0.338171,0.019422,HIGH,7
sirolimus,EFO_0003086,kidney disease,2.2455332537921544,0.635,0.0,0.8265,0.0,1.0,1.856,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.315161,0.33205,0.01689,HIGH,7
sirolimus,EFO_0000574,lymphoma,2.0963499320510484,0.635,0.0,0.8265,0.0693,1.0693,1.8528,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.24282,0.412796,0.169976,MEDIUM,7
sirolimus,EFO_0005761,lupus nephritis,2.2328043504009334,0.635,0.0,0.8265,0.0,1.0,1.8455,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.311004,0.334908,0.023903,HIGH,7
sirolimus,EFO_0003884,chronic kidney disease,2.212535421150921,0.635,0.0,0.8265,0.0,1.0,1.8288,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.308573,0.331083,0.02251,HIGH,7
sirolimus,EFO_0005952,non-Hodgkins lymphoma,2.1914213112581873,0.635,0.0,0.8265,0.0,1.0,1.8113,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.272794,0.393592,0.120798,MEDIUM,7
sirolimus,EFO_0000349,clear cell renal carcinoma,1.9610139506504307,0.635,0.0,0.8265,0.1099,1.1099,1.7989,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.274296,0.291843,0.017548,HIGH,7
sirolimus,EFO_0004208,Vitiligo,1.9038358098101864,0.635,0.0,0.8265,0.1386,1.1386,1.7917,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.271977,0.271977,0.0,HIGH,7
sirolimus,HP_0009720,Adenoma sebaceum,2.1632079065002965,0.635,0.0,0.8265,0.0,1.0,1.788,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.30903,0.30903,0.0,HIGH,7
sirolimus,EFO_0000694,severe acute respiratory syndrome,2.153744216287335,0.635,0.0,0.8265,0.0,1.0,1.7802,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.294314,0.334405,0.040091,HIGH,7
sirolimus,MONDO_0001187,urinary bladder cancer,1.8278880349450457,0.635,0.0,0.8265,0.1609,1.1609,1.754,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.23348,0.316421,0.082941,HIGH,7
sirolimus,MONDO_0011705,lymphangioleiomyomatosis,1.9095585820496055,0.635,0.0,0.8265,0.1099,1.1099,1.7517,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.272794,0.272794,0.0,HIGH,7
sirolimus,MONDO_0008315,prostate cancer,2.114000485177445,0.635,0.0,0.8265,0.0,1.0,1.7473,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.243063,0.419874,0.17681,MEDIUM,7
sirolimus,EFO_0003966,eye disease,2.098701482340027,0.635,0.0,0.8265,0.0,1.0,1.7347,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.294314,0.310815,0.016501,HIGH,7
sirolimus,MONDO_0002898,skin cancer,2.069202518020546,0.635,0.0,0.8265,0.0,1.0,1.7103,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.293292,0.300217,0.006925,HIGH,7
sirolimus,EFO_0010134,kidney transplant,2.0601980061907588,0.635,0.0,0.8265,0.0,1.0,1.7028,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.294314,0.294314,0.0,HIGH,7
sirolimus,MONDO_0004768,keratoconjunctivitis,2.0530445408914852,0.635,0.0,0.8265,0.0,1.0,1.6969,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.293292,0.293292,0.0,HIGH,7
sirolimus,MONDO_0024327,chronic renal failure syndrome,2.043722262808428,0.635,0.0,0.8265,0.0,1.0,1.6892,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Acute Lung Injury; Adenocarcinoma of Lung; Adenomatous Polyposis Coli; Anemia; Anemia, Aplastic",,,0.288084,0.299712,0.011628,HIGH,7
spironolactone,MONDO_0014421,glucocorticoid resistance,3.8606368674344367,0.8814,0.0,0.7676,0.2398,1.2398,3.6742,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.286879,1.286879,0.0,HIGH,3
spironolactone,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,3.712397474885377,0.8814,0.0,0.7676,0.2398,1.2398,3.5331,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.237466,1.237466,0.0,HIGH,3
spironolactone,EFO_0000537,hypertension,3.864579948014754,0.8814,0.0,0.7676,0.1609,1.1609,3.4441,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.234072,1.315254,0.081181,HIGH,3
spironolactone,MONDO_0005148,type 2 diabetes mellitus,3.8017844638651064,0.8814,0.0,0.7676,0.1792,1.1792,3.4413,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.770839,1.515473,0.744634,LOW,3
spironolactone,MONDO_0005301,multiple sclerosis,3.5340402945570055,0.8814,0.0,0.7676,0.2398,1.2398,3.3634,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.14962,1.19221,0.04259,HIGH,3
spironolactone,Orphanet_171871,Renal pseudohypoaldosteronism type 1,3.4961644104611516,0.8814,0.0,0.7676,0.2398,1.2398,3.3273,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.165388,1.165388,0.0,HIGH,3
spironolactone,EFO_0000729,ulcerative colitis,3.4431628292846135,0.8814,0.0,0.7676,0.2398,1.2398,3.2769,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.131711,1.155726,0.024014,HIGH,3
spironolactone,EFO_0000400,diabetes mellitus,3.4820054197067662,0.8814,0.0,0.7676,0.2197,1.2197,3.2602,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.809298,1.336354,0.527056,LOW,3
spironolactone,EFO_0000275,atrial fibrillation,3.2798012995946566,0.8814,0.0,0.7676,0.2398,1.2398,3.1214,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.052752,1.174297,0.121545,MEDIUM,3
spironolactone,EFO_0000341,chronic obstructive pulmonary disease,3.782509846998157,0.8814,0.0,0.7676,0.0693,1.0693,3.1049,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.260837,1.260837,0.0,HIGH,3
spironolactone,EFO_0000685,rheumatoid arthritis,3.2426071917878567,0.8814,0.0,0.7676,0.2398,1.2398,3.086,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.054817,1.093895,0.039078,HIGH,3
spironolactone,EFO_0000676,psoriasis,3.1256961482788186,0.8814,0.0,0.7676,0.2398,1.2398,2.9748,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.018514,1.053591,0.035077,HIGH,3
spironolactone,EFO_0000384,Crohn's disease,3.095689656127832,0.8814,0.0,0.7676,0.2398,1.2398,2.9462,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.970935,1.062377,0.091443,HIGH,3
spironolactone,EFO_0004255,nephrotic syndrome,3.0784166803245627,0.8814,0.0,0.7676,0.2398,1.2398,2.9298,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.026139,1.026139,0.0,HIGH,3
spironolactone,MONDO_0011517,pseudohyperaldosteronism type 2,3.230367788178371,0.8814,0.0,0.7676,0.1792,1.1792,2.9241,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.076789,1.076789,0.0,HIGH,3
spironolactone,EFO_0000274,atopic eczema,3.019195740605292,0.8814,0.0,0.7676,0.2398,1.2398,2.8734,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.970745,1.024225,0.05348,HIGH,3
spironolactone,MONDO_0004979,asthma,3.147540067005836,0.8814,0.0,0.7676,0.1792,1.1792,2.8491,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.023892,1.061824,0.037932,HIGH,3
spironolactone,MONDO_0005178,osteoarthritis,2.989520165321954,0.8814,0.0,0.7676,0.2303,1.2303,2.8233,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.978537,1.032446,0.053909,HIGH,3
spironolactone,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,2.921171249549041,0.8814,0.0,0.7676,0.2398,1.2398,2.7801,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.973724,0.973724,0.0,HIGH,3
spironolactone,MONDO_0007915,systemic lupus erythematosus,2.8780456321909305,0.8814,0.0,0.7676,0.2398,1.2398,2.7391,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.925362,0.976342,0.05098,HIGH,3
spironolactone,EFO_0007160,autoimmune thrombocytopenic purpura,3.0429812993462235,0.8814,0.0,0.7676,0.1609,1.1609,2.7119,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.983453,1.076075,0.092622,HIGH,3
spironolactone,EFO_0000574,lymphoma,3.2962438322604575,0.8814,0.0,0.7676,0.0693,1.0693,2.7057,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.022605,1.251034,0.228429,MEDIUM,3
spironolactone,MONDO_0010679,Duchenne muscular dystrophy,2.8185768115678655,0.8814,0.0,0.7676,0.2398,1.2398,2.6825,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.919366,0.979845,0.060479,HIGH,3
spironolactone,EFO_0000768,idiopathic pulmonary fibrosis,2.8146749526619983,0.8814,0.0,0.7676,0.2398,1.2398,2.6788,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.938225,0.938225,0.0,HIGH,3
spironolactone,MONDO_0004992,cancer,3.4401182912402706,0.8814,0.0,0.7676,0.0,1.0,2.6408,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.090448,1.259222,0.168774,MEDIUM,3
spironolactone,MONDO_0011448,PPARG-related familial partial lipodystrophy,2.7333795678810473,0.8814,0.0,0.7676,0.2398,1.2398,2.6014,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.36669,1.36669,0.0,HIGH,2
spironolactone,HP_0001873,Thrombocytopenia,2.804040268673799,0.8814,0.0,0.7676,0.2079,1.2079,2.6001,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.90623,0.991579,0.085349,HIGH,3
spironolactone,EFO_0000565,leukemia,3.372260570121913,0.8814,0.0,0.7676,0.0,1.0,2.5887,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.058205,1.25585,0.197644,MEDIUM,3
spironolactone,EFO_0000544,infection,3.325775423018213,0.8814,0.0,0.7676,0.0,1.0,2.553,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.10051,1.124755,0.024244,HIGH,3
spironolactone,EFO_0000616,neoplasm,3.3185730013043244,0.8814,0.0,0.7676,0.0,1.0,2.5475,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.001201,1.316172,0.314971,LOW,3
spironolactone,EFO_0003144,heart failure,3.312145708420883,0.8814,0.0,0.7676,0.0,1.0,2.5425,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.063134,1.185877,0.122743,MEDIUM,3
spironolactone,EFO_0001645,coronary artery disease,2.6669594372256893,0.8814,0.0,0.7676,0.2303,1.2303,2.5187,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.757917,0.954521,0.196604,MEDIUM,3
spironolactone,EFO_0003060,non-small cell lung carcinoma,2.7792392194184243,0.8814,0.0,0.7676,0.1792,1.1792,2.5157,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.747877,1.283486,0.535609,LOW,3
spironolactone,EFO_0000612,myocardial infarction,3.2766738610256025,0.8814,0.0,0.7676,0.0,1.0,2.5153,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.048328,1.180018,0.131689,MEDIUM,3
spironolactone,EFO_0001378,multiple myeloma,2.77621751872127,0.8814,0.0,0.7676,0.1792,1.1792,2.513,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.797094,1.182029,0.384934,LOW,3
spironolactone,Orphanet_93160,Hypocalcemic vitamin D-resistant rickets,2.6202316654776707,0.8814,0.0,0.7676,0.2398,1.2398,2.4937,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,1.310116,1.310116,0.0,HIGH,2
spironolactone,EFO_1001051,mycosis fungoides,2.63361978458052,0.8814,0.0,0.7676,0.2197,1.2197,2.4659,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.877873,0.877873,0.0,HIGH,3
spironolactone,EFO_0004719,pemphigus vulgaris,2.6852481775463937,0.8814,0.0,0.7676,0.1792,1.1792,2.4306,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.895083,0.895083,0.0,HIGH,3
spironolactone,EFO_0003884,chronic kidney disease,3.1567972602343404,0.8814,0.0,0.7676,0.0,1.0,2.4233,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.943587,1.106605,0.163019,MEDIUM,3
spironolactone,EFO_0003099,Cushing syndrome,2.535899431539365,0.8814,0.0,0.7676,0.2398,1.2398,2.4134,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.8453,0.8453,0.0,HIGH,3
spironolactone,EFO_0004274,gout,3.1299097619656937,0.8814,0.0,0.7676,0.0,1.0,2.4026,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.983222,1.163465,0.180243,MEDIUM,3
spironolactone,EFO_0001422,cirrhosis of liver,2.5041329531328302,0.8814,0.0,0.7676,0.2398,1.2398,2.3832,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.80514,0.849497,0.044357,HIGH,3
spironolactone,EFO_1000941,frozen shoulder,3.0338979817878395,0.8814,0.0,0.7676,0.0,1.0,2.3289,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.975472,1.029213,0.05374,HIGH,3
spironolactone,MONDO_0019338,sarcoidosis,3.0327456356286335,0.8814,0.0,0.7676,0.0,1.0,2.3281,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.975102,1.028822,0.05372,HIGH,3
spironolactone,EFO_0000319,cardiovascular disease,3.016699708616916,0.8814,0.0,0.7676,0.0,1.0,2.3157,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.96332,1.02669,0.06337,HIGH,3
spironolactone,EFO_0005854,allergic rhinitis,3.006042419335226,0.8814,0.0,0.7676,0.0,1.0,2.3076,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.966516,1.019763,0.053247,HIGH,3
spironolactone,HP_0001915,Aplastic anemia,2.7080609632201353,0.8814,0.0,0.7676,0.1099,1.1099,2.3072,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.902687,0.902687,0.0,HIGH,3
spironolactone,EFO_0003894,acne,2.997132685377313,0.8814,0.0,0.7676,0.0,1.0,2.3007,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,True,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.974964,1.011084,0.03612,HIGH,3
spironolactone,EFO_0000701,skin disease,2.9929334325069954,0.8814,0.0,0.7676,0.0,1.0,2.2975,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.962301,1.015316,0.053015,HIGH,3
spironolactone,EFO_0002609,juvenile idiopathic arthritis,2.990407044284281,0.8814,0.0,0.7676,0.0,1.0,2.2956,1,TERMINATED,STOPPED,Type2 Diabetes | Hyperkalemia,The study could not enroll patients owing to the inclusion exclusion criteria,False,Acne Vulgaris; Acute Kidney Injury; Alcoholism; Aortic Valve Stenosis; Arrhythmogenic Right Ventricular Dysplasia,,,0.961489,1.014459,0.05297,HIGH,3
tacrolimus,EFO_0000274,atopic eczema,3.3818918782979153,0.8705,0.0,0.7702,0.2398,1.2398,3.2292,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.475134,0.499113,0.023979,HIGH,7
tacrolimus,EFO_0000681,renal cell carcinoma,3.3613289125629713,0.8705,0.0,0.7702,0.1386,1.1386,2.9477,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.470164,0.500242,0.030078,HIGH,7
tacrolimus,EFO_0000305,breast carcinoma,3.0201979841254167,0.8705,0.0,0.7702,0.1609,1.1609,2.7004,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.400543,0.493285,0.092742,HIGH,7
tacrolimus,MONDO_0007254,breast cancer,3.4644924314953145,0.8705,0.0,0.7702,0.0,1.0,2.6682,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.467169,0.550444,0.083275,HIGH,7
tacrolimus,EFO_0000616,neoplasm,3.415959547447897,0.8705,0.0,0.7702,0.0,1.0,2.6309,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.456832,0.550318,0.093485,HIGH,7
tacrolimus,EFO_1001901,neuroendocrine neoplasm,2.9981665004263323,0.8705,0.0,0.7702,0.0,1.0,2.3091,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.417086,0.450756,0.03367,HIGH,7
tacrolimus,EFO_1000634,hamartoma,2.9329207727021225,0.8705,0.0,0.7702,0.0,1.0,2.2588,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.418989,0.418989,0.0,HIGH,7
tacrolimus,EFO_0000676,psoriasis,2.292937549807291,0.8705,0.0,0.7702,0.2398,1.2398,2.1894,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.285272,0.412143,0.126871,MEDIUM,7
tacrolimus,EFO_0000729,ulcerative colitis,2.2855929201983556,0.8705,0.0,0.7702,0.2398,1.2398,2.1824,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.284904,0.409732,0.124827,MEDIUM,7
tacrolimus,MONDO_0004992,cancer,2.797646777477134,0.8705,0.0,0.7702,0.0,1.0,2.1546,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.358648,0.481696,0.123048,MEDIUM,7
tacrolimus,MONDO_0005147,type 1 diabetes mellitus,2.2381563143674272,0.8705,0.0,0.7702,0.2398,1.2398,2.1371,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.314149,0.330911,0.016762,HIGH,7
tacrolimus,EFO_0004255,nephrotic syndrome,2.2341720640670215,0.8705,0.0,0.7702,0.2398,1.2398,2.1333,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.281225,0.395052,0.113827,MEDIUM,7
tacrolimus,MONDO_0001734,tuberous sclerosis,2.7526063093333946,0.8705,0.0,0.7702,0.0,1.0,2.12,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.390159,0.399371,0.009212,HIGH,7
tacrolimus,EFO_0001645,coronary artery disease,2.2085541859220275,0.8705,0.0,0.7702,0.2303,1.2303,2.0926,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.303769,0.338986,0.035217,HIGH,7
tacrolimus,EFO_0000685,rheumatoid arthritis,2.158876619667233,0.8705,0.0,0.7702,0.2398,1.2398,2.0614,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.264065,0.397103,0.133038,MEDIUM,7
tacrolimus,EFO_1001469,Mantle cell lymphoma,2.6495635097827455,0.8705,0.0,0.7702,0.0,1.0,2.0406,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.363413,0.408701,0.045288,HIGH,7
tacrolimus,MONDO_0004555,kidney angiomyolipoma,2.6210296856537987,0.8705,0.0,0.7702,0.0,1.0,2.0186,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.374433,0.374433,0.0,HIGH,7
tacrolimus,EFO_0000183,Hodgkins lymphoma,2.2566061390415357,0.8705,0.0,0.7702,0.1609,1.1609,2.0177,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.277268,0.41258,0.135311,MEDIUM,7
tacrolimus,EFO_0005772,neurodegenerative disease,2.6172578355598444,0.8705,0.0,0.7702,0.0,1.0,2.0157,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.343907,0.433868,0.089961,HIGH,7
tacrolimus,HP_0000964,Eczematoid dermatitis,2.5752475077384487,0.8705,0.0,0.7702,0.0,1.0,1.9834,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.367893,0.367893,0.0,HIGH,7
tacrolimus,MONDO_0002603,angiomyolipoma,2.5752475077384487,0.8705,0.0,0.7702,0.0,1.0,1.9834,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.367893,0.367893,0.0,HIGH,7
tacrolimus,EFO_0000182,hepatocellular carcinoma,2.2061254949015647,0.8705,0.0,0.7702,0.1609,1.1609,1.9725,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.30369,0.338102,0.034412,HIGH,7
tacrolimus,EFO_1000045,pancreatic neuroendocrine tumor,2.5259555421377504,0.8705,0.0,0.7702,0.0,1.0,1.9454,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.358033,0.366486,0.008453,HIGH,7
tacrolimus,EFO_0004991,Myasthenia gravis,1.990930601019913,0.8705,0.0,0.7702,0.2398,1.2398,1.901,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.280416,0.292424,0.012008,HIGH,7
tacrolimus,EFO_1001496,Autosomal dominant polycystic kidney disease,1.984027907684095,0.8705,0.0,0.7702,0.2398,1.2398,1.8944,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.283433,0.283433,0.0,HIGH,7
tacrolimus,EFO_0000540,immune system disease,2.131849828396141,0.8705,0.0,0.7702,0.1386,1.1386,1.8695,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.294314,0.325022,0.030708,HIGH,7
tacrolimus,EFO_0003869,breast neoplasm,2.0698868498402567,0.8705,0.0,0.7702,0.1386,1.1386,1.8152,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.242402,0.40229,0.159888,MEDIUM,7
tacrolimus,MONDO_0001056,gastric cancer,2.06815413692482,0.8705,0.0,0.7702,0.1386,1.1386,1.8136,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.268198,0.349956,0.081759,HIGH,7
tacrolimus,MONDO_0013730,graft versus host disease,2.348256349485143,0.8705,0.0,0.7702,0.0,1.0,1.8085,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.327113,0.35217,0.025057,HIGH,7
tacrolimus,EFO_0000272,astrocytoma,2.322437396824964,0.8705,0.0,0.7702,0.0,1.0,1.7887,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.319289,0.356752,0.037462,HIGH,7
tacrolimus,EFO_0007141,allergic conjunctivitis,2.3065838161266887,0.8705,0.0,0.7702,0.0,1.0,1.7764,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.297282,0.393973,0.096691,HIGH,7
tacrolimus,EFO_1002048,kidney failure,2.2880240813616792,0.8705,0.0,0.7702,0.0,1.0,1.7622,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.322521,0.335539,0.013018,HIGH,7
tacrolimus,EFO_0004599,acute graft vs. host disease,2.2765621694635065,0.8705,0.0,0.7702,0.0,1.0,1.7533,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.318749,0.338171,0.019422,HIGH,7
tacrolimus,EFO_0003086,kidney disease,2.2455332537921544,0.8705,0.0,0.7702,0.0,1.0,1.7294,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.315161,0.33205,0.01689,HIGH,7
tacrolimus,EFO_0000574,lymphoma,2.0963499320510484,0.8705,0.0,0.7702,0.0693,1.0693,1.7264,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.24282,0.412796,0.169976,MEDIUM,7
tacrolimus,EFO_0005761,lupus nephritis,2.2328043504009334,0.8705,0.0,0.7702,0.0,1.0,1.7196,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.311004,0.334908,0.023903,HIGH,7
tacrolimus,EFO_0003884,chronic kidney disease,2.212535421150921,0.8705,0.0,0.7702,0.0,1.0,1.704,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.308573,0.331083,0.02251,HIGH,7
tacrolimus,EFO_0005952,non-Hodgkins lymphoma,2.1914213112581873,0.8705,0.0,0.7702,0.0,1.0,1.6878,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.272794,0.393592,0.120798,MEDIUM,7
tacrolimus,EFO_0000349,clear cell renal carcinoma,1.9610139506504307,0.8705,0.0,0.7702,0.1099,1.1099,1.6762,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.274296,0.291843,0.017548,HIGH,7
tacrolimus,EFO_0004208,Vitiligo,1.9038358098101864,0.8705,0.0,0.7702,0.1386,1.1386,1.6695,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.271977,0.271977,0.0,HIGH,7
tacrolimus,HP_0009720,Adenoma sebaceum,2.1632079065002965,0.8705,0.0,0.7702,0.0,1.0,1.666,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.30903,0.30903,0.0,HIGH,7
tacrolimus,EFO_0000694,severe acute respiratory syndrome,2.153744216287335,0.8705,0.0,0.7702,0.0,1.0,1.6587,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.294314,0.334405,0.040091,HIGH,7
tacrolimus,MONDO_0001187,urinary bladder cancer,1.8278880349450457,0.8705,0.0,0.7702,0.1609,1.1609,1.6343,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.23348,0.316421,0.082941,HIGH,7
tacrolimus,MONDO_0011705,lymphangioleiomyomatosis,1.9095585820496055,0.8705,0.0,0.7702,0.1099,1.1099,1.6322,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.272794,0.272794,0.0,HIGH,7
tacrolimus,MONDO_0008315,prostate cancer,2.114000485177445,0.8705,0.0,0.7702,0.0,1.0,1.6281,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.243063,0.419874,0.17681,MEDIUM,7
tacrolimus,EFO_0003966,eye disease,2.098701482340027,0.8705,0.0,0.7702,0.0,1.0,1.6163,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.294314,0.310815,0.016501,HIGH,7
tacrolimus,MONDO_0002898,skin cancer,2.069202518020546,0.8705,0.0,0.7702,0.0,1.0,1.5936,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.293292,0.300217,0.006925,HIGH,7
tacrolimus,EFO_0010134,kidney transplant,2.0601980061907588,0.8705,0.0,0.7702,0.0,1.0,1.5867,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.294314,0.294314,0.0,HIGH,7
tacrolimus,MONDO_0004768,keratoconjunctivitis,2.0530445408914852,0.8705,0.0,0.7702,0.0,1.0,1.5812,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,True,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.293292,0.293292,0.0,HIGH,7
tacrolimus,MONDO_0024327,chronic renal failure syndrome,2.043722262808428,0.8705,0.0,0.7702,0.0,1.0,1.574,1,TERMINATED,STOPPED,Atherosclerosis | Kidney Failure,See termination reason in detailed description.,False,"Anemia, Aplastic; Anemia, Sickle Cell; Conjunctivitis, Allergic; Delayed Graft Function; Dermatitis, Atopic",,,0.288084,0.299712,0.011628,HIGH,7
temsirolimus,EFO_0000274,atopic eczema,3.3818918782979153,0.5955,0.0,0.8364,0.2398,1.2398,3.5069,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.475134,0.499113,0.023979,HIGH,7
temsirolimus,EFO_0000681,renal cell carcinoma,3.3613289125629713,0.5955,0.0,0.8364,0.1386,1.1386,3.2011,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.470164,0.500242,0.030078,HIGH,7
temsirolimus,EFO_0000305,breast carcinoma,3.0201979841254167,0.5955,0.0,0.8364,0.1609,1.1609,2.9326,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.400543,0.493285,0.092742,HIGH,7
temsirolimus,MONDO_0007254,breast cancer,3.4644924314953145,0.5955,0.0,0.8364,0.0,1.0,2.8977,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.467169,0.550444,0.083275,HIGH,7
temsirolimus,EFO_0000616,neoplasm,3.415959547447897,0.5955,0.0,0.8364,0.0,1.0,2.8571,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.456832,0.550318,0.093485,HIGH,7
temsirolimus,EFO_1001901,neuroendocrine neoplasm,2.9981665004263323,0.5955,0.0,0.8364,0.0,1.0,2.5076,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.417086,0.450756,0.03367,HIGH,7
temsirolimus,EFO_1000634,hamartoma,2.9329207727021225,0.5955,0.0,0.8364,0.0,1.0,2.4531,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.418989,0.418989,0.0,HIGH,7
temsirolimus,EFO_0000676,psoriasis,2.292937549807291,0.5955,0.0,0.8364,0.2398,1.2398,2.3777,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.285272,0.412143,0.126871,MEDIUM,7
temsirolimus,EFO_0000729,ulcerative colitis,2.2855929201983556,0.5955,0.0,0.8364,0.2398,1.2398,2.37,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.284904,0.409732,0.124827,MEDIUM,7
temsirolimus,MONDO_0004992,cancer,2.797646777477134,0.5955,0.0,0.8364,0.0,1.0,2.3399,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.358648,0.481696,0.123048,MEDIUM,7
temsirolimus,MONDO_0005147,type 1 diabetes mellitus,2.2381563143674272,0.5955,0.0,0.8364,0.2398,1.2398,2.3209,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.314149,0.330911,0.016762,HIGH,7
temsirolimus,EFO_0004255,nephrotic syndrome,2.2341720640670215,0.5955,0.0,0.8364,0.2398,1.2398,2.3167,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.281225,0.395052,0.113827,MEDIUM,7
temsirolimus,MONDO_0001734,tuberous sclerosis,2.7526063093333946,0.5955,0.0,0.8364,0.0,1.0,2.3023,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.390159,0.399371,0.009212,HIGH,7
temsirolimus,EFO_0001645,coronary artery disease,2.2085541859220275,0.5955,0.0,0.8364,0.2303,1.2303,2.2726,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.303769,0.338986,0.035217,HIGH,7
temsirolimus,EFO_0000685,rheumatoid arthritis,2.158876619667233,0.5955,0.0,0.8364,0.2398,1.2398,2.2386,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.264065,0.397103,0.133038,MEDIUM,7
temsirolimus,EFO_1001469,Mantle cell lymphoma,2.6495635097827455,0.5955,0.0,0.8364,0.0,1.0,2.2161,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.363413,0.408701,0.045288,HIGH,7
temsirolimus,MONDO_0004555,kidney angiomyolipoma,2.6210296856537987,0.5955,0.0,0.8364,0.0,1.0,2.1922,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.374433,0.374433,0.0,HIGH,7
temsirolimus,EFO_0000183,Hodgkins lymphoma,2.2566061390415357,0.5955,0.0,0.8364,0.1609,1.1609,2.1912,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.277268,0.41258,0.135311,MEDIUM,7
temsirolimus,EFO_0005772,neurodegenerative disease,2.6172578355598444,0.5955,0.0,0.8364,0.0,1.0,2.1891,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.343907,0.433868,0.089961,HIGH,7
temsirolimus,HP_0000964,Eczematoid dermatitis,2.5752475077384487,0.5955,0.0,0.8364,0.0,1.0,2.1539,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.367893,0.367893,0.0,HIGH,7
temsirolimus,MONDO_0002603,angiomyolipoma,2.5752475077384487,0.5955,0.0,0.8364,0.0,1.0,2.1539,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.367893,0.367893,0.0,HIGH,7
temsirolimus,EFO_0000182,hepatocellular carcinoma,2.2061254949015647,0.5955,0.0,0.8364,0.1609,1.1609,2.1422,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.30369,0.338102,0.034412,HIGH,7
temsirolimus,EFO_1000045,pancreatic neuroendocrine tumor,2.5259555421377504,0.5955,0.0,0.8364,0.0,1.0,2.1127,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.358033,0.366486,0.008453,HIGH,7
temsirolimus,EFO_0004991,Myasthenia gravis,1.990930601019913,0.5955,0.0,0.8364,0.2398,1.2398,2.0645,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.280416,0.292424,0.012008,HIGH,7
temsirolimus,EFO_1001496,Autosomal dominant polycystic kidney disease,1.984027907684095,0.5955,0.0,0.8364,0.2398,1.2398,2.0573,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.283433,0.283433,0.0,HIGH,7
temsirolimus,EFO_0000540,immune system disease,2.131849828396141,0.5955,0.0,0.8364,0.1386,1.1386,2.0302,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.294314,0.325022,0.030708,HIGH,7
temsirolimus,EFO_0003869,breast neoplasm,2.0698868498402567,0.5955,0.0,0.8364,0.1386,1.1386,1.9712,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.242402,0.40229,0.159888,MEDIUM,7
temsirolimus,MONDO_0001056,gastric cancer,2.06815413692482,0.5955,0.0,0.8364,0.1386,1.1386,1.9696,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.268198,0.349956,0.081759,HIGH,7
temsirolimus,MONDO_0013730,graft versus host disease,2.348256349485143,0.5955,0.0,0.8364,0.0,1.0,1.9641,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.327113,0.35217,0.025057,HIGH,7
temsirolimus,EFO_0000272,astrocytoma,2.322437396824964,0.5955,0.0,0.8364,0.0,1.0,1.9425,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.319289,0.356752,0.037462,HIGH,7
temsirolimus,EFO_0007141,allergic conjunctivitis,2.3065838161266887,0.5955,0.0,0.8364,0.0,1.0,1.9292,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.297282,0.393973,0.096691,HIGH,7
temsirolimus,EFO_1002048,kidney failure,2.2880240813616792,0.5955,0.0,0.8364,0.0,1.0,1.9137,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.322521,0.335539,0.013018,HIGH,7
temsirolimus,EFO_0004599,acute graft vs. host disease,2.2765621694635065,0.5955,0.0,0.8364,0.0,1.0,1.9041,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.318749,0.338171,0.019422,HIGH,7
temsirolimus,EFO_0003086,kidney disease,2.2455332537921544,0.5955,0.0,0.8364,0.0,1.0,1.8781,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.315161,0.33205,0.01689,HIGH,7
temsirolimus,EFO_0000574,lymphoma,2.0963499320510484,0.5955,0.0,0.8364,0.0693,1.0693,1.8749,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.24282,0.412796,0.169976,MEDIUM,7
temsirolimus,EFO_0005761,lupus nephritis,2.2328043504009334,0.5955,0.0,0.8364,0.0,1.0,1.8675,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.311004,0.334908,0.023903,HIGH,7
temsirolimus,EFO_0003884,chronic kidney disease,2.212535421150921,0.5955,0.0,0.8364,0.0,1.0,1.8505,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.308573,0.331083,0.02251,HIGH,7
temsirolimus,EFO_0005952,non-Hodgkins lymphoma,2.1914213112581873,0.5955,0.0,0.8364,0.0,1.0,1.8329,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.272794,0.393592,0.120798,MEDIUM,7
temsirolimus,EFO_0000349,clear cell renal carcinoma,1.9610139506504307,0.5955,0.0,0.8364,0.1099,1.1099,1.8204,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.274296,0.291843,0.017548,HIGH,7
temsirolimus,EFO_0004208,Vitiligo,1.9038358098101864,0.5955,0.0,0.8364,0.1386,1.1386,1.8131,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.271977,0.271977,0.0,HIGH,7
temsirolimus,HP_0009720,Adenoma sebaceum,2.1632079065002965,0.5955,0.0,0.8364,0.0,1.0,1.8093,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.30903,0.30903,0.0,HIGH,7
temsirolimus,EFO_0000694,severe acute respiratory syndrome,2.153744216287335,0.5955,0.0,0.8364,0.0,1.0,1.8014,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.294314,0.334405,0.040091,HIGH,7
temsirolimus,MONDO_0001187,urinary bladder cancer,1.8278880349450457,0.5955,0.0,0.8364,0.1609,1.1609,1.7749,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.23348,0.316421,0.082941,HIGH,7
temsirolimus,MONDO_0011705,lymphangioleiomyomatosis,1.9095585820496055,0.5955,0.0,0.8364,0.1099,1.1099,1.7726,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.272794,0.272794,0.0,HIGH,7
temsirolimus,MONDO_0008315,prostate cancer,2.114000485177445,0.5955,0.0,0.8364,0.0,1.0,1.7681,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,True,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.243063,0.419874,0.17681,MEDIUM,7
temsirolimus,EFO_0003966,eye disease,2.098701482340027,0.5955,0.0,0.8364,0.0,1.0,1.7553,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.294314,0.310815,0.016501,HIGH,7
temsirolimus,MONDO_0002898,skin cancer,2.069202518020546,0.5955,0.0,0.8364,0.0,1.0,1.7307,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.293292,0.300217,0.006925,HIGH,7
temsirolimus,EFO_0010134,kidney transplant,2.0601980061907588,0.5955,0.0,0.8364,0.0,1.0,1.7231,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.294314,0.294314,0.0,HIGH,7
temsirolimus,MONDO_0004768,keratoconjunctivitis,2.0530445408914852,0.5955,0.0,0.8364,0.0,1.0,1.7172,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.293292,0.293292,0.0,HIGH,7
temsirolimus,MONDO_0024327,chronic renal failure syndrome,2.043722262808428,0.5955,0.0,0.8364,0.0,1.0,1.7094,1,TERMINATED,STOPPED,Peripheral Arterial Disease,Halted due to pandemic.,False,"Adenocarcinoma; Adenoma; Arthritis, Rheumatoid; Astrocytoma; Brain Neoplasms",,,0.288084,0.299712,0.011628,HIGH,7
temsirolimus + dexamethasone sodium phosphate,MONDO_0014421,glucocorticoid resistance,3.2477208898657226,0.0,0.0,1.0,0.2398,1.2398,4.0265,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.81193,0.81193,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0005301,multiple sclerosis,2.884815112490701,0.0,0.0,1.0,0.2398,1.2398,3.5766,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.695549,0.748876,0.053327,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000729,ulcerative colitis,2.692297450806866,0.0,0.0,1.0,0.2398,1.2398,3.3379,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.634776,0.71164,0.076864,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000685,rheumatoid arthritis,2.6469200832678146,0.0,0.0,1.0,0.2398,1.2398,3.2816,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.638191,0.687121,0.048929,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000341,chronic obstructive pulmonary disease,3.0058495744594236,0.0,0.0,1.0,0.0693,1.0693,3.2142,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.718435,0.78449,0.066055,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000676,psoriasis,2.5709238250449515,0.0,0.0,1.0,0.2398,1.2398,3.1874,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.616017,0.676615,0.060597,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000384,Crohn's disease,2.54619406826739,0.0,0.0,1.0,0.2398,1.2398,3.1567,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.612592,0.660265,0.047673,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0004255,nephrotic syndrome,2.543370586443314,0.0,0.0,1.0,0.2398,1.2398,3.1532,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.617842,0.656039,0.038197,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000274,atopic eczema,2.51247159873651,0.0,0.0,1.0,0.2398,1.2398,3.1149,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.612472,0.644989,0.032517,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0005178,osteoarthritis,2.5035652961087305,0.0,0.0,1.0,0.2303,1.2303,3.08,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.617388,0.638646,0.021258,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0004979,asthma,2.5617335952561295,0.0,0.0,1.0,0.1792,1.1792,3.0207,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.619481,0.662482,0.043001,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000275,atrial fibrillation,2.421273183510201,0.0,0.0,1.0,0.2398,1.2398,3.0019,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.544198,0.660607,0.116409,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0007915,systemic lupus erythematosus,2.4038620505960164,0.0,0.0,1.0,0.2398,1.2398,2.9803,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.583838,0.620182,0.036344,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000768,idiopathic pulmonary fibrosis,2.3956913454293973,0.0,0.0,1.0,0.2398,1.2398,2.9702,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.591954,0.61286,0.020906,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0007160,autoimmune thrombocytopenic purpura,2.5574892853612345,0.0,0.0,1.0,0.1609,1.1609,2.9691,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.62049,0.666801,0.046311,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,2.3772090500914933,0.0,0.0,1.0,0.2398,1.2398,2.9472,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.582273,0.606332,0.024059,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000574,lymphoma,2.666291197826248,0.0,0.0,1.0,0.0693,1.0693,2.8511,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.619925,0.731236,0.11131,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0010679,Duchenne muscular dystrophy,2.297803975253279,0.0,0.0,1.0,0.2398,1.2398,2.8488,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.55734,0.596332,0.038993,HIGH,8
temsirolimus + dexamethasone sodium phosphate,HP_0001873,Thrombocytopenia,2.3495879862897584,0.0,0.0,1.0,0.2079,1.2079,2.8382,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.571768,0.609757,0.03799,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001051,mycosis fungoides,2.2415874767720823,0.0,0.0,1.0,0.2197,1.2197,2.7341,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.553876,0.573438,0.019562,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0004992,cancer,2.71631440252757,0.0,0.0,1.0,0.0,1.0,2.7163,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.630867,0.739358,0.108491,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,EFO_0004719,pemphigus vulgaris,2.285530630524097,0.0,0.0,1.0,0.1792,1.1792,2.695,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.564734,0.584679,0.019945,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000565,leukemia,2.686768327093382,0.0,0.0,1.0,0.0,1.0,2.6868,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.624553,0.732821,0.108269,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000544,infection,2.6603548843502662,0.0,0.0,1.0,0.0,1.0,2.6604,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.628992,0.701863,0.072871,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0003099,Cushing syndrome,2.1332992045641737,0.0,0.0,1.0,0.2398,1.2398,2.6448,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.533325,0.533325,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000616,neoplasm,2.5720312236741245,0.0,0.0,1.0,0.0,1.0,2.572,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.570153,0.738051,0.167898,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,HP_0001915,Aplastic anemia,2.3135814510928574,0.0,0.0,1.0,0.1099,1.1099,2.5678,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.569532,0.596122,0.02659,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0001378,multiple myeloma,2.1527131243488777,0.0,0.0,1.0,0.1792,1.1792,2.5384,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.461151,0.643441,0.18229,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,EFO_0004274,gout,2.537078893569717,0.0,0.0,1.0,0.0,1.0,2.5371,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.596051,0.686054,0.090003,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1000941,frozen shoulder,2.495724552141626,0.0,0.0,1.0,0.0,1.0,2.4957,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.615455,0.636646,0.021192,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0019338,sarcoidosis,2.494776616970647,0.0,0.0,1.0,0.0,1.0,2.4948,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.615221,0.636404,0.021183,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0005854,allergic rhinitis,2.489607780125049,0.0,0.0,1.0,0.0,1.0,2.4896,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.609804,0.635,0.025196,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0003060,non-small cell lung carcinoma,2.111290688437392,0.0,0.0,1.0,0.1792,1.1792,2.4896,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.425893,0.66989,0.243997,MEDIUM,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001494,psoriasis vulgaris,2.475053007968675,0.0,0.0,1.0,0.0,1.0,2.4751,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.60335,0.635383,0.032033,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0000701,skin disease,2.462026572835356,0.0,0.0,1.0,0.0,1.0,2.462,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.607144,0.62805,0.020905,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0002609,juvenile idiopathic arthritis,2.459948332514317,0.0,0.0,1.0,0.0,1.0,2.4599,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.606632,0.62752,0.020888,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0007141,allergic conjunctivitis,2.440498821225389,0.0,0.0,1.0,0.0,1.0,2.4405,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.603026,0.624323,0.021297,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0003106,pneumonia,2.4351423848707427,0.0,0.0,1.0,0.0,1.0,2.4351,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.608786,0.608786,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0003956,seasonal allergic rhinitis,2.4330500713556757,0.0,0.0,1.0,0.0,1.0,2.4331,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.604102,0.616583,0.01248,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001417,"Rhinitis, Allergic, Perennial",2.416519717003027,0.0,0.0,1.0,0.0,1.0,2.4165,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.599998,0.612394,0.012396,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001194,subacute thyroiditis,2.4129732342496286,0.0,0.0,1.0,0.0,1.0,2.413,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.603243,0.603243,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0003778,psoriatic arthritis,2.3984901081600736,0.0,0.0,1.0,0.0,1.0,2.3985,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.599623,0.599623,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001435,tenosynovitis,2.3949000732657613,0.0,0.0,1.0,0.0,1.0,2.3949,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.598725,0.598725,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001119,posterior uveitis,2.3921426116259203,0.0,0.0,1.0,0.0,1.0,2.3921,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.589911,0.610223,0.020312,HIGH,8
temsirolimus + dexamethasone sodium phosphate,MONDO_0018479,congenital adrenal hyperplasia,2.3823137787084634,0.0,0.0,1.0,0.0,1.0,2.3823,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.583523,0.607634,0.02411,HIGH,8
temsirolimus + dexamethasone sodium phosphate,HP_0001742,Nasal congestion,2.3674372367297387,0.0,0.0,1.0,0.0,1.0,2.3674,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.591859,0.591859,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_0005752,eye inflammation,2.3633221905236312,0.0,0.0,1.0,0.0,1.0,2.3633,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.590831,0.590831,0.0,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1001231,uveitis,2.357840506886736,0.0,0.0,1.0,0.0,1.0,2.3578,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.582601,0.603177,0.020576,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1000764,seborrheic dermatitis,2.355024862899123,0.0,0.0,1.0,0.0,1.0,2.355,,,,,,True,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.584729,0.59681,0.01208,HIGH,8
temsirolimus + dexamethasone sodium phosphate,EFO_1000906,dry eye syndrome,2.3514995319280843,0.0,0.0,1.0,0.0,1.0,2.3515,,,,,,False,"Addison Disease; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Anemia, Aplastic; Anemia, Hemolytic",,,0.578866,0.605892,0.027026,HIGH,8
ticagrelor,MONDO_0012354,platelet-type bleeding disorder 8,1.7194684294023383,0.8075,0.0,0.7849,0.2197,1.2197,1.6461,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.573156,0.573156,0.0,HIGH,3
ticagrelor,Orphanet_36355,P2Y12 defect,1.6023435254816034,0.8075,0.0,0.7849,0.2197,1.2197,1.534,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.534115,0.534115,0.0,HIGH,3
ticagrelor,EFO_0001645,coronary artery disease,1.5071440486259289,0.8075,0.0,0.7849,0.2303,1.2303,1.4553,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.48709,0.532964,0.045874,HIGH,3
ticagrelor,EFO_0000712,stroke,1.4160623664361789,0.8075,0.0,0.7849,0.1386,1.1386,1.2655,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.463509,0.489044,0.025536,HIGH,3
ticagrelor,EFO_0000612,myocardial infarction,1.5146976650948338,0.8075,0.0,0.7849,0.0,1.0,1.1888,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.484781,0.545136,0.060355,HIGH,3
ticagrelor,MONDO_0030030,Nizon-Isidor syndrome,1.1834680998443794,0.8075,0.0,0.7849,0.2398,1.2398,1.1516,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.394489,0.394489,0.0,HIGH,3
ticagrelor,EFO_0005672,acute coronary syndrome,1.4597556147353623,0.8075,0.0,0.7849,0.0,1.0,1.1457,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.486585,0.486585,0.0,HIGH,3
ticagrelor,EFO_0008583,acute myocardial infarction,1.425978263976451,0.8075,0.0,0.7849,0.0,1.0,1.1192,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.466755,0.492469,0.025714,HIGH,3
ticagrelor,EFO_0004265,peripheral arterial disease,1.3431350978152992,0.8075,0.0,0.7849,0.0,1.0,1.0542,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.447712,0.447712,0.0,HIGH,3
ticagrelor,HP_0004419,Recurrent thrombophlebitis,1.32206549944891,0.8075,0.0,0.7849,0.0,1.0,1.0376,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.440688,0.440688,0.0,HIGH,3
ticagrelor,MONDO_0005148,type 2 diabetes mellitus,1.1057517768833676,0.8075,0.0,0.7849,0.1792,1.1792,1.0234,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.353897,0.397957,0.04406,HIGH,3
ticagrelor,MONDO_0000831,thrombotic disease,1.2950060458128914,0.8075,0.0,0.7849,0.0,1.0,1.0164,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.431669,0.431669,0.0,HIGH,3
ticagrelor,EFO_0000275,atrial fibrillation,1.0123430858058808,0.8075,0.0,0.7849,0.2398,1.2398,0.9851,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.331363,0.349618,0.018255,HIGH,3
ticagrelor,HP_0001249,Intellectual disability,1.011550814273387,0.8075,0.0,0.7849,0.2398,1.2398,0.9843,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.331103,0.349344,0.018241,HIGH,3
ticagrelor,HP_0001873,Thrombocytopenia,0.95948865206519,0.8075,0.0,0.7849,0.2079,1.2079,0.9097,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.31983,0.31983,0.0,HIGH,3
ticagrelor,EFO_0000508,genetic disorder,1.1420205257968972,0.8075,0.0,0.7849,0.0,1.0,0.8963,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.373809,0.394403,0.020594,HIGH,3
ticagrelor,EFO_0000556,ischemia,1.1313115877073967,0.8075,0.0,0.7849,0.0,1.0,0.8879,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.377104,0.377104,0.0,HIGH,3
ticagrelor,MONDO_0011382,sickle cell disease,0.8780974725618862,0.8075,0.0,0.7849,0.2398,1.2398,0.8545,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.281036,0.316025,0.034989,HIGH,3
ticagrelor,EFO_0000266,aortic stenosis,0.8820835868172695,0.8075,0.0,0.7849,0.2303,1.2303,0.8517,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.294028,0.294028,0.0,HIGH,3
ticagrelor,HP_0002140,Ischemic stroke,1.00522261735663,0.8075,0.0,0.7849,0.0,1.0,0.789,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.324875,0.355472,0.030597,HIGH,3
ticagrelor,EFO_0003884,chronic kidney disease,0.9830770900901408,0.8075,0.0,0.7849,0.0,1.0,0.7716,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.321783,0.339511,0.017728,HIGH,3
ticagrelor,MONDO_0100096,COVID-19,0.9570458391205484,0.8075,0.0,0.7849,0.0,1.0,0.7512,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.293252,0.370541,0.077289,HIGH,3
ticagrelor,HP_0001892,Abnormal bleeding,0.953577362865437,0.8075,0.0,0.7849,0.0,1.0,0.7484,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.317859,0.317859,0.0,HIGH,3
ticagrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.9500770150638485,0.8075,0.0,0.7849,0.0,1.0,0.7457,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.316692,0.316692,0.0,HIGH,3
ticagrelor,EFO_0003875,peripheral vascular disease,0.9354034733108256,0.8075,0.0,0.7849,0.0,1.0,0.7342,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.311801,0.311801,0.0,HIGH,3
ticagrelor,EFO_0000341,chronic obstructive pulmonary disease,0.8475056310805047,0.8075,0.0,0.7849,0.0693,1.0693,0.7113,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.271245,0.305015,0.03377,HIGH,3
ticagrelor,EFO_1000985,intermediate coronary syndrome,0.8829420026531825,0.8075,0.0,0.7849,0.0,1.0,0.693,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.294314,0.294314,0.0,HIGH,3
ticagrelor,EFO_0007328,influenza,0.8598431686956941,0.8075,0.0,0.7849,0.0,1.0,0.6749,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.281446,0.296951,0.015505,HIGH,3
ticagrelor,EFO_0002618,pancreatic carcinoma,0.727870109936644,0.8075,0.0,0.7849,0.1792,1.1792,0.6736,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.207222,0.313427,0.106206,MEDIUM,3
ticagrelor,EFO_0003106,pneumonia,0.8522842942277244,0.8075,0.0,0.7849,0.0,1.0,0.6689,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.284095,0.284095,0.0,HIGH,3
ticagrelor,EFO_0003914,atherosclerosis,0.841839671704794,0.8075,0.0,0.7849,0.0,1.0,0.6607,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.272072,0.297696,0.025624,HIGH,3
ticagrelor,EFO_0002615,internal carotid artery stenosis,0.8092163454316417,0.8075,0.0,0.7849,0.0,1.0,0.6351,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.269739,0.269739,0.0,HIGH,3
ticagrelor,Orphanet_51636,WHIM syndrome,0.6480893110504493,0.8075,0.0,0.7849,0.2398,1.2398,0.6306,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.6480893110504491,0.6480893110504491,0.0,HIGH,1
ticagrelor,MONDO_0024327,chronic renal failure syndrome,0.7823847190176809,0.8075,0.0,0.7849,0.0,1.0,0.6141,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.260795,0.260795,0.0,HIGH,3
ticagrelor,EFO_0003870,brain aneurysm,0.7816444113397121,0.8075,0.0,0.7849,0.0,1.0,0.6135,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.260548,0.260548,0.0,HIGH,3
ticagrelor,EFO_0001365,age-related macular degeneration,0.6294093955478851,0.8075,0.0,0.7849,0.2398,1.2398,0.6125,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.20602,0.21737,0.01135,HIGH,3
ticagrelor,HP_0002239,Gastrointestinal hemorrhage,0.7725742523215346,0.8075,0.0,0.7849,0.0,1.0,0.6064,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.257525,0.257525,0.0,HIGH,3
ticagrelor,HP_0030680,Abnormal cardiovascular system morphology,0.7725742523215346,0.8075,0.0,0.7849,0.0,1.0,0.6064,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.257525,0.257525,0.0,HIGH,3
ticagrelor,EFO_0003913,angina pectoris,0.7481169656613191,0.8075,0.0,0.7849,0.0,1.0,0.5872,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,True,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.249372,0.249372,0.0,HIGH,3
ticagrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.7377470955502146,0.8075,0.0,0.7849,0.0,1.0,0.579,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.245916,0.245916,0.0,HIGH,3
ticagrelor,EFO_1000359,Malignant Pancreatic Neoplasm,0.6180594018572275,0.8075,0.0,0.7849,0.1386,1.1386,0.5523,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.20602,0.20602,0.0,HIGH,3
ticagrelor,EFO_0003764,transient ischemic attack,0.7021465675503611,0.8075,0.0,0.7849,0.0,1.0,0.5511,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.234049,0.234049,0.0,HIGH,3
ticagrelor,MONDO_0004992,cancer,0.6691770779557803,0.8075,0.0,0.7849,0.0,1.0,0.5252,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.052256,0.564665,0.512409,LOW,3
ticagrelor,MONDO_8000006,WHIM syndrome 1,0.5266648178595232,0.8075,0.0,0.7849,0.2398,1.2398,0.5125,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.526664817859523,0.526664817859523,0.0,HIGH,1
ticagrelor,EFO_0009959,diverticular disease,0.6511849190966823,0.8075,0.0,0.7849,0.0,1.0,0.5111,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.217062,0.217062,0.0,HIGH,3
ticagrelor,EFO_1000044,pancreatic adenocarcinoma,0.636602645782718,0.8075,0.0,0.7849,0.0,1.0,0.4996,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.208374,0.219854,0.01148,HIGH,3
ticagrelor,EFO_0003144,heart failure,0.6361434177182461,0.8075,0.0,0.7849,0.0,1.0,0.4993,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.208224,0.219695,0.011471,HIGH,3
ticagrelor,HP_0011869,Abnormal platelet function,0.6357182419102911,0.8075,0.0,0.7849,0.0,1.0,0.499,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.211906,0.211906,0.0,HIGH,3
ticagrelor,EFO_0009086,arteriosclerosis,0.6303085518272392,0.8075,0.0,0.7849,0.0,1.0,0.4947,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.206314,0.21768,0.011366,HIGH,3
ticagrelor,EFO_0020925,angina unstable,0.6278642200270136,0.8075,0.0,0.7849,0.0,1.0,0.4928,5,"TERMINATED,WITHDRAWN",STOPPED,Coronary Artery Disease | Stents | Atherosclerosis,cannot use bioabsorbable scaffold,False,"Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Stable; Aortic Aneurysm, Abdominal; Aortic Valve Stenosis",,,0.209288,0.209288,0.0,HIGH,3
trilipix,MONDO_0005148,type 2 diabetes mellitus,7.837992335340784,0.0,0.0,1.0,0.1792,1.1792,9.2424,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,True,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.696803,0.870795,0.173992,MEDIUM,10
trilipix,EFO_0000400,diabetes mellitus,6.803715946129082,0.0,0.0,1.0,0.2197,1.2197,8.2986,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.597212,0.763535,0.166322,MEDIUM,10
trilipix,EFO_0001645,coronary artery disease,6.071841149152083,0.0,0.0,1.0,0.2303,1.2303,7.4699,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.557746,0.6703,0.112554,MEDIUM,10
trilipix,HP_0003124,Hypercholesterolemia,6.423956816306698,0.0,0.0,1.0,0.0,1.0,6.424,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,True,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.597113,0.701253,0.10414,MEDIUM,10
trilipix,EFO_0000319,cardiovascular disease,6.2704419081008735,0.0,0.0,1.0,0.0,1.0,6.2704,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.593852,0.666079,0.072228,HIGH,10
trilipix,MONDO_0011448,PPARG-related familial partial lipodystrophy,4.591598549494713,0.0,0.0,1.0,0.2398,1.2398,5.6926,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.217285,0.701035,0.48375,LOW,10
trilipix,EFO_0000537,hypertension,4.792973778444817,0.0,0.0,1.0,0.1609,1.1609,5.5644,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.34997,0.619184,0.269215,LOW,10
trilipix,HP_0003119,Abnormal circulating lipid concentration,5.503534078363644,0.0,0.0,1.0,0.0,1.0,5.5035,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.528705,0.582826,0.054121,HIGH,10
trilipix,Orphanet_79211,Combined hyperlipidemia,4.359780940524052,0.0,0.0,1.0,0.2303,1.2303,5.3637,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.426314,0.447164,0.02085,HIGH,10
trilipix,EFO_0000729,ulcerative colitis,4.282324746257909,0.0,0.0,1.0,0.2398,1.2398,5.3092,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.249611,0.590915,0.341305,LOW,10
trilipix,EFO_0001073,obesity,4.113635364154506,0.0,0.0,1.0,0.1946,1.1946,4.9141,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.256244,0.563003,0.306758,LOW,10
trilipix,MONDO_0021187,hyperlipidemia,4.86137110822923,0.0,0.0,1.0,0.0,1.0,4.8614,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.407528,0.598252,0.190724,MEDIUM,10
trilipix,Orphanet_309005,Disorder of lipid metabolism,4.592936956841971,0.0,0.0,1.0,0.0,1.0,4.5929,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.429981,0.49779,0.06781,HIGH,10
trilipix,EFO_0000195,metabolic syndrome,3.63821133271639,0.0,0.0,1.0,0.2398,1.2398,4.5106,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.253633,0.472316,0.218683,MEDIUM,10
trilipix,EFO_1001486,primary biliary cirrhosis,4.437461186046076,0.0,0.0,1.0,0.0,1.0,4.4375,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.436609,0.450884,0.014275,HIGH,10
trilipix,MONDO_0004975,Alzheimer disease,3.472067524174794,0.0,0.0,1.0,0.2398,1.2398,4.3046,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.218696,0.48004,0.261344,LOW,10
trilipix,EFO_0000612,myocardial infarction,4.2822343211435125,0.0,0.0,1.0,0.0,1.0,4.2822,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.313248,0.543991,0.230743,MEDIUM,10
trilipix,EFO_0003770,diabetic retinopathy,4.180956798289074,0.0,0.0,1.0,0.0,1.0,4.181,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.374667,0.474423,0.099757,HIGH,10
trilipix,EFO_0004211,Hypertriglyceridemia,4.122533474358606,0.0,0.0,1.0,0.0,1.0,4.1225,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,True,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.40776,0.418993,0.011232,HIGH,10
trilipix,EFO_0003914,atherosclerosis,4.100104553534541,0.0,0.0,1.0,0.0,1.0,4.1001,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.337847,0.495925,0.158078,MEDIUM,10
trilipix,EFO_0004705,hypothyroidism,4.0350371122340265,0.0,0.0,1.0,0.0,1.0,4.035,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.384323,0.42874,0.044417,HIGH,10
trilipix,EFO_0000589,metabolic disease,4.0142682782789105,0.0,0.0,1.0,0.0,1.0,4.0143,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.350801,0.472512,0.121711,MEDIUM,10
trilipix,EFO_1000727,lipodystrophy,3.852092884139857,0.0,0.0,1.0,0.0,1.0,3.8521,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.314312,0.449679,0.135367,MEDIUM,10
trilipix,EFO_0004268,sclerosing cholangitis,3.0444839405389423,0.0,0.0,1.0,0.2398,1.2398,3.7745,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.293151,0.322785,0.029634,HIGH,10
trilipix,HP_0002027,Abdominal pain,3.71382920101241,0.0,0.0,1.0,0.0,1.0,3.7138,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.371383,0.371383,0.0,HIGH,10
trilipix,EFO_0000384,Crohn's disease,2.993107770956096,0.0,0.0,1.0,0.2398,1.2398,3.7108,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.290961,0.55353,0.262568,LOW,7
trilipix,MONDO_0005301,multiple sclerosis,2.9516808661785343,0.0,0.0,1.0,0.2398,1.2398,3.6595,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.09761,0.492726,0.395116,LOW,10
trilipix,EFO_0001074,morbid obesity,3.5475227811069536,0.0,0.0,1.0,0.0,1.0,3.5475,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.182054,0.512905,0.330852,LOW,10
trilipix,MONDO_0005180,Parkinson disease,2.8496558571521673,0.0,0.0,1.0,0.2398,1.2398,3.533,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.18363,0.40281,0.21918,MEDIUM,10
trilipix,EFO_1001249,non-alcoholic steatohepatitis,3.420159042923246,0.0,0.0,1.0,0.0,1.0,3.4202,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.334731,0.349477,0.014745,HIGH,10
trilipix,EFO_0000275,atrial fibrillation,2.709518033505665,0.0,0.0,1.0,0.2398,1.2398,3.3592,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.1375,0.418892,0.281392,LOW,10
trilipix,EFO_0003095,non-alcoholic fatty liver disease,3.0067386780125336,0.0,0.0,1.0,0.1099,1.1099,3.3371,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.207587,0.394526,0.186939,MEDIUM,10
trilipix,EFO_0000341,chronic obstructive pulmonary disease,3.073657286118092,0.0,0.0,1.0,0.0693,1.0693,3.2867,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.158957,0.491815,0.332858,LOW,10
trilipix,MONDO_0002009,major depressive disorder,2.9479932319360547,0.0,0.0,1.0,0.1099,1.1099,3.2719,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.210008,0.387656,0.177648,MEDIUM,10
trilipix,HP_0001397,Hepatic steatosis,3.254286511047467,0.0,0.0,1.0,0.0,1.0,3.2543,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.296643,0.355579,0.058936,HIGH,10
trilipix,MONDO_0018473,hyperlipoproteinemia type 3,3.24376271713937,0.0,0.0,1.0,0.0,1.0,3.2438,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.268176,0.408677,0.140502,MEDIUM,10
trilipix,MONDO_0004979,asthma,2.727969072159747,0.0,0.0,1.0,0.1792,1.1792,3.2168,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.345348,0.563975,0.218628,MEDIUM,6
trilipix,EFO_0009321,diabetic macular edema,3.197156002742531,0.0,0.0,1.0,0.0,1.0,3.1972,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.289544,0.364974,0.07543,HIGH,10
trilipix,EFO_1001375,Myocardial Ischemia,3.168624607999939,0.0,0.0,1.0,0.0,1.0,3.1686,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.288938,0.355618,0.066681,HIGH,10
trilipix,EFO_0000660,polycystic ovary syndrome,2.569757361627562,0.0,0.0,1.0,0.2079,1.2079,3.1041,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.173529,0.338633,0.165105,MEDIUM,10
trilipix,EFO_0000182,hepatocellular carcinoma,2.6667970962337613,0.0,0.0,1.0,0.1609,1.1609,3.096,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.19144,0.345523,0.154083,MEDIUM,10
trilipix,EFO_0003767,inflammatory bowel disease,2.581397831756751,0.0,0.0,1.0,0.1792,1.1792,3.0439,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.173315,0.34329,0.169976,MEDIUM,10
trilipix,MONDO_0019182,inherited obesity,2.5418189817569132,0.0,0.0,1.0,0.1946,1.1946,3.0364,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.508364,0.508364,0.0,HIGH,5
trilipix,MONDO_0015515,carnitine palmitoyltransferase II deficiency,2.9452508932403907,0.0,0.0,1.0,0.0,1.0,2.9453,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.289788,0.299262,0.009475,HIGH,10
trilipix,EFO_0000616,neoplasm,2.941449194334525,0.0,0.0,1.0,0.0,1.0,2.9414,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.190219,0.423913,0.233695,MEDIUM,10
trilipix,EFO_0000685,rheumatoid arthritis,2.3678236697461905,0.0,0.0,1.0,0.2398,1.2398,2.9356,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.230959,0.558315,0.327356,LOW,6
trilipix,EFO_0005422,skin aging,2.902942752307782,0.0,0.0,1.0,0.0,1.0,2.9029,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.290294,0.290294,0.0,HIGH,10
trilipix,EFO_0001378,multiple myeloma,2.4084425699594405,0.0,0.0,1.0,0.1792,1.1792,2.84,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.151331,0.346955,0.195624,MEDIUM,10
trilipix,MONDO_0018883,Berardinelli-Seip congenital lipodystrophy,2.265426281484382,0.0,0.0,1.0,0.2398,1.2398,2.8087,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.117844,0.335242,0.217398,MEDIUM,10
trilipix,EFO_0000676,psoriasis,2.2607732984535858,0.0,0.0,1.0,0.2398,1.2398,2.8029,1,WITHDRAWN,STOPPED,Coronary Atherosclerosis,Lack of patient population,False,"Alcoholism; Cholestasis; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertriglyceridemia",,,0.299343,0.604966,0.305624,LOW,5
urokinase,MONDO_0011136,Quebec platelet disorder,2.149329359108869,0.0,0.0,1.0,0.2079,1.2079,2.5963,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.045856,1.103474,0.057618,HIGH,2
urokinase,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.5041761154058717,0.0,0.0,1.0,0.2398,1.2398,1.8649,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.059769,1.444407,1.384638,LOW,2
urokinase,MONDO_0004976,amyotrophic lateral sclerosis,1.416900905603781,0.0,0.0,1.0,0.2398,1.2398,1.7567,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.41690090560378,1.41690090560378,0.0,HIGH,1
urokinase,EFO_0003767,inflammatory bowel disease,1.471696880333475,0.0,0.0,1.0,0.1792,1.1792,1.7354,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.716122,0.755575,0.039452,HIGH,2
urokinase,EFO_0003060,non-small cell lung carcinoma,1.4613578947884471,0.0,0.0,1.0,0.1792,1.1792,1.7232,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.150922,1.310435,1.159513,LOW,2
urokinase,EFO_0004214,Abdominal Aortic Aneurysm,1.67368455313435,0.0,0.0,1.0,0.0,1.0,1.6737,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.814409,0.859276,0.044867,HIGH,2
urokinase,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.0,0.0,1.0,0.2398,1.2398,1.6286,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.313641444940749,1.313641444940749,0.0,HIGH,1
urokinase,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.0,0.0,1.0,0.2398,1.2398,1.6277,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.312919255867715,1.312919255867715,0.0,HIGH,1
urokinase,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,0.0,0.0,1.0,0.2398,1.2398,1.6089,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.297733536121243,1.297733536121243,0.0,HIGH,1
urokinase,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",1.2786414434034508,0.0,0.0,1.0,0.2398,1.2398,1.5852,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.27864144340345,1.27864144340345,0.0,HIGH,1
urokinase,Orphanet_183506,Genetic central nervous system malformation,1.2763070556018696,0.0,0.0,1.0,0.2398,1.2398,1.5824,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.276307055601869,1.276307055601869,0.0,HIGH,1
urokinase,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,1.0,0.1792,1.1792,1.5571,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.320513540780355,1.320513540780355,0.0,HIGH,1
urokinase,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,1.0,0.1792,1.1792,1.5548,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.318525014371726,1.318525014371726,0.0,HIGH,1
urokinase,MONDO_0019200,retinitis pigmentosa,1.2850784056268851,0.0,0.0,1.0,0.2079,1.2079,1.5523,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.285078405626885,1.285078405626885,0.0,HIGH,1
urokinase,EFO_1001985,congenital fibrosis of the extraocular muscles,1.2462325847941036,0.0,0.0,1.0,0.2398,1.2398,1.5451,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.246232584794103,1.246232584794103,0.0,HIGH,1
urokinase,EFO_0000616,neoplasm,1.539771175516489,0.0,0.0,1.0,0.0,1.0,1.5398,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.189842,1.349929,1.160088,LOW,2
urokinase,MONDO_0012905,hypomyelinating leukodystrophy 6,1.2303472963501092,0.0,0.0,1.0,0.2398,1.2398,1.5254,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.230347296350109,1.230347296350109,0.0,HIGH,1
urokinase,EFO_0000305,breast carcinoma,1.301626846415899,0.0,0.0,1.0,0.1609,1.1609,1.5111,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.067743,1.233883,1.16614,LOW,2
urokinase,EFO_0005772,neurodegenerative disease,1.5082515139452746,0.0,0.0,1.0,0.0,1.0,1.5083,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.400619,1.107632,0.707013,LOW,2
urokinase,MONDO_0008170,ovarian cancer,1.2759066576405158,0.0,0.0,1.0,0.1792,1.1792,1.5045,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.138739,1.137167,0.998428,LOW,2
urokinase,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,1.213336275379104,0.0,0.0,1.0,0.2398,1.2398,1.5043,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.213336275379104,1.213336275379104,0.0,HIGH,1
urokinase,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,1.2090169792908507,0.0,0.0,1.0,0.2398,1.2398,1.4989,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.20901697929085,1.20901697929085,0.0,HIGH,1
urokinase,MONDO_0007254,breast cancer,1.4959507103475584,0.0,0.0,1.0,0.0,1.0,1.496,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.172995,1.322956,1.149961,LOW,2
urokinase,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,1.200098212718321,0.0,0.0,1.0,0.2398,1.2398,1.4879,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.200098212718321,1.200098212718321,0.0,HIGH,1
urokinase,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,1.200066497163491,0.0,0.0,1.0,0.2398,1.2398,1.4878,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.20006649716349,1.20006649716349,0.0,HIGH,1
urokinase,EFO_0003869,breast neoplasm,1.298066778620186,0.0,0.0,1.0,0.1386,1.1386,1.478,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.067118,1.230949,1.163831,LOW,2
urokinase,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,1.1875585571904996,0.0,0.0,1.0,0.2398,1.2398,1.4723,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.187558557190499,1.187558557190499,0.0,HIGH,1
urokinase,Orphanet_98805,"Primary dystonia, DYT4 type",1.1805625585435782,0.0,0.0,1.0,0.2398,1.2398,1.4636,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.180562558543578,1.180562558543578,0.0,HIGH,1
urokinase,EFO_0001378,multiple myeloma,1.236474857620992,0.0,0.0,1.0,0.1792,1.1792,1.458,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.035381,1.201094,1.165713,LOW,2
urokinase,MONDO_0008315,prostate cancer,1.4561097599280524,0.0,0.0,1.0,0.0,1.0,1.4561,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.144869,1.311241,1.166372,LOW,2
urokinase,Orphanet_404469,Female infertility due to fertilization defect,1.2136046598229504,0.0,0.0,1.0,0.1792,1.1792,1.4311,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.21360465982295,1.21360465982295,0.0,HIGH,1
urokinase,MONDO_0004992,cancer,1.424116339518516,0.0,0.0,1.0,0.0,1.0,1.4241,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.17145,1.252666,1.081216,LOW,2
urokinase,MONDO_0002974,cervical cancer,1.2505473636280948,0.0,0.0,1.0,0.1386,1.1386,1.4239,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.159526,1.091021,0.931494,LOW,2
urokinase,MONDO_0007493,torsion dystonia 4,1.1464047185131627,0.0,0.0,1.0,0.2398,1.2398,1.4213,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.146404718513162,1.146404718513162,0.0,HIGH,1
urokinase,EFO_0003914,atherosclerosis,1.39533476223681,0.0,0.0,1.0,0.0,1.0,1.3953,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.556425,0.83891,0.282485,LOW,2
urokinase,MONDO_0018998,Leber congenital amaurosis,1.105326947068426,0.0,0.0,1.0,0.2398,1.2398,1.3704,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.105326947068426,1.105326947068426,0.0,HIGH,1
urokinase,EFO_0001422,cirrhosis of liver,1.0940240067497369,0.0,0.0,1.0,0.2398,1.2398,1.3564,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.060288,1.033736,0.973448,LOW,2
urokinase,EFO_0000183,Hodgkins lymphoma,1.1599017756147956,0.0,0.0,1.0,0.1609,1.1609,1.3466,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.159901775614795,1.159901775614795,0.0,HIGH,1
urokinase,MONDO_0014341,complex cortical dysplasia with other brain malformations 6,1.0765187665341702,0.0,0.0,1.0,0.2398,1.2398,1.3347,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.07651876653417,1.07651876653417,0.0,HIGH,1
urokinase,HP_0001339,Lissencephaly,1.0471078353307095,0.0,0.0,1.0,0.2398,1.2398,1.2982,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.047107835330709,1.047107835330709,0.0,HIGH,1
urokinase,MONDO_0060650,Leber congenital amaurosis with early-onset deafness,1.0257955750077703,0.0,0.0,1.0,0.2398,1.2398,1.2718,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.02579557500777,1.02579557500777,0.0,HIGH,1
urokinase,EFO_0002618,pancreatic carcinoma,1.0716699961263496,0.0,0.0,1.0,0.1792,1.1792,1.2637,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.071669996126349,1.071669996126349,0.0,HIGH,1
urokinase,EFO_0000574,lymphoma,1.1817188701483212,0.0,0.0,1.0,0.0693,1.0693,1.2636,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.181718870148321,1.181718870148321,0.0,HIGH,1
urokinase,EFO_0000712,stroke,1.095789395668725,0.0,0.0,1.0,0.1386,1.1386,1.2477,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,True,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.533207,0.562582,0.029375,HIGH,2
urokinase,MONDO_0015372,autosomal dominant macrothrombocytopenia,1.244239704511393,0.0,0.0,1.0,0.0,1.0,1.2442,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.244239704511393,1.244239704511393,0.0,HIGH,1
urokinase,EFO_0000673,prostate adenocarcinoma,1.092280300968928,0.0,0.0,1.0,0.1386,1.1386,1.2437,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.092280300968928,1.092280300968928,0.0,HIGH,1
urokinase,MONDO_0100153,tubulinopathy,1.241911280655119,0.0,0.0,1.0,0.0,1.0,1.2419,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,1.241911280655119,1.241911280655119,0.0,HIGH,1
urokinase,HP_0001249,Intellectual disability,0.9721168921473198,0.0,0.0,1.0,0.2398,1.2398,1.2052,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.9721168921473191,0.9721168921473191,0.0,HIGH,1
urokinase,MONDO_0001056,gastric cancer,1.0489694385434765,0.0,0.0,1.0,0.1386,1.1386,1.1944,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,False,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.126399,0.922571,0.796172,LOW,2
urokinase,HP_0004419,Recurrent thrombophlebitis,1.1772560035375763,0.0,0.0,1.0,0.0,1.0,1.1773,1,TERMINATED,STOPPED,Diabetic Foot | Critical Limb Ischemia,recruition number was not reached,True,"Empyema; Empyema, Pleural; Infections; Pulmonary Embolism; ST Elevation Myocardial Infarction",,,0.588628,0.588628,0.0,HIGH,2
veliflapon (dg-031),MONDO_0004985,bipolar disorder,1.9093555233579316,0.0,0.0,1.0,0.0,1.0,1.9094,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.636452,0.636452,0.0,HIGH,3
veliflapon (dg-031),EFO_0000729,ulcerative colitis,1.5353039648148106,0.0,0.0,1.0,0.2398,1.2398,1.9035,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.511768,0.511768,0.0,HIGH,3
veliflapon (dg-031),HP_0002140,Ischemic stroke,1.8275135044215132,0.0,0.0,1.0,0.0,1.0,1.8275,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.609171,0.609171,0.0,HIGH,3
veliflapon (dg-031),EFO_0003767,inflammatory bowel disease,1.529250302691651,0.0,0.0,1.0,0.1792,1.1792,1.8033,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.50975,0.50975,0.0,HIGH,3
veliflapon (dg-031),EFO_0005672,acute coronary syndrome,1.247682891332538,0.0,0.0,1.0,0.0,1.0,1.2477,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,True,Acute Coronary Syndrome,,,0.415894,0.415894,0.0,HIGH,3
veliflapon (dg-031),MONDO_0004979,asthma,0.5466041894608349,0.0,0.0,1.0,0.1792,1.1792,0.6445,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.182201,0.182201,0.0,HIGH,3
veliflapon (dg-031),HP_0000924,Abnormality of the skeletal system,0.6145009866769142,0.0,0.0,1.0,0.0,1.0,0.6145,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.204834,0.204834,0.0,HIGH,3
veliflapon (dg-031),EFO_0003898,ankylosing spondylitis,0.5597934951380291,0.0,0.0,1.0,0.0,1.0,0.5598,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.186598,0.186598,0.0,HIGH,3
veliflapon (dg-031),MONDO_0009061,cystic fibrosis,0.4414710013265909,0.0,0.0,1.0,0.2398,1.2398,0.5473,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.147157,0.147157,0.0,HIGH,3
veliflapon (dg-031),EFO_0005543,glioma,0.3652201299774622,0.0,0.0,1.0,0.2398,1.2398,0.4528,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.12174,0.12174,0.0,HIGH,3
veliflapon (dg-031),EFO_0000222,acute myeloid leukemia,0.3804008461430793,0.0,0.0,1.0,0.1386,1.1386,0.4331,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.1268,0.1268,0.0,HIGH,3
veliflapon (dg-031),MONDO_0005178,osteoarthritis,0.2979599339801302,0.0,0.0,1.0,0.2303,1.2303,0.3666,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.09932,0.09932,0.0,HIGH,3
veliflapon (dg-031),MONDO_0008170,ovarian cancer,0.3040636426870243,0.0,0.0,1.0,0.1792,1.1792,0.3585,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.101355,0.101355,0.0,HIGH,3
veliflapon (dg-031),EFO_0009003,ovarian dysfunction,0.3541579134567177,0.0,0.0,1.0,0.0,1.0,0.3542,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.118053,0.118053,0.0,HIGH,3
veliflapon (dg-031),EFO_0009482,drug allergy,0.3541579134567177,0.0,0.0,1.0,0.0,1.0,0.3542,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.118053,0.118053,0.0,HIGH,3
veliflapon (dg-031),MONDO_0007319,chondrocalcinosis 2,0.2748833905460063,0.0,0.0,1.0,0.1792,1.1792,0.3241,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.091628,0.091628,0.0,HIGH,3
veliflapon (dg-031),EFO_0000637,osteosarcoma,0.2799338048974595,0.0,0.0,1.0,0.1386,1.1386,0.3187,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.093311,0.093311,0.0,HIGH,3
veliflapon (dg-031),HP_0000505,Visual impairment,0.3096103079464928,0.0,0.0,1.0,0.0,1.0,0.3096,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.103203,0.103203,0.0,HIGH,3
veliflapon (dg-031),EFO_0000182,hepatocellular carcinoma,0.2398482518807279,0.0,0.0,1.0,0.1609,1.1609,0.2785,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.079949,0.079949,0.0,HIGH,3
veliflapon (dg-031),MONDO_0015699,immunodeficiency due to a classical component pathway complement deficiency,0.1882520643856848,0.0,0.0,1.0,0.2398,1.2398,0.2334,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.062751,0.062751,0.0,HIGH,3
veliflapon (dg-031),MONDO_0004975,Alzheimer disease,0.1847675429510512,0.0,0.0,1.0,0.2398,1.2398,0.2291,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.061589,0.061589,0.0,HIGH,3
veliflapon (dg-031),EFO_1000860,cerebral atherosclerosis,0.2285065480483188,0.0,0.0,1.0,0.0,1.0,0.2285,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.076169,0.076169,0.0,HIGH,3
veliflapon (dg-031),EFO_0001645,coronary artery disease,0.1821715218864384,0.0,0.0,1.0,0.2303,1.2303,0.2241,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.060724,0.060724,0.0,HIGH,3
veliflapon (dg-031),Orphanet_169142,Recurrent infection due to specific granule deficiency,0.1788134143773225,0.0,0.0,1.0,0.2398,1.2398,0.2217,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.059604,0.059604,0.0,HIGH,3
veliflapon (dg-031),EFO_1001348,HIV-Associated Lipodystrophy Syndrome,0.2207355006632954,0.0,0.0,1.0,0.0,1.0,0.2207,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.073579,0.073579,0.0,HIGH,3
veliflapon (dg-031),MONDO_0008903,lung cancer,0.1803536576486172,0.0,0.0,1.0,0.1792,1.1792,0.2127,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.060118,0.060118,0.0,HIGH,3
veliflapon (dg-031),EFO_0000519,glioblastoma multiforme,0.2074277795358278,0.0,0.0,1.0,0.0,1.0,0.2074,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.069143,0.069143,0.0,HIGH,3
veliflapon (dg-031),EFO_0000571,lung adenocarcinoma,0.1734636489252585,0.0,0.0,1.0,0.1792,1.1792,0.2045,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.057821,0.057821,0.0,HIGH,3
veliflapon (dg-031),EFO_0000616,neoplasm,0.2013569281310758,0.0,0.0,1.0,0.0,1.0,0.2014,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.067119,0.067119,0.0,HIGH,3
veliflapon (dg-031),MONDO_0007114,Angel-shaped phalango-epiphyseal dysplasia,0.1635208588913689,0.0,0.0,1.0,0.1946,1.1946,0.1953,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.054507,0.054507,0.0,HIGH,3
veliflapon (dg-031),EFO_0009028,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,0.1481223503650974,0.0,0.0,1.0,0.2398,1.2398,0.1836,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.049374,0.049374,0.0,HIGH,3
veliflapon (dg-031),MONDO_0009296,glycoprotein storage disease,0.1598125024802259,0.0,0.0,1.0,0.1386,1.1386,0.182,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.053271,0.053271,0.0,HIGH,3
veliflapon (dg-031),EFO_0001071,lung carcinoma,0.1747076233090338,0.0,0.0,1.0,0.0,1.0,0.1747,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.058236,0.058236,0.0,HIGH,3
veliflapon (dg-031),MONDO_0004992,cancer,0.17335743623348,0.0,0.0,1.0,0.0,1.0,0.1734,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.057786,0.057786,0.0,HIGH,3
veliflapon (dg-031),EFO_0000341,chronic obstructive pulmonary disease,0.1590767174780146,0.0,0.0,1.0,0.0693,1.0693,0.1701,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.053026,0.053026,0.0,HIGH,3
veliflapon (dg-031),MONDO_0100319,COVID-19associated multisystem inflammatory syndrome in adults,0.1677589805041043,0.0,0.0,1.0,0.0,1.0,0.1678,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.05592,0.05592,0.0,HIGH,3
veliflapon (dg-031),MONDO_0012330,talo-patello-scaphoid osteolysis,0.1557509692680209,0.0,0.0,1.0,0.0,1.0,0.1558,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.051917,0.051917,0.0,HIGH,3
veliflapon (dg-031),HP_0001297,Stroke,0.1415911341666207,0.0,0.0,1.0,0.0,1.0,0.1416,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.047197,0.047197,0.0,HIGH,3
veliflapon (dg-031),MONDO_0005575,colorectal cancer,0.1119864773365117,0.0,0.0,1.0,0.2079,1.2079,0.1353,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.037329,0.037329,0.0,HIGH,3
veliflapon (dg-031),EFO_1000391,Nasal Cavity Polyp,0.1283209043855956,0.0,0.0,1.0,0.0,1.0,0.1283,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.042774,0.042774,0.0,HIGH,3
veliflapon (dg-031),EFO_0004265,peripheral arterial disease,0.1183142283555263,0.0,0.0,1.0,0.0,1.0,0.1183,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.039438,0.039438,0.0,HIGH,3
veliflapon (dg-031),EFO_0004911,familial hypercholesterolemia,0.094376689616929,0.0,0.0,1.0,0.2303,1.2303,0.1161,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.031459,0.031459,0.0,HIGH,3
veliflapon (dg-031),EFO_0000612,myocardial infarction,0.1149935858093071,0.0,0.0,1.0,0.0,1.0,0.115,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.038331,0.038331,0.0,HIGH,3
veliflapon (dg-031),EFO_0003914,atherosclerosis,0.1118379233436397,0.0,0.0,1.0,0.0,1.0,0.1118,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.037279,0.037279,0.0,HIGH,3
veliflapon (dg-031),MONDO_0002679,cerebral infarction,0.0993633359348576,0.0,0.0,1.0,0.0,1.0,0.0994,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.033121,0.033121,0.0,HIGH,3
veliflapon (dg-031),EFO_0003075,xanthoma,0.0988895042971564,0.0,0.0,1.0,0.0,1.0,0.0989,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.032963,0.032963,0.0,HIGH,3
veliflapon (dg-031),EFO_0003060,non-small cell lung carcinoma,0.0833499322270873,0.0,0.0,1.0,0.1792,1.1792,0.0983,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.027783,0.027783,0.0,HIGH,3
veliflapon (dg-031),EFO_0003918,obstructive sleep apnea,0.0820155015797841,0.0,0.0,1.0,0.1946,1.1946,0.098,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.027339,0.027339,0.0,HIGH,3
veliflapon (dg-031),MONDO_0002108,thyroid cancer,0.0899619796036629,0.0,0.0,1.0,0.0,1.0,0.09,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.029987,0.029987,0.0,HIGH,3
veliflapon (dg-031),HP_0100806,Sepsis,0.0832610292988191,0.0,0.0,1.0,0.0,1.0,0.0833,1,SUSPENDED,STOPPED,Acute Coronary Syndrome,,False,Acute Coronary Syndrome,,,0.027754,0.027754,0.0,HIGH,3
vonapanitase,MONDO_0008504,supravalvular aortic stenosis,3.725054510332811,0.0,0.0,1.0,0.1792,1.1792,4.3925,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.241685,1.241685,0.0,HIGH,3
vonapanitase,MONDO_0007411,"cutis laxa, autosomal dominant 1",3.510372775804687,0.0,0.0,1.0,0.2398,1.2398,4.3521,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.170124,1.170124,0.0,HIGH,3
vonapanitase,MONDO_0019571,autosomal dominant cutis laxa,3.057560344296528,0.0,0.0,1.0,0.0,1.0,3.0576,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.019187,1.019187,0.0,HIGH,3
vonapanitase,MONDO_0008678,Williams syndrome,2.247321778506728,0.0,0.0,1.0,0.2398,1.2398,2.7862,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.749107,0.749107,0.0,HIGH,3
vonapanitase,HP_0000023,Inguinal hernia,2.775243000607517,0.0,0.0,1.0,0.0,1.0,2.7752,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.925081,0.925081,0.0,HIGH,3
vonapanitase,EFO_0009959,diverticular disease,2.651827977308746,0.0,0.0,1.0,0.0,1.0,2.6518,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.883943,0.883943,0.0,HIGH,3
vonapanitase,HP_0004299,Hernia of the abdominal wall,2.599454783479925,0.0,0.0,1.0,0.0,1.0,2.5995,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.866485,0.866485,0.0,HIGH,3
vonapanitase,EFO_0005422,skin aging,2.439673047715772,0.0,0.0,1.0,0.0,1.0,2.4397,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.813224,0.813224,0.0,HIGH,3
vonapanitase,HP_0100790,Hernia,2.4364744610037583,0.0,0.0,1.0,0.0,1.0,2.4365,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.812158,0.812158,0.0,HIGH,3
vonapanitase,EFO_0005772,neurodegenerative disease,2.3260187753664905,0.0,0.0,1.0,0.0,1.0,2.326,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.761358,0.803303,0.041945,HIGH,3
vonapanitase,HP_0004381,Supravalvular aortic stenosis,2.2428785729336993,0.0,0.0,1.0,0.0,1.0,2.2429,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.747626,0.747626,0.0,HIGH,3
vonapanitase,EFO_0009552,hemorrhoid,2.2282075292339405,0.0,0.0,1.0,0.0,1.0,2.2282,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.742736,0.742736,0.0,HIGH,3
vonapanitase,EFO_0000508,genetic disorder,2.20339874251507,0.0,0.0,1.0,0.0,1.0,2.2034,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.721222,0.760955,0.039733,HIGH,3
vonapanitase,EFO_0009547,eyelid disease,2.1699429458025947,0.0,0.0,1.0,0.0,1.0,2.1699,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.723314,0.723314,0.0,HIGH,3
vonapanitase,HP_0010750,Dermatochalasis,2.0770235316405823,0.0,0.0,1.0,0.0,1.0,2.077,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.692341,0.692341,0.0,HIGH,3
vonapanitase,HP_0004936,Venous thrombosis,1.6402964847769153,0.0,0.0,1.0,0.2398,1.2398,2.0336,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.546765,0.546765,0.0,HIGH,3
vonapanitase,MONDO_0016175,cutis laxa,1.7954968342963848,0.0,0.0,1.0,0.0,1.0,1.7955,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.598499,0.598499,0.0,HIGH,3
vonapanitase,EFO_0000341,chronic obstructive pulmonary disease,1.6175843601063264,0.0,0.0,1.0,0.0693,1.0693,1.7297,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.529472,0.558641,0.02917,HIGH,3
vonapanitase,EFO_0008561,diaphragmatic hernia,1.7169388219312045,0.0,0.0,1.0,0.0,1.0,1.7169,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.572313,0.572313,0.0,HIGH,3
vonapanitase,EFO_0003884,chronic kidney disease,1.654478660596587,0.0,0.0,1.0,0.0,1.0,1.6545,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,True,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.541548,0.571383,0.029835,HIGH,3
vonapanitase,EFO_0009431,intestinal disease,1.6419356376858496,0.0,0.0,1.0,0.0,1.0,1.6419,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.547312,0.547312,0.0,HIGH,3
vonapanitase,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.3200815622781068,0.0,0.0,1.0,0.2398,1.2398,1.6366,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.3200815622781061,1.3200815622781061,0.0,HIGH,1
vonapanitase,HP_0000316,Hypertelorism,1.6246132848818555,0.0,0.0,1.0,0.0,1.0,1.6246,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.541538,0.541538,0.0,HIGH,3
vonapanitase,HP_0011297,Abnormal digit morphology,1.6246132848818555,0.0,0.0,1.0,0.0,1.0,1.6246,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.541538,0.541538,0.0,HIGH,3
vonapanitase,HP_0012721,Venous malformation,1.6246132848818555,0.0,0.0,1.0,0.0,1.0,1.6246,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.541538,0.541538,0.0,HIGH,3
vonapanitase,HP_0100775,Dural ectasia,1.6246132848818555,0.0,0.0,1.0,0.0,1.0,1.6246,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.541538,0.541538,0.0,HIGH,3
vonapanitase,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,1.0,0.1792,1.1792,1.5571,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.320513540780355,1.320513540780355,0.0,HIGH,1
vonapanitase,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,1.0,0.1792,1.1792,1.5548,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,1.318525014371726,1.318525014371726,0.0,HIGH,1
vonapanitase,EFO_0007233,diaphragm disease,1.4319384512928932,0.0,0.0,1.0,0.0,1.0,1.4319,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.477313,0.477313,0.0,HIGH,3
vonapanitase,EFO_0009559,nerve plexus disease,1.424096014779507,0.0,0.0,1.0,0.0,1.0,1.4241,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.474699,0.474699,0.0,HIGH,3
vonapanitase,EFO_0001666,aortic aneurysm,1.3612701563314389,0.0,0.0,1.0,0.0,1.0,1.3613,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.453757,0.453757,0.0,HIGH,3
vonapanitase,HP_0011024,Abnormality of the gastrointestinal tract,1.334258756792658,0.0,0.0,1.0,0.0,1.0,1.3343,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.444753,0.444753,0.0,HIGH,3
vonapanitase,EFO_0004282,thoracic aortic aneurysm,1.2533573554663566,0.0,0.0,1.0,0.0,1.0,1.2534,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.417786,0.417786,0.0,HIGH,3
vonapanitase,EFO_0000756,melanoma,0.9359987788640404,0.0,0.0,1.0,0.2197,1.2197,1.1417,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.306373,0.323252,0.016879,HIGH,3
vonapanitase,EFO_0005543,glioma,0.9102749558706448,0.0,0.0,1.0,0.2398,1.2398,1.1285,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.297953,0.314368,0.016415,HIGH,3
vonapanitase,EFO_0000389,cutaneous melanoma,0.8829420026531825,0.0,0.0,1.0,0.2398,1.2398,1.0947,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.294314,0.294314,0.0,HIGH,3
vonapanitase,MONDO_0011719,gastrointestinal stromal tumor,0.8829420026531825,0.0,0.0,1.0,0.2398,1.2398,1.0947,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.294314,0.294314,0.0,HIGH,3
vonapanitase,EFO_0000182,hepatocellular carcinoma,0.940819219197736,0.0,0.0,1.0,0.1609,1.1609,1.0922,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.313606,0.313606,0.0,HIGH,3
vonapanitase,EFO_0000365,colorectal adenocarcinoma,0.8882396546691015,0.0,0.0,1.0,0.2079,1.2079,1.0729,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.29608,0.29608,0.0,HIGH,3
vonapanitase,EFO_0000571,lung adenocarcinoma,0.9048104737574602,0.0,0.0,1.0,0.1792,1.1792,1.0669,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.296165,0.312481,0.016316,HIGH,3
vonapanitase,EFO_0004329,alcohol drinking,1.0553098294977443,0.0,0.0,1.0,0.0,1.0,1.0553,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.35177,0.35177,0.0,HIGH,3
vonapanitase,EFO_0001378,multiple myeloma,0.8917714226797144,0.0,0.0,1.0,0.1792,1.1792,1.0516,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.297257,0.297257,0.0,HIGH,3
vonapanitase,EFO_0000222,acute myeloid leukemia,0.9174950745381708,0.0,0.0,1.0,0.1386,1.1386,1.0447,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.300317,0.316862,0.016545,HIGH,3
vonapanitase,EFO_0000305,breast carcinoma,0.8983821906468918,0.0,0.0,1.0,0.1609,1.1609,1.043,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.299461,0.299461,0.0,HIGH,3
vonapanitase,EFO_0000478,esophageal adenocarcinoma,0.8829420026531825,0.0,0.0,1.0,0.1792,1.1792,1.0411,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.294314,0.294314,0.0,HIGH,3
vonapanitase,EFO_0003860,pancreatic neoplasm,0.8829420026531825,0.0,0.0,1.0,0.1792,1.1792,1.0411,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.294314,0.294314,0.0,HIGH,3
vonapanitase,MONDO_0004986,urinary bladder carcinoma,0.889564067673081,0.0,0.0,1.0,0.1609,1.1609,1.0327,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.296521,0.296521,0.0,HIGH,3
vonapanitase,EFO_0000641,papillary thyroid carcinoma,0.8873567126664481,0.0,0.0,1.0,0.1609,1.1609,1.0302,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.295786,0.295786,0.0,HIGH,3
vonapanitase,EFO_0000095,chronic lymphocytic leukemia,0.8970690746956331,0.0,0.0,1.0,0.1386,1.1386,1.0214,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.299023,0.299023,0.0,HIGH,3
vonapanitase,EFO_0001663,prostate carcinoma,0.8855908286611417,0.0,0.0,1.0,0.1386,1.1386,1.0084,1,WITHDRAWN,STOPPED,Peripheral Artery Disease,Change in operating plans,False,"Peripheral Arterial Disease; Renal Insufficiency, Chronic",,,0.295197,0.295197,0.0,HIGH,3
